{
    "data": [
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56bc751eac7ad10019000013",
                            "question": "Name synonym of Acrokeratosis paraneoplastica."
                        }
                    ],
                    "context": "Acrokeratosis paraneoplastica of Bazex is a rare but important paraneoplastic dermatosis, usually manifesting as psoriasiform rashes over the acral sites.[Paraneoplastic palmoplantar hyperkeratosis. Minor form of acrokeratosis neoplastica Bazex?].Acrokeratosis paraneoplastica Bazex is a rare, obligate paraneoplasia initially presenting with palmoplantar hyperkeratosis. We diagnosed a minor form of acrokeratosis paraneoplastica Bazex. Acrokeratosis paraneoplastica (Bazex syndrome): report of a case associated with small cell lung carcinoma and review of the literature."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f01def6e394741000045",
                            "question": "Orteronel was developed for treatment of which cancer?"
                        }
                    ],
                    "context": "Pooled-analysis was also performed, to assess the effectiveness of agents targeting the androgen axis via identical mechanisms of action (abiraterone acetate, orteronel).The experimental interventions tested in these studies were enzalutamide, ipilimumab, abiraterone acetate, orteronel and cabazitaxel.  Pooled analysis of androgen synthesis inhibitors orteronel and abiraterone resulted in significantly increased overall and progression-free survival for anti-androgen agents, compared to placebo (hazard ratio for death: 0.76, 95% CI 0.67 to 0.87, P<0.0001; hazard ratio for radiographic progression: 0.7, 95% CI 0.63 to 0.77, P<0.00001). Agents targeting the androgen axis (enzalutamide, abiraterone, orteronel) significantly prolonged rPFS, compared to placebo. Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56af9f130a360a5e45000015",
                            "question": "Where is the protein Pannexin1 located?"
                        }
                    ],
                    "context": "zfPanx1 was identified on the surface of horizontal cell dendrites invaginating deeply into the cone pedicle near the glutamate release sites of the cones, providing in vivo evidence for hemichannel formation at that location.pannexin1, a vertebrate homolog of invertebrate gap junction proteins.The specific profile of gap junction proteins, the connexins, expressed in these different cell types forms compartments of intercellular communication that can be further shaped by the release of extracellular nucleotides via pannexin1 channels. Recent studies demonstrated that ATP can be released from cells in a controlled manner through pannexin (Panx) channels.The ATP release channel Pannexin1 (Panx1) is self-regulated"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf1b0a03868f1b06000009",
                            "question": "What is the mode of inheritance of Wilson's disease?"
                        }
                    ],
                    "context": "The disease has an autosomal recessive mode of inheritance, and is characterized by excessive copper deposition, predominantly in the liver and brain. The inheritance is autosomal recessive. Wilson's disease (WD), or hepatolenticular degeneration, is an autosomal recessive inheritance disorder of copper metabolism caused by ATP7B gene mutation. Inheritance seems most likely to be autosomal recessiveWhen familial, it is inherited recessively and has been linked to chromosome 20. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf19c503868f1b06000001",
                            "question": "What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?"
                        }
                    ],
                    "context": "autosomal dominant FSHD1Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.Facioscapulohumeral dystrophy (FSHD) is an autosomal-dominant disorder characterized by weakness of the face, upper arm, shoulder, and lower limb musculature, with an onset between the first and third decades. Clinical diagnosis is made from the distinctive pattern of weakness, autosomal-dominant inheritance, and confirmed by genetic testing. In one family together with prenatal diagnosis founder mutation in FSHD A1 gene was detected, according to the autosomal dominant (AD) inheritance."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5505edac8e1671127b000005",
                            "question": "What kind of chromatography is HILIC?"
                        }
                    ],
                    "context": "hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC LC-MS/MS) methodHydrophilic-interaction liquid chromatography (HILIC) is a widely used technique for small polar molecule analysis hydrophilic-interaction LC (HILIC)A hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC LC-MS/MS) method Hydrophilic Interaction Chromatography (HILIC) "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5518e7da622b194345000004",
                            "question": "Which MAP kinase phosphorylates the transcription factor c-jun?"
                        }
                    ],
                    "context": " c-Jun NH2-terminal kinase (JNK) c-jun N-terminal kinase (JNK) of mitogen-activated protein kinase (MAPK) family -Jun N-terminal kinase (JNK)activated c-Jun N-terminal kinase (JNK)-Jun N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK) signaling pathways"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "552fac4fbc4f83e828000006",
                            "question": "Which fusion protein is involved in the development of Ewing sarcoma?"
                        }
                    ],
                    "context": "Ewing sarcoma is the second most common bone malignancy in children and young adults. It is driven by oncogenic fusion proteins (i.e. EWS/FLI1) acting as aberrant transcription factors that upregulate and downregulate target genes, leading to cellular transformationEWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine modelEwing sarcoma/primitive neuroectodermal tumors (EWS/PNET) are characterized by specific chromosomal translocations most often generating a chimeric EWS/FLI-1 geneThe resulting EWS-FLI-1 fusion protein is believed to behave as an aberrant transcriptional activator that contributes to ESFT development by altering the expression of its target genes in a permissive cellular environmentHerein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54cf7051f693c3b16b000013",
                            "question": "Treatment of which disease was investigated in the MR CLEAN study?"
                        }
                    ],
                    "context": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS). INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).CONCLUSIONS: In patients with acute ischemic stroke caused by a proximal intracranial occlusion of the anterior circulation, intraarterial treatment administered within 6 hours after stroke onset was effective and safe. (Funded by the Dutch Heart Foundation and others; MR CLEAN Netherlands Trial Registry number, NTR1804, and Current Controlled Trials number, ISRCTN10888758.).MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. In our view, a rational and ethical approach would now be to treat quickly with IV rtPA and when possible, refer and include in new randomized clinical trials that compare intra-arterial treatment with standard care, such as MR CLEAN or BASICS in the Netherlands."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54e0d1491388e8454a000014",
                            "question": "Which enzyme is targeted by Evolocumab?"
                        }
                    ],
                    "context": "Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence.AREAS COVERED: Evolocumab (AMG145) is a monoclonal antibody inhibiting the proprotein convertase subtilisin/kexin type 9 that binds to the liver LDL receptor and prevents it from normal recycling by targeting it for degradation. Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials.We report a pooled analysis from four phase 2 studies of evolocumab (AMG 145), a monoclonal antibody to PCSK9. Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51404dd723fec90375000002",
                            "question": "What is the methyl donor of DNA (cytosine-5)-methyltransferases?"
                        }
                    ],
                    "context": "The product of the dcm gene is the only DNA cytosine-C5 methyltransferase of Escherichia coli K-12; it catalyses transfer of a methyl group from S-adenosyl methionine (SAM) to the C-5 position of the inner cytosine residue of the cognate sequence CCA/TGG. Deoxycytosine methylase (Dcm) enzyme activity causes mutagenesis in vitro either directly by enzyme-induced deamination of cytosine to uracil in the absence of the methyl donor, S-adenosylmethionine (SAM), or indirectly through spontaneous deamination of [5-methyl]cytosine to thymineIn the absence of DNA substrate, the DNA methyltransferase (MTase) M.BspRI can methylate itself using the methyl donor S-adenosyl-L-methionine (AdoMet). The methyl group is transferred to two Cys residues of the MTase.The reaction is fairly insensitive to the methyl donor in the reaction, S-adenosylmethionine.Formation of the complex was dependent upon the presence of the methyl donor S-adenosylmethionine, suggesting that it comprises an enzyme-linked 5-substituted dihydrocytosine moiety in DNA. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56d0451c3975bb303a00000e",
                            "question": "Which signaling pathway does sonidegib inhibit?"
                        }
                    ],
                    "context": "The association between Hh activation status and tumor response to the Hh pathway inhibitor sonidegib (LDE225) was analyzed.Distinct molecular subgroups of medulloblastoma, including hedgehog (Hh) pathway-activated disease, have been reported. We assessed the antitumour activity of sonidegib, a Hedgehog signalling inhibitor, in patients with advanced basal cell carcinoma.Among such pathways, RAS/RAF/MEK/ERK, PI3K/AKT/mTOR, EGFR, and Notch are of particular interest because agents that selectively inhibit these pathways are available and can be readily combined with agents such as vismodegib, sonidegib (LDE225), and BMS-833923, which target smoothened-a key Hh pathway regulator.This phase I trial was undertaken to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLT), safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of the novel smoothened inhibitor sonidegib (LDE225), a potent inhibitor of hedgehog signaling, in patients with advanced solid tumors."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54ede8c594afd61504000009",
                            "question": "In which phase of the cell cycle arrest is impaired in Fanconi anemia?"
                        }
                    ],
                    "context": "We found that ICLs activate a branched pathway downstream of the ATR kinase: one branch depending on CHK1 activity and the other on the FANCs-RMN complex. The transient slow-down of DNA synthesis was abolished in cells lacking ATR, whereas CHK1-siRNA-treated cells, NBS1 or FA cells showed partial S-phase arrestArrest of S-phase progression is impaired in Fanconi anemia cellsFanconi anemia (FA) is an inherited cancer-susceptibility disorder, characterized by genomic instability, hypersensitivity to DNA cross-linking agents, and a prolonged G2 phase of the cell cycleWe observed a marked dose-dependent accumulation of FA cells in the G2 compartment after treatment with 4,5',8-trimethylpsoralen (Me(3)Pso) in combination with 365 nm irradiationTaken together, the above data suggest that, in response to damage induced by DNA cross-linking agents, the S-phase checkpoint is inefficient in FA cells. This would lead to accumulation of secondary lesions, such as single- and double-strand breaks and gaps. The prolonged time in G2 phase seen in FA cells therefore exists in order to allow the cells to remove lesions which accumulated during the preceding abnormal S phase"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "551c23bc6b348bb82c00000b",
                            "question": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?"
                        }
                    ],
                    "context": "The cause of familial isolated pituitary adenomas (FIPA) remains unknown in a high percentage of cases, but the AIP gene plays an important role in the etiology. Familial isolated pituitary adenoma caused by a Aip gene mutation not described before in a family context.We report a Spanish family with FIPA in whom a mutation in the AIP gene previously unreported in a familiar context was identified.FIPA, an autosomal-dominant disease with variable penetrance, is explained in 20% of patients by germline mutations in the tumor suppressor aryl hydrocarbon receptor interacting protein(AIP), while no gene abnormality has been identified to date in the majority of the FIPA families.Understanding the tumorigenic process in AIP-positive and AIP-negative FIPA patients could result in better diagnostic and treatment options for both familial and sporadic cases."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f02cef6e39474100004c",
                            "question": "GV1001 vaccine targets which enzyme?"
                        }
                    ],
                    "context": "A reverse-transcriptase-subunit of telomerase (hTERT) derived peptide, GV1001, has been developed as a vaccine against various cancers. Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients.A study was conducted to investigate safety and immunogenicity in non-resectable pancreatic carcinoma patients using a 16-amino acid telomerase peptide (GV1001) for vaccination in combination with GM-CSF and gemcitabine as first line treatment. Telomerase vaccination (GV1001) in combination with chemotherapy appeared to be safe but the immune responses were weak and transient. Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550af222c2af5d5b7000000b",
                            "question": "Which is the E3 ubiquitin ligase which ubiquitinates IkB leading to its proteasomal degradation?"
                        }
                    ],
                    "context": "IKK activation and I\u03baB degradation involve different ubiquitination modes; the latter is mediated by a specific E3 ubiquitin ligase SCF(\u03b2-TrCP) . The F-box component of this E3, \u03b2-TrCP, recognizes the I\u03baB degron formed following phosphorylation by IKK and thus couples I\u03baB phosphorylation to ubiquitination. SCF(\u03b2-TrCP) -mediated I\u03baB ubiquitination and degradation is a very efficient process, often resulting in complete degradation of the key inhibitor I\u03baB\u03b1 within a few minutes of cell stimulation. In vivo ablation of \u03b2-TrCP results in accumulation of all the I\u03baBs and complete NF-\u03baB inhibition. Sequence comparison analysis showed sequence motif identity between CLU and beta-transducin repeat-containing protein (beta-TrCP), a main E3 ubiquitin ligase involved in IkappaB-alpha degradation.IkappaB degradation is dependent upon its phosphorylation by the IkappaB kinase (IKK) complex and subsequent ubiquitination facilitated by beta-Trcp E3 ubiquitin ligase.Here we show that beta-catenin stabilizes the mRNA encoding the F-box protein betaTrCP1, and identify the RNA-binding protein CRD-BP (coding region determinant-binding protein) as a previously unknown target of beta-catenin/Tcf transcription factor. CRD-BP binds to the coding region of betaTrCP1 mRNA. Overexpression of CRD-BP stabilizes betaTrCP1 mRNA and elevates betaTrCP1 levels (both in cells and in vivo), resulting in the activation of the Skp1-Cullin1-F-box protein (SCF)(betaTrCP) E3 ubiquitin ligase and in accelerated turnover of its substrates including IkappaB and beta-catenin. The multisubunit IkappaB kinase (IKK) responsible for inducible IkappaB phosphorylation is the point of convergence for most NF-kappaB-activating stimuli. IKK contains two catalytic subunits, IKKalpha and IKKbeta, both of which are able to correctly phosphorylate IkappaB. Gene knockout studies have shed light on the very different physiological functions of IKKalpha and IKKbeta. After phosphorylation, the IKK phosphoacceptor sites on IkappaB serve as an essential part of a specific recognition site for E3RS(IkappaB/beta-TrCP), an SCF-type E3 ubiquitin ligase, thereby explaining how IKK controls IkappaB ubiquitination and degradation. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f03bef6e394741000053",
                            "question": "Mutation of which gene is implicated in the Brain-lung-thyroid syndrome?"
                        }
                    ],
                    "context": " The disorder is caused by mutations to the NKX2.1 (TITF1) gene and also forms part of the \"brain-lung-thyroid syndrome\", in which additional developmental abnormalities of lung and thyroid tissue are observed. Novel NKX2-1 Frameshift Mutations in Patients with Atypical Phenotypes of the Brain-Lung-Thyroid Syndrome.OBJECTIVES: To verify the involvement of NKX2-1 gene in infants with brain-lung-thyroid (BLT) syndrome and hypothyroid phenotypes variable among congenital hypothyroidism (CH) or idiopathic mild hypothyroidism (IMH) of postnatal onset.They were carriers of new de novo heterozygous frameshift mutations of NKX2-1 (c.177delG and c.153_166del14).CONCLUSIONS: Two novel heterozygous frameshift mutations of NKX2-1 were identified in 2 cases selected on the basis of a BLT-like phenotype among 183 hypothyroid infants. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "532498959b2d7acc7e000017",
                            "question": "Which enzyme is targeted by the drug Imetelstat?"
                        }
                    ],
                    "context": "Imetelstat (a telomerase antagonist) exerts off\u2011target effects on the cytoskeleton.imetelstat sodium (GRN163L), is a 13-mer oligonucleotide N3'\u2192P5' thio-phosphoramidate lipid conjugate, which represents the latest generation of telomerase inhibitors targeting the template region of the human functional telomerase RNA (hTR) subunit. In preclinical trials, this compound has been found to inhibit telomerase activity in multiple cancer cell lines, as well as in vivo xenograft mouse models. In addition to the inhibition of telomerase activity in cancer cell lines, GRN163L causes morphological cell rounding changes, independent of hTR expression or telomere length.We sought to evaluate the potential of the thio-phosphoramidate oligonucleotide inhibitor of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer. Our results showed that imetelstat inhibited telomerase activity in a dose-dependent manner in esophageal cancer cellsFurthermore, long-term treatment with imetelstat decreased cell growth of esophageal cancer cells with different kinetics regarding telomere lengths"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5509f433c2af5d5b70000008",
                            "question": "What is the method FASP used for?"
                        }
                    ],
                    "context": "FASP (filter-aided sample preparation) mouse brain tissue lysate was prepared using filter-aided sample preparation (FASP) method  an increased number of confident protein identifications are attained with a filter-aided digestion approach as compared to an in-solution digestion.filter-aided sample preparation (FASP)In the second step the isolated cells are lysed and processed using 'filter aided sample preparation' (FASP) technique. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "533f9df0c45e133714000016",
                            "question": "What is being measured with an accelerometer in back pain patients"
                        }
                    ],
                    "context": "accelerometer assessment measuring overall physical activity (PAL), constant strain postures (CSP), standing time (ST) and lying time (LT)Physical activity was measured for 7 days at both baseline and at 3 months with an RT3 accelerometerwearing an accelerometer to assess physical activity in daily lifeAn accelerometer was used to objectively assess their activity level objective activity data to determine whether patients with chronic lower back pain report their activity levels as accurately as controls do. DESIGN: A cross-sectional study was performed in patients and controls. SETTING: The study was carried out in the daily environment of the subjects. SUBJECTS: Thirty-two chronic lower back pain patients with symptoms more than three months and 20 healthy controls from the Netherlands, aged 18-65 years. MAIN MEASURES: A tri-axial accelerometer was worn for five weekdays"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "531a34d5b166e2b806000036",
                            "question": "Which gene is required for the efficient function of clopidogrel?"
                        }
                    ],
                    "context": "The CYP2C19 G681A single polymorphism has been proven to affect clopidogrel responsiveness. This study investigated the effect of coexisting polymorphisms of CYP2C19 and P2Y12 on clopidogrel responsiveness and adverse clinical events in Chinese patientssociation of a functional polymorphism in the clopidogrel target receptor gene, P2Y12We tested for an association of gene sequence variations in P2Y12 and occurrence of neurological adverse events in patients with symptomatic peripheral artery disease (PAD) during clopidogrel treatmentVariability in clopidogrel response might be influenced by polymorphisms in genes coding for drug metabolism enzymes (cytochrome P450 [CYP] family), transport proteins (P-glycoprotein) and/or target proteins for the drug (adenosine diphosphate-receptor P2Y12)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cdf40d5795f9a73e00003d",
                            "question": "Which transcription factor is considered as a master regulator of lysosomal genes?"
                        }
                    ],
                    "context": "In this paper, we identify a novel role for Rags in controlling activation of transcription factor EB (TFEB), a master regulator of autophagic and lysosomal gene expressionInteraction of TFEB with active Rag heterodimers promoted recruitment of TFEB to lysosomes, leading to mTORC1-dependent phosphorylation and inhibition of TFEBDepletion or inactivation of Rags prevented recruitment of TFEB to lysosomes, whereas expression of active Rags induced association of TFEB with lysosomal membranesThe identification of a master regulator, transcription factor EB (TFEB), that regulates lysosomal biogenesis and autophagy has revealed how the lysosome adapts to environmental cues, such as starvation, and targeting TFEB may provide a novel therapeutic strategy for modulating lysosomal function in human diseaseTFEB regulates lysosomal proteostasis"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "553653a5bc4f83e828000007",
                            "question": "Which technique is used for detection of EWS/FLI1 fusion transcripts?"
                        }
                    ],
                    "context": "We evaluated the feasibility and usefulness of reverse transcriptase-polymerase chain reaction (RT-PCR) on fine-needle aspirates for categorization of small blue round cell tumors (SBRCTs). A total of 51 cases, including 25 Ewing sarcoma/peripheral primitive neuroectodermal tumors (PNETs), 11 rhabdomyosarcomas, 13 neuroblastomas, and 2 desmoplastic small round cell tumors (DSRCTs) were analyzed. The detection of the EWS-FLI1 (20/25) and EWS-ERG (4/25) fusion transcripts resolved 24 of 25 cases of Ewing sarcoma/PNETMolecular detection of EWS-FLI1 chimeric transcripts in Ewing family tumors by nested reverse transcription-polymerase chain reactionTo assess the feasibility and reliability of the molecular detection of the transcript originating from the chimeric gene in paraffin-embedded tumor specimens, we performed a nested reverse transcription-polymerase chain reaction (RT-PCR)-based assay to detect the EWS-FLI1 chimeric message in a series of Ewing family tumors. Of 24 paraffin-embedded tumor specimens from 23 cases analyzed, the chimeric message was detectable in 20 (83%) specimens from 20 cases (87%) by this nested RT-PCR assay, whereas none of 7 small round cell tumors not from this family (3 alveolar rhabdomyosarcomas, 2 neuroblastomas, 2 malignant lymphomas) showed detectable chimeric messagesUsing our different sets of exon specific primer pairs, it was possible to detect 4 different breakpoints of ews/fli1 fusion transcripts and the ews/erg fusion by RT-PCR in RNA isolates from formalin-fixed, paraffin-embedded Ewing's tumor tissue.Molecular detection of EWS-Fli1 fusion transcripts in formalin-fixed paraffin-embedded material by nested RT-PCR is feasible and is useful for the diagnosis and differential diagnosis of ES/pPNETs."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c3323a50c68dd416000009",
                            "question": "How is spastic diplegia diagnosed?"
                        }
                    ],
                    "context": "Spastic diplegia is the most common form of cerebral palsy worldwide.Hereditary spastic paraplegia (HSP) and spastic diplegia (SD) patients share a strong clinical resemblance. Thus, HSP patients are frequently misdiagnosed with a mild form of SD. Clinical gait analysis (CGA) has been highlighted as a possible tool to support the differential diagnosis of HSP and SDThe predominant clinical feature of patients with Hereditary Spastic Paraparesis (HSP) is gait disturbance owing to spasticity and weakness of the lower limbs; the spasticity in early-onset disease (infancy or childhood) often cannot be distinguished from mild form of spastic diplegia (SD)The aim of this study was to quantify the gait strategy in HSP and SD children, focusing on the differences between groups as concerns functional limitation during gait. 9 HSP and 16 SD children were evaluated using Gait Analysis; kinematic and kinetic parameters and EMG pattern during walking were identified and calculated to compare the two gait strategiesIn contrast to other urea cycle disorders, hyperammonemic encephalopathy is rarely observed in patients with argininemia. Rather, most exhibit an insidious onset and progression of neurologic manifestations, including spastic diplegia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f223e02059c6d71c00000e",
                            "question": "Which is the genetic defect causing Neurofibromatosis type 1?"
                        }
                    ],
                    "context": "Neurofibromatosis type 1 and Noonan syndrome are both common genetic disorders with autosomal dominant inheritance.Molecular analysis showed a missense mutation in exon 25 of the NF1 gene (4288A>G, p.N1430D)Identification of forty-five novel and twenty-three known NF1 mutations in Chinese patients with neurofibromatosis type 1Neurofibromatosis type 1 (NF1), characterized by skin neurofibromas and an excess of caf\u00e9-au-lait spots, is due to mutations in the neurofibromin (NF1) gene. Identifying the genetic defect in individuals with the disease represents a significant challenge because the gene is extremely large with a high incidence of sporadic mutations across the entire gene ranging from single nucleotide substitutes to large deletions.Fifty-eight were initially identified using heteroduplex analytical techniques and confirmed by sequence analysis. A further five were identified by direct sequence analysis alone. The reminders were shown to carry large deletions in the NF1 gene by demonstrating loss of heterozygosity that was confirmed by gene dosage measurements using quantitative-PCR techniques. Mis-sense, non-sense, frame-shift or splice-site mutations were identified across the entire gene of which the majority (45/68) were novel in nature."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5343caffaeec6fbd07000002",
                            "question": "Which is the human selenoprotein that contains several Se-Cys residues?"
                        }
                    ],
                    "context": "selenoprotein P and several other selenoproteins are known to contain multiple selenocysteinesSepp1) is a secreted protein that is made up of 2 domains. The larger N-terminal domain contains 1 selenocysteine residue in a redox motif and the smaller C-terminal domain contains the other 9 selenocysteinesselenoprotein P genes encode multiple UGAs and two SECIS elementsHuman selenoprotein P (HSelP) is unique protein that contains 10 selenocysteines encoded by 10 inframe UGASeP) is an extracellular glycoprotein with 8-10 selenocysteines per molecule"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56a39d60496b62f23f000006",
                            "question": "Which package is available for analysing genomic interactions in R/Bioconductor?"
                        }
                    ],
                    "context": "r3Cseq: an R/Bioconductor package for the discovery of long-range genomic interactions from chromosome conformation capture and next-generation sequencing data.We present r3Cseq, an R/Bioconductor package designed to perform 3C-seq data analysis in a number of different experimental designs. The package reads a common aligned read input format, provides data normalization, allows the visualization of candidate interaction regions and detects statistically significant chromatin interactions, thus greatly facilitating hypothesis generation and the interpretation of experimental results. We further demonstrate its use on a series of real-world applicationsr3Cseq: an R/Bioconductor package for the discovery of long-range genomic interactions from chromosome conformation capture and next-generation sequencing data"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5150b807d24251bc05000072",
                            "question": "How many clinical trials for off-label drugs in neonates are cited in the literature."
                        }
                    ],
                    "context": "Of the 17 Paediatric Investigation Plans submitted, 14 have resulted in an EMA Decision, 3 were withdrawn by the applicants, 8 were granted a full waiver from development, and 1 resulted in a negative opinion. Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products. Neonates were included in four of the products. CONCLUSIONS: The small number of submissions indicates a lack of new drugs being developed for the management of pain. Ethical concerns that too many vulnerable children will be recruited into clinical trials must be balanced against limiting the number of off-label prescribing and obtaining age-appropriate information on paediatric use.Paediatric Investigations Plans (PIPs) submitted with a Decision (outcome) reached between September 2007 and March 2010 were included in the analysis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1d857ef6e394741000033",
                            "question": "What enzyme is inhibied by Opicapone?"
                        }
                    ],
                    "context": "PURPOSE: Opicapone (OPC) is a novel catechol-O-methyltransferase (COMT) inhibitor to be used as adjunctive therapy in levodopa-treated patients with Parkinson's disease. Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor.OBJECTIVE: The present study aimed at evaluating the effect of opicapone, a third generation nitrocatechol catechol-O-methyltransferase (COMT) inhibitor, on the systemic and central bioavailability of 3,4-dihydroxy-l-phenylalanine (levodopa) and related metabolites in the cynomolgus monkey.CONCLUSIONS: Opicapone behaved as long-acting COMT inhibitor that markedly increased systemic and central levodopa bioavailability. BACKGROUND AND OBJECTIVES: Opicapone is a novel third generation catechol-O-methyltransferase (COMT) inhibitor. The purpose of this study was to compare the levodopa pharmacokinetic profile throughout a day driven by the COMT inhibition either following repeated doses of opicapone or concomitant administration with entacapone."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5319ac99b166e2b806000034",
                            "question": "Which is the third subunit of the TSC1-TSC2 complex upstream of mTORC1?"
                        }
                    ],
                    "context": "The tuberous sclerosis complex (TSC) tumor suppressors form the TSC1-TSC2 complex, which limits cell growth in response to poor growth conditions. Through its GTPase-activating protein (GAP) activity toward Rheb, this complex inhibits the mechanistic target of rapamycin (mTOR) complex 1 (mTORC1), a key promoter of cell growth.Here, we identify and biochemically characterize TBC1D7 as a stably associated and ubiquitous third core subunit of the TSC1-TSC2 complex. We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity.TBC1D7 knockdown decreases the association of TSC1 and TSC2 leading to decreased Rheb-GAP activity, without effects on the localization of TSC2 to the lysosome.Like the other TSC-TBC components, TBC1D7 knockdown results in increased mTORC1 signaling, delayed induction of autophagy, and enhanced cell growth under poor growth conditions."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f89e1a06d9727f76000001",
                            "question": "Which kinase is inhibited by the small molecule KN-93?"
                        }
                    ],
                    "context": "KN-93, a membrane-permeant calcium/calmodulin- dependent kinase-selective inhibitor, induces apoptosis in some lines of human tumor cells.Knockdown of \u03b2CaMKII by lentiviral-mediated expression of shRNA prevented the synaptic inactivity-induced increase in GluA1, as did treatment with the CaM kinase inhibitor KN-93, but not the inactive analog KN-92.To investigate the effects of KN-93, a CaMKII selective inhibitor on cell proliferation and the expression of p53 or p21 protein in human hepatic stellate cells. Injection of the CaM kinase inhibitor KN-93 into pupae resulted in a reduced number of antennal lobe glial cells migrating into the neuropil to form borders around glomeruli.In contrast, addition of the intracellular Ca2+ chelator BAPTA-AM or the Ca2+/calmodulin-dependent (CaM) kinase inhibitor KN93 blocked reporter gene activation in response to IH."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51739df58ed59a060a00001c",
                            "question": "Which is the most important prognosis sub-classification in Chronic Lymphocytic Leukemia?"
                        }
                    ],
                    "context": "One of the most reliable prognostic markers in chronic lymphocytic leukemia (CLL) is the mutational status of immunoglobulin heavy variable (IGHV) genes, which defines 2 subsets, mutated CLL (M-CLL) and unmutated CLL (U-CLL), with different clinical courses.Mutational status of the immunoglobulin heavy chain variable regions (IGHVs) of CLL cells offers useful prognostic information for high-risk patientsbut time and economical costs originally prevented it from being routinely used in a clinical setting. Instead, alternative markers of IGHV status, such as zeta-associated protein (ZAP70) or messenger RNA levels are often usedPatients with unmutated IgV(H) gene show a shorter progression-free and overall survival than patients with immunoglobulin heavy chain variable regions (IgV(H)) gene mutated"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56e857ae42442bac75000004",
                            "question": "What is needed for MMP proteins to be functional?"
                        }
                    ],
                    "context": "matrix metalloproteinase (MMP)-9matrix metalloproteinase-3 (MMP-3) gene matrix metalloproteinases (MMPs)Matrix metalloproteinase-9 (MMP-9) is a secreted glycoprotein with a major role in shaping the extracellular matrix and a detailed understanding of the secretory mechanism could help identify methods to correct diseases resulting from dysregulation of secretion.Gelatinase B/matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) cleaves many substrates and is produced by most cell types\u00a0as a zymogen"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "535d2cf09a4572de6f000004",
                            "question": "What is the number of long non coding RNAs in the human genome"
                        }
                    ],
                    "context": "The recent ENCODE (Encyclopedia of DNA Elements) study reported 9,640 lncRNA loci in the human genome, which corresponds to around half the number of protein-coding genes. Over 18,000 transcripts are presently annotated as lncRNA, and encompass previously annotated classes of noncoding transcripts including large intergenic noncoding RNA, antisense RNA and processed pseudogenesBACKGROUND: Over 10,000 long intergenic non-coding RNAs (lincRNAs) have been identified in the human genome."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55475dc2f35db75526000001",
                            "question": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?"
                        }
                    ],
                    "context": "Botulism is a serious foodborne neuroparalytic disease, caused by botulinum neurotoxin (BoNT), produced by the anaerobic bacterium Clostridium botulinum.Cattle botulism is a fatal intoxication caused by botulinum neurotoxins (BoNTs) produced by Clostridium botulinum serotypes C and DBotulism in horses in the USA is attributed to Clostridium botulinum types A, B or C.Clostridium botulinum is the etiological agent of botulism. Due to food-borne poisoning and the potential use of the extremely toxic botulinum neurotoxin (BoNT) from C. botulinumBotulism is a serious neuroparalytic disease caused by toxins of Clostridium botulinum. Botulinum toxin is produced under anaerobic conditions and is one of the most dangerous toxin in the world."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52fe52702059c6d71c000078",
                            "question": "Where is the histone variant CENPA preferentially localized?"
                        }
                    ],
                    "context": "centromere protein A (CENPA),Centromere activity of the alphoid YAC was suppressed at ectopic locations on the host chromosome, as indicated by the absent or reduced assembly of CENP-A and -C.Heterozygous and homozygous Cenpa-GFP fusion-protein mouse mutants, generated through targeted insertion of the green fluorescent protein (GFP) gene into the mouse Cenpa gene locus, show specific localized fluorescence at all the centromeres.Co-immunoprecipitation assay demonstrates interaction between PARP-2 and its functional homolog PARP-1, constitutive centromere proteins Cenpa and Cenpb, and spindle checkpoint protein Bub3, but not with a third constitutive centromere protein Cenpc.Here we investigated the interaction of this protein with, and poly(ADP-ribosyl)ation of, three constitutive centromere proteins, Cenpa, Cenpb, and Cenpc, and a spindle checkpoint protein, Bub3"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5717d64f29809bbe7a000001",
                            "question": "Which is the cellular localization of the protein Opa1?"
                        }
                    ],
                    "context": ". The subcellular distribution of mOPA1 overexpressed in COS-7 cells largely overlapped that of endogenous cytochrome c, a well known mitochondrial marker,elease of high MW Opa-1 isoforms from the mitochondria to the cytosol mitochondrial fusion (opa-1)mitochondrial fusion genes Mfn1 (mitofusin 1), Mfn2 (mitofusin 2), Opa1 (optic atrophy 1) Biochemical examinations indicate that both of the OPA1 isoforms are present in the intermembrane space. Submitochondrial fractionation by sucrose density-gradient centrifugation shows that the 88-kDa protein predominantly associates with the mitochondrial outer membrane, on the contrary, the 93-kDa protein associates with the inner membrane. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c8f4615795f9a73e00001a",
                            "question": "Which genome browser database for DNA shape annotations is available?"
                        }
                    ],
                    "context": "GBshape: a genome browser database for DNA shape annotations.Our Genome Browser for DNA shape annotations (GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/) provides minor groove width, propeller twist, roll, helix twist and hydroxyl radical cleavage predictions for the entire genomes of 94 organisms. Additional genomes can easily be added using the GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution. As biological applications, we illustrate the periodicity of DNA shape features that are present in nucleosome-occupied sequences from human, fly and worm, and we demonstrate structural similarities between transcription start sites in the genomes of four Drosophila species.GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution. Our Genome Browser for DNA shape annotations (GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/) provides minor groove width, propeller twist, roll, helix twist and hydroxyl radical cleavage predictions for the entire genomes of 94 organisms.GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "552421082c8b63434a000005",
                            "question": "What is the enzymatic activity of the breast cancer associated gene BRCA1?"
                        }
                    ],
                    "context": "E3-ubiquitin ligase activity is the only known enzymatic activity of BRCA1, which is mediated by the N-terminal RING finger domain.BRCA1 nuclear transport and ubiquitin E3 ligase enzymatic activity are tightly regulated by the BRCA1 dimeric binding partner BARD1 and further modulated by cancer mutations and diverse signaling pathways.E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks.The protein encoded by BRCA1 interacts in vivo with the related BARD1 protein to form a heterodimeric complex that acts as a ubiquitin E3 ligase. Because the enzymatic activity of the BRCA1/BARD1 heterodimer is conserved over a broad phylogenetic range, it is thought to be critical for the central functions of BRCA1.A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5710a592cf1c32585100002a",
                            "question": "Which metabolite activates AtxA?"
                        }
                    ],
                    "context": "Here we report that bioinformatic analyses suggested the presence in AtxA of two PTS (phosphenolpyruvate : sugar phosphotransferase system) regulation domains (PRD) generally regulated by phosphorylation/dephosphorylation at conserved histidine residues.Our results link virulence factor production in B. anthracis to carbohydrate metabolism and, for the first time, provide a mechanistic explanation for AtxA transcriptional activity.Upon infection of a mammalian host, Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer.The 475 amino acid sequence of AtxA reveals DNA binding motifs and regions similar to proteins associated with the phosphoenolpyruvate: carbohydrate phosphotransferase system (PTS). cultures grown with elevated CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate, suggesting that this host-associated signal enhances AtxA function by shifting the dimer/monomer equilibrium towards the dimeric state."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "532366f09b2d7acc7e000015",
                            "question": "Which amino acid residue appears mutated in most of the cases reported with  cadasil syndrome?"
                        }
                    ],
                    "context": "missense mutations and small deletions in the NOTCH3 gene, not involving cysteine residues, have been described in patients considered to be affected by paucisymptomatic CADASIL. However, the significance of such molecular variants is still unclearCADASIL is caused mostly by missense mutations in the NOTCH3 gene, invariably involving a cysteine residue.Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited cerebrovascular disease due to mutations involving loss or gain of a cysteine residue in the NOTCH3 gene. A cluster of mutations around exons 3 and 4 was originally reportedThe authors report a family with CADASIL carrying a deletion in the Notch3 gene that did not involve a cysteine residue"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55000cc4e9bde69634000004",
                            "question": "Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?"
                        }
                    ],
                    "context": "Hirschsprung's disease (HSCR), also known as aganglionic megacolon, derives from a congenital malformation of the enteric nervous system (ENS).This severe congenital condition is caused by the absence of colonic neural ganglia and thus lack of intrinsic innervation of the colon due in turn to improper colonization of the developing intestines by ENS progenitor cells.Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of intrinsic ganglion cells in the nerve plexuses of the lower colon.Hirschsprung disease (HSCR, aganglionic megacolon) is a common congenital malformation leading to bowel obstruction, with an incidence of 1/5,000 live births. It is characterized by the absence of intrinsic ganglion cells in the myenteric and submucosal plexuses along variable lengths of the gastrointestinal tract.Hirschsprung disease (HSCR) is a congenital disorder associated with the absence of intrinsic ganglion cells in the distal gastrointestinal tract."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54ede28094afd61504000003",
                            "question": "What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations?"
                        }
                    ],
                    "context": "Fanconi anemia (FA) is an autosomal disorder that causes genome instability. FA patients suffer developmental abnormalities, early-onset bone marrow failure, and a predisposition to cancer. The disease is manifested by defects in DNA repair, hypersensitivity to DNA crosslinking agents, and a high degree of chromosomal aberrations.Fanconi anemia (FA) is characterized at the cellular level by a high frequency of spontaneous chromosomal aberrations; crosslinking agents cause an abnormal increase in the frequency of chromosomal damage, and semiconservative DNA synthesis is severely inhibited.Features of chromosomal aberrations, hypersensitivity to DNA crosslinking agents, and predisposition to malignancy have suggested a fundamental anomaly of DNA repair in Fanconi anemia.Cells from patients wtih Fanconi's anemia are unusually sensitive to agents which are capable of crosslinking DNA.An elevated frequency of chromosome aberrations, which is further exaggerated by exposure of cells to DNA crosslinking agents, is a general feature of Fanconi's anemia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56ecfd572ac5ed1459000002",
                            "question": "How is oprozomib administered?"
                        }
                    ],
                    "context": "Further, new orally administered second-generation PI oprozomib is being investigated. Carfilzomib and its orally bioavailable structural analog oprozomib are second-generation, highly-selective, proteasome inhibitors.This review provides an overview of the role of oral proteasome inhibitors including Marizomib, Oprozomib, Delanzomib, chemical proteasome inhibitors, and cinnabaramides, in the therapy of MM, focusing on developments over the past five years. In addition, novel drug classes have shown promising activity in RR MM, including the orally-administered proteasome inhibitors ixazomib and oprozomib; monoclonal antibodies such as the anti-CS1 monoclonal antibody elotuzumab and anti-CD38 monoclonal antibody daratumumab; and histone deacetylase inhibitors such as panobinostat and rocilinostat.Further, new orally administered second-generation PI oprozomib is being investigated."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5709ee36cf1c32585100001e",
                            "question": "Which syndrome is associated with mutant DVL1?"
                        }
                    ],
                    "context": "Mutations in DVL1 cause an osteosclerotic form of Robinow syndrome.Here, we identified de novo frameshift mutations in DVL1, a mediator of both canonical and non-canonical Wnt signaling, as the cause of RS-OS, an RS subtype involving osteosclerosis, in three unrelated individuals.DVL1 frameshift mutations clustering in the penultimate exon cause autosomal-dominant Robinow syndrome.argeted Sanger sequencing in additional subjects with DRS uncovered DVL1 exon 14 mutations in five individuals, including a pair of monozygotic twins."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d649843706e89528000009",
                            "question": "What is the target of the drug Olaparib?"
                        }
                    ],
                    "context": "We show that targeting PARP by the small molecule inhibitors, Olaparib Following treatment with the PARP1 inhibitor olaparib, the PARP inhibitor olaparibOlaparib (AZD-2281, Ku-0059436) is an orally bioavailable and well-tolerated poly(ADP-ribose) polymerase (PARP) inhibitor currently under investigation in patients with solid tumors.The poly(ADP-ribose) polymerase inhibitor olaparib"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5335c7f2d6d3ac6a34000051",
                            "question": "Inhibition of which transporter is the mechanism of action of drug Canagliflozin?"
                        }
                    ],
                    "context": "During the past year, two SGLT2 inhibitors, canagliflozin and dapagliflozin, have been approved for the treatment of type 2 diabetes.Currently dapagliflozin, one of the three most advanced SGLT2 inhibitors in the development (along with canagliflozin and empagliflozin), is already in the market in few European countries and canagliflozin has been approved from the Food and Drug Administration (FDA) in US.Sodium glucose co-transporter 2 (SGLT2) inhibition with canagliflozin in type 2 diabetes mellitus.This report reviews the potentially beneficial effects of SGLT2 inhibitors in type 2 diabetes mellitus, specifically focusing on canagliflozin, the only SGLT2 inhibitor approved for use in the United States.The sodium glucose co-transporter 2 inhibitor canagliflozin lowered blood glucose, blood pressure, and body weight, with increased risk of urogenital infections in Phase 2 studies. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5545186cbf90a13052000002",
                            "question": "Which gene strand is targeted by transcription-coupled repair (TCR)?"
                        }
                    ],
                    "context": "Transcription-coupled repair (TCR) is the major pathway involved in the removal of UV-induced photolesions from the transcribed strand of active genes.transcription-coupled repair (TCR) provides faster repair of the transcribed strand of active genes.there are two sub-pathways of nucleotide excision repair (NER), the global genome (gg) NER and the transcription-coupled repair (TCR). TCR can preferentially remove the bulky DNA lesions located at the transcribed strand of a transcriptional active gene more rapidly than those at the untranscribed strand or overall genomic DNA.transcription-coupled repair (TCR) since targets for DNA damage are situated on the transcribed or coding strand of DNANucleotide Excision Repair (NER), which removes a variety of helix-distorting lesions from DNA, is initiated by two distinct DNA damage-sensing mechanisms. Transcription Coupled Repair (TCR) removes damage from the active strand of transcribed genes"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5357a6d0f1005d6b58000004",
                            "question": "Which is the branch site consensus sequence in U12-dependent introns?"
                        }
                    ],
                    "context": "Highly conserved sequences at the 5' splice site and branch site of U12-dependent introns are important determinants for splicing by U12-dependent spliceosomes. This study investigates the in vivo splicing phenotypes of mutations in the branch site consensus sequence of the U12-dependent intron F from a human NOL1 (P120) minigene. Intron F contains a fully consensus branch site sequence (UUCCUUAAC). Intron F contains a fully consensus branch site sequence (UUCCUUAAC).Intron F contains a fully consensus branch site sequence (UUCCUUAAC)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56ed03862ac5ed1459000004",
                            "question": "Which enzyme does MLN4924 inhibit?"
                        }
                    ],
                    "context": "Finally, MLN4924, an investigational small molecule inhibitor of NEDD8-activating enzyme (NAE) that inhibits CRL, suppresses in vitro migration, proliferation and tube formation, as well as in vivo angiogenesis and tumorigenesis. MLN4924, a small molecule inhibitor of NEDD8 activating enzyme (NAE), has been reported to elicit an anti-tumor effect on various malignancies. The more targeted impact of NEDD8-activating enzyme on protein degradation prompted us to study MLN4924, an investigational NEDD8-activating enzyme inhibitor, in preclinical multiple myeloma models.A gatekeeper residue for NEDD8-activating enzyme inhibition by MLN4924.Treatment-emergent mutations in NAE\u03b2 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f9cb34dd3fc62544000002",
                            "question": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?"
                        }
                    ],
                    "context": "To identify additional proteins that may interact with PLN, we used the yeast-two-hybrid system to screen an adult human cardiac cDNA library. HS-1 associated protein X-1 (HAX-1) was identified as a PLN-binding partner.Analysis of the anti-apoptotic function of HAX-1 revealed that the presence of PLN enhanced the HAX-1 protective effects from hypoxia/reoxygenation-induced cell death. These findings suggest a possible link between the Ca(2+) handling by the sarcoplasmic reticulum and cell survival mediated by the PLN/HAX-1 interaction.The sarco(endo)plasmic reticulum Ca(2+) transport adenosine triphosphatase (SERCA2a) and its regulator phospholamban (PLN) have a central role in modulating Ca(2+) homeostasis and, therefore, cardiac function. Herein, we discuss the mechanisms through which SERCA2a and PLN control cardiomyocyte function in health and disease. Emphasis is placed on our newly identified PLN-binding partner HS-1-associated protein X-1 (HAX-1), which has an anti-apoptotic function and presents with numerous similarities to Bcl-2.The discovery of the PLN/HAX-1 interaction therefore unveils an important new link between Ca(2+) homeostasis and cell survival, with significant therapeutic potential.The sarco(endo)plasmic reticulum (SR) Ca(2+) transport ATPase (SERCA2a) and its inhibitor phospholamban (PLN) control the uptake of Ca(2+) by SR membranes during relaxation. Recently, the antiapoptotic HS-1-associated protein X-1 (HAX-1) was identified as a binding partner of PLN, and this interaction was postulated to regulate cell apoptosis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "535d3c069a4572de6f000006",
                            "question": "What is the number of protein coding genes in the human genome?"
                        }
                    ],
                    "context": "Here, seven membrane protein topology prediction methods based on different underlying algorithms, such as hidden Markov models, neural networks and support vector machines, have been used for analysis of the protein sequences from the 21,416 annotated genes in the human genome.he GENCODE 7 release contains 20,687 protein-coding and 9640 long noncoding RNA loci and has 33,977 coding transcripts not represented in UCSC genes and RefSeqCurrent catalogs list a total of approximately 24,500 putative protein-coding genes.Clustering of these sequences using cross-species relationships suggests that millions of expressed sequences may correspond to only approximately 20,000 distinct protein-coding transcripts."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "515df063298dcd4e51000029",
                            "question": "What is the indication for prophylactic use of antibiotics in COPD?"
                        }
                    ],
                    "context": "Yet recent well-designed studies have demonstrated that prophylactic antibiotic use is of significant benefit to patients prone to developing infections. Study patients suffered from recurrent urinary tract infections, COPD or were mechanically ventilated in intensive care units. In the first 2 populations, use of antibiotics was associated with an increase in carriage of antibiotic-resistant bacteria, but in intensive care patients the opposite was documentedGuidelines do not recommend the use of prophylactic antibiotics in COPD but there is preliminary evidence to suggest that they may reduce the number of exacerbations.A short prophylactic treatment course with azithromycin is a good alternative in the management of patients with severe, advanced COPD, and could lead to an improvement in social and healthcare costs"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d73e223706e89528000010",
                            "question": "What is the generic name of Gliolan?"
                        }
                    ],
                    "context": "BACKGROUND: Five-aminolevulinic acid (Gliolan, medac, Wedel, Germany, 5-ALA) is approved for fluorescence-guided resections of adult malignant gliomas. OBJECTIVE: This study evaluates the cost-effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan\u00ae) in patients undergoing surgery for malignant glioma, in standard clinical practice conditions in Spain. OBJECTIVE: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan(\u00ae)) in patients treated for malignant glioma under typical daily practice conditions in Spain, using complete resection rate (CR) and progression free survival at 6 months (PFS6). Today, ALA is approved as Levulan for actinic keratoses, the ALA-methyl ester Metvix for actinic keratoses and basal cell carcinoma, the ALA-hexyl ester Hexvix for the diagnosis of bladder cancer and Gliolan for malignant glioma. MATERIAL AND METHODS: All patients who had undergone 5-ALA fluorescence-guided surgery due to suspected malignant glioma were included. Patients received a standard preoperative dose of Gliolan. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "515db083298dcd4e51000012",
                            "question": "How many genes does the human hoxD cluster contain?"
                        }
                    ],
                    "context": "Both children are heterozygous for a deletion that eliminates at least eight (HOXD3-HOXD13) of the nine genes in the HOXD cluster"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55058af6f73303d458000004",
                            "question": "Which protein is the E3-ubiquitin ligase that targets the tumor suppressor p53 for proteasomal degradation?"
                        }
                    ],
                    "context": "p53 levels and activity are controlled in large part through regulated ubiquitination and subsequent destruction by the 26S proteasome. Monoubiquitination of p53 is mediated primarily by the RING-finger E3 ubiquitin ligase MDM2 and impacts p53 activity through modulation of p53 localization and transcription activities. The RING domain E3 ubiquitin ligase Mdm2 is the master regulator of the tumor suppressor p53. It targets p53 for proteasomal degradation, restraining the potent activity of p53 and enabling cell survival and proliferation.The p53 transcription factor and tumor suppressor is regulated primarily by the E3 ubiquitin ligase Mdm2, which ubiquitinates p53 to target it for proteasomal degradation. Aside from its ubiquitin ligase function, Mdm2 has been believed to be capable of suppressing p53's transcriptional activity by binding with and masking the transactivation domain of p53.The regulation of p53 expression levels is critical in controlling p53 activity in normal and damaged cells. This is well illustrated by the E3 ubiquitin ligase MDM2 that targets p53 for proteasomal degradation under normal conditions and is essential for controlling p53 activity during development.p53 is inactivated in many human malignancies through missense mutations or overexpression of the human homologue of Mdm2 (Hdm2), an E3 ubiquitin ligase that ubiquitinates p53, thereby promoting its proteasomal degradation."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "535d35779a4572de6f000005",
                            "question": "What is the proportion of non canonical splice sites in the human genome?"
                        }
                    ],
                    "context": "Of these, 98.71% contain canonical GT-AG junctions (22 199 entries) and 0.56% have non-canonical GC-AG splice site pairs. The remainder (0.73%) occurs in a lot of small groups (with a maximum size of 0.05%).Of these, 98.71% contain canonical dinucleotides GT and AG for donor and acceptor sites, respectively; 0.56% hold non-canonical GC-AG splice site pairs; and the remaining 0.73% occurs in a lot of small groups (with a maximum size of 0.05%). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56b7083376d8bf8d13000001",
                            "question": "What is the causative agent of the \"Panama disease\" affecting bananas?"
                        }
                    ],
                    "context": "Fusarium oxysporum f. sp. cubense (Foc), the causal agent of Fusarium wilt (Panama disease), is one of the most devastating diseases of banana (Musa spp.)avendish, the most widely grown banana cultivar, is relatively resistant to Race 1 of Fusarium oxysporum f. sp. cubense (Foc1) which caused widespread Panama disease during the first half of the 20th century but is susceptible to Tropical Race 4 of Foc (Foc TR4) which is threatening world banana production. Fusarium oxysporum f. sp. cubense race 4 (FOC), the causal agent of Panama disease in banana,Fusarium oxysporum f.sp. cubense, a causative agent of Panama diseaseFusarium wilt of banana (also known as Panama disease) is caused by Fusarium oxysporum f. sp. cubense"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55376663bc4f83e82800000a",
                            "question": "Which biomarker is widely used in the diagnosis of Ewing sarcoma?"
                        }
                    ],
                    "context": "half of B-LBL patients are negative for CD45 (leucocyte common antigen, LCA), a widely used marker for the diagnosis of lymphoma, and a significant portion express CD99, a marker for Ewing's sarcoma (ES) or primitive neuroectodermal tumor (PNET)Moreover, half of B-LBL patients are negative for CD45 (leucocyte common antigen, LCA), a widely used marker for the diagnosis of lymphoma, and a significant portion express CD99, a marker for Ewing's sarcoma (ES) or primitive neuroectodermal tumor (PNET)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f11b922059c6d71c000004",
                            "question": "Which signalling pathway is involved in Tuberous Sclerosis?"
                        }
                    ],
                    "context": "Tuberous Sclerosis Complex (TSC) is a multisystem genetic disorder caused by mutation in either Tsc1 or Tsc2 genes that leads to the hyper activation of the mTOR pathway, a key signalling pathway for synaptic plasticity. Tuberous sclerosis, caused by germline mutations in the TSC1 or TSC2 genes, is associated with aberrant upregulation of the mammalian target of rapamycin (mTOR) signalling pathway, resulting in growth of tumours, including renal angiomyolipomas (AMLs).Tuberous Sclerosis Complex is genetically determined with an autosomal dominant inheritance and is caused by inactivating mutations in either the TSC1 or TSC2 genes. TSC1/2 genes play a fundamental role in the regulation of phosphoinositide 3-kinase (PI3K) signalling pathway, inhibiting the mammalian target of rapamycin (mTOR) through activation of the GTPase activity of Rheb.TSC is an autosomal dominant disorder caused by mutation in either of two genes: TSC1, encoding hamartin, and TSC2, encoding tuberin. Both proteins form a complex inhibiting mTOR signalling pathway and thus regulate cell size and proliferation.Recent findings from this laboratory and others suggests that the tumour suppressor complex made of two proteins TSC1/hamartin and TSC2/tuberin, acts as a negative regulator of mTOR/S6K1 signalling. Mutations in either TSC1 or TSC2 are genetically linked to tuberous sclerosis complex (TSC) syndrome, which can lead to severe pathological consequences, including mental retardation, epilepsy and autism, as well as cardiac, pulmonary and renal failure."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "536787467d100faa09000010",
                            "question": "Which is the relation between sweating and anaerobic threshold?"
                        }
                    ],
                    "context": "It is concluded that the sweating response during upright recovery is significantly modified by exercise intensity and may likely be influenced by the nonthermal baroreceptor reflex adjustments postexercise. The purpose of this paper is to delineate the effects of training status, heat acclimation, environmental conditions and host factors on the sweating response to exercise.These results would suggest that at a given exercise intensity in subjects with a higher aerobic capacity body temperature is maintained with a lower sweating rate than that in subjects with a lower aerobic capacity."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c077e9ef6e394741000021",
                            "question": "Name monoclonal antibody against SLAMF7."
                        }
                    ],
                    "context": "BACKGROUND: Elotuzumab, an immunostimulatory monoclonal antibody targeting signaling lymphocytic activation molecule F7 (SLAMF7), showed activity in combination with lenalidomide and dexamethasone in a phase 1b-2 study in patients with relapsed or refractory multiple myeloma.Elotuzumab is a humanized monoclonal antibody specific for signaling lymphocytic activation molecule-F7 (SLAMF7, also known as CS1, CD319, or CRACC) that enhances natural killer (NK) cell-mediated antibody-dependent cellular cytotoxicity (ADCC) of SLAMF7-expressing myeloma cells.This led to development of an anti-SLAMF7 antibody, elotuzumab, showing efficacy against MM.One of the most promising MoAb is elotuzumab, the only humanized IgG1 MoAb specifically targeting CS1 (SLAMF7), a cell surface glycoprotein that is highly expressed in plasma cells. This led to development of an anti-SLAMF7 antibody, elotuzumab, showing efficacy against MM."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571f609c0fd6f91b6800000c",
                            "question": "Which enzyme deficiency can cause GM1 gangliosidoses?"
                        }
                    ],
                    "context": "GM1 and GM2 gangliosidosis are associated with deficiency of \u03b2-galactosidase and \u03b2-hexosaminidase respectivelyThe total content and distribution of retinal glycosphingolipids was studied for the first time in control mice and in Sandhoff disease (SD) and GM1 gangliosidosis miceThe GSL abnormalities in the SD and the GM1 retinas reflect significant reductions in beta-hexosaminidase and beta-galactosidase enzyme activities, respectivelyIn the absence of macular or retinal degeneration, organomegaly, and somatic-facial features suggesting mucopolysaccharidosis, the presence of hyperacusis together with sea-blue histiocytes in bone marrow biopsies and deficient beta-galactosidase activity but normal glucosidase, hexosaminidase, and neuraminidase activity on lysosomal enzyme assays constitutes the clinical-pathologic-biochemical profile of GM1 gangliosidosis type 2. This is a rare, late infantile onset, progressive gray-matter disease in which beta-galactosidase deficiency is largely localized to the brain, though it can be demonstrated in leukocytes and cultured skin fibroblastsGM1-gangliosidosis (genetic beta-galactosidase deficiency)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55032e65e9bde69634000034",
                            "question": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome."
                        }
                    ],
                    "context": "Dyke-Davidoff-Masson syndrome is a rare condition characterized by cerebral hemiatrophy, calvarial thickening, skull and facial asymmetry, contralateral hemiparesis, cognitive impairment and seizures.Dyke-Davidoff-Masson syndrome refers to atrophy of one cerebral hemisphere (hemiatrophy) due to an insult to the brain in fetal or early childhood period. Acquired cerebral hemiatrophy: Dyke-Davidoff-Masson Syndrome - a case report.CT and MRI scan of the head showed hemiatrophic cerebral parenchyma with prominent sulci and encephalomalacia.CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5717d86029809bbe7a000003",
                            "question": "Which gene is involved in the development of Barth syndrome?"
                        }
                    ],
                    "context": "Tafazzin is a mitochondrial phospholipid transacylase, and its mutations cause Barth syndrome (BTHS)Tafazzin, a mitochondrial acyltransferase, plays an important role in cardiolipin side chain remodeling. Previous studies have shown that dysfunction of tafazzin reduces cardiolipin content, impairs mitochondrial function, and causes dilated cardiomyopathy in Barth syndromewe combined patient-derived and genetically engineered induced pluripotent stem cells (iPSCs) with tissue engineering to elucidate the pathophysiology underlying the cardiomyopathy of Barth syndrome (BTHS), a mitochondrial disorder caused by mutation of the gene encoding tafazzin (TAZ)A zebrafish model of human Barth syndrome reveals the essential role of tafazzin in cardiac development and function.Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53319916d6d3ac6a3400003f",
                            "question": "Where is the protein CLIC1 localized?"
                        }
                    ],
                    "context": "CLIC1 expression was obtained in the cytoplasm and plasma membrane of cells in both cell lines.CLIC1, an intracellular chloride ion channel,Like NCC27/CLIC1, CLIC3 is predominantly localized in the nucleus the nuclear localization pattern of CLIC1 was remarkably changed by insulin stimulation"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "514a0f4ad24251bc05000053",
                            "question": "How many genes are in the gene signature screened by MammaPrint?"
                        }
                    ],
                    "context": "The 70 gene-signature (MammaPrint(\u00ae)) is a prognostic profile of distant recurrence and survival of primary breast cancer (BC)The 70-gene signature was analysed using MammaPrintthe prognostic value of the MammaPrint(TM) signatureby the 70-gene signaturethe 70-gene signature"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51651e24298dcd4e51000054",
                            "question": "How many genera comprise the Flaviviridae family?"
                        }
                    ],
                    "context": "Within a project aimed at discovering new Flaviviridae inhibitors, new variously substituted 2-phenylbenzimidazoles were synthesized and evaluated in cell-based assays for cytotoxicity and antiviral activity against viruses representatives of the three genera of the Flaviviridae family, i.e.: Pestivirus (BVDV), Flavivirus (YFV) and Hepacivirus (HCV).Compounds were tested in cell-based assays against viruses representative of: i) two of the three genera of the Flaviviridae family, i.e. Pestiviruses and Flaviviruses;The RNA-stimulated NTPase activity of this protein from prototypic members of the Pestivirus and Flavivirus genera has recently been established and enzymologically characterized.Compounds were tested in cell-based assays against viruses representative of: i) two of the three genera of the Flaviviridae family, i.e. Flaviviruses and Pestiviruses; ii) other RNA virus families, such as Retroviridae, Picornaviridae, Paramyxoviridae, Rhabdoviridae and Reoviridae; iii) two DNA virus families (Herpesviridae and Poxviridae).Forty-three 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles, bearing either linear (dialkylamino)alkyl- or bulkier (quinolizidin-1-yl)alkyl moieties at position 1, were evaluated in cell-based assays for cytotoxicity and antiviral activity against viruses representative of two of the three genera of the Flaviviridae family, i.e. Flaviviruses (Yellow Fever Virus (YFV)) and Pestiviruses (Bovine Viral Diarrhoea Virus (BVDV)), as Hepaciviruses can hardly be used in routine cell-based assays."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52b2e498f828ad283c000010",
                            "question": "Mutation of which gene is associated with Achondroplasia?"
                        }
                    ],
                    "context": "She was subsequently diagnosed with hypochondroplasia at the age of 6 years when disproportional short stature, stocky habitus and macrocephaly were observed. These phenotypic findings were later confirmed by the presence of fibroblast growth factor receptor 3 (FGFR3) gene mutation N540K.Achondroplasia can be diagnosed by characteristic clinical and radiographic findings in most affected individuals. In individuals who may be too young to diagnose with certainty or in individuals with atypical findings, molecular genetic testing can be used to detect a mutation in FGFR3.Achondroplasia comes from the genetic point mutations in the fibroblastic growth factor receptor 3 gene (FGFR3), which enables abnormal cartilage growth-plate differentiation and insufficient bony development. The most common genetic mutations in this receptor are G to A at position 1138 (G1138A), which result in the substitution of glycine to arginine at codon 380.To investigate the mutation at the transmembrane domain of fibroblast growth factor receptor 3 (FGFR3) nucleotide 1138 site for identifying the major pathologic mechanism of achondroplasia (ACH) and to evaluate the efficacy of denaturing gradient gel electrophoresis(DGGE) method for screening the point mutations. Nucleotide 1138 in transmembrane domain of FGFR3 gene is the hot point for mutation in ACH and hence its major pathologic cause. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5147c088d24251bc05000026",
                            "question": "Which type of lung cancer is the most strongly associated with Lambert-Eaton syndrome?"
                        }
                    ],
                    "context": "The autoantibodies implicated in the Lambert-Eaton myasthenic syndrome (LES), which are known to inhibit ICa and INa in bovine adrenal chromaffin cells, also significantly inhibited INa in SCLC cells.These results indicate that (i) action potentials in human SCLC cells result from the regenerative increase in voltage-gated Na+ channel conductance; (ii) fundamental characteristics of SCLC Na+ channels are the same as the classical sodium channels found in a variety of excitable cells; and (iii) in some LES patients, SCLC Na+ channels are an additional target of the pathological IgG present in the patients' sera.Clinical features were those of LES and occurred insidiously in this 68-year old man: proximal weakness predominant in the lower limbs, generalized areflexia, dryness of the mouth and partial right eye palsy. Investigations disclosed a small cell lung cancer.Voltage-gated Ca2+ channels may be important to the secretion of ectopic hormones and the etiology and pathogenesis of Lambert-Eaton syndrome, an autoimmune disorder of the motor nerve terminal in which autoantibodies directed against voltage-gated Ca2+ channels are produced.Lambert-Eaton syndrome is a myasthenia-like syndrome of paraneoplastic origin which is often associated with anaplastic small-cell lung cancer."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5719f5c67de986d80d00000d",
                            "question": "What distinguishes lantibiotics from antibiotics?"
                        }
                    ],
                    "context": "One potentially interesting class of antimicrobials are the modified bacteriocins termed lantibiotics, which are bacterially produced, posttranslationally modified, lanthionine/methyllanthionine-containing peptides.low levels of resistance have been reported for lantibiotics compared with commercial antibioticsMechanisms that hinder the action of lantibiotics are often innate systems that react to the presence of any cationic peptides/proteins or ones which result from cell well damage, rather than being lantibiotic specific.Lantibiotics are biologically active peptides produced by Gram-positive bacteria. Lantibiotics are post-translationally modified, ribosomally synthesised antimicrobial peptides with a broad spectrum antimicrobial activity."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "517901bc8ed59a060a00003b",
                            "question": "The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?"
                        }
                    ],
                    "context": "we find that using an anti-PD-1 antibody (CT-011)PD-1 blockade by CT-011, anti-PD-1 antibody,. Presence of CT-011, an anti-PD1 antibody,CT-011, a novel monoclonal anti-PD-1 antibodyCT-011, a humanized antibody interacting with PD-1,"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54e0e902ae9738404b000001",
                            "question": "What family do mDia proteins belong in?"
                        }
                    ],
                    "context": "mDia proteins are members of the formin family of actin nucleating proteins that polymerize linear actin filaments.mDia1, a linear actin nucleator of the Formin familythe mammalian Diaphanous members of the formin family of proteins (mDia) are two key players in the formation of filopodia and neurites.mDia proteins are mammalian homologues of Drosophila diaphanous and belong to the formin family proteins that catalyze actin nucleation and polymerization.  The mDia family of formins "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "554356d0ed966d112c000005",
                            "question": "Which is the most common measure of differences between dinucleotide relative abundance \"genomic signatures\""
                        }
                    ],
                    "context": "The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature',the concept of a genomic signature was introduced with the observation of species-type specific Dinucleotide Relative Abundance Profiles (DRAPs)The dinucleotide relative abundance profile can be regarded as a genomic signature because, despite diversity between species, it varies little between 50 kilobase or longer windows on a given genome.The profile is computed from the base step \"odds ratios\" that compare dinucleotide frequencies to those expected under the assumption of stochastic equilibrium (thorough shuffling).The genome signatures (dinucleotide relative abundance values)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "532206819b2d7acc7e00000f",
                            "question": "Name a method for enrichment of arginine-methylated peptides."
                        }
                    ],
                    "context": "To better study protein methylation, we have developed highly specific antibodies against monomethyl arginine; asymmetric dimethyl arginine; and monomethyl, dimethyl, and trimethyl lysine motifs. These antibodies were used to perform immunoaffinity purification of methyl peptides followed by LC-MS/MS analysis to identify and quantify arginine and lysine methylation sites in several model studies. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d8fd334b1fd0d33c000005",
                            "question": "Rindopepimut is an analog of which growth factor?"
                        }
                    ],
                    "context": "Rindopepimut consists of a 14-mer peptide that spans the length of EGF receptor variant III, a mutant variant of EGF receptor found on approximately 30% of primary GBM, conjugated to the carrier protein keyhole limpet hemocyanin.Rindopepimut is a peptide vaccine which elicits EGFRvIII-specific humoral and cellular immune responses. A peptide vaccine, rindopepimut (CDX-110, Celldex Therapeutics), is directed against the novel exon 1-8 junction produced by the EGFRvIII deletion, and it has shown high efficacy in preclinical models. Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f89fc62059c6d71c000050",
                            "question": "From which tissue was the NCI-H520 cell-line derived?"
                        }
                    ],
                    "context": "The nanostructures target the cells with high affinity and specificity via the specific interaction between the aptamer (a 45-base oligonucleotide) and the cell, and distinguish A549 cells from other types of cancer cells (HeLa and MCF-7 cells) and subtypes of lung cancer cells (NCI-H157, NCI-H520, NCI-H1299, and NCI-H446 cells). Functional studies in A549 bronchioalveolar carcinoma and NCI-H520 squamous cell carcinoma cells revealed that Msi1 was enriched in spheroid cultures of tumor cells and in the CD133+ cell population. BHLHB3 gene overexpression inhibited colony formation of A549, NCI-H520 and NCI-H596 lung cancer cells. Cellular proliferation was inhibited in non-small cell lung cancer (NSCLC) cell lines NCI-H460, NCI-H520, NCI-H1299, and SK-MES-1 by CTGF overexpression.Human NCI-H520 cancer cells transfected with PDCD5 cDNA showed decreased colony-forming ability. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f350042059c6d71c000010",
                            "question": "What is the incidence of Edwards syndrom in the european population?"
                        }
                    ],
                    "context": "dwards syndrome (trisomy 18) occurs in 1: 8000 live births and is closely related to the mother's ageMean incidence was 390.06 (449.08 in boys and 327.93 in girls) per 10 000 live birthsThe incidence of Edwards syndrome is 1:5000 of live-bornThe OR for Patau syndrome was 1.10 (95% CI 0.83 to 1.45); for Edwards syndrome, 1.15 (0.96 to 1.38); for Klinefelter syndrome, 1.35 (1.02 to 1.79); and for XYY syndrome, 1.99 (0.75 to 5.26)The live birth prevalence in the absence of prenatal screening and selective termination in England and Wales from 1997 to 2004 was 1.4 (95% CI: 1.2-1.6) per 10 000 births for trisomy 13 and 2.3 (95% CI: 2.1-2.5) for trisomy 18"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f60ae05f206a0c06000008",
                            "question": "What is the substrate of the microbial enzyme inulinase?"
                        }
                    ],
                    "context": "Inulinases mainly produced by the microorganism and it degrades inulin into fructose which is a digestible form.  Inulin or inulin-rich materials can be actively hydrolyzed by microbial inulinases to produce glucose and fructose syrups that can be used in bioprocesses. The catalysts treated at these conditions in both fluids were then used for the production of fructooligosaccharides (FOS) using sucrose and inulin as substrates in aqueous and organic systems.This work is focused on the synthesis of the fructooligosaccharides (FOS) from sucrose and inulin, using free, immobilized and pre-treated immobilized inulinaseUsing inulinases from K. marxianus NRRL Y 7571, 11.89% of GF2 and 20.83% of GF3 were obtained, using inulin as substrate. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5324a8ac9b2d7acc7e000018",
                            "question": "What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?"
                        }
                    ],
                    "context": "CR-ABL-targeted TKI that inhibits BCR-ABL with greater potency compared with imatinibreciprocal translocation between chromosomes 9 and 22 [t(9;22)(q34;q11), Philadelphia chromosome] creates a BCR-ABL1 fusion proteinA novel tyrosine kinase inhibitor (TKI), imatinib, has been confirmed as an effective targeted treatment in most CML patientsThe availability of tyrosine kinase inhibitors (TKIs) has considerably changed the management of Philadelphia chromosome positive leukemia. The BCR-ABL inhibitor imatinib iThe BCR/ABL fusion tyrosine kinase is expressed in chronic myeloid leukemia and Philadelphia-positive (Ph+) acute lymphoblastic leukemia cells, and its inhibition by the clinically used tyrosine kinase inhibitors imatinib "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571e172bbb137a4b0c000002",
                            "question": "When was empagliflozin FDA approved?"
                        }
                    ],
                    "context": "To review available studies of empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor approved in 2014 by the European Commission and the United States Food and Drug Administration for the treatment of type 2 diabetes mellitus (T2DM).To review available studies of empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor approved in 2014 by the European Commission and the United States Food and Drug Administration for the treatment of type 2 diabetes mellitus (T2DM)To review available studies of empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor approved in 2014 by the European Commission and the United States Food and Drug Administration for the treatment of type 2 diabetes mellitus (T2DM)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56b330bb39c782df06000001",
                            "question": "Which R/bioconductor package is used for integrative genomics visualizations?"
                        }
                    ],
                    "context": "Sushi.R: flexible, quantitative and integrative genomic visualizations for publication-quality multi-panel figures.Interpretation and communication of genomic data require flexible and quantitative tools to analyze and visualize diverse data types, and yet, a comprehensive tool to display all common genomic data types in publication quality figures does not exist to date. To address this shortcoming, we present Sushi.R, an R/Bioconductor package that allows flexible integration of genomic visualizations into highly customizable, publication-ready, multi-panel figures from common genomic data formats including Browser Extensible Data (BED), bedGraph and Browser Extensible Data Paired-End (BEDPE). Sushi.R is open source and made publicly available through GitHub (https://github.com/dphansti/Sushi) and Bioconductor (http://bioconductor.org/packages/release/bioc/html/Sushi.html).To address this shortcoming, we present Sushi.R, an R/Bioconductor package that allows flexible integration of genomic visualizations into highly customizable, publication-ready, multi-panel figures from common genomic data formats including Browser Extensible Data (BED), bedGraph and Browser Extensible Data Paired-End (BEDPE)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "57090c33cf1c325851000013",
                            "question": "How many genes are imprinted in the human genome?"
                        }
                    ],
                    "context": "Among approximately 70 known imprinted genes are some causing disorders affecting growth, metabolism and cancer predisposition. By applying dsPIG to the mRNA-Seq data, we predicted 94 imprinted genes in 20 cerebellum samples and 57 imprinted genes in 9 diverse tissue samples with expected low false discovery rates. Interestingly, we found that, among biallelically expressed genes, at least 18 genes expressed significantly more transcripts from one allele than the other among different individuals and tissues.To date, however, fewer than 100 imprinted genes have been identified in the human genome.Approximately 150 imprinted genes are known to date, in humans and mice but, though computational searches have tried to extract intrinsic characteristics of these genes to identify new ones, the existing list is probably far from being comprehensive."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5157539ed24251bc0500008a",
                            "question": "Gene silencing can be achieved by RNA interference (RNAi) in eukaryotic organisms. What is the name of the analogous process in prokaryotic organisms?"
                        }
                    ],
                    "context": "he CRISPR-Cas (clustered regularly interspaced short palindromic repeats, CRISPR-associated genes) is an adaptive immunity system in bacteria and archaea that functions via a distinct self-non-self recognition mechanism that is partially analogous to the mechanism of eukaryotic RNA interference (RNAi).RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex.Compelling evidence indicates that the CRISPR-Cas system protects prokaryotes from viruses and other potential genome invaders.RNA in defense: CRISPRs protect prokaryotes against mobile genetic elements.n this article, we discuss our current understanding of this fascinating adaptive and heritable defense system, and describe functional similarities and differences with RNAi in eukaryotes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "530cf4e0c8a0b4a00c000006",
                            "question": "Which is the most common cause of sudden cardiac death in young athletes?"
                        }
                    ],
                    "context": "The most common cause of death was hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %). The most common cause of this, hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and is manageable.HCM is the most common cause of sudden death in young competitive athletes and preparticipation screening programs have to be implemented to avoid these tragic fatalities. Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people, including trained athletes.Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including trained athletes). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "530cf4e0c8a0b4a00c000007",
                            "question": "What is the rate of survival after commotio cordis?"
                        }
                    ],
                    "context": "At their commotio cordis event, 216 study patients were 0.2-51 years old (mean age 15\u00b19 years); 95% were males. Death occurred in 156 individuals (72%), while the other 60 (28%) survived.In the 2 groups, events were largely similar demographically, including frequency of survival (26% in U.S. vs 25%; P = .84),Survival of commotio cordis has risen from 10% to 15% since 2001.Only 21 (16%) individuals survived their event, with particularly prompt cardiopulmonary resuscitation/defibrillation (most commonly reversing ventricular fibrillation) the only identifiable factor associated with a favorable outcome.Survival rates for commotio cordis are low, even with prompt CPR and defibrillation."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "530a34eb970c65fa6b000004",
                            "question": "What is the oldest human sample analysed by paleontology proteomics?"
                        }
                    ],
                    "context": "Paleoproteomic study of the Iceman's brain tissue.We report the first use of shotgun proteomics to detect the protein expression profile of buccal swabs and cloth samples from two 500-year-old Andean mummies.Identification of ancient biological samples from the 1991-discovered and more than 5300-year-old Tyrolean mummy, also called iceman or Oetzi, is very difficult. TTo determine whether a 2,700-year-old tumor can be reliably diagnosed using microscopic and proteomic techniques "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "572096c90fd6f91b6800000e",
                            "question": "Which gene is involved in Giant Axonal Neuropathy?"
                        }
                    ],
                    "context": "Giant axonal neuropathy (GAN) is a progressive neurodegenerative disease caused by autosomal recessive mutations in the GAN gene resulting in a loss of a ubiquitously expressed protein, gigaxoninWe describe a toddler with clinical features suggesting giant axonal neuropathy (GAN), whose diagnosis was confirmed by minimally invasive skin biopsy and corroborated by the finding of compound heterozygous mutations involving the GAN geneGiant Axonal Neuropathy is a pediatric neurodegenerative disorder caused by autosomal recessive mutations in the GAN gene on chromosome 16q24.1Giant axonal neuropathy (GAN) is a rare autosomal recessive neurodegenerative disorder caused by mutations in the GAN geneGiant axonal neuropathy (GAN) is a rare pediatric neurodegenerative disease. It is best known for the \"giant\" axons caused by accumulations of intermediate filaments. The disease is progressive, with onset around age 3 years and death by the third decade of life. GAN results from recessive mutations in the GAN gene encoding gigaxonin"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5173bdb38ed59a060a000020",
                            "question": "How many TAp73 isoforms have been identified in humans?"
                        }
                    ],
                    "context": "A member of the p53 family, p73, has several isoforms and differentially regulates transcription of genes involved in the control of the cell cycle and apoptosis.The p73 gene, a homologue of the p53 tumor suppressor, is expressed as TA and \u0394N isoforms. TAp73 has similar activity as p53 and functions as a tumor suppressor whereas \u0394Np73 has both pro- and anti-survival functions.Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions.We have evaluated the differential expression and subcellular localization of the functionally distinct apoptotic (TA) and anti-apoptotic (DeltaN) isoforms of p73 in non-small cell lung cancer (NSCLC), their possible association with p53 expression and determined the methylation status of the two p73 gene promoters (P1 and P2) in this tumor type.The role of various p73 isoforms in tumorigenesis has been controversial. However, as we have recently shown, the generation of TAp73-deficient (TAp73(-/-)) mice reveals that TAp73 isoforms exert tumor-suppressive functions, indicating an emerging role for Trp-73 in the maintenance of genomic stability. Unlike mice lacking all p73 isoforms, TAp73(-/-) mice show a high incidence of spontaneous tumors."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52efbfccc8da898910000018",
                            "question": "At which kind of individuals is pharmacological treatment of subclinical hypothyroidism effective in reducing cardiovascular events?"
                        }
                    ],
                    "context": "sHT in older people should be not regarded as a unique condition, and moderately old patients (aged <70-75 y) could be considered clinically similar to the adult population, albeit with a higher optimal TSH target value. Conversely, the oldest old subjects should be carefully followed with a wait-and-see strategy, generally avoiding hormonal treatment. The decision to treat elderly people is still an unresolved clinical challenge--first, due to a lack of appropriately powered randomized controlled trials of L-T4 in sHT patients, examining cardiovascular hard endpoints in various classes of age; and second, because of the negative effects of possible overtreatment.Treatment of SCH with levothyroxine was associated with fewer IHD events in younger individuals, but this was not evident in older people. An appropriately powered randomized controlled trial of levothyroxine in SCH examining vascular outcomes is now warranted.SCH appears to influence the postoperative outcome for patients by increasing the development of postoperative atrial fibrillation. However, it is still unproven whether preoperative thyroxine replacement therapy for patients with SCH might prevent postoperative atrial fibrillation after CABG.Sustained normalization of thyroid function during l-T(4) replacement therapy significantly decreases baPWV in female subclinical hypothyroid patients with autoimmune chronic thyroiditis, suggesting the improvement of arterial stiffening and, consequently, possible prevention of cardiovascular disease.Our results suggest that L-T(4) replacement therapy may be especially beneficial in female subclinical hypothyroid patients with high baseline baPWV and pulse pressure. The beneficial effects of L-T(4) replacement therapy in decreasing arterial stiffening and thus preventing cardiovascular disease might be limited to this sub-population."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "530cefaaad0bf1360c000012",
                            "question": "Which deficiency is the cause of restless leg syndrome?"
                        }
                    ],
                    "context": "We describe a unique case of a 23-yr-old female patient affected by a homozygous loss of function mutation in the L-ferritin gene, idiopathic generalized seizures, and atypical restless leg syndrome (RLS). We show that L chain ferritin is undetectable in primary fibroblasts from the patient, and thus ferritin consists only of H chains.Our results demonstrate for the first time the pathophysiological consequences of L-ferritin deficiency in a human and help to define the concept for a new disease entity hallmarked by idiopathic generalized seizure and atypical RLS.These results when viewed along with prior RLS SPECT and autopsy studies of DAT, and cell culture studies with iron deficiency and DAT, suggest that membrane-bound striatal DAT, but not total cellular DAT, may be decreased in RLS. Compared with the PD or healthy group, the level of serum ferritin and the H-reflex latency of tibial nerve were significantly decreased in PD with RLS group (P < 0.05).Deficiency of iron and decreased inhibition function of spinal cord may lead to the occurrence of RLS in PD patients. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53398855d6d3ac6a3400005b",
                            "question": "What histone modification is recognized by the bromodomain?"
                        }
                    ],
                    "context": "acetyllysine-specific protein-protein interaction with bromodomain reader modulesBromodomains bind acetylated lysines, acting as readers of the histone-acetylation code three acetyllysine ligands are indentified for a PHD-adjacent bromodomain in BPTF via systematic screening and biophysical characterization.acetyl-lysine binding bromodomain (BRD)bromodomain proteins bind to acetylated lysines in histones"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56d1da3b67f0cb3d66000006",
                            "question": "How many periods of regulatory innovation led to the evolution of vertebrates?"
                        }
                    ],
                    "context": "Three periods of regulatory innovation during vertebrate evolution.To investigate the gain of regulatory elements throughout vertebrate evolution, we identified genome-wide sets of putative regulatory regions for five vertebrates, including humans. These putative regulatory regions are conserved nonexonic elements (CNEEs), which are evolutionarily conserved yet do not overlap any coding or noncoding mature transcript. We then inferred the branch on which each CNEE came under selective constraint. Our analysis identified three extended periods in the evolution of gene regulatory elements. Early vertebrate evolution was characterized by regulatory gains near transcription factors and developmental genes, but this trend was replaced by innovations near extracellular signaling genes, and then innovations near posttranslational protein modifiers.Early vertebrate evolution was characterized by regulatory gains near transcription factors and developmental genes, but this trend was replaced by innovations near extracellular signaling genes, and then innovations near posttranslational protein modifiers.Our analysis identified three extended periods in the evolution of gene regulatory elements. Our analysis identified three extended periods in the evolution of gene regulatory elements. Early vertebrate evolution was characterized by regulatory gains near transcription factors and developmental genes, but this trend was replaced by innovations near extracellular signaling genes, and then innovations near posttranslational protein modifiers."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "530cefaaad0bf1360c00000d",
                            "question": "Which hormone abnormalities are common in Williams syndrome ?"
                        }
                    ],
                    "context": "WS and TD participants had similar profiles in a familiar setting, while participants with WS had elevated cortisol late in the day in the novel setting when social demands were higher. The cortisol awakening response in WS was associated with parent-reported levels of somatic complaints and social difficulties. Results suggest that adults with WS have a typical diurnal cortisol profile that may be sensitive to social and activity transitions throughout the day.Results revealed significantly higher median levels of OT in WS versus controls at baseline, with a less marked increase in AVP. Further, in WS, OT and AVP increased in response to music and to cold, with greater variability and an amplified peak release compared to controls. In WS, baseline OT but not AVP, was correlated positively with approach, but negatively with adaptive social behaviors. These results indicate that WS deleted genes perturb hypothalamic-pituitary release not only of OT but also of AVP, implicating more complex neuropeptide circuitry for WS features and providing evidence for their roles in endogenous regulation of human social behavior. Three quarters of the WS subjects showed abnormal glucose curves, meeting diagnostic criteria for either diabetes or the pre-diabetic state of impaired glucose tolerance. Fasting mean glucose and median insulin levels did not differ significantly in the total WS cohort versus age-gender-BMI matched controls, though the glucose area under the curve was greater in the WS subjects. Williams syndrome (WS) is characterized by cardiovascular disease (elastin arteriopathy, peripheral pulmonary stenosis, supravalvular aortic stenosis, hypertension), distinctive facies, connective tissue abnormalities, intellectual disability (usually mild), a specific cognitive profile, unique personality characteristics, growth abnormalities, and endocrine abnormalities (hypercalcemia, hypercalciuria, hypothyroidism, and early puberty).In the Williams-Beuren syndrome (WBS), disorders of the thyroid function and morphology have been reported and programs of thyroid screening and surveillance are recommended. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f6d11c09dd18d46b00000f",
                            "question": "Which is the protein encoded by the human gene GRIK?"
                        }
                    ],
                    "context": "GRIK\u2009=\u2009glutamate receptor, ionotropic, kainate To this end, the effects of chronic ethanol self-administration on glutamate receptor ionotropic AMPA (GRIA) subunit variant and kainate (GRIK)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550c4011a103b78016000009",
                            "question": "Which residue of alpha-synuclein was found to be phosphorylated in Lewy bodies?"
                        }
                    ],
                    "context": "Alpha-synuclein phosphorylated at serine 129 (S129) is highly elevated in Parkinson's disease patients where it mainly accumulates in the Lewy bodiesApproximately 90% of \u03b1-syn deposited in Lewy bodies is phosphorylated at serine 129 (Ser129). In contrast, only 4% or less of total \u03b1-syn is phosphorylated at this residue in the normal brain. This suggests that the accumulation of Ser129-phosphorylated \u03b1-syn leads to the formation of Lewy bodies and dopaminergic neurodegeneration in Parkinson's diseaseAlpha-synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies. These inclusion bodies are the characteristic pathologic lesions of Parkinson diseaseAlpha-synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies.\ufffd-Synuclein is causative for autosomal dominant familial Parkinson disease and dementia with Lewy bodies, and the phosphorylation of \ufffd-synuclein at residue Ser-129 is a key posttranslational modification detected in Parkinson disease/dementia with Lewy bodies lesions."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56bc9268ac7ad1001900001b",
                            "question": "What molecule is targeted by brodalumab?"
                        }
                    ],
                    "context": "BACKGROUND: Early clinical studies suggested that the anti-interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis.METHODS: We reviewed the results of the phase II clinical trials for the anti-IL-17 agents secukinumab, ixekizumab and brodalumab in order to assess the efficacy and safety profile of each agent.These include the IL-17 antagonists, secukinumab, brodalumab and ixekizumab; the IL-23 antagonists, guselkumab and tildrakizumab; and the oral small molecule therapies, tofacitinib and apremilast. RECENT FINDINGS: New drugs that are designed to inhibit steps in this pathway, the IL12/IL23 inhibitor, ustekinumab, the IL17A inhibitors secukinumab and ixekizumab, the IL17A receptor inhibitor, brodalumab, and the IL23 inhibitors guselkumab and tildrakizumab, have demonstrated significant effectiveness in treating these diseases, particularly psoriasis, psoriatic arthritis and ankylosing spondylitis.Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54ff5197e9bde69634000001",
                            "question": "How long, in kb (kilobases),  is a \"Long interspersed nuclear element\"?"
                        }
                    ],
                    "context": " A combination of molecular hybridization studies and long-range polymerase chain reaction was used to isolate a 6-kb full-length long interspersed nuclear element (LINE or L1)LINE (7kb long interspersed nuclear element),The retrotransposon known as long interspersed nuclear element-1 (L1) is 6 kb long, although most L1s in mammalian and other eukaryotic cells are truncated."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5343fc1aaeec6fbd07000003",
                            "question": "Which is the gene mutated in type 1 neurofibromatosis?"
                        }
                    ],
                    "context": "Individuals with NF1 harbor 1 mutated NF1 alleletype 1 (NF1) is a hereditary disorder caused by mutations in the NF1 geneThe NF1 gene, mutated in NF1, is also commonly mutated in sporadic glioblastoma multiforme (GBM) type 1 (NF1) is a common genetic disease caused by haploinsufficiency of the NF1 tumor-suppressor geneNeurofibromatosis type 1 (NF1) is a common disorder of dysregulated tissue growth secondary to mutations in the tumor suppressor gene NF1"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "516be1d6298dcd4e5100006a",
                            "question": "What is the mode of inheritance of nemaline myopathy?"
                        }
                    ],
                    "context": "The results indicate that mutations in TPM2 may cause nemaline myopathy as well as cap disease with a dominant mode of inheritance.Autosomal recessive inheritance had been verified or appeared likely in all nebulin casesMost cases were sporadic, but in addition there were instances of both autosomal dominant and autosomal recessive inheritance, while two families showed mosaicism for dominant mutations.Finding the causative mutation(s) determines the mode of inheritanceWe conclude that in the Finnish CNM patients, the mode of inheritance appears to be recessive. Apart from a few instances of dominant inheritance, most cases published also seem compatible with recessive inheritance."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56d860ad51531f7e33000002",
                            "question": "Which syndrome is NHE6 associated with?"
                        }
                    ],
                    "context": "A novel mutation in the endosomal Na+/H+ exchanger NHE6 (SLC9A6) causes Christianson syndrome with electrical status epilepticus during slow-wave sleep (ESES)Mutations in the solute carrier family 9, subfamily A member 6 (SLC9A6) gene, encoding the endosomal Na+/H+ exchanger 6 (NHE6) are associated with Christianson syndrome, a syndromic form of X-linked intellectual disability characterized by microcephaly, severe global developmental delay, autistic behavior, early onset seizures and ataxia.Genetic and phenotypic diversity of NHE6 mutations in Christianson syndrome.Recently, Christianson syndrome (CS) has been determined to be caused by mutations in the X-linked Na(+) /H(+) exchanger 6 (NHE6).Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf1cad03868f1b0600000a",
                            "question": "Which virus is Cidofovir (Vistide) indicated for?"
                        }
                    ],
                    "context": "Currently, there are four antivirals available that are active against CMV: ganciclovir, valganciclovir, foscarnet, and cidofovir. At present, the antiviral drugs ganciclovir, foscarnet and cidofovir are commonly used in the treatment of CMV infection and disease.Cidofovir can be considered as second-line therapy in patients with CMV disease failing previous antiviral therapy.dditional drugs like lobucavir and cidofovir have been used for specific indications. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "552faababc4f83e828000005",
                            "question": "Which translocation is the hallmark of Ewing sarcoma?"
                        }
                    ],
                    "context": "Tumours defined as Ewing sarcoma (ES) constitute a group of highly malignant neoplasms that most often affect children and young adults in the first 2 decades of life. The EWS/Fli-1 fusion gene, a product of the translocation t(11;22) (q24; 12), is detected in 95% of ES patientsEwing's sarcoma is a malignancy characterized by a specific 11:22 chromosomal translocation which generates a novel EWS-FLI1 fusion protein functioning as an aberrant transcription factorThe hallmark of Ewing's sarcoma (EWS) is a translocation--t(11;22)(q24;q12)--that most frequently results in the EWS/FLI1 aberrant chimeric geneThe chromosomal translocation t(11;22)(q24;q12) yields the EWS-Fli1 fusion gene, which contributes to the development of Ewing Family Tumors (EFTs)Ewing sarcoma is extremely rare in people from East and Southeast Asia"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53189656b166e2b80600001c",
                            "question": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?"
                        }
                    ],
                    "context": "\u03b1-Synuclein is the major protein associated with Lewy body dementia, Parkinson's disease and multiple system atrophy.With the aim to develop antibodies showing high specificity and sensitivity for disease-associated \u03b1-synuclein, synthetic peptides containing different amino acid sequences were used for immunization of mice.Parkinson's disease and dementia with Lewy bodies are very frequent neurological disorders of the elderly. Mutations in the alpha-synuclein (alphaSYN) gene cause Parkinson's disease, often associated with dementia. Neuropathologically these diseases are characterized by the presence of Lewy bodies and Lewy neurites, intraneuronal inclusions mostly composed of alphaSYN protein fibrils.Immunohistochemistry for alpha-synuclein revealed LBs in 31 of 290 PSP cases (11%).We immunohistochemically investigated the degeneration processes of the nigro-striatal and nigro-amygdaloid pathways and the relationship between the loss of dopaminergic neurons and Lewy bodies (LB) formation in the substantia nigra using 15 autopsied cases of dementia with Lewy bodies (DLB)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d6562c3706e8952800000b",
                            "question": "Which is the enzymatic activity of the myotubularin family of proteins?"
                        }
                    ],
                    "context": "myotubularin family of phosphatases.Myotubularin belongs to a large family of conserved lipid phosphatases that include both catalytically active and inactive myotubularin-related proteins (i.e., \"MTMRs\")myotubalarin family phosphataseMTMR2 is a member of the myotubularin family of inositol lipid phosphatases, Myotubularin related protein 2 (MTMR2) is a member of the myotubularin family of phosphoinositide lipid phosphatases. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "515ddda6298dcd4e5100001f",
                            "question": "What is the percentage of responders to tetrabenazine treatment for dystonia in children?"
                        }
                    ],
                    "context": "report a patient with dystonia secondary to bilateral lesions of the basal gangliaThe patient's dystonia responded to Trihexyphenidyl and to tetrabenazine, but these medications needed to be stopped because of side effects.An 8-year-old girl received 53 grays radiotherapy after surgery for craniopharyngioma. One year later she developed generalized dystoniaPharmacological treatment with tetrabenazine, clonazepam and trihexiphenydile allowed a very limited improvement of dystonia;welve cases of status dystonicus, of various underlying aetiologies, are presented"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56bc7d71ac7ad10019000018",
                            "question": "Which disease can be treated with Delamanid?"
                        }
                    ],
                    "context": "Recently approved anti-Tb drugs (bedaquiline and delamanid) have the potential to induce arrhythmia and are recommended in patients with MDR-Tb when other alternatives fail.Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.Delamanid (Deltyba(\u00ae)), a nitroimidazo-oxazole derivative, is a new anti-tuberculosis (TB) drug which exhibits potent in vitro and in vivo antitubercular activity against drug-susceptible and -resistant strains of Mycobacterium tuberculosis. In a robust phase\u00a0II trial in adult patients with MDR-TB, oral delamanid 100\u00a0mg twice daily for 2\u00a0months plus an optimized background regimen improved sputum culture conversion rates to a significantly greater extent than placebo. In conclusion, delamanid is a useful addition to the treatment options currently available for patients with MDR-TB."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52b2e1d8f828ad283c00000c",
                            "question": "What is the indication of Daonil (Glibenclamide)?"
                        }
                    ],
                    "context": "Metformin and glibenclamide are now increasingly viewed as a rational alternative to insulin therapy--a treatment both preferred by the women and a less expensive one, during pregnancy and breastfeeding.The effect of TFG on blood glucose were studied and the levels of lipid peroxidation [MDA (Malondialdehyde)] and antioxidant enzymes [SOD (Superoxide dismutase), GPx (Reduced Glutathione peroxidase)] were estimated and compared with standard drugs glibenclamide and insulin.Treatment with TFG, insulin and glibenclamide resulted in significantly reduced blood glucose in LM (8.71%) and HM (3.87%) in comparison with normal controls.Potency of TFG in restoring several parameters to normal values is comparable to glibenclamide, though not as efficient as insulin, an indication of its antihyperglycemic and antioxidant effect.However, dietary supplementation with PB (6 g/kg extract for 4 weeks administered orally using an intragastric tube) ameliorated the alloxan-induced diabetes in a manner comparable with that of the reference antidiabetic drug glibenclamide"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55411d9f379ddf3f47000001",
                            "question": "Which is the most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus?"
                        }
                    ],
                    "context": "Retention of soluble proteins in the endoplasmic reticulum is dependent on their interaction with the KDEL (Lys-Asp-Glu-Leu) receptor in the Golgi apparatus and their subsequent retrieval back to the endoplasmic reticulum.the retrieval system for lumenal ER proteins. These proteins carry a specific sorting signal, typically the tetrapeptide KDEL, which is bound by a receptor in the Golgi apparatus.The carboxyl-terminal Lys-Asp-Glu-Leu (KDEL), or a closely-related sequence, is important for ER localization of both lumenal as well as type II membrane proteins. This sequence functions as a retrieval signal at post-ER compartment(s)the KDEL receptor is concentrated in the intermediate compartment, as well as in the Golgi stackretrieval of KDEL-containing proteins occurs at multiple post-ER compartments up to the TGN along the exocytotic pathway"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d907c84b1fd0d33c000008",
                            "question": "Which molecule is targeted by a monoclonal antibody Mepolizumab?"
                        }
                    ],
                    "context": "Mepolizumab, a humanized monoclonal antibody that binds to and inactivates interleukin-5, has been shown to reduce asthma exacerbations in patients with severe eosinophilic asthma. Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or a 100-mg subcutaneous dose, or placebo every 4 weeks for 32 weeks. Among developing therapies, biologics designed to block certain pro-inflammatory cytokines, such as IL-5 (mepolizumab) and IL-13 (lebrikizumab), have a greater chance of being used in the clinic.Imatinib and mepolizumab, a humanized anti-interleukin 5 monoclonal antibody, may be useful in patients with eosinophilic myositis as part of a hypereosinophilic syndrome. Recent results of the treatment of idiopathic hypereosinophilic syndrome (HES) with the anti-interleukin 5 monoclonal antibody mepolizumab showed its efficacy and manageable safety profile. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550342a8f8aee20f27000002",
                            "question": "Which is the major symptom of the Doose syndrome?"
                        }
                    ],
                    "context": "KD is particularly effective in myoclonic astatic epilepsy (MAE; Doose Syndrome) and West syndrome with 100% and 81.25% of the patients having a greater than 50% seizure reduction, respectively. Myoclonic astatic epilepsy (Doose syndrome) - a lamotrigine responsive epilepsy?PURPOSE: Myoclonic astatic epilepsy (MAE, Doose syndrome) is a difficult to treat idiopathic generalized epilepsy of early childhood.Herman Doose first described the generalized childhood epilepsy syndrome of myoclonic astatic epilepsy (MAE) in 1970, attributing a genetic cause from this first description. RECENT FINDINGS: In the past several years, neurologists are finding new indications to use these dietary treatments, perhaps even as first-line therapy, including infantile spasms, myoclonic-astatic epilepsy (Doose syndrome), Dravet syndrome, and status epilepticus (including FIRES syndrome)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550313aae9bde6963400001f",
                            "question": "Which treatment leads to an increase in neutrophil counts in severe congenital neutropenia?"
                        }
                    ],
                    "context": "This chapter focuses on cyclic and congenital neutropenia, two very interesting and rare hematological conditions causing severe chronic neutropenia. Both disorders respond well to treatment with the myeloid growth factor, granulocyte colony-stimulating factor (G-CSF)Data on more than 600 patients with CN collected by the Severe Chronic Neutropenia International Registry (SCNIR) demonstrate that, regardless of the particular CN subtype, more than 95% of these patients respond to recombinant human (rHu)G-CSF with ANCs that can be maintained above 1.0 x 10(9)/L.Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropeniasIn phase I/II/III studies in patients with severe congenital and cyclic neutropenia, treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) resulted in a rise in the absolute neutrophil counts (ANC) and a reduction in infectionsA sustained ANC response was seen in 40/44 severe congenital neutropenia patients and 10/10 cyclic neutropenia patients"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56bdc79bef6e394741000001",
                            "question": "Which eye condition is managed by the athens protocol?"
                        }
                    ],
                    "context": "Keratoconus management: long-term stability of topography-guided normalization combined with high-fluence CXL stabilization (the Athens Protocol).The Athens Protocol to arrest keratectasia progression and improve corneal regularity demonstrates safe and effective results as a keratoconus management option. Progressive potential for long-term flattening validates using caution in the surface normalization to avoid overcorrection.The management of cornea blindness from severe corneal scarring, with the Athens Protocol (transepithelial topography-guided PRK therapeutic remodeling, combined with same-day, collagen cross-linking). To evaluate the safety and efficacy of combined transepithelial topography-guided photorefractive keratectomy (PRK) therapeutic remodeling, combined with same-day, collagen cross-linking (CXL). This protocol was used for the management of cornea blindness due to severe corneal scarring.Management of corneal ectasia after LASIK with combined, same-day, topography-guided partial transepithelial PRK and collagen cross-linking: the athens protocol."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "534ebb59288f4dae47000004",
                            "question": "Which methyl-CpG-binding protein when mutant becomes the hallmark for Rett syndrome?"
                        }
                    ],
                    "context": "Rett syndrome (RTT) results from loss-of-function mutations in the gene encoding the methyl-CpG-binding protein 2 (MeCP2) and is characterized by abnormal motor, respiratory and autonomic control, cognitive impairment, autistic-like behaviors and increased risk of seizures. Rett syndrome (RTT) is an autism spectrum disorder caused by mutation in the gene encoding methyl CpG binding protein 2 (MECP2).Severely arrhythmic breathing is a hallmark of Rett syndrome (RTT) and profoundly affects quality of life for patients and their families. The last decade has seen the identification of the disease-causing gene, methyl-CpG-binding protein 2 (Mecp2) and the development of mouse models that phenocopy many aspects of the human syndrome, including breathing dysfunction.Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder that manifests in females, typically after the first year of life.It was recently discovered that RTT is caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene. MECP2 assists in the transcriptional silencing process via DNA methylation; we hypothesize that disruption of this gene alters the normal developmental expression of various other genes, some of which must account for the peculiar neurologic phenotype of RTT."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d7ae1fe19bba8909000001",
                            "question": "Which is the molecular weight of the protein angiogenin?"
                        }
                    ],
                    "context": "Angiogenin is a potent blood-vessel-inducing polypeptide with a molecular weight of 14,000 that has a unique ribonucleolytic activity. Bovine angiogenin is a single-chain protein of 125 amino acids; it contains six cysteines and has a calculated molecular weight of 14,595.The amino acid composition of this basic (isoelectric point greater than 9.5), single-chain protein of molecular weight approximately 14 400 has been determined.was found to have a molecular weight of 15 kDa on SDS-PAGE, and the sequence of the N-terminal 25 amino acid residues was identical to that of bovine angiogeninHuman angiogenin is a 14-kDa plasma protein with angiogenic and ribonucleolytic activities. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "532f55fed6d3ac6a34000036",
                            "question": "What is the gene mutated in the Gaucher disease?"
                        }
                    ],
                    "context": "The glucocerebrosidase gene (GBA), located in a gene-rich region on chromosome 1q 21, is mutated in Gaucher disease(GD) is the most common of the lysosomal storage disorders and is caused by defects in the GBA gene encoding glucocerebrosidase(GD) results from a deficiency of the lysosomal enzyme glucocerebrosidaseGaucher disease is caused by defective glucocerebrosidase activityGaucher disease (GD), the inherited deficiency of glucocerebrosidase"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5519110f622b19434500000c",
                            "question": "Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?"
                        }
                    ],
                    "context": "Goldberg-Shprintzen syndrome (GOSHS, MIM #609460) is an autosomal recessive disorder of intellectual disability, specific facial gestalt and Hirschsprung's disease (HSCR).Goldberg-Shprintzen syndrome (GOSHS) is a rare clinical disorder characterized by central and enteric nervous system defects.Thus, our data indicate that KBP is involved in neuronal differentiation and that the central and enteric nervous system defects seen in GOSHS are likely caused by microtubule-related defects.Mutations in Kif1-binding protein/KIAA1279 (KBP) cause the devastating neurological disorder Goldberg-Shprintzen syndrome (GSS) in humans.We describe a brother and sister with Hirschsprung disease, hypotonia, and ptosis. Their condition resembles that in 2 sibs reported by Goldberg and Shprintzen."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54ff45966ad7dcbc12000010",
                            "question": "Which protein is causing Netherton syndrome?"
                        }
                    ],
                    "context": "Netherton syndrome (NTS) is a rare genetic skin disease caused by mutations in the serine protease inhibitor Kazal-type 5 gene, which encodes the lympho-epithelial Kazal-type-related inhibitor.Netherton syndrome is caused by loss-of-function mutations in SPINK5 encoding the Kazal-type inhibitor LEKTI-1 Netherton syndrome (NS) is a serious inherited skin disorder caused by mutations in the gene SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI (lymphoepithelial Kazal type-related inhibitor)Mutations in the serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.NS is due to loss-of-function mutations in the SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the skin and all stratified epithelial tissues."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550c3754a103b78016000007",
                            "question": "Which disease of the central nervous system is characterized by the presence of Lewy bodies?"
                        }
                    ],
                    "context": "Parkinson's disease (PD) is one of the most common degenerative disorders of the central nervous system that produces motor and non-motor symptoms. The majority of cases are idiopathic and characterized by the presence of Lewy bodies containing fibrillar \u03b1-synucleinParkinson's disease is characterized by \u03b1-synuclein pathology in the form of Lewy bodies and Lewy neuritesParkinson's disease is characterized by neuronal death in the substantia nigra and the presence of intracellular inclusions of \u03b1-synuclein in the Lewy bodiesParkinson's disease, also known as paralysis agitans, is a progressive degenerative disorder of the central nervous system, with onset usually between the ages of 50 and 65 years, and is associated with loss of dopaminergic neurons in the subsantia nigra and the presence of Lewy bodiesThe protein \u03b1-synuclein is well recognized to contribute to the pathogenesis of Parkinson disease and is the major component of Lewy bodies and Lewy neurites"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "517a8b768ed59a060a00003f",
                            "question": "Which deiodinase is known to be present in liver?"
                        }
                    ],
                    "context": "Iodothyronine deiodinase in vitro activity studies in the chicken showed the presence of type I and type III iodothyronine deiodinase activity in both liver and kidney.In embryonic chicken liver (ECL) two types of iodothyronine deiodinases are expressed: D1 and D3.In liver homogenates, D1 activity was not correlated with age, whereas D3 activity showed a strong negative correlation with age (r -0.84), with high D3 activities in preterm infants and (except in 1 infant of 35 weeks) absent D3 activity in full-term infants. In microsomes, D1 activities amounted to 4.3-60 pmol/min/mg protein in fetal livers and to 170-313 pmol/min/mg protein in adult livers, whereas microsomal D3 activities were 0.15-1.45 pmol/min/mg protein in fetuses and <0.1 pmol/min/mg protein in all but one adult.high D1 and D3 activities in fetal human liver, and high D1 and mostly absent D3 activities in adult human liver."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f003ef6e394741000039",
                            "question": "What molecule is targeted by suvorexant?"
                        }
                    ],
                    "context": "Suvorexant is the first DORA to be approved and has demonstrated efficacy at decreasing both time to sleep onset and increasing total sleep time compared with placebo. Suvorexant: a dual orexin receptor antagonist for the treatment of sleep onset and sleep maintenance insomnia.CONCLUSION: Suvorexant is the first dual orexin receptor antagonist approved for the treatment of insomnia. Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant. The human OX2 receptor (OX2R) belongs to the \u03b2 branch of the rhodopsin family of GPCRs, and can bind to diverse compounds including the native agonist peptides orexin-A and orexin-B and the potent therapeutic inhibitor suvorexant. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571e14fbbb137a4b0c000001",
                            "question": "For which type of diabetes can empagliflozin be used?"
                        }
                    ],
                    "context": "Empagliflozin, an SGLT2 inhibitor for the treatment of type 2 diabetes mellitus: a review of the evidence.To review available studies of empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor approved in 2014 by the European Commission and the United States Food and Drug Administration for the treatment of type 2 diabetes mellitus (T2DM).In Phase II trials in patients with type 2 diabetes, empagliflozin provided improvements in glycosylated hemoglobin (HbA1c) and other measures of glycemic control when given as monotherapy or add-on to metformin, as well as reductions in weight and systolic blood pressure.Empagliflozin: a review of its use in patients with type 2 diabetes mellitus.This article reviews the pharmacological properties and clinical use of empagliflozin in patients with type 2 diabetes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "57136a7e1174fb1755000006",
                            "question": "How early during pregnancy does non-invasive cffDNA testing allow sex determination of the fetus?"
                        }
                    ],
                    "context": "The use of cffDNA in fetal sex determination during the first trimester of pregnancy of female DMD carriers.We determined fetal sex during the first trimester using a quantitative real-time polymerase chain reaction (PCR) assay of cffDNA in pregnant carriers of DMD.Early fetal gender determination using real-time PCR analysis of cell-free fetal DNA during 6th-10th weeks of gestation.Considerable 97.3% sensitivity and 97.3% specificity were obtained in fetal gender determination which is significant in the first trimester of pregnancy.Therefore in this study, the probability of detecting sequences on the human Y-chromosome in pregnant women has been evaluated to identify the gender of fetuses. Peripheral blood samples were obtained from 80 pregnant women with gestational age between 6th to 10th weeks and the fetal DNA was extracted from the plasma."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56b469448525abca1e000007",
                            "question": "What is the main characteristic of Amyotrophic Lateral Sclerosis?"
                        }
                    ],
                    "context": "Motor neuron diseases (MND), such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), are progressive neurodegenerative diseases that share the common characteristic of upper and/or lower motor neuron degeneration.Amyotrophic lateral sclerosis (ALS) is a progressive degeneration of upper and lower motor neurons.There are four main hypotheses about the cause of ALS: excitotoxicity linked to glutamate receptor overactivation; mutation of the superoxide dismutase gene; production of autoantibodies to calcium channels; neurofilament accumulation. The motoneuron degeneration characteristic of ALS could be caused by any one or a combination of these mechanisms.Amyotrophic lateral sclerosis is the most common adult-onset motor neuron disease and evidence from mice expressing amyotrophic lateral sclerosis-causing SOD1 mutations suggest that neurodegeneration is a non-cell autonomous process where microglial cells influence disease progression"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53357193d6d3ac6a34000047",
                            "question": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?"
                        }
                    ],
                    "context": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.Tofacitinib is the first oral Janus kinase inhibitor indicated for treatment of moderate to severe RA.Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.The preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA).With tofacitinib, the first Janus kinase (JAK) inhibitor has been approved in the USA, as well as in Switzerland and other countries. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5708a845cf1c32585100000f",
                            "question": "Which signaling pathway is activating the dishevelled proteins?"
                        }
                    ],
                    "context": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be regulated by the proteins Dishevelled and Axin. Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned off. The Dishevelled protein mediates several diverse biological processes. Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling,Dishevelled (DVL) proteins, three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt signaling pathways."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51405cd123fec90375000005",
                            "question": "Which is the defective protein causing the lysosomal storage disease Fabry?"
                        }
                    ],
                    "context": "The lysosomal storage disorder Fabry disease is characterized by excessive globotriaosylceramide (Gb3) accumulation in major organs such as the heart and kidney. Defective lysosomal alpha-galactosidase A (Gla) is responsible for excessive Gb3 accumulation, and one cell sensitive to the effects of Gb3 accumulation is vascular endothelium.Anderson-Fabry disease (referred to as Fabry disease) is an X-linked disorder characterized by a deficiency of the lysosomal enzyme alpha-galactosidase A and the subsequent accumulation in various tissues of globotriaosylceramide (Gb(3)), the main substrate of the defective enzyme.Human alpha-galactosidase A (EC 3.2.1.22; alpha-Gal A) is the lysosomal exoglycosidase responsible for the hydrolysis of terminal alpha-galactosyl residues from glycoconjugates and is the defective enzyme causing Fabry disease (McKusick 301500).Transgenic mice expressing a human mutant alpha-galactosidase with an R301Q substitution, which was found in a patient with a variant form of Fabry disease, were established."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5503133ae9bde6963400001d",
                            "question": "Which gene is most commonly associated with severe congenital and cyclic neutropenia?"
                        }
                    ],
                    "context": "Neutrophil elastase gene (ELANE) mutations are responsible for the majority of cases of severe congenital neutropenia (CN) and cyclic neutropenia (CyN)We screened CN (n\u00a0=\u00a0395) or CyN (n\u00a0=\u00a092) patients for ELANE mutations and investigated the impact of mutations on mRNA expression, protein expression, and activity. We found 116 different mutations in 162 (41%) CN patients and 26 in 51 (55%) CyN patients, 69 of them were novelCyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotypeCyclic neutropenia (CN) and severe congenital neutropenia (SCN) are disorders of neutrophil production that differ markedly in disease severity. Mutations of the ELANE gene (the symbol recently replacing ELA2) are considered largely responsible for most cases of CN and SCN, but specific mutations are typically associated with one or the otherOne patient with CN had the same S97L ELANE mutation as seven patients with the SCN phenotype"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "513832a75274a5fb07000012",
                            "question": "What is the function of the mammalian gene Irg1?"
                        }
                    ],
                    "context": "IRG1 is highly upregulated in murine ANA-1 macrophages by several proinflammatory cytokines and Toll-like receptor (TLR) agonists, as well as in spleen and lung of Listeria monocytogenes or Toxoplasma gondii infected mice, respectivelyThe proinflammatory cytokine-induced IRG1 protein associates with mitochondriamultiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammationOne of these genes, IRG1, was confirmed by single nucleotide polymorphism analysis to be involved in susceptibility. Its precise mechanism remains to be elucidated, although the analysis of gene expression data suggests it has a role in apoptosis.Murine immune-responsive gene 1 (IRG1) plays significant roles in embryonic implantation and neurodegeneration"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52b2e409f828ad283c00000e",
                            "question": "What disease in Loxapine prominently used for?"
                        }
                    ],
                    "context": "To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia in Canada from 2005 to 2009.Antipsychotic recommendations were estimated using CDTI data in which schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38% between 2005 and 2009, from 329 380 to 454 960 recommendations. There were notable increases in recommendations for chlorpromazine, loxapine, zuclopenthixol, and flupentixol.Loxapine has been prescribed in France since 1980. Its pharmacological profile is close to that of clozapine: it has dopamine (D2), histamine (H1), serotonin (5-HT2) and adrenergic (alpha 1)-blocking activities. Its best indication seems to be paranoid schizophrenia, although some data suggest bipolar action."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f040ef6e394741000055",
                            "question": "Which antibodies cause Riedel thyroiditis?"
                        }
                    ],
                    "context": "LEARNING POINTS: There are potential clinical applications of identifying subsets of patients with IgG4 thyroiditis (FVHT and Riedel thyroiditis).The importance of IgG4 in the predictive model of thyroiditis.Increased lymphangiogenesis in Riedel thyroiditis (Immunoglobulin G4-related thyroid disease).The present study describes in depth a case of Riedel thyroiditis (RT) to clarify its pathogenesis and its putative inclusion in the spectrum of IgG4-related disease. Our findings support the inclusion of RT within the spectrum of IgG4-related thyroid disease (IgG4-RTD). Although the etiology and physiopathology of IgG4-RTD still remain elusive, the results obtained in the present case suggest the participation of lymphatic vessels in the pathogenesis of RT."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f24fec2ac5ed1459000015",
                            "question": "Which RNA polymerase is used for the replication of viroids?"
                        }
                    ],
                    "context": "DNA-dependent RNA polymerase II of plant origin transcribes viroid RNA into full-length copiesDNA-dependent RNA polymerase II purified from healthy plant tissue is capable of synthesizing linear (-)-viroid RNA copies of full length from (+)-viroid RNA templates in vitro.Viroid RNA is accepted as a template for in vitro transcription by DNA-dependent DNA polymerase I and RNA polymerase from Escherichia coliThe RNA genome of potato spindle tuber viroid (PSTV) is transcribed in vitro into complementary DNA and RNA by DNA-dependent DNA polymerase I and RNA polymerase, respectively, from Escherichia coli.In vitro transcription of viroid RNA into full-length copies by RNA-dependent RNA polymerase from healthy tomato leaf tissue"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54e1bdacae9738404b000009",
                            "question": "What is generic name of drug Adempas?"
                        }
                    ],
                    "context": "Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Riociguat (Adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Riociguat (Adempas(\u00ae)), a soluble guanylate cyclase stimulator, is a new, first-in-class drug approved for the treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH) [inoperable or persistent/recurrent following surgery] or pulmonary arterial hypertension (PAH). On October 8, 2013, riociguat (Adempas\u00ae) became the first medication approved for multiple etiologies of PH.Duavee, an oral contraceptive; riociguat (Adempas) for two types of pulmonary hypertension; and macitentan (Opsumit) for pulmonary arterial hypertension."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f146db2ac5ed145900000f",
                            "question": "Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?"
                        }
                    ],
                    "context": "Cas9, an RNA-guided DNA endonuclease found in clustered regularly interspaced short palindromic repeats (CRISPR) bacterial immune systems, is a versatile tool for genome editing, transcriptional regulation, and cellular imaging applications. Structures of Streptococcus pyogenes Cas9 alone or bound to single-guide RNA (sgRNA) and target DNA revealed a bilobed protein architecture that undergoes major conformational changes upon guide RNA and DNA binding.Although the lobes do not interact on their own, the sgRNA recruits them into a ternary complex that recapitulates the activity of full-length Cas9 and catalyzes site-specific DNA cleavage. The use of a modified sgRNA abrogates split-Cas9 activity by preventing dimerization, allowing for the development of an inducible dimerization system. This new type of genetic library is constructed through the lentiviral delivery of single-guide RNA collections that direct Cas9 or inactive dead Cas9 fused with effectors to interrogate gene function or regulate gene transcription in targeted cells. The CRISPR/Cas9 system has recently emerged as a\u00a0powerful tool for functional genomic studies in Drosophila melanogaster. However, single-guide RNA (sgRNA) parameters affecting the specificity and efficiency of the system in flies are still not clear. Here, we found that off-target effects did not occur in regions of genomic DNA with three or more nucleotide mismatches to sgRNAs.Our work demonstrates a comprehensive optimization of sgRNA and promises to vastly simplify CRISPR/Cas9 experiments in Drosophila."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5321bc309b2d7acc7e00000d",
                            "question": "What is the target protein of the drug Idelalisib?"
                        }
                    ],
                    "context": " PI3K\u03b4 (idelalisib). Idelalisib (PI3K inhibitor) In the last few years, several classes of potent and selective small molecule PI3K inhibitors have been developed, and at least fifteen compounds have progressed into clinical trials as new anticancer drugs. Among these, idelalisib idelalisib represents a first-in-class specific inhibitor of the phosphoinositol-3 kinase (PI3K) delta isoform.PI3K inhibitor idelalisib "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51588bb2d24251bc05000091",
                            "question": "Which antiepileptic drug is most strongly associated with spina bifida? "
                        }
                    ],
                    "context": "The teratogenicity of antiepilepsy drug valproic acid (VPA) mostly is found in genetic and somatic levels, causing teratogenesis involving neurotubular defects (NTDs), anencephaly, lumbosacral meningomyelocele, and leg dysfunction due to spina bifida aperta.The summary odds ratio estimate for the association between valproic acid and spina bifida was 11.9 (95% uncertainty interval (UI): 4.0-21.2); for valproic acid and cleft palate 5.8 (95% UI: 3.3-9.5); for carbamazepine and spina bifida 3.6 (95% UI: 1.3-7.8); and for carbamazepine and cleft palate 2.4 (95% UI: 1.1-4.5) in the United States.Increased risk for MCMs could be demonstrated only for exposure to valproate (5.6%, p = 0.005) and AED polytherapy (6.1%, p = 0.02). Neonatal spina bifida was not significantly increased, but was a major indication for elective pregnancy termination among women with epilepsy. Valproic acid, a drug commonly used to treat seizures and other psychiatric disorders, causes neural tube defects (NTDs) in exposed fetuses at a rate 20 times higher than in the general population. Failure of the neural tube to close during development results in exencephaly or anencephaly, as well as spina bifida.Associations were found for spina bifida with valproic acid. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571cdd227de986d80d00000f",
                            "question": "Which bacteria caused plague?"
                        }
                    ],
                    "context": " the causative bacteria Yersinia pestis as an agent of biological warfare have highlighted the need for a safe, efficacious, and rapidly producible vaccine. Yersinia, the causative bacteria of the bubonic plague and other enteric diseases"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f9b74306d9727f76000004",
                            "question": "The drug JTV519 is derivative of which group of chemical compounds?"
                        }
                    ],
                    "context": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca\u00b2\u207a leak.The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial.K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "531d744c267d7dd053000009",
                            "question": "What is the function of the protein encoded by the gene PABPC4?"
                        }
                    ],
                    "context": "In testis mRNA stability and translation initiation are extensively under the control of poly(A)-binding proteins (PABP).Taken together, our findings indicate that PABPC4 may play a role in the pathogenesis of colorectal cancer.Consistent with these biochemical activities, plus corresponding histological profiles, the identified RNA processing factors are predicted to collectively drive post-transcriptional expression of an alternative exome that fuels finishing steps of sperm maturation and fitness.This is the first evidence that PABPCs have a targeted role in hTERT regulation leading to a growth advantage in cells expressing HPV16 E6.to play a role in chronic inflammation (PPP1R3B, SALL1, PABPC4,"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55241f9e2c8b63434a000004",
                            "question": "What kind of enzyme is encoded by the proto-oncogene ABL1?"
                        }
                    ],
                    "context": "The Abelson (ABL) family of nonreceptor tyrosine kinases, ABL1 and ABL2, transduces diverse extracellular signals to protein networks that control proliferation, survival, migration and invasion. ABL1 was first identified as an oncogene required for the development of leukaemias initiated by retroviruses or chromosome translocations. Chromosomal rearrangements involving the ABL1 gene, leading to a BCR-ABL1 fusion gene, have been mainly associated with chronic myeloid leukemia and B-cell acute lymphoblastic leukemia (ALL). At present, six other genes have been shown to fuse to ABL1. The kinase domain of ABL1 is retained in all chimeric proteins that are also composed of the N-terminal part of the partner protein that often includes a coiled-coil or a helix-loop-helix domain. These latter domains allow oligomerization of the protein that is required for tyrosine kinase activation, cytoskeletal localization, and neoplastic transformation.ABL-family proteins comprise one of the best conserved branches of the tyrosine kinases. Each ABL protein contains an SH3-SH2-TK (Src homology 3-Src homology 2-tyrosine kinase) domain cassette, which confers autoregulated kinase activity and is common among nonreceptor tyrosine kinases. This cassette is coupled to an actin-binding and -bundling domain, which makes ABL proteins capable of connecting phosphoregulation with actin-filament reorganization. Two vertebrate paralogs, ABL1 and ABL2, have evolved to perform specialized functions. Protein tyrosine kinases form a large family of signaling proteins implicated in both normal and malignant cell signaling. The aim of this study was to identify protein tyro-sine kinases that can transform hematopoietic cells to growth factor independent proliferation when constitutively activated by homodimerization. We used a modified retroviral insertion mutagenesis screen with a retroviral vector containing the homodimerization domain of ETV6 followed by an artificial splice donor site. Integration of this retroviral vector within a gene of the host genome would generate a fusion transcript containing the dimerization domain and part of the disrupted gene. Using this strategy with the IL3 dependent Ba/F3 cell line, we identified 8 different protein tyrosine kinases (Abl1, Fgfr1, Hck, Jak2, Lck, Mertk, Mst1r, Tnk1) that transformed the cells.Three families of tyrosine kinases have long been recognized to play critical roles in TCR-dependent signaling. They are the Src, zeta-associated protein of 70 kDa, and Tec families of kinases. More recently, the Abelson (Abl) tyrosine kinases have been shown to be activated by TCR engagement and to be required for maximal TCR signaling. Using T-cell conditional knockout mice deficient for Abl family kinases, Abl (Abl1) and Abl-related gene (Arg) (Abl2), it was recently shown that loss of Abl kinases results in defective T-cell development and a partial block in the transition to the CD4(+)CD8(+) stage. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52ee9f55c8da898910000009",
                            "question": "What is the mode of inheritance of Romano Ward long QT syndrome?"
                        }
                    ],
                    "context": "KCNQ1 is associated with two different entities of LQTS, the autosomal-dominant Romano-Ward syndrome (RWS), and the autosomal-recessive Jervell and Lange-Nielsen syndrome (JLNS) characterized by bilateral deafness in addition to cardiac arrhythmias.The Romano Ward long QT syndrome (LQTS) has an autosomal dominant mode of inheritance.The genetic forms of LQTS include Romano-Ward syndrome (RWS), which is characterized by isolated LQTS and an autosomal dominant pattern of inheritance, and syndromes with LQTS in association with other conditions.The Jervell and Lange-Nielsen syndrome (JLNS) is characterized by prolongation of the QT interval, deafness, and autosomal-recessive inheritance, and the Romano-Ward syndrome is characterized by a prolonged QT interval, autosomal-dominant inheritance, and no deafness. Different mutations in KVLQT1 cause the dominant Romano-Ward (RW) syndrome and the recessive Jervell and Lange-Nielsen (JLN) syndrome, which, in addition to cardiac abnormalities, includes congenital deafness. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52e92c6e98d0239505000024",
                            "question": "Which gene is associated with the Mitchell-Riley syndrome?"
                        }
                    ],
                    "context": "Mutations in rfx6 were recently associated with Mitchell-Riley syndrome, which involves neonatal diabetes, and other digestive system defects. bi-allelic mutations in the transcription factor RFX6 were described as the cause of a rare condition characterized by neonatal diabetes with pancreatic and biliary hypoplasia and duodenal/jejunal atresia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550c3d45a103b78016000008",
                            "question": "What is the main component of the Lewy bodies?"
                        }
                    ],
                    "context": "\u03b1-syn is the main component of Lewy bodies in Parkinson's disease (PD) and Lewy body dementiaParkinson's disease (PD) is one of the most common neurodegenerative diseases. Majority of PD are sporadic, for which genetic causes remain largely unknown. Alpha-synuclein, the main component of Lewy bodies, plays a central role in the PD pathogenesisParkinson's disease (PD) is characterized by the progressive degeneration of substantia nigra pars compacta (SNpc) dopaminergic neurones and the formation of Lewy bodies (LB) in a proportion of the remaining neurones. \u03b1-synuclein is the main component of LB, but the pathological mechanisms that lead to neurodegeneration associated with LB formation remain unclear\u03b1-Synuclein is the main component of Lewy bodies, the intraneuronal inclusion bodies characteristic of Parkinson's diseaseParkinson's disease (PD) is the second most common neurodegenerative disease. The majority of PD cases are sporadic, for which genetic causes and underlying molecular mechanisms remain largely unclear. Autophagy, a highly conserved cellular process that governs the breakdown of long-lived proteins and organelles, has been involved in the degradation of \u03b1-synuclein (\u03b1-Syn), the main component of Lewy bodies"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cdf5315795f9a73e000046",
                            "question": "Which is the enzyme that degrades decapped mRNAs?"
                        }
                    ],
                    "context": "The removal of the 5'-cap structure by the decapping enzyme DCP2 and its coactivator DCP1 shuts down translation and exposes the mRNA to 5'-to-3' exonucleolytic degradation by XRN1DCP2 activation by DCP1 occurs preferentially on the EDC4 scaffold, which may serve to couple DCP2 activation by DCP1 with 5'-to-3' mRNA degradation by XRN1 in human cellsXRN1 is a 5' \u2192 3' processive exoribonuclease that degrades mRNAs after they have been decapped"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f780cb09dd18d46b000011",
                            "question": "Which is the target protein of the drug nivolumab?"
                        }
                    ],
                    "context": "nivolumab, a fully human IgG4 programmed death 1 (PD-1) immune-checkpoint-inhibitor antibody Nivolumab (a programmed death 1 [PD-1] checkpoint inhibitor)Nivolumab, a fully human immunoglobulin G4 programmed death 1 immune checkpoint inhibitor antibody,  programmed death receptor-1 (PD-1) inhibitors pembrolizumab and nivolumab were approved for the treatment of advanced melanomaNivolumab was developed as a monoclonal antibody against programmed death receptor-1, an immune checkpoint inhibitor which negatively regulates T-cell proliferation and activation. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5717dbfe7de986d80d000001",
                            "question": "What is the functional role of the protein Drp1?"
                        }
                    ],
                    "context": "dynamin-related protein 1 (Drp1), a GTPase that mediates mitochondrial fission,dynamin-related protein 1 (DRP1), a protein required for mitochondrial network division.dynamin-related protein 1 (Drp1)-mediated mitochondrial fissionMitochondrial fission is mediated by dynamin-related protein 1 (Drp1),Drp1 is a dynamin-like GTPase that mediates mitochondrial and peroxisomal division in a process dependent on self-assembly and coupled to GTP hydrolysis. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "517575558ed59a060a00002d",
                            "question": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?"
                        }
                    ],
                    "context": "About 1-2% of introns are non-canonical, with the most abundant subtype of non-canonical introns being characterized by GC and AG dinucleotides at their 5'- and 3'-termini, respectively.Our results indicate that the incorporation of non-canonical splice site models yields dramatic improvements in annotating genes containing GC-AG and AT-AC non-canonical intronsIf we assume that approximately the same situation is true for the whole set of annotated mammalian non-canonical splice sites, then the 99.24% of splice site pairs should be GT-AG, 0.69% GC-AG, 0.05% AT-AC and finally only 0.02% could consist of other types of non-canonical splice sites."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cf20eb3975bb303a000001",
                            "question": "What does isradipine do to L-type channels?"
                        }
                    ],
                    "context": "The L-type channel blocker, isradipine (5 microM), had no significant effect on the amplitude or kinetics of the Ca(2+) signal.A comparison of the sensitivity to blockade by isradipine of the L-type currents in Purkinje cells and ventricular epicardial myocytes, which only express Ca(v)1.2, suggests that the Ca(v)1.3 channels make, at most, a minor contribution to the L-type current in canine Purkinje cells.Action potential repolarisation in hippocampal pyramidal neurons was slowed by the N-type channel blocker omega-conotoxin GVIA, but not by the L-type channel blocker isradipine.Systemic administration of isradipine, a dihydropyridine blocker of L-type channels, forces dopaminergic neurons in rodents to revert to a juvenile, Ca(2+)-independent mechanism to generate autonomous activity.The release of glutamate was significantly inhibited by both omega-agatoxin IVA, a P/Q-type calcium channel antagonist, and isradipine, an L type calcium channel antagonist."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56ed0ffe2ac5ed1459000008",
                            "question": "Which type of myeloma is ixazomib being evaluated for?"
                        }
                    ],
                    "context": "Next generation proteasome inhibitors include carfilzomib and oprozomib which are irreversible epoxyketone proteasome inhibitors; and ixazomib and delanzomib which are reversible boronic acid proteasome inhibitors. Two proteasome inhibitors, bortezomib and carfilzomib are FDA approved drugs and ixazomib and oprozomib are in late stage clinical trials. The disease focus for all the proteasome inhibitors is multiple myeloma.In addition, novel drug classes have shown promising activity in RR MM, including the orally-administered proteasome inhibitors ixazomib and oprozomib; monoclonal antibodies such as the anti-CS1 monoclonal antibody elotuzumab and anti-CD38 monoclonal antibody daratumumab; and histone deacetylase inhibitors such as panobinostat and rocilinostat.These findings have informed the subsequent clinical development of ixazomib in multiple myeloma.Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56b76d916e3f8eaf4c000001",
                            "question": "To which family does the Zika virus belong?"
                        }
                    ],
                    "context": "Zika virus (ZIKV; genus Flavivirus, family Flaviviridae) "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f4011709dd18d46b000003",
                            "question": "What is the main symptom of Marfan syndrome patients?"
                        }
                    ],
                    "context": "The diagnosis and surgical treatment of patients with Marfan syndrome remain controversial. It is of utmost importance to identify patients at risk for acute aortic events to establish the correct surgical timing and the appropriate surgical treatmentThe not-uncommon spinal abnormalities associated with Marfan's syndrome rarely undergird clinical problems, and neurological features accompanying such bone abnormalities are rare.The major cardiovascular manifestations of this condition are aortic dilation, which may involve the proximal and distal aorta, aortic regurgitation, aortic dissection, mitral valve prolapse, and mitral regurgitation. For the first time Bernhard Marfan described the Marfan-Syndrome in 1896; it is a meso- and ectodermed variety with the conducting symptom of \"arachnodactyly\".Initial physical examination revealed an aortic systolic murmur and musculoskeletal morphological abnormalities compatible with Marfan syndrome"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "552033206b348bb82c00001b",
                            "question": "What species is associated with Tetrodotoxin?"
                        }
                    ],
                    "context": "The selling and importing of puffer fish species and their products was banned in Thailand in 2002, because of possible neurotoxic effects.Efficiency of a rapid test for detection of tetrodotoxin in puffer fish.Marine pufferfish contain tetrodotoxin (TTX), an extremely potent neurotoxinTetrodotoxin is a potent low weight marine toxin found in warm waters, especially of the Indian and Pacific Oceans. Intoxications are usually linked to the consumption of the puffer fish, although TTX was already detected in several different edible taxa.Food poisoning due to ingestion of a puffer fish occurred in Nagasaki Prefecture, Japan, in October 2008, causing neurotoxic symptoms similar to those of tetrodotoxin (TTX) poisoning."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51635202298dcd4e5100004f",
                            "question": "How is myotonic dystrophy inherited?"
                        }
                    ],
                    "context": "Myotonic dystrophy type 2 (DM2) is an autosomal dominant, multisystem disorder caused by a CCTG tetranucleotide repeat expansion located in intron 1 of the zinc finger protein 9 gene (ZNF9 gene) on chromosome 3q 21.3.Myotonic dystrophy type 1 (DM1) is an autosomal dominant disorder, caused by an expansion of a CTG triplet repeat in the DMPK gene.Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, is a clinically and genetically heterogeneous neuromuscular disorder. DM is characterized by autosomal dominant inheritance, muscular dystrophy, myotonia, and multisystem involvement. Type 1 DM (DM1) is caused by a (CTG)(n) expansion in the 3' untranslated region of DMPK in 19q13.3.proximal myotonic myopathy (PROMM) and type 2 DM (DM2) but without the DM1 mutation, showed linkage to the 3q21 region and were recently shown to segregate a (CCTG)(n) expansion mutation in intron 1 of ZNF9.All patients have the DM2 (CCTG)(n) expansion."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "553f72edab98a37113000007",
                            "question": "What is the typical outer diameter of microtubules (tubulin heterodimers)?"
                        }
                    ],
                    "context": "microtubules are highly anisotropic structures built from tubulin heterodimers. They are hollow cylindrical shells with a \u223c 25\u00a0nm outer diametersingle microtubules (diameter 25 nmThe individual microtubules measured about 24 nm in outer diameterMicrotubules are hollow tubes some 25 nm in diameter participating in the eukaryotic cytoskeleton.Microtubule assembly is accompanied by hydrolysis of GTP associated with beta-tubulin so that microtubules consist principally of \"GDP-tubulin\" stabilized by a short \"GTP cap.\" Microtubules are polar, cylindrical structures some 25 nm in diameter."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5506ce078e1671127b00000b",
                            "question": "Which protein phosphatase has been found to interact with the heat shock protein, HSP20?"
                        }
                    ],
                    "context": " Moreover, protein phosphatase-1 activity is regulated by two binding partners, inhibitor-1 and the small heat shock protein 20, Hsp20. Indeed, human genetic variants of inhibitor-1 (G147D) or Hsp20 (P20L) result in reduced binding and inhibition of protein phosphatase-1, suggesting aberrant enzymatic regulation in human carriers. Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling. Hsp20 overexpression in intact animals resulted in significant enhancement of cardiac function, coupled with augmented Ca cycling and sarcoplasmic reticulum Ca load in isolated cardiomyocytes. This was associated with specific increases in phosphorylation of phospholamban (PLN) at both Ser16 and Thr17, relieving its inhibition of the apparent Ca affinity of SERCA2a. Accordingly, the inotropic effects of Hsp20 were abrogated in cardiomyocytes expressing nonphosphorylatable PLN (S16A/T17A). Interestingly, the activity of type 1 protein phosphatase (PP1), a known regulator of PLN signaling, was significantly reduced by Hsp20 overexpression, suggesting that the Hsp20 stimulatory effects are partially mediated through the PP1-PLN axis. This hypothesis was supported by cell fractionation, coimmunoprecipitation, and coimmunolocalization studies, which revealed an association between Hsp20, PP1, and PLN.Hsp20 is a novel regulator of sarcoplasmic reticulum Ca cycling by targeting the PP1-PLN axis. These findings, coupled with the well-recognized cardioprotective role of Hsp20, suggest a dual benefit of targeting Hsp20 in heart disease.Moreover, protein phosphatase-1 activity is regulated by two binding partners, inhibitor-1 and the small heat shock protein 20, Hsp20."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54fc99f36ad7dcbc12000004",
                            "question": "Neurostimulation of which nucleus is used for treatment of dystonia?"
                        }
                    ],
                    "context": "Bilateral globus pallidus internus (GPi) DBS was performed in five SD patients and unilateral ventralis oralis anterior and posterior (Voa/Vop) nucleus of the thalamus DBS in two post-stroke hemiballismus patients. BACKGROUND: Deep brain stimulation of the internal pallidum (GPi-DBS) is effective for various types of drug-refractory primary dystonias. METHODS: In the parent trial, 40 patients were randomly assigned to either sham neurostimulation or neurostimulation of the internal globus pallidus for a period of 3 months and thereafter all patients completed 6 months of active neurostimulation. 38 patients agreed to be followed up annually after the activation of neurostimulation, including assessments of dystonia severity, pain, disability, and quality of life.INTERPRETATION: 3 years and 5 years after surgery, pallidal neurostimulation continues to be an effective and relatively safe treatment option for patients with severe idiopathic dystonia. This long-term observation provides further evidence in favour of pallidal neurostimulation as a first-line treatment for patients with medically intractable, segmental, or generalised dystonia.We describe a patient who received bilateral globus pallidus internus DBS for dystonia with initially good clinical response, but the device eventually failed. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "551d8b3a6b348bb82c000011",
                            "question": "Where is the angiogenin binding element  located?"
                        }
                    ],
                    "context": "ANG binds at the upstream control element (UCE) of the promoter and enhances promoter occupancy of RNA Pol I as well as the selectivity factor SL1 components TAFI 48 and TAFI 110.  Here we report that angiogenin binds to CT repeats that are abundant in the nontranscribed region of the ribosomal RNA gene. An angiogenin-binding DNA sequence (CTCTCTCTCTCTCTCTCCCTC) has been identified and designated angiogenin-binding element (ABE). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "532f0bd6d6d3ac6a3400002d",
                            "question": "What is the mode of inheritance of Marchesani syndrome?"
                        }
                    ],
                    "context": "Autosomal recessive and autosomal dominant WMS cannot be distinguished by clinical findings alone. Weill-Marchesani syndrome (WMS) is a well-characterized disorder in which patients develop eye and skeletal abnormalities. Autosomal-recessive and autosomal-dominant forms of WMS are caused by mutations in ADAMTS10 and FBN1 genes, respectively. Finally, WMS is transmitted either by an autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance. Weill-Marchesani syndrome (WMS) is a rare condition characterized by short stature, brachydactyly, joint stiffness, and characteristic eye abnormalities including microspherophakia, ectopia of lens, severe myopia, and glaucoma. Both autosomal recessive (AR) and autosomal dominant (AD) modes of inheritance have been described for WMS.Weill-Marchesani syndrome (WMS) is a connective tissue disorder characterised by short stature, brachydactyly, joint stiffness, and characteristic eye anomalies including microspherophakia, ectopia of the lenses, severe myopia, and glaucoma. Both autosomal recessive (AR) and autosomal dominant (AD) modes of inheritance have been described and a gene for AR WMS has recently been mapped to chromosome 19p13.3-p13.2."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "551173c26a8cde6b72000004",
                            "question": "Which event results in the acetylation of S6K1?"
                        }
                    ],
                    "context": "S6K1 is acetylated at lysine 516 in response to growth factor stimulationIn addition to phosphorylation, we have recently shown that S6K1 is also targeted by lysine acetylationHere, using tandem mass spectrometry we have mapped acetylation of S6K1 to lysine 516, a site close to the C-terminus of the kinase that is highly conserved amongst vertebrate S6K1 orthologuesUsing acetyl-specific K516 antibodies, we show that acetylation of endogenous S6K1 at this site is potently induced upon growth factor stimulationWe propose that K516 acetylation may serve to modulate important kinase-independent functions of S6K1 in response to growth factor signalling"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571e4293bb137a4b0c00000b",
                            "question": "What is the cause of episodic ataxia type 6?"
                        }
                    ],
                    "context": "There are several genetically and clinically distinct forms of this disease, and one of them, episodic ataxia type 6, is caused by mutations in the gene encoding a glial glutamate transporter, the excitatory amino acid transporter-1. So far, reduced glutamate uptake by mutant excitatory amino acid transporter-1 has been thought to be the main pathophysiological process in episodic ataxia type 6. Episodic ataxia type 6 represents the first human disease found to be associated with altered function of excitatory amino acid transporter anion channels and illustrates possible physiological and pathophysiological impacts of this functional mode of this class of glutamate transporters.There are several genetically and clinically distinct forms of this disease, and one of them, episodic ataxia type 6, is caused by mutations in the gene encoding a glial glutamate transporter, the excitatory amino acid transporter-1. So far, reduced glutamate uptake by mutant excitatory amino acid transporter-1 has been thought to be the main pathophysiological process in episodic ataxia type 6.There are several genetically and clinically distinct forms of this disease, and one of them, episodic ataxia type 6, is caused by mutations in the gene encoding a glial glutamate transporter, the excitatory amino acid transporter-1."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "530cf22aa177c6630c000004",
                            "question": "What is the main role of Ctf4 in dna replication?"
                        }
                    ],
                    "context": "In this report, interactions between human Ctf4 (hCtf4) and the replicative helicase containing the cell division cycle 45 (Cdc45)/minichromosome maintenance 2-7 (Mcm2-7)/Go, Ichi, Nii, and San (GINS) (CMG) proteins [human CMG (hCMG) complex] were examinedWe demonstrate that the hCtf4-CMG complex contains a homodimeric hCtf4 and a monomeric hCMG complex and suggest that the homodimeric hCtf4 acts as a platform linking polymerase \u03b1 to the hCMG complexDrosophila Ctf4 is essential for efficient DNA replication and normal cell cycle progressionThe Ctf4 protein has been shown to be a central member of the replication fork and links the replicative MCM helicase and DNA polymerase \u03b1 primase it has been implicated as a member of a complex that promotes replication fork stability, the Fork Protection Complex (FPC), and as being important for sister chromatid cohesion"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53130a77e3eabad02100000f",
                            "question": "Which hormone deficiency is implicated in the Costello syndrome ?"
                        }
                    ],
                    "context": "Measurements obtained after growth hormone exposure in 15 individuals were excluded in this analysis.Furthermore, we observed that RasGRF1 becomes phosphorylated in ARMS after stimulation by several pro-metastatic factors, such as SDF-1 and HGF/SF, as well as after exposure to growth-promoting Igf-2 and insulin.Progressively worsening hypertrophic cardiomyopathy in a child with newly diagnosed Costello syndrome while receiving growth hormone therapy.This report highlights two important concepts: the association of genetic syndromes with hypertrophic cardiomyopathy and the possibility of worsening severity of hypertrophic cardiomyopathy linked to growth hormone therapy.Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55167dec46478f2f2c00000a",
                            "question": "What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?"
                        }
                    ],
                    "context": "Hirschsprung's disease (HSCR) is a fairly frequent cause of intestinal obstruction in children. It is characterized as a sex-linked heterogonous disorder with variable severity and incomplete penetrance giving rise to a variable pattern of inheritance. Although Hirschsprung's disease occurs as an isolated phenotype in at least 70% of cases, it is not infrequently associated with a number of congenital abnormalities and associated syndromes, demonstrating a spectrum of congenital anomalies. Certain of these syndromic phenotypes have been linked to distinct genetic sites, indicating underlying genetic associations of the disease and probable gene-gene interaction, in its pathogenesis. These associations with HSCR include Down's syndrome and other chromosomal anomalies, Waardenburg syndrome and other Dominant sensorineural deafness, the Congenital Central Hypoventilation and Mowat-Wilson and other brain-related syndromes, as well as the MEN2 and other tumour associationsOn the other hand, about 30% of HSCR are syndromic. Hitherto, the disease causing gene has been identified for eight Mendelian syndromes with HSCR: congenital central hypoventilation (CCHS), Mowat-Wilson (MWS), Bardet-Biedl (BBS), Shah-Waardenburg (WS4), cartilage-hair-hypoplasia (CHH), Smith-Lemli-Opitz (SLO), Goldberg-Sprintzsen (GSS), and hydrocephalus due to congenital stenosis of the aqueduct of sylvius (HSAS)The syndromic HSCR entities studied were congenital central hypoventilation (CCHS) and Mowat-Wilson syndrome (MWS), caused by PHOX2B and ZFHX1B gene mutations, respectivelyThe RET locus was genotyped in 143 CCHS patients, among whom 44 had HSCR, and in 30 MWS patients, among whom 20 had HSCRRET was shown to act as a modifier gene for the HSCR phenotype in patients with CCHS but not with MWS"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c5feb75795f9a73e000006",
                            "question": "Which is the most common CFTR mutation in Caucasians?"
                        }
                    ],
                    "context": "Exposure to WCS caused a pronounced reduction in CFTR activity in both CFTR (+/+) cells and F508del CFTR (+/-) cellMoreover, the common heterozygous F508del/5T and F508del/R117H were observed in 17 and 4% of CBAVD cases respectively, and the allele frequency in CBAVD was 17% for F508del, 25% for 5T and 3% for R117H.The most common mutations were p.F508del (DeltaF508) (18.1%), c.2183_2184delAAinsG (2183AA>G) (6.5%), p.S466X (5.8%), p.N1303K (4.3%), c.2789+5G>A (4.3%), p.G542X (3.6%), c.3120+1G>A (3.6%), p.R334W (2.9%) and c.3130delA (2.9%). These 9 types of mutant CFTR genes totaled for 52% of all CFTR genes derived from the 69 Iranian CF patients. Eight mutations, c.406-8T>C, p.A566D, c.2576delA, c.2752-1_2756delGGTGGCinsTTG, p.T1036I, p.W1145R, c.3850-24G>A, c.1342-?_1524+?del, were found for the first time in this study.The commonest CFTR mutation, deltaF508, is found in 74.1% of all CF chromosomes. In the Caucasian CF population, 57.5% are deltaF508 homozygotes but the UK ISC CF population with only 24.7%, has significantly fewer deltaF508 homozygotes patients (95% confidence interval (CI) 0.2-0.4).Although the major mutation that results in a single amino acid deletion (F508) accounts for 70% of the disease alleles, more than 550 additional mutant alleles of different forms have been detected."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d669003706e8952800000e",
                            "question": "When are itaconic acid levels elevated?"
                        }
                    ],
                    "context": "taconic acid (P = 0.0003), with a false discovery rate of 0.012, was found to be significantly more abundant in women who subsequently developed gestational diabetes mellitus, when compared to controls with uncomplicated pregnancies.Using a gain-and-loss-of-function approach in both mouse and human immune cells, we found Irg1 expression levels correlating with the amounts of itaconic acid, a metabolite previously proposed to have an antimicrobial effect.Here we show that itaconic acid inhibits the growth of bacteria expressing isocitrate lyase, such as Salmonella enterica and Mycobacterium tuberculosis. immune defense "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f010ef6e394741000041",
                            "question": "Simpson grading is used to describe resection of which brain tumor?"
                        }
                    ],
                    "context": "The impact of age (\u2264 70 vs.>70 years), sex, tumor diameter (<6 vs. \u2265 6 cm), pre- and postoperative KPS (<80 vs. \u2265 80), Simpson grade (I-II vs. III-IV), and World Health Organization (WHO) histologic grade (I vs. II-III) on survival was assessed. Kaplan-Meier survival curves were plotted and differences in survival between groups of patients were compared. A multivariate analysis adjusted for age, pre- and postoperative KPS, Simpson grade, tumor diameter, and WHO histologic grade also was performed.RESULTS: The fronto-orbito-basal approach (n = 22) allowed a significantly greater percentage of Simpson I-II removals than the bifrontal (n = 70) and pterional approach (n = 21) (P = 0.0354 and P = 0.0485, respectively). Simpson Grade I-III Resection of Spinal Atypical (World Health Organization Grade II) Meningiomas is Associated With Symptom Resolution and Low Recurrence.Simpson grade I, II, III, and IV resection were achieved in 3 (15%), 13 (65%), 2 (10%), and 2 (10%) tumors, respectively. One patient that underwent Simpson grade III resection received adjuvant radiation therapy. After Simpson grade I-III or gross total resection, no tumors recurred (0%; confidence interval, 0%-17.6%). After Simpson grade IV resection, 1 tumor recurred (50%; confidence interval, 1.3%-98.7%).  The Simpson grading system was used to assess the extent of surgical resection.Simpson grade: an opportunity to reassess the need for complete resection of meningiomas."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51596a8ad24251bc0500009e",
                            "question": "Where in the cell do we find the protein Cep135?"
                        }
                    ],
                    "context": "CEP family protein is the active component of centrosomeCep135/Bld10 is a conserved centriolar protein required for the formation of the central cartwheel, an early intermediate in centriole assembly.Thus, in flies, Cep135/Bld10 is not essential for cartwheel assembly or for establishing the ninefold symmetry of centrioles; rather, it appears to stabilize the connection between inner and outer centriole components.Cep135 is a 135-kDa, coiled-coil centrosome protein important for microtubule organization in mammalian cells135\u00a0kDa centrosomal protein (CEP135)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f00def6e39474100003f",
                            "question": "Which enzyme is inhibited by Varespladib?"
                        }
                    ],
                    "context": "The VISTA-16 trial of varespladib, a secretory phospholipase A2 (sPLA2) inhibitor, in patients with an acute coronary syndrome was terminated prematurely owing to futility and a signal towards harm.Large-scale Phase III trials are now underway with agents that lead to marked reductions in IL-6 and C-reactive protein (such as canakinumab and methotrexate) as well as with agents that impact on diverse non-IL-6-dependent pathways (such as varespladib and darapladib). The sPLA2 inhibitor varespladib has favorable effects on lipid and inflammatory markers; however, its effect on cardiovascular outcomes is unknown.OBJECTIVE: To determine the effects of sPLA2 inhibition with varespladib on cardiovascular outcomes.The sPLA2 inhibition with varespladib may be harmful and is not a useful strategy to reduce adverse cardiovascular outcomes after ACS.The potential pro-atherogenic role of PLA(2) led to the development of two small molecules, varespladib, a reversible sPLA(2) inhibitor, and darapladib, a selective Lp-PLA(2) inhibitor. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571e12097de986d80d000017",
                            "question": "Which protein does empagliflozin inhibit?"
                        }
                    ],
                    "context": "Empagliflozin (Jardiance): a novel SGLT2 inhibitor for the treatment of type-2 diabetes.AIMS: Empagliflozin is a selective sodium glucose cotransporter 2 (SGLT2) inhibitor that inhibits renal glucose reabsorption and is being investigated for the treatment of type 2 diabetes mellitus (T2DM). Effect of food on the pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, and assessment of dose proportionality in healthy volunteers.Safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects.Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "533ba218fd9a95ea0d000007",
                            "question": "What is the clinical indication of cardiac T1 mapping magnetic resonance?"
                        }
                    ],
                    "context": "More diverse patterns of late enhancement including patchy, mid-wall, subepicardial, or diffuse enhancement are of interest in diagnosing nonischemic cardiomyopathies.Methods for quantification of T1 and extracellular volume fraction are emerging to tackle the issue of discriminating globally diffuse fibrosis from normal healthy tissue which is challenging using conventional late enhancement methods. Recent T1 mapping techniques aim to overcome the limitations of late gadolinium enhancement to assess diffuse fibrosis.T1 mapping techniques performed both with and without contrast are enabling quantification of diffuse myocardial fibrosis and myocardial infiltration.Noncontrast T1 mapping has high diagnostic accuracy for detecting cardiac AL amyloidosis, correlates well with markers of systolic and diastolic dysfunction, and is potentially more sensitive for detecting early disease than LGE imaging."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5540fbce234c5a7c75000001",
                            "question": "Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?"
                        }
                    ],
                    "context": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.The significance of the receptor glycoprotein lamp2a in the chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been described in details as well as the chaperone protein Hsc73 and other chaperones involved in this process.We investigated chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of proteins containing a specific lysosomal import consensus sequence (KFERQ motif). The significance of the receptor glycoprotein lamp2a in the chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been described in details as well as the chaperone protein Hsc73 and other chaperones involved in this process.We investigated chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of proteins containing a specific lysosomal import consensus sequence (KFERQ motif)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5343bdd6aeec6fbd07000001",
                            "question": "Which is the phosphorylated residue in the promoter paused form of RNA polymerase II?"
                        }
                    ],
                    "context": "increase levels of serine-5 phosphorylated RNA polymerase II in the mutation target region, consistent with an effect on transcriptional elongation/pausingpol-II accumulated in the 5'-region of the gene, which indicated postinitiation pausing. pol-II binding, 5'-accumulation, C-terminal domain Ser-5 and Ser-2 phosphorylationThe carboxy-terminal domain of the paused polymerase large subunit is hyperphosphorylated on serine 5, and phosphorylation of serine 2 is first detected herethe promoter-paused form of Pol II (Pol IIo(ser5)Pause release depends on Cdk9-cyclin T1 (P-TEFb); Cdk7 is also required for Cdk9-activating phosphorylation and Cdk9-dependent downstream events--Pol II C-terminal domain Ser2 phosphorylation "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5518414a15fa47643f000001",
                            "question": "Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?"
                        }
                    ],
                    "context": "Treatment of metastatic colorectal cancer with targeted anti-EGFR therapeutics such as cetuximab extends survival in only 25% of patients who test wild-type for KRAS, while the majority of patients prove resistant (J Clin Oncol 28(7):1254-1261, 2010).. Somatic mutation of the EGFR signalling pathway is a prevalent mechanism of resistance to cetuximab (Nature 486(7404):532-536, 2012). If the human genome harbours variants that influence susceptibility of the EGFR pathway to oncogenic mutation, such variants could also be prognostic for cetuximab responsiveness. KRAS mutations are strong predictors for clinical outcomes of EGFR-targeted treatments such as cetuximab and panitumumab in metastatic colorectal cancer (mCRC).KRAS mutation is widely accepted as a strong, negative predictive marker for anti-epidermal growth factor receptor antibodies, including cetuximab and panitumumab. KRAS status is now a mandatory prerequisite in order to treat metastatic colorectal patients with anti-Epidermal Growth Factor Receptor (EGFR) antibodies, such as cetuximab or panitumumab. KRAS mutations are unambiguously linked to a lack of response to these targeted therapies."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56ae57350a360a5e4500000a",
                            "question": "Which is the physiological target for LeuRS translational quality control?"
                        }
                    ],
                    "context": "The physiological target for LeuRS translational quality control is norvaline.The physiological target for LeuRS translational quality control is norvalineRather, as shown by kinetic, structural and in vivo approaches, the prime biological function of LeuRS editing is to prevent mis-incorporation of the non-standard amino acid norvaline"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56e6ec49edfc094c1f000005",
                            "question": "Which is the target of the drug Denosumab?"
                        }
                    ],
                    "context": "Denosumab is a human monoclonal antibody which specifically blocks receptor activator of nuclear factor \u03baB ligand and is a very potent antiresorptive drug. denosumab, a monoclonal antibody against RANKLDenosumab is a human monoclonal antibody indicated for the treatment of osteoporosis in postmenopausal women with a high risk of fractures. Denosumab (Dmab) is a fully human monoclonal antibody against the receptor activator of nuclear factor-\u03baB ligand (RANKL), which, through the prevention of the RANKL/RANK interaction, inhibits osteoclast-mediated bone resorption and significantly reduces the risk of vertebral, nonvertebral, and hip fractures. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53357ca0d6d3ac6a3400004b",
                            "question": "Which enzyme is inhibited by a drug fostamatinib?"
                        }
                    ],
                    "context": "It outlines preclinical and early clinical experiences with the Syk inhibitor fostamatinib disodium (R788) and discusses various options for further clinical development of this compound. To assess the efficacy and safety of R788 (fostamatinib disodium), an inhibitor of spleen tyrosine kinase (Syk), in patients with active rheumatoid arthritis (RA) that did not respond to biologic therapies. The mTOR inhibitors temsirolimus and everolimus have demonstrated antitumor activity in all types of lymphoma, the Syk inhibitor fostamatinib has activity in diffuse large B-cell lymphoma and chronic lymphocytic leukemia, and the PKC-\u03b2 inhibitor enzastaurin is being used as consolidation therapy after remission in diffuse large B-cell lymphoma. Fostamatinib, a Syk-kinase inhibitor, does not affect methotrexate pharmacokinetics in patients with rheumatoid arthritis.The objective of this phase 2 study was to evaluate the efficacy and safety of R788, an oral inhibitor of Syk, in patients with active rheumatoid arthritis despite methotrexate therapy."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51542dabd24251bc0500007d",
                            "question": "Which gene test can be used for the X-linked myotubular myopathy?"
                        }
                    ],
                    "context": "X-linked myotubular myopathy (MTM) is a severe neuromuscular disease of infancy caused by mutations of MTM1, which encodes the phosphoinositide lipid phosphatase, myotubularinAs a gene for X linked MTM was recently identified in Xq28, we screened the obligatory carrier mothers for mutation. We found a 4 bp deletion in exon 4 of the MTM1 gene,X-linked Myotubular Myopathy has clearly shown the benefits to be gained from a multinational research consortium with a common interest in identifying and cloning the MTM1 gene.Myotubular myopathy (MTM1) is an X-linked disease, characterized by severe neonatal hypotonia and generalized muscle weakness, with pathological features suggesting an impairment in maturation of muscle fibres. The MTM1 gene encodes a protein (myotubularin) with a phosphotyrosine phosphatase consensus.myotubular myopathy (XLMTM), a severe congenital muscular disorder due to loss-of-function mutations in the MTM1 gene,"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550718e9fd1abe1741000001",
                            "question": "Where in a protein can a signal sequence be found?"
                        }
                    ],
                    "context": "A transmembrane domain (TMD) at the N-terminus of a membrane protein is a signal sequence that targets the protein to the endoplasmic reticulum (ER) membrane.  an N-terminal signal sequence,soluble AMO possesses an N-terminal signal sequencen N-terminal \"twin arginine\" signal sequence suggested Proteins destined for the mitochondrial matrix space have leader sequences that are typically present at the most N-terminal end of the nuclear-encoded precursor protein. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f039ef6e394741000052",
                            "question": "Which antibody is implicated in the Bickerstaff's brainstem encephalitis?"
                        }
                    ],
                    "context": "In addition, BBE and Fisher syndrome, which are clinically similar and are both associated with the presence of the immunoglobulin G anti-GQ1b antibody, represent a specific autoimmune disease with a wide spectrum of symptoms that include ophthalmoplegia and ataxia.The syndrome defined by Bickerstaff of progressive, external ophthalmoplegia and ataxia, with disturbance of consciousness or hyperreflexia, has subsequently been associated with anti-GQ1b antibodies.An anti-GQ1b antibody syndrome has been proposed to underlie the common pathophysiology for the three disorders; however, other studies have found a positive anti-GM1 instead of anti-GQ1b antibody.Serologic analysis of antibodies against ganglioside complexes (anti-GDIa, anti-GDIb, anti-GM1, anti-GM2, anti-GM3, anti-GQIb and anti-GTIb antibodies) showed negative results.However, contrary to a proposed anti-GQ1b antibody syndrome, we would suggest that pathogenesis of this clinical spectrum is not limited to anti-ganglioside antibodies."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55203ae78e534a4535000001",
                            "question": "In which condition was protein S100A7 originally identified?"
                        }
                    ],
                    "context": "Psoriasin (S100A7), originally identified in psoriasis, is a calcium-binding protein belonging to the multigenic S100 familyPsoriasin (S100 A7) was discovered two decades ago as a protein abundantly expressed in psoriatic keratinocytes.  Psoriasin, originally isolated from psoriasis as an overexpressed molecule of unknown function, has recently been identified as a principal Escherichia coli-killing antimicrobial peptide of healthy skin. Inflammation-prone psoriatic skin constitutively expresses elevated concentrations of S100A7 (psoriasin)S100A7 (psoriasin) and S100A15 (koebnerisin) were first identified in inflamed psoriatic skin. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "532670e7d6d3ac6a34000008",
                            "question": "What is the typical alteration of the thyroid profile metabolism early after coronary artery bypass graft surgery?"
                        }
                    ],
                    "context": "FT3 concentration dropped significantly (p < 0.0001), reaching its lowest value 12 hours postoperatively. There were no significant differences between CPB and OPCAB patients. In on-pump CABG surgery, inflammatory effects encompass activation of total leukocytes, neutrophils and platelets, reduction of serum level of total proteins and albumin and decreased thyroid hormones levels, especially within first postoperative 24 hours.Typical NTIS was observed in all patients, and the FT3 concentration was still reduced by postoperative day 5 (p<0.0001).We could demonstrate that CPB induces a low T3 syndrome up to 3 days after surgery. Those patients with low T3 concentrations prior to surgery demonstrate postoperatively a more severe degree of nonthyroidal illness (NTI).It is concluded that the coronary bypass operation evokes a rapid decline in T3, which is not normalized by the TSH induced response of the thyroid gland, while the post-operative period is characterized by a \"low T3 state\". "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56b76f496e3f8eaf4c000002",
                            "question": "What does the SAGA complex acronym stands for?"
                        }
                    ],
                    "context": "SAGA (Spt-Ada-Gcn5 Acetyltransferase)SAGA (Spt-Ada-Gcn5-acetyltransferase)Spt-Ada-Gcn5-acetyltransferase (SAGA) Spt-Ada-Gcn5-acetyltransferase (SAGA) complex is a transcription coactivator the yeast transcriptional coactivator Spt-Ada-Gcn5 acetyltransferase (SAGA)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5319a7f2b166e2b80600002a",
                            "question": "What is the result of the interaction between TSC1 and PLK1?"
                        }
                    ],
                    "context": "Phosphorylated hamartin interacts with Plk1 independent of tuberin with all three proteins present in a complex.Hamartin negatively regulates the protein levels of Plk1.Finally, Tsc1(-/-) mouse embryonic fibroblasts (MEFs) have increased number of centrosomes and increased DNA content, compared to Tsc1(+/+) cells.Both phenotypes are rescued after pre-treatment with the mTOR inhibitor rapamycin. RNAi inhibition of Plk1 in Tsc1(-/-) MEFs failed to rescue the increased centrosome number phenotype. These data reveal a novel subcellular localization for hamartin and a novel interaction partner for the hamartin/tuberin complex and implicate hamartin and mTOR in the regulation of centrosome duplication."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cae60f5795f9a73e00002b",
                            "question": "Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?"
                        }
                    ],
                    "context": "Ataxin-2 is an evolutionarily conserved protein first identified in humans as responsible for spinocerebellar ataxia type 2 (SCA2). The molecular basis of SCA2 is the expansion of a polyglutamine tract in Ataxin-2, encoding a Lsm domain that may bind RNA and a PAM2 motif that enables interaction with the poly (A) binding protein.In SCA2 brains, we found cytoplasmic, but not nuclear, microaggregates. Mice expressing ataxin-2 with Q58 showed progressive functional deficits accompanied by loss of the Purkinje cell dendritic arbor and finally loss of Purkinje cells.Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited, neurodegenerative disease caused by an expansion of polyglutamine tracts in the cytosolic protein ataxin-2 (Atx2). Our analysis provides valuable information on the evolution and domain structure of Ataxin-2 proteins. Proline-rich motifs that may mediate protein interactions are widespread in Ataxin-2 proteins, but expansion of polyglutamine tracts associated with spinocerebellar ataxia type 2, is present only in primates, as well as some insects.The expansion of a polyQ repeat within the ataxin-2 protein causes spinocerebellar ataxia type 2 (SCA2). However, neither the precise pathological mechanism nor the physiological functions of ataxin-2 are known."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56bb621fac7ad10019000009",
                            "question": "What causes Katayama Fever?"
                        }
                    ],
                    "context": "The laboratory diagnosis of schistosomiasis and Katayama syndrome in returning travellers is difficult because the number of excreted eggs is often very limited.Eosinophilia (sometimes exceeding 50%) is often present in patients with acute schistosomiasis (Katayama fever), but may be limited or absent in late fibrotic manifestations of the disease.Laboratory diagnosis of schistosomiasis and Katayama syndrome in returning travellersThe specific diagnosis of early schistosomiasis and Katayama fever relies essentially on serologic tests or preferably on PCR (if available). BACKGROUND: Katayama fever is an acute clinical condition characterised by high fever, dry cough and general malaise occurring during early Schistosoma spp. infection."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "554140ad182542114d000003",
                            "question": "Which is the database of molecular recognition features in membrane proteins?"
                        }
                    ],
                    "context": "mpMoRFsDB: a database of molecular recognition features in membrane proteinsmpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteinsmpMoRFsDB: a database of molecular recognition features in membrane proteins."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "554148c23f2354b713000001",
                            "question": "Which database is available for the identification of chorion proteins in Lepidopteran proteomes?"
                        }
                    ],
                    "context": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomesA database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work. A total of 413 Lepidopteran chorion proteins from 9 moths and 1 butterfly species were retrieved. These data were enriched and organised in order to populate LepChorionDB, the first relational database, available on the web, containing Lepidopteran chorion proteins grouped in A and B classes. LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators, since it also provides access to the two pHMMs developed in this work, which may be used to discriminate A and B class chorion proteinsLepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.These data were enriched and organised in order to populate LepChorionDB, the first relational database, available on the web, containing Lepidopteran chorion proteins grouped in A and B classes.LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators, since it also provides access to the two pHMMs developed in this work, which may be used to discriminate A and B class chorion proteins."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cb9b065795f9a73e000032",
                            "question": "Which kinase is inhibited by Tripolin A?"
                        }
                    ],
                    "context": "Tripolin A, a novel small-molecule inhibitor of aurora A kinase, reveals new regulation of HURP's distribution on microtubules.The human Aurora kinases are a family of such targets. In this study, from a panel of 105 potential small-molecule inhibitors, two compounds Tripolin A and Tripolin B, inhibited Aurora A kinase activity in vitro. In human cells however, only Tripolin A acted as an Aurora A inhibitor. In this study, from a panel of 105 potential small-molecule inhibitors, two compounds Tripolin A and Tripolin B, inhibited Aurora A kinase activity in vitroTripolin A, a novel small-molecule inhibitor of aurora A kinase, reveals new regulation of HURP&apos;s distribution on microtubulesIn this study, from a panel of 105 potential small-molecule inhibitors, two compounds Tripolin A and Tripolin B, inhibited Aurora A kinase activity in vitro. In human cells however, only Tripolin A acted as an Aurora A inhibitor."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53188480b166e2b806000018",
                            "question": "Which is the cellular target of gefitinib?"
                        }
                    ],
                    "context": "Gefitinib, the specific inhibitor of the epidermal growth factor receptor (EGFR), may cause growth delay in cancer cell lines.Gefitinib (Iressa) is a specific and effective epidermal growth factor receptor inhibitor.Gefitinib is a specific inhibitor of the epidermal growth factor receptor (EGFR) that causes growth delay in cancer cell lines and human tumor xenografts expressing high levels of EGFR."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54ede76294afd61504000008",
                            "question": "What is the risk of developing acute myelogenous leukemia in Fanconi anemia?"
                        }
                    ],
                    "context": "Sixteen of the 59 FA-C patients (27%) have developed acute myelogenous leukemiaActuarial risk of MDS or AML was 52% (37% to 67%) by 40 years of ageA review of all of the cases of Fanconi anemia (FA) reported to the International Fanconi Anemia Registry (IFAR) indicates that at least 15% manifest acute myelogenous leukemia (AML) or preleukemiaA review of all of the cases of Fanconi anemia (FA) reported to the International Fanconi Anemia Registry (IFAR) indicates that at least 15% manifest acute myelogenous leukemia (AML) or preleukemia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52c7311903868f1b0600001d",
                            "question": "How many different mutations have been associated with Muenke syndrome?"
                        }
                    ],
                    "context": "Muenke syndrome is an autosomal dominant craniosynostosis syndrome resulting from a defining point mutation in the Fibroblast Growth Factor Receptor3 (FGFR3) gene. The associated of FGFR3 mutations with craniosynostosis has been restricted to three mutations, the common p.Pro250Arg in Muenke syndrome, p.Ala391Glu in Crouzon syndrome with acanthosis nigricans, and p.Pro250Leu identified in a family with isolated craniosynostosis. The Pro250Arg mutation in the FGFR3 gene is found in patients with Muenke syndrome and is one of the most frequently encountered mutations in craniosynostosis syndromes.  Fibroblasts from 10 individuals each with Apert syndrome (FGFR2 substitution S252W), Muenke syndrome (FGFR3 substitution P250R), Saethre-Chotzen syndrome (various mutations in TWIST1) and non-syndromic sagittal synostosis (no mutation detected) were cultured. The identification of the P250R mutation allowed the confirmation of the Muenke Syndrome in 9 out of the 52 cases referred. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f1e031c409818c32000001",
                            "question": "DX-88 is investigational name of which drug?"
                        }
                    ],
                    "context": "Ecallantide (known as DX-88 previously), a potent and specific inhibitor of plasma kallikrein is an innovative medicinal product. Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.Several novel therapies have completed phase III trials in the US, including: (i) plasma-derived C1-INH replacement therapies (Berinert P and Cinryze); (ii) a recombinant C1-INH replacement therapy (conestat alfa; Rhucin); (iii) a kallikrein inhibitor (ecallantide [DX-88]); and (iv) a bradykinin-2-receptor antagonist (icatibant).Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery.OBJECTIVE: Ecallantide (DX-88) is a potent and specific inhibitor of plasma kallikrein. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "513ce494bee46bd34c000009",
                            "question": "Which is the most common disease attributed to malfunction or absence of primary cilia?"
                        }
                    ],
                    "context": "role of primary cilia in autosomal dominant polycystic kidney diseaseRecent research has focused on defects in signaling mediated by the primary cilia as the causative factor in ADPKDInterestingly, primary cilia concentrate p75NTR receptors in their membranes and are abnormally structured/damaged in transgenic (Tg) AD\u2011model mice, which could impact on the adult neurogenesis occurring in the dentate gyrus's subgranular zone (SGZ) that is necessary for new memory encoding, thereby favouring typical AD cognitive declinemalformation of primary cilia, and in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease (PKD)While PKD was one of the first diseases to be linked to dysfunctional primary cilia, defects in this organelle have subsequently been associated with many other phenotypes, including cancer, obesity, diabetes as well as a number of developmental defects"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c86aa95795f9a73e000018",
                            "question": "Treprostinil is an analogue for which prostaglandin?"
                        }
                    ],
                    "context": "We investigated the effects of 3 conventional (iloprost, beraprost, and treprostinil) and 1 new (ONO-1301) PGI2 analogs, on the expression of MIP-1\u03b1 expression in human monocytes.PGI(2) analogues (iloprost, treprostinil and beraprost) significantly increased IL-17A and IL-22 in vitro while decreasing IFN\u03b3 production both in SSc and HD PBMC.The effects of PGI(2) analogs iloprost and treprostinil on cytokine production, maturation and T-cell stimulatory function of human mDCs were investigated.Treprostinil, a stable prostacyclin analogue used in the treatment of pulmonary arterial hypertension, is in development as a sustained release oral tablet, treprostinil diolamine (United Therapeutics Corp, Research Triangle Park, NC)Treprostinil diolamine is an oral prostacyclin analogue; sustained release tablets of oral treprostinil are currently being evaluated for efficacy and safety as a potential therapy in patients with PAH"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571f5e740fd6f91b6800000b",
                            "question": "Which enzyme is deficient in Gaucher's disease?"
                        }
                    ],
                    "context": "Gaucher's disease is caused by deficient lysosomal glucocerebrosidase activityGaucher's disease is due to glucocerebrosidase deficiency which is responsible for the accumulation of non degraded glucosylceramide within the lysosomes of macrophages: these \"Gaucher cells\", overloaded and alternatively activated, release in patient's plasma numerous compounds (cytokines, chemokines, hydrolases...) some of which contribute to the various tissue damagesGaucher's disease is an uncommon inborn recessive autosomal disease, due to a deficient activity of the lysosomal enzyme beta glucocerebrosidaseGaucher disease is an inborn recessive autosomal disease due to a partial deficiency of the lysosomal enzyme beta glucocerebrosidase. The deficient activity leads to accumulation of the lipid glucocerebroside in the liver, the spleen and bone marrow with concomitant anemia and thrombocytopeniaAlglucerase is a modified form of human placental glucocerebrosidase used as enzyme replacement therapy for patients with Gaucher's disease, in whom functional glucocerebrosidase is deficient"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55376f19bc4f83e82800000c",
                            "question": "Which is the most common type of pediatric cerebellar tumor?"
                        }
                    ],
                    "context": "Medulloblastoma (MDB) is the most common malignant cerebellar tumor in childrenMedulloblastoma is a malignant cerebellar tumor seen primarily in the pediatric age group that has a known ability to metastasize extraneurallyMedulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.Medulloblastoma (MDB) is the most common malignant cerebellar tumor in children.Medulloblastoma, the most common pediatric brain tumor, is thought to arise from deregulated proliferation of cerebellar granule precursor (CGP) cells."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5319a7d2b166e2b806000029",
                            "question": "Which is the E3 ubiquitin ligase of Hsp90?"
                        }
                    ],
                    "context": "C-terminal Hsp-interacting protein (CHIP) is an HSP70 and HSP90 interacting co-chaperone and an E3 ubiquitin ligase. Previous studies have reported the role of CHIP in cancer progression by targeting protein degradation.The U-box E3 ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein) binds Hsp90 and/or Hsp70 via its tetratricopeptide repeat (TPR), facilitating ubiquitination of the chaperone-bound client proteins.In vitro ubiquitination assays indicated that Ca(2+)/S100A2 and S100P are efficient and specific inhibitors of CHIP-mediated ubiquitination of Hsp70, Hsp90, HSF1, and Smad1.The E3 ubiquitin ligase CHIP (C-terminus of Hsc70-interacting protein) is believed to be a central player in the cellular triage decision, as it links the molecular chaperones Hsp70/Hsc70 and Hsp90 to the ubiquitin proteasomal degradation pathway.We found that CHIP has a sixfold higher affinity for Hsp90 compared with Hsc70."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5547a01cf35db75526000005",
                            "question": "In which kingdom do microsporidia belong, according to their current classification scheme?"
                        }
                    ],
                    "context": "Microsporidia are a diverse group of obligate, intracellular, eukaryotic, spore-forming parasites. Traditionally, these were considered as protozoans but recently have been reclassified as fungi. Microsporidia are ubiquitous fungi with genomes that have undergone a strong reductionMicrosporidia are unicellular fungi that are obligate endoparasites. Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.A combined analysis of thousands of gene trees supports a topology in which microsporidia is a sister group to all other sequenced fungi."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51656c94298dcd4e51000058",
                            "question": "What is the inheritance pattern of Emery-Dreifuss muscular dystrophy? "
                        }
                    ],
                    "context": ". Loss-of-function truncation mutations in EMD, encoding the nuclear membrane protein emerin, cause X-linked Emery-Dreifuss muscular dystrophy (EDMD) characterized by localized contractures and skeletal myopathy in adolescence, sinus node dysfunction (SND) in early adulthood, and atrial fibrillation as a variably associated trait.Mutation of EMD can underlie X-linked familial AF. Lys37del is associated with epithelial cell emerin deficiency, as in EDMD, yet it causes electrical atriomyopathy in the absence of skeletal muscle disease. Targeted genetic testing of EMD should be considered in patients with SND-associated AF and/or family history suggesting X-linked inheritance.The Emery-Dreifuss muscular dystrophy is a form of muscular dystrophy that frequently presents early contractures and cardiac conduction defects, caused by emerin deficiency in the inner nuclear membrane of the muscular fibers.compatible with X-linked inheritance formThe first patient was a member of a family with molecularly proven X-linked EDMD."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5319a6e9b166e2b806000023",
                            "question": "Which is the genetic lesion associated with Huntington\u2019s disease?"
                        }
                    ],
                    "context": "Early in 1993, an unstable, expanded trinucleotide repeat in a novel gene of unknown function was identified on HD chromosomes. This discovery unleased a flurry of experimentation that has established the expanded CAG repeat the almost universal cause of the characteristic neurologic symptoms and pathology of this neurodegenerative disorder of midlife onset."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c703445795f9a73e00000a",
                            "question": "Which histone modification discriminates between active and poised enhancers?"
                        }
                    ],
                    "context": "Monomethylation of histone H3 on Lys 4 (H3K4me1) and acetylation of histone H3 on Lys 27 (H3K27ac) are histone modifications that are highly enriched over the body of actively transcribed genes and on enhancerSince Trr and mammalian Mll3/4 complexes are distinguished by bearing a unique subunit, the H3K27 demethylase UTX, we propose a model in which the H3K4 monomethyltransferases Trr/Mll3/Mll4 and the H3K27 demethylase UTX cooperate to regulate the transition from inactive/poised to active enhancers.We used ChIP-seq to measure changes in histone H3K27 acetylation, a mark of active enhancers, to identify enhancers in myelinating rat peripheral nerve and their dynamics after demyelinating nerve injury.However, the majority of Egr2-bound enhancers retain H3K27ac, indicating that other transcription factors maintain active enhancer status after nerve injury.Recent studies using mammalian cells showed that a chromatin state signature is associated with active developmental enhancers, defined by high levels of histone H3 lysine 27 acetylation (H3K27ac) and strong depletion of H3K27 trimethylation (H3K27me3"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf208003868f1b06000019",
                            "question": "What is the inheritance pattern of Li\u2013Fraumeni syndrome?"
                        }
                    ],
                    "context": "It therefore appears that the LFS phenotype has been conferred by an aberrant gene, showing a dominant pattern of inheritance, which may be acting to compromise normal p53 function rather than by a mutation in p53 itself.In addition, there seem to be predispositions to a wider range of different, but well-defined neoplasms: e.g., adenocarcinomatosis of the colon and the endometrium, or the Li-Fraumeni/SBLA syndrome. The latter shows a spectrum of sarcoma, brain tumours, breast cancer, leukaemias, lung and adenocortical cancer. The genes leading to these types of dominantly inherited predispositions appear to be the tentatively so-called tumour suppressor genes, for which the Rb gene serves as a modelhe Li-Fraumeni syndrome is a rare autosomal-dominant disease whose hallmark is a predisposition to a wide range of cancers among members of a family.Li-Fraumeni Syndrome (LFS) is characterized by early-onset carcinogenesis involving multiple tumor types and shows autosomal dominant inheritance.BACKGROUND: Li-Fraumeni-Syndrome (LFS) is an autosomal-dominant, inherited tumour predisposition syndrome associated with heterozygous germline mutations in the TP53 gene."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "514a51c2d24251bc0500005c",
                            "question": "Which pituitary adenoma is common cause of infertility is women?"
                        }
                    ],
                    "context": "Prolactinoma is the most common secreting pituitary adenoma. It is typically diagnosed in women of reproductive age and is common cause of infertility.Examination of the tissue excised by transsphenoidal excision of the mass showed a pituitary adenoma that stained strongly for FSH. RESULTS: Regular menses resumed soon after excision of the gonadotroph adenoma, followed by a spontaneous pregnancy.CONCLUSIONS: Gonadotroph adenoma should be suspected in a reproductive age woman with oligomenorrhea or amenorrhea, infertility, multiple preovulatory follicles, and a persistently elevated serum estradiol concentration.Hyperprolactinemia is the most common endocrine disorder of the hypothalamic-pituitary axis, occurring mostly in women and presenting most commonly with amenorrhea and galactorrhea. Causes of hyperprolactinemia include physiologic, pharmacologic and pathologic factors; pituitary adenoma is a common pathologic cause. Women may present with decreased libido, infertility, oligomenorrhea/amenorrhea and galactorrhea.When specific treatable underlying causes have been eliminated and in cases of severe hyperprolactinemia, the most likely cause is a prolactin (PRL)-secreting pituitary adenoma. Microadenomas should be treated medically, with a dopamine agonist, if there is an indication for therapy (such as amenorrhea, infertility or bothersome galactorrhea)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56b397a98525abca1e000003",
                            "question": "What is the lipid droplet used for in the cell?"
                        }
                    ],
                    "context": "Eukaryotic cells store excess fatty acids as neutral lipids, predominantly triacylglycerols and sterol esters, in organelles termed lipid droplets (LDs) that bulge out from the endoplasmic reticulum. Lipid droplets (LD) are spherical cellular inclusion devoted to lipids storage.Cells store fatty acids (FAs) as triacylglycerol and package them into cytoplasmic lipid droplets (LDs). Lipid droplets are found in all cell typesLipid droplets (LDs) are ubiquitous and physiologically active organelles regulating storage and mobilization of lipids in response to metabolic demands. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54edf72c94afd61504000013",
                            "question": "What is the presumed key event in Fanconi anemia pathogenesis?"
                        }
                    ],
                    "context": "A key event in FA pathway activation is the monoubiquitylation of the FA complementation group I (FANCI)-FANCD2 (ID) complex by FA complementation group L (FANCL), an E3 ubiquitin ligaseMonoubiquitination of the Fanconi anaemia protein FANCD2 is a key event leading to repair of interstrand cross-linksHere we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCAFanconi anemia (FA) is characterized by congenital abnormalities, bone marrow failure, chromosome fragility, and cancer susceptibility. Eight FA-associated genes have been identified so far, the products of which function in the FA/BRCA pathway. A key event in the pathway is the monoubiquitination of the FANCD2 protein, which depends on a multiprotein FA core complex Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56d138fe3975bb303a000015",
                            "question": "Which trancription factor activates the betalain pathway?"
                        }
                    ],
                    "context": "The beet Y locus encodes an anthocyanin MYB-like protein that activates the betalain red pigment pathway.Some putative MYB, bHLH, and environmental stress-responsive transcription factor binding sites were detected in the PaDOD1 and PaDOD2 promoter regions."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5326a85ad6d3ac6a3400000b",
                            "question": "What does polyadenylate-binding protein 4 (PABP4) bind to?"
                        }
                    ],
                    "context": "RNA binding proteomeIn vertebrates, poly(A) binding protein (PABP) is known to exist in five different isoforms.Cytoplasmic poly(A)-binding proteins (PABPs) regulate mRNA stability and translation.  poly(A) binding proteins 1 and 4 (PABPC1 and PABPC4)Cytoplasmic poly(A) binding protein 4 (PABPC4) is an RNA-processing protein that plays an important role in the regulation of gene expression."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "515db3d8298dcd4e51000015",
                            "question": "What is the average diameter of intermediate filaments?"
                        }
                    ],
                    "context": "Negative staining showed that supernatants from the centrifugation assays contained protofilaments, protofibrils and short particles (less than 300 nm), but pellets contained long filaments (greater than 1 micron) with an average diameter of 10 nm.Ultrastructurally, rhabdoid cells showed paranuclear aggregates and whorls of intermediate filaments with a 9-10 nm diameter.After removing IFs by calcination, electron microscopy revealed hollow silica nanotubes several micrometers long, with outer diameters of 35-55 nm and an average inner diameter of 10 nm (comparable to that of IFs)Intermediate filaments are filaments 10\u2009nm in diameter that make up an important component of the cytoskeleton in most metazoan taxa.Neurofilaments (NFs) are essential cytoskeletal filaments that impart mechanical integrity to nerve cells. They are assembled from three distinct molecular mass proteins that bind to each other to form a 10-nm-diameter filamentous rod with sidearm extensions."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5540ca8a0083d1bf0e000003",
                            "question": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?"
                        }
                    ],
                    "context": "Nestin is a unique intermediate filament protein. While it is robustly expressed in developing brain, postnatal expression is limited to the brain's subventricular zone (SVZ)nestin, a marker protein for precursor cells in the subventricular zoneadult subventricular zone (SVZ) stem and progenitor cells express nestinthe typical protein of neural progenitors, nestinthe nonspecific precursor cell marker Nestin"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51585b28d24251bc0500008d",
                            "question": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?"
                        }
                    ],
                    "context": "his defect does not appear in mouse models with mutations in Dnmt3a and Mthfr genes and, therefore, it is specific for the Dnmt1 gene and is suggestive of a role of DNMT1 in imprint resetting or maintenance in the male germ line.Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain.We obtained evidence that some 5-methylcytosine residues in these single-stranded DNAs can stimulate de novo methylation of adjacent sites by murine DNA 5-cytosine methyltransferase as effectively as 5-methylcytosine residues in double-stranded DNA stimulate maintenance methylation.We present in vitro evidence that the mammalian de novo DNA methyltransferases DNMT3A and DNMT3B, but not the maintenance enzyme DNMT1, are also redox-dependent DNA dehydroxymethylases.Direct comparison to met1 plants, deficient in maintenance methyltransferase MET1, showed higher sensitivity of ddm1 plants to NaCl."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "515dd3d5298dcd4e5100001c",
                            "question": "In what proportion of children with heart failure has Enalapril been shown to be safe and effective?"
                        }
                    ],
                    "context": "The responses to IV KCl were attenuated by concomitant furosemide (p\u00a0=\u00a00.01), amphotericin B (p\u00a0<\u00a00.01), and KCl in parenteral nutrition (p\u00a0<\u00a00.01). The responses were augmented by concomitant enalaprilTo determine whether an angiotensin-converting enzyme (ACE) inhibitor, enalapril, prevents cardiac function deterioration (defined using maximal cardiac index [MCI] on exercise testing or increase in left ventricular end-systolic wall stress [LVESWS]) in long-term survivors of pediatric cancer.Enalapril treatment did not influence exercise performance, but did reduce LVESWS in the first yearPatients with intraatrial baffle procedure for transposition of the great arteries (TGA) have diastolic dysfunction, decreased exercise capacity, stroke volume response and elevated systemic vascular resistance (SVR) during exercise.We conclude that short-term (<1 year) use of enalapril does not improve exercise performance in patients with TGA in whom the intraatrial baffle procedure has been performed."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54e262daae9738404b000018",
                            "question": "Which cell type has the protein Chromogranin A as marker?"
                        }
                    ],
                    "context": "Neuroendocrine differentiation (chromogranin A and/or synaptophysin positivity) All paragangliomas were universally positive for chromogranin A chromogranin A (CGA) is a useful marker for pancreatic neuroendocrine tumors (pNET)Together with Chromogranin B and Secretogranins, Chromogranin A (CGA) is stored in secretory (chromaffin) granules of the diffuse neuroendocrine systemChromogranin A (CgA) is the most important general tumour marker used in the diagnosis and follow-up of patients with neuroendocrine tumours (NET)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56d1f790f22319765a000001",
                            "question": "Which gene harbors the mutation T790M?"
                        }
                    ],
                    "context": "Nearly one half of all cases of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for non-small-cell lung cancer (NSCLC) are due to the T790M mutation in EGFR exon 20. Two types of epidermal growth factor receptor (EGFR) mutations in exon 19 and exon 21 (ex19del and L858R) are prevalent in lung cancer patients and sensitive to targeted EGFR inhibition. A resistance mutation in exon 20 (T790M) has been found to accompany drug treatment when patients relapse. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.However, resistance to the EGFR TKIs develops mostly secondary to T790M mutation in exon 20. The T790M mutation in EGFR accounts for approximately half of all lung cancer cases with acquired resistance to the current clinical EGFR tyrosine kinase inhibitors."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "57138eb21174fb175500000a",
                            "question": "Which is the protein implicated in Spinocerebellar ataxia type 3?"
                        }
                    ],
                    "context": "Spinocerebellar ataxia type 3 (SCA3) is the most frequent inherited cerebellar ataxia in Europe, the US and Japan, leading to disability and death through motor complications. Although the affected protein ataxin-3 is found ubiquitously in the brain, grey matter atrophy is predominant in the cerebellum and the brainstemSpinocerebellar ataxia type 3 (SCA3) is an inherited spinocerebellar ataxia caused by the expansion of trinucleotide CAG repeats in the gene encoding ataxin-3Ataxin-3 is a ubiquitously expressed deubiqutinating enzyme with important functions in the proteasomal protein degradation pathway and regulation of transcription. The C-terminus of the ataxin-3 protein contains a polyglutamine (PolyQ) region that, when mutationally expanded to over 52 glutamines, causes the neurodegenerative disease spinocerebellar ataxia 3 (SCA3)Spinocerebellar ataxia type 3 is a neurodegenerative disorder caused by the expansion of the polyglutamine repeat region within the ataxin-3 protein.Spinocerebellar ataxia type 3 is caused by a polyglutamine expansion in the ataxin-3 protein, resulting in gain of toxic function of the mutant protein."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "513ce5f2bee46bd34c00000a",
                            "question": "Which is the prevalence of cystic fibrosis in the human population?"
                        }
                    ],
                    "context": "The allelic frequency of this variant was calculated to be 0.7% for this populationThe results of literature reviews, surveys, and registry analyses revealed a mean prevalence of 0.737/10,000 in the 27 EU countries, which is similar to the value of 0.797 in the United States, and only one outlier, namely the Republic of Ireland at 2.98The age related prevalence of CF among the South Asian and general populations was: 0-14 years, 1:9200 versus 1:6600; 15-24 years, 1:13,200 versus 1:7600; older than 25 years, 1:56,600 versus 1:12,400.A theoretical estimate of the prevalence of cystic fibrosis based on anthropological data suggested a frequency of 25 affected individuals/100,000 inhabitants. However, our data indicated that the true prevalence in the population was considerably lower (6.9 cases/100,000 inhabitants)CF mutations were identified in 374 (4.0%) individuals."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5505a587f73303d458000005",
                            "question": "What does mTOR stands for?"
                        }
                    ],
                    "context": " mammalian target of rapamycin (mTOR)mammalian target of rapamycin (mTOR)mammalian target of rapamycin (mTOR)mammalian target or rapamycin (mTOR)mammalian target of rapamycin (mTOR)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5722027a0fd6f91b68000014",
                            "question": "Which is the most common genetic lesion among patients with Joubert Syndrome and a cerebello-oculo-renal phenotype?"
                        }
                    ],
                    "context": "Nephronophthisis (NPHP) is the major cause of pediatric renal failure, yet the disease remains poorly understood, partly due to the lack of appropriate animal models. Joubert syndrome (JBTS) is an inherited ciliopathy giving rise to NPHP with cerebellar vermis aplasia and retinal degeneration. Among patients with JBTS and a cerebello-oculo-renal phenotype, mutations in CEP290 (NPHP6) are the most common genetic lesionAmong patients with JBTS and a cerebello-oculo-renal phenotype, mutations in CEP290 (NPHP6) are the most common genetic lesion.Among patients with JBTS and a cerebello-oculo-renal phenotype, mutations in CEP290 (NPHP6) are the most common genetic lesionAmong patients with JBTS and a cerebello-oculo-renal phenotype, mutations in CEP290 (NPHP6) are the most common genetic lesion. Joubert syndrome (JBTS) is an inherited ciliopathy giving rise to NPHP with cerebellar vermis aplasia and retinal degeneration. Among patients with JBTS and a cerebello-oculo-renal phenotype, mutations in CEP290 (NPHP6) are the most common genetic lesion."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cf236f3975bb303a000002",
                            "question": "Which calcium channels does ethosuximide target?"
                        }
                    ],
                    "context": "In the present study, we examined whether ethosuximide (ETX), a T-channel antagonist, could decrease the severity of ethanol withdrawal seizures by evaluating electrographical and behavioral correlates of seizure activity.In rats, intraplantar (i.pl.) administration of db-cAMP or PGE(2)  caused mechanical hyperalgesia, an effect suppressed by AKAPI, two distinct T-channel blockers, NNC 55-0396 and ethosuximide, or ZnCl(2) , known to inhibit Ca(v) 3.2 among T channels.Theta rhythms remained disrupted during a subsequent week of withdrawal but were restored with the T-type channel blocker ethosuximide.Given evidence that chemotherapy-induced neuropathic pain is blocked by ethosuximide, known to block T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-\u03b3-lyase (CSE), a major H\u2082S-forming enzyme in the peripheral tissue, are capable of reversing the neuropathic pain evoked by paclitaxel, an anti-cancer drug.The results demonstrate that both ethosuximide and the active metabolite of methsuximide, alpha-methyl-alpha-phenylsuccinimide (MPS), block human T-type channels in a state-dependent manner, with higher affinity for inactivated channels."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55201a316b348bb82c000019",
                            "question": "What is the sedimentation coefficient of the mammalian mitoribosome?"
                        }
                    ],
                    "context": " The mammalian mitochondrial ribosomes (55S)The mammalian mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S, consisting of 39 S large and 28 S small subunits.The 55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice as much protein as the Escherichia coli ribosome. 59 of 78 proteins of the 55S mitoribosome, several TIM and TOM proteins and cell death proteins were present.The sedimentation coefficient of the intact monosome was about 55 S. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55032efde9bde69634000035",
                            "question": "Which receptor is targeted by telcagepant?"
                        }
                    ],
                    "context": "In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232.Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: results from a randomized study in patients with migraine.Olcegepant is the first selective CGRP receptor antagonist of proven efficacy in migraine. Olcegepant could only be administered intravenously and never taken beyond Phase II. Telcagepant is orally available and several completed Phase III trials have revealed positive results. Telcagepant (MK-0974) is a novel calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com/research/pipeline/home.html).Four chemically unrelated CGRP receptor (CGRP-R) antagonists (olcegepant, telcagepant, MK-3207 and BI 44370 TA) have displayed efficacy in the treatment of migraine. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "553656c4bc4f83e828000009",
                            "question": "Which translocation is harbored in the Askin tumor cells?"
                        }
                    ],
                    "context": "The Ewing sarcoma family of tumors includes osseous Ewing sarcoma, extraskeletal Ewing sarcoma, primitive neuroectodermal tumor, and Askin tumor. They share a karyotype abnormality with translocation involving chromosomes 11 and 22Ewing tumor family consists of Ewing tumor of bone, extraosseous Ewing tumor, primitive neurectodermal tumor and Askin tumor. All of them share genetic abnormality, reciprocal translocation (11; 22) (q24; q12), and originate from the same primordial stem cellChromosomal analysis of the neoplastic cells revealed translocation (11;22)(q24;q12), which is often found in Ewing's sarcoma and Askin tumorMalignant small cell tumor of the thoracopulmonary region (MSCT) was first described in 1979 and has been referred to as the Askin tumorMSCT and PPNET have a common reciprocal cytogenetic translocation [t(11;22)q(24;q12)], which is shared with Ewing's sarcoma"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56bdcc4cef6e394741000002",
                            "question": "Which R/bioconductor package utilizes the Hilbert curve in order to visualize genomic data?"
                        }
                    ],
                    "context": "In many genomic studies, one works with genome-position-dependent data, e.g. ChIP-chip or ChIP-Seq scores. Using conventional tools, it can be difficult to get a good feel for the data, especially the distribution of features. This article argues that the so-called Hilbert curve visualization can complement genome browsers and help to get further insights into the structure of one's data. This is demonstrated with examples from different use cases. An open-source application, called HilbertVis, is presented that allows the user to produce and interactively explore such plots.AVAILABILITY: http://www.ebi.ac.uk/huber-srv/hilbert/."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1d856ef6e394741000032",
                            "question": "Which pathway is activated by ficolin-3?"
                        }
                    ],
                    "context": "This study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway and SLE. Ficolin-3 (also called H-ficolin or Hakata antigen) is a complement-activating pattern recognition molecule, possessing a fibrinogen-like domain involved in carbohydrate binding. Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine serum albumin (acBSA) and measured as Ficolin-3 binding and deposition of C4, C3 and the terminal complement complex (TCC).Furthermore, Ficolin-3 mediated complement activation may be valuable in monitoring disease activity in SLE patients due to the high sensitivity for complement consumption in the assay independent of the Ficolin-3 concentration.OBJECTIVES: To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH) pathology and outcome."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f01aef6e394741000043",
                            "question": "What is targeted by monoclonal antibody Pembrolizumab?"
                        }
                    ],
                    "context": "gents currently in active clinical development for lung cancer include ipilimumab, which modulates the cytotoxic T-lymphocyte-associated antigen 4 pathway, and multiple agents targeting the programmed death protein 1 (PD-1) pathway, both anti-PD-1 compounds (nivolumab, pembrolizumab [MK-3475]) and those that target programmed death ligand 1 (PD-L1), a key ligand for PD-1 (BMS-936559, MPDL3280A). Ipilimumab (CTLA-4) and pembrolizumab (PD-1) are approved by the US Food and Drug Administration for the treatment of advanced melanoma, and additional regulatory approvals are expected across the oncologic spectrum for a variety of other agents that target these pathways.Pembrolizumab inhibits the programmed cell death 1 (PD-1) immune checkpoint and has antitumor activity in patients with advanced melanoma.CONCLUSIONS: The anti-PD-1 antibody pembrolizumab prolonged progression-free survival and overall survival and had less high-grade toxicity than did ipilimumab in patients with advanced melanoma. METHODS: We conducted a phase 2 study to evaluate the clinical activity of pembrolizumab, an anti-programmed death 1 immune checkpoint inhibitor, in 41 patients with progressive metastatic carcinoma with or without mismatch-repair deficiency."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52e8e93498d023950500001e",
                            "question": "What is the mode of inheritance of Facioscapulohumeral muscular\r\ndystrophy (FSHD)?"
                        }
                    ],
                    "context": "autosomal dominant mode of inheritance"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56bb68f9ac7ad1001900000b",
                            "question": "What is the cause of Phthiriasis Palpebrarum?"
                        }
                    ],
                    "context": "Phthiriasis palpebrarum is an uncommon cause of blepharoconjunctivitis in which Pthirus pubis infest the eyelashes. We report a case of unilateral phthiriasis palpebrarum with crab louse. BACKGROUND: Pediculosis capitis is a common parasitic infestation, whereas phthiriasis palpebrarum is an uncommon infection due to Phthirus pubis (pubic lice) inoculating the eyelashes and surrounding tissues of the eye. Head lice typically do not infect the eyes, and given the different morphology of the lice on the patient's head and eyes, a diagnosis of phthiriasis palpebrarum was made. P. pubis can cause pruritic eyelid margins or unusual blepharoconjunctivitis. We present a case of phthiriasis palpebrarum in a 4-year-old boy.INTRODUCTION: Phthiriasis palpebrarum is an ectoparasitosis in which Phthirus pubis infest the eyelashes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f9ae2506d9727f76000002",
                            "question": "Which gene is mutated in a subtype of arrhythmogenic right ventricular cardiomyopathy known as Naxos disease?"
                        }
                    ],
                    "context": "Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inheritable myocardial disorder associated with fibrofatty replacement of myocardium and ventricular arrhythmia. A subset of ARVC is categorized as Naxos disease, which is characterized by ARVC and a cutaneous disorder. A homozygous loss-of-function mutation of the Plakoglobin (Jup) gene, which encodes a major component of the desmosome and the adherens junction, had been identified in Naxos patients, although the underlying mechanism remained elusive.Loss-of-function mutation of Jup has been associated with Naxos disease, which is characterized by arrhythmogenic cardiomyopathy and the cutaneous disorder palmoplantar keratoderma.Previously, we have shown that genetic ablation of Jup in cardiomyocytes in mice leads to arrhythmogenic cardiomyopathy similar to Naxos disease in humans.As similar phenotypes have been described in Naxos disease and Carvajal syndrome, respectively, the genes for plakoglobin (JUP) and desmoplakin (DSP) were screened for mutations using direct genomic sequencing. One is a C-terminal mutation causing Naxos disease, a recessive syndrome of arrhythmogenic right ventricular cardiomyopathy (ARVC) and abnormal skin and hair."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f020ef6e394741000047",
                            "question": "Which disorder is rated by Palmini classification?"
                        }
                    ],
                    "context": "This study also provides an opportunity to compare the predictive value of the ILAE and Palmini et al classification schemes with regard to the type I focal cortical dysplasias.Of the 91 patients, there were 50 patients with ILAE focal cortical dysplasia type Ib, 41 with ILAE focal cortical dysplasia type Ic, 63 with Palmini et al focal cortical dysplasia type IA, and 28 with Palmini et al focal cortical dysplasia type IB. Crude analysis revealed no significant difference between patients with subtypes of ILAE focal cortical dysplasia type I or Palmini et al focal cortical dysplasia type I concerning postoperative outcome according to the Engel and ILAE scoring systems on seizure frequency. Our findings revealed no significant difference concerning surgical outcome with respect to seizure frequency for the histologic subtypes of ILAE focal cortical dysplasia type I (Ib vs Ic) or Palmini et al focal cortical dysplasia type I (IA vs IB).MCD were classified following the existing classification schemes (Barkovich et al., 2012. Brain. 135, 1348-1369; Palmini et al., 2004. Neurology. 62, S2-S8) and the ILAE classification for FCD recently proposed by Bl\u00fcmcke in 2011. DISCUSSION: This short review provides an overview of the issues which account for the varied historical approaches to FCD classification and descriptions of gross pathologic findings associated with FCD and an overview of two more recently developed and widely used schema, the Palmini et al. (Neurology 62: S2-8, 2004) and the International League Against Epilepsy (ILAE) classifications Blumcke et al. Epilepsia 52: 158-174, 2011. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5713c8d71174fb1755000015",
                            "question": "Which peripheral neuropathy has been associated with NDRG1 mutations?"
                        }
                    ],
                    "context": "CMT4D disease is a severe autosomal recessive demyelinating neuropathy with extensive axonal loss leading to early disability, caused by mutations in the N-myc downstream regulated gene 1 (NDRG1)In a previous study, we have shown that N-myc downstream-regulated gene 1 (NDRG1), classified in databases as a tumor suppressor and heavy metal-response protein, is mutated in hereditary motor and sensory neuropathy Lom (HMSNL), a severe autosomal recessive form of Charcot-Marie-Tooth (CMT) diseaseIn the primary peripheral demyelinating neuropathies(CMT1), at least 9 genes have been associated with the disorders; altered dosage of peripheral myelin protein 22(PMP22) or point mutation of PMP22, the gap junction protein 1(GJB1), the myelin protein zero gene(MPZ), the early growth response gene 2(EGR2), the myotubularin-related protein 2 gene(MTMR2), the N-myc downstream-regulated gene 1 (NDRG1), the L-periaxin gene(PRX), SRY-related HMG-BOX gene 10(SOX10) and the ganglioside-induced differentiation-associated protein 1 gene(GDAP1).The NDRG1 gene is located within this interval and NDRG1 mutations have been shown to cause hereditary motor and sensory neuropathy-Lom in humans (CMT4D).Genetic studies have revealed the following gene mutations as the causes of inherited neuropathies; PMP22, MPZ, EGR2, SOX10, SIMPLE/LITAF, ARHGEF10 for CMT1 (autosomal dominant demyelinating form); GDAP1, MTMR2, SBF2/MTMR13, KIAA1985, NDRG1 PRX for CMT4 (autosomal recessive demyelinating form), MFN2, KIF1B, RAB7, GARS, NEFL, HSPB1, HSPB8 for CMT2 (autosomal dominant axonal form); LMNA, GAN1, KCC3, TDP1, APTX, SETX for AR-CMT2 (autosomal recessive axonal form); GIB1 for CMTX (X-linked CMT); DNM2 for CMT-DI (autosomal dominant CMT with intermediate nerve conduction velocities); and DHH for minifascicular neuropathy."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51bdd9c2047fa84d1d000002",
                            "question": "Which is the receptor for substrates of Chaperone Mediated Autophagy?"
                        }
                    ],
                    "context": "These proteins are targeted by chaperones and delivered to lysosomes where they are translocated into the lysosomal lumen and degraded via the lysosome-associated membrane protein type 2A (LAMP-2A)Macroautophagy is followed by chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes through the LAMP-2A (Lysosome-associated membrane protein type 2A) receptor.CMA activity has been shown to be proportional to levels of the CMA receptor Lamp-2a.Lysosomes from livers of lipid-challenged mice had a marked decrease in the levels of the CMA receptor, the lysosome-associated membrane protein type 2A,We report that Bcl-2-related early rod apoptosis was associated with the upregulation of autophagy markers including chaperone-mediated autophagy (CMA) substrate receptor LAMP-2"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f509512059c6d71c000020",
                            "question": "What is the mode of inheritance of short QT syndrome?"
                        }
                    ],
                    "context": "Congenital short QT syndrome is a new familial primary electrical disease of the heart, which is characterized by abnormally short QT interval and paroxysmal atrial and ventricular tachyarrhythmias, including sudden cardiac death. An autosomal dominant mode of inheritance has been suggested. From 1993, the Short QT Syndrome (SQTS) came to our attention, as a new inherited \"electrical disease\" associated with increased risk of sudden cardiac death and atrial fibrillation. Mutations of Ikr, Iks, Ikl channels cause dysfunctional Iks, Ikr, Ikl channels with an increase in the net outward K current leading to shortening of repolarization. This in turn leads to a shorter QT interval on the ECG and shorter atrial and ventricular refractory periods with increased susceptibility to VF and AF. There seems to be an autosomal dominant mode of inheritance."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "57279ef20fd6f91b68000018",
                            "question": "Which intraflagellar transport (IFT) motor protein has been linked to human skeletal ciliopathies?"
                        }
                    ],
                    "context": "Cytoplasmic dynein-2 (dynein-2) performs intraflagellar transport and is associated with human skeletal ciliopathiesCytoplasmic dynein-2 is the motor for retrograde intraflagellar transport (IFT), and mutations in dynein-2 are known to cause skeletal ciliopathiesIntraflagellar transport (IFT) depends on two evolutionarily conserved modules, subcomplexes A (IFT-A) and B (IFT-B), to drive ciliary assembly and maintenance. All six IFT-A components and their motor protein, DYNC2H1, have been linked to human skeletal ciliopathies, including asphyxiating thoracic dystrophy (ATD; also known as Jeune syndrome), Sensenbrenner syndrome, and Mainzer-Saldino syndrome (MZSDS)Bidirectional (anterograde and retrograde) motor-based intraflagellar transport (IFT) governs cargo transport and delivery processes that are essential for primary cilia growth and maintenance and for hedgehog signaling functions. The IFT dynein-2 motor complex that regulates ciliary retrograde protein transport contains a heavy chain dynein ATPase/motor subunit, DYNC2H1, along with other less well functionally defined subunits. Deficiency of IFT proteins, including DYNC2H1, underlies a spectrum of skeletal ciliopathiesAll six IFT-A components and their motor protein, DYNC2H1, have been linked to human skeletal ciliopathies, including asphyxiating thoracic dystrophy (ATD; also known as Jeune syndrome), Sensenbrenner syndrome, and Mainzer-Saldino syndrome (MZSDS)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5353aedb288f4dae47000006",
                            "question": "Which is the transcript responsible for X-chromosome inactivation?"
                        }
                    ],
                    "context": "Xist, a gene responsible for X chromosome inactivation (XCI)X inactivation-specific transcript (XIST) is a long ncRNA that mediates X chromosome inactivationthe X inactive specific transcript (Xist) gene, which is known now to represent the master switch locus regulating X inactivationIST, a long non-coding RNA, plays an important role in triggering X chromosome inactivation in eutheriansX inactive-specific transcript (XIST) gene in humans"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c83f365795f9a73e000011",
                            "question": "Which domain allowing self-association do exist in TDP-43 and FUS proteins?"
                        }
                    ],
                    "context": "Using transient expression of a panel of deletion and chimeric FUS variants in various cultured cells, we demonstrated that FUS accumulating in the cytoplasm nucleates a novel type of RNA granules, FUS granules (FGs), that are structurally similar but not identical to physiological RNA transport granules. Formation of FGs requires FUS N-terminal prion-like domain and the ability to bind specific RNAs. Clustering of FGs coupled with further recruitment of RNA and proteins produce larger structures, FUS aggregates (FAs), that resemble but are clearly distinct from stress granules.Approximately 1% of human proteins harbor a prion-like domain (PrLD) of similar low complexity sequence and amino acid composition to domains that drive prionogenesis of yeast proteins like Sup35. PrLDs are over-represented in human RNA-binding proteins and mediate phase transitions underpinning RNP granule assembly. This modality renders PrLDs prone to misfold into conformers that accrue in pathological inclusions that characterize various fatal neurodegenerative diseases. For example, TDP-43 and FUS form cytoplasmic inclusions in amyotrophic lateral sclerosis (ALS) and mutations in TDP-43 and FUS can cause ALS.FUS and TDP-43, which rank 1st and 10th among RRM-bearing prion candidates, form cytoplasmic inclusions in the degenerating motor neurons of ALS patients and mutations in TDP-43 and FUS cause familial ALS. Amyotrophic lateral sclerosis (ALS) is a devastating and universally fatal neurodegenerative disease. Mutations in two related RNA-binding proteins, TDP-43 and FUS, that harbor prion-like domains, cause some forms of ALS.two RNA-binding proteins, FUS and TDP-43, which form cytoplasmic aggregates in amyotrophic lateral sclerosis, harbor a 'prion domain' similar to those found in several yeast prion proteins."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56d042ae3975bb303a00000d",
                            "question": "When ceritinib used instead of crizotinib?"
                        }
                    ],
                    "context": "Ceritinib is a second-generation ALK inhibitor that has demonstrated activity in crizotinib-resistant patients, becoming a promising treatment option in this population. Ceritinib is approved for the treatment of ALK-positive metastatic NSCLC in patients who are intolerant to or have progressed despite therapy with crizotinib. Ceritinib has activity in crizotinib-resistant and crizotinib-na\u00efve patients and appears to be a viable alternative for ALK-positive NSCLC.In this review, we aim to present the current knowledge on acquired resistance of crizotinib known as a first-in-class ALK inhibitor and potential solutions to improve the cost-effectiveness, and to review the difference between ceritinib and crizotinib; preclinical data and results of the elegant early clinical trial of ceritinib which promoted its accelerated approval, pharmacokinetics, safety profile, and tolerability, the updated results (eg, efficacy on brain metastases), and robust design of ongoing phase II/III trials, and future directions of ceritinib to be a potent alternative to crizotinib for ALK-rearranged non-small-cell lung cancer are also presented.Altogether, our results demonstrate that ceritinib can overcome crizotinib resistance, consistent with clinical data showing marked efficacy of ceritinib in patients with crizotinib-resistant disease."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf1f1303868f1b06000014",
                            "question": "What type of enzyme is peroxiredoxin 2 (PRDX2)?"
                        }
                    ],
                    "context": "Peroxiredoxin-2 (PRDX-2) is an antioxidant and chaperone-like protein critical for cell function.We found that the antioxidant enzyme peroxiredoxin-2 (Prx2) inversely correlated with the metastatic capacity of human melanoma cells.The aim of this study was to examine gonadotropin regulation of antioxidant enzyme sulfiredoxin (Srx) and peroxiredoxin 2 (PRDX2) expressions and modification during the ovulatory process in rats. The mRNA profiler array showed more than 2-fold differential expression of 32 oxidative stress-related genes in unstimulated moDCs, including peroxiredoxin-2 (PRDX2), an enzyme reducing hydrogen peroxide and lipid peroxides. Peroxiredoxin-2 (Prx-2) is an abundant mammalian enzyme that protects against oxidative stress."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550f0e4c6a8cde6b72000003",
                            "question": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?"
                        }
                    ],
                    "context": "e expression of DUX4 has been confirmed in both FSHD cells and biopsies by several laboratories.These results indicate that molecular markers of the disease are already expressed during fetal life, thus opening a new field of investigation for mechanisms leading to FSHD.Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.DUX4, the primary candidate for FSHD pathogenesis, is upregulated over ten-fold in FSHD myoblasts and myotubes with short telomeres, and its expression is inversely proportional to telomere length. FSHD may be the first known human disease in which TPE contributes to age-related phenotype.Upregulation of the DUX4 retrogene from the last D4Z4 repeated unit is thought to underlie FSHD pathophysiology. However, no one knows what triggers muscle defect and when alteration arises. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5319ac36b166e2b806000031",
                            "question": "Which G protein is essential in the formation and function of lamellipodia?"
                        }
                    ],
                    "context": "We specifically identified that the Spa homology domain (aa 250-420) of GIT1 is required for GIT1-cortactin complex localization to the leading edge. The mechanisms involved extracellular signal-regulated kinases 1 and 2-mediated Cortactin-S405 phosphorylation and activation of Rac1/Cdc42.We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1 to the plasma membrane and induce the local formation of lamellipodia in response to focal illumination.We found that fibroblasts from EDG-1 null embryos did not migrate toward PDGF or SPP, and inhibition of motility correlated with defective activation of the small guanosine triphosphatase Rac, which is required for lamellipodia formation and directional locomotionDeletion of edg-1 or inhibition of sphingosine kinase suppressed chemotaxis toward PDGF and also activation of the small guanosine triphosphatase Rac, which is essential for protrusion of lamellipodia and forward movement.Evidence from these models indicates that migration is a highly complex process, which is likely to involve the tightly controlled spatial and temporal interaction of multiple factors:"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf217003868f1b0600001b",
                            "question": "What can Nothobranchius furzeri be used as a model system for?"
                        }
                    ],
                    "context": "The short-lived annual fish Nothobranchius furzeri shows extremely short captive life span and accelerated expression of age markers, making it an interesting model system to investigate the effects of experimental manipulations on longevity and age-related pathologies.Owing to large differences in aging phenotypes in different lines, N. furzeri could represent a model system for studying the genetic control of life-history traits in natural populations.It is very close to the Japanese Medaka, and close to the pufferfishes and stickleback and might represent a very useful model for comparative genomics of aging.In the last three years, N. furzeri has moved from biological curiosity to a promising model system for drug validation. This result identifies resveratrol as the first molecule which consistently retards aging in organisms as diverse as yeast, worm, fly and fish, but it also reveals the potential of this short-lived fish as an animal model for pharmacological research. Moreover, being related to stickleback (Gasterosteus aculeatus) the \"pufferfishes\" Takifugu and Tetraodon, and even more closely related to medaka (Oryzias latipes), it can greatly beneficiate from the recent development of genomic resources for these fish models and in the future become a complete model system for the aging research community."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f2228e64850a5854000002",
                            "question": "Which is the mass-tag that reveal the ubiquitination of a lysine residue?"
                        }
                    ],
                    "context": "antibodies that recognize the Lys-\u025b-Gly-Gly (K-\u025b-GG) remnant produced by trypsin digestion of proteins having ubiquitinated lysine side chains have markedly improved the ability to enrich and detect endogenous ubiquitination sites by mass spectrometry (MS). Recent publications have also highlighted the use of peptide-level immunoaffinity enrichment of K-GG modified peptides from whole cell lysates for global characterization of ubiquitination sites. In this work, levels of lysine ubiquitination were quantitated using a structurally homologous label that is chemically similar to the diglycine (GlyGly) tag, which is left at the ubiquitination site upon trypsinolysisTandem mass spectrometry (LC-MS/MS) analysis of immunoprecipitated proteins resulted in the identification of five peptides containing ubiquitin (diglycine) modifications on eIF2B\u03b5"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5323640b9b2d7acc7e000014",
                            "question": "Which gene is involved in CADASIL?"
                        }
                    ],
                    "context": "leukoencephalopathy (CADASIL), the most common form of familial vascular dementia, is caused by mutations of the NOTCH3 geneCerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary disease caused by mutations of the Notch3 gene encoding the Notch3 protein. Notch3 is involved in the regulation of apoptosis, modulating Fas-Ligand (Fas-L)- induced apoptosis.: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease of the brain caused by mutations in the NOTCH3 geneMutations in Notch3 gene are linked to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a disorder characterized by stroke and dementia in young adults(CADASIL) is caused by mutations in the NOTCH3 gene and is clinically characterized by recurrent stroke, cognitive decline, psychiatric disturbances and migraine"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf1d2e03868f1b0600000c",
                            "question": "Which gene is associated with Muenke syndrome?"
                        }
                    ],
                    "context": "Abstract Muenke is a fibroblast growth factor receptor 3 (FGFR-3) associated syndrome, which was first described in late 1990s. The syndrome is defined molecularly by a unique point mutation c.749C>G in exon 7 of the FGFR3 gene which results to an amino acid substitution p.Pro250Arg of the protein product. Muenke syndrome is an autosomal dominant craniosynostosis syndrome resulting from a defining point mutation in the Fibroblast Growth Factor Receptor3 (FGFR3) gene. Muenke syndrome is caused by a single defining point mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.Muenke syndrome is characterized by various craniofacial deformities and is caused by an autosomal-dominant activating mutation in fibroblast growth factor receptor 3 (FGFR3(P250R)               )."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56bc77a3ac7ad10019000015",
                            "question": "RTS S AS01 vaccine was developed to prevent which disease?"
                        }
                    ],
                    "context": "This randomized, double-blind study (NCT01323972) assessed consistency of three RTS,S/AS01 malaria vaccine batches formulated from commercial-scale purified antigen bulk lots in terms of anti-CS-responses induced.Until now, only one candidate malaria vaccine RTS,S/AS01 has shown modest protection in phase 3 trial in African infants. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.BACKGROUND: The efficacy and safety of the RTS,S/AS01 candidate malaria vaccine during 18 months of follow-up have been published previously. INTERPRETATION: RTS,S/AS01 prevented a substantial number of cases of clinical malaria over a 3-4 year period in young infants and children when administered with or without a booster dose. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54cb9c94f693c3b16b000005",
                            "question": "Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?"
                        }
                    ],
                    "context": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN). Dephosphorylated PLN is an inhibitor of SERCA2a and phosphorylation by protein kinase A (PKA) or calcium-calmodulin-dependent protein kinases (CAMKII) relieves these inhibitory effects.SERCA2a activity can be regulated at multiple levels of a signaling cascade comprised of phospholambanPhospholamban (PLN), the reversible inhibitor of the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a), is a key regulator of myocyte Ca(2+) cycling with a significant role in heart failure.The sarco(endo)plasmic reticulum (SR) Ca(2+) transport ATPase (SERCA2a) and its inhibitor phospholamban (PLN) control the uptake of Ca(2+) by SR membranes during relaxation. phospholamban (PLN), a muscle-specific SR Ca(2+)-ATPase (SERCA2a) inhibitor"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5519113b622b19434500000f",
                            "question": "Which gene is responsible for the development of the Mowat-Wilson syndrome?"
                        }
                    ],
                    "context": "The cause of MWS is a de novo mutation in the ZEB2 gene.zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.Intrahepatic biliary anomalies in a patient with Mowat-Wilson syndrome uncover a role for the zinc finger homeobox gene zfhx1b in vertebrate biliary developmentWe used the zebrafish model system to determine whether zfhx1b has a role in vertebrate biliary developmentComprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "531d6bfc267d7dd053000007",
                            "question": "How is active neurotoxin of Clostridium botulinum detected?"
                        }
                    ],
                    "context": "The neurotoxin detection is based on the mouse lethality assay. which could be shown by bioassay to produce biologically active type B toxin in culture.Human induced pluripotent stem cells (hiPSC) hold great promise for providing various differentiated cell models for in vitro toxigenicity testing. A direct comparison of BoNT detection using primary rat spinal cord cells and hiPSC-derived neurons showed equal or increased sensitivityBoNT/A intoxication studies demonstrate that the hiPSC-derived neurons reproducibly and quantitatively detect biologically active BoNT/A with high sensitivity (EC(50) \u223c0.3 U)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56d19a363975bb303a000017",
                            "question": "Which factor interacts with Treslin/TICRR throughout the cell cycle of human cells?"
                        }
                    ],
                    "context": "We identified MDM two binding protein (MTBP) as a factor that interacts with Treslin/TICRR throughout the cell cycle. We show that MTBP depletion by means of small interfering RNA inhibits DNA replication by preventing assembly of the CMG (Cdc45-MCM-GINS) holohelicase during origin firing. Although MTBP has been implicated in the function of the p53 tumor suppressor, we found MTBP is required for DNA replication irrespective of a cell's p53 status. We propose that MTBP acts with Treslin/TICRR to integrate signals from cell cycle and DNA damage response pathways to control the initiation of DNA replication in human cells.We identified MDM two binding protein (MTBP) as a factor that interacts with Treslin/TICRR throughout the cell cycleTreslin/TICRR (TopBP1-interacting, replication stimulating protein/TopBP1-interacting, checkpoint, and replication regulator), the human ortholog of the yeast Sld3 protein, is an essential DNA replication factor that is regulated by cyclin-dependent kinases and the DNA damage checkpoint. We identified MDM two binding protein (MTBP) as a factor that interacts with Treslin/TICRR throughout the cell cycle."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5149f494d24251bc0500004c",
                            "question": "Which medication should be administered when managing patients with suspected acute opioid overdose?"
                        }
                    ],
                    "context": "Opioid overdose has a high mortality, but is often reversible with appropriate overdose management and naloxone (opioid antagonist). Training clinicians how to manage an opioid overdose and administer naloxone was effective.For patients who have ingested dextromethorphan and are sedated or comatose, naloxone, in the usual doses for treatment of opioid overdose, can be considered for prehospital administration, particularly if the patient has respiratory depressionNaloxone hydrochloride, an injectable opioid antagonist which reverses the respiratory depression, sedation and hypotension associated with opioids, has long been used to treat opioid overdose. Experts have suggested that, as part of a comprehensive overdose prevention strategy, naloxone should be provided to heroin users for peer administration after an overdose. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cdf3e55795f9a73e00003c",
                            "question": "Which type of GTPases is required for amino acid-dependent activation of mTORC1?"
                        }
                    ],
                    "context": "Heterodimeric Rag GTPases are required for amino-acid-mediated mTORC1 activation at the lysosomeAmino acids stimulate, in a Rag-, Ragulator-, and vacuolar adenosine triphosphatase-dependent fashion, the translocation of mTORC1 to the lysosomal surface, where it interacts with its activator RhebmTORC1 promotes growth in response to the availability of nutrients, such as amino acids, which drive mTORC1 to the lysosomal surface, its site of activation. How amino acid levels are communicated to mTORC1 is only recently coming to light by the discovery of a lysosome-based signaling system composed of Rags (Ras-related GTPases) and Ragulator v-ATPase, GATOR (GAP activity towards Rags), and folliculin (FLCN) complexesThe mechanistic target of rapamycin complex 1 (mTORC1) kinase is a major regulator of cell growth that responds to numerous environmental cues. A key input is amino acids, which act through the heterodimeric Rag GTPases (RagA or RagB bound to RagC or RagD) in order to promote the translocation of mTORC1 to the lysosomal surface, its site of activationThe heterodimeric Rag GTPases localize mTORC1 to lysosomes by their amino-acid-dependent interaction with the lysosomal Ragulator complex."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54df695b1388e8454a000004",
                            "question": "What is the synonym of the lubag disease?"
                        }
                    ],
                    "context": "IMPORTANCE: Despite recessive inheritance, X-linked dystonia-parkinsonism (Lubag disease) has also been described in women presenting with a late-onset isolated parkinsonian syndrome.Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men. X-linked dystonia parkinsonism syndrome (XDP, lubag): disease-specific sequence change DSC3 in TAF1/DYT3 affects genes in vesicular transport and dopamine metabolism.X-chromosomal dystonia parkinsonism syndrome (XDP, 'lubag') is associated with sequence changes within the TAF1/DYT3 multiple transcript system. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51724fca8ed59a060a000013",
                            "question": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences"
                        }
                    ],
                    "context": "The problem of finding an optimal structural alignment for a pair of superimposed proteins is often amenable to the Smith-Waterman dynamic programming algorithm, which runs in time proportional to the product of lengths of the sequences being aligned.While this result is not an asymptotic improvement over the original Smith-Waterman algorithm, its complexity is characterized in terms of some sparse features of the matrix and it yields the fastest software implementation to date for such searches.If we use N, M and C to represent the size of an amino acid sequence, the size of a structure template, and the maximum cut size of long-range interactions, respectively, the algorithm finds an optimal structure-sequence alignment in O(21C NM) time, a polynomial function of N and M when C = O(log(N + M)). When running on structure-sequence alignment problems without long-range intersections, i.e. C = 0, the algorithm achieves the same asymptotic computational complexity of the Smith-Waterman sequence-sequence alignment algorithm.The algorithm is based on fractional programming and its running time is O(n2log n). In practice, normalized local alignment is only 3-5 times slower than the standard Smith-Waterman algorithm."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5506c3e38e1671127b00000a",
                            "question": "The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?"
                        }
                    ],
                    "context": "The plasma membrane Na(+)/Ca(2+) exchanger (NCX) is a bidirectional ion transporter that couples the translocation of Na(+) in one direction with that of Ca(2+) in the opposite direction. This system contributes to the regulation of intracellular Ca(2+) concentration via the forward mode (Ca(2+) efflux) or the reverse mode (Ca(2+) influx).Concerning the role of NCX in NO cytotoxicity, we have found, using the specific inhibitor of NCX 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline (SEA0400), that NCX is involved in NO-induced cytotoxicity in cultured microglia, astrocytes, and neuronal cells.The Na(+)/Ca(2+)exchanger (NCX) principal function is taking 1 Ca(2+) out of the cytoplasm and introducing 3 Na(+). The increase of cytoplasmic Na(+) concentration induces the NCX reverse mode (NCX(REV)), favoring Ca(2+) influx. NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.SEA0400 (1 \u03bcM), a pharmacological inhibitor of NCX, significantly shortened the MAP duration (P < .01) and reduced dispersion (P < .05). We have recently shown that the Na(+)/Ca(2+) exchanger (NCX) is involved in nitric oxide (NO)-induced cytotoxicity in cultured astrocytes and neurons. However, there is no in vivo evidence suggesting the role of NCX in neurodegenerative disorders associated with NO. NO is implicated in the pathogenesis of neurodegenerative disorders such as Parkinson's disease. This study examined the effect of SEA0400, the specific NCX inhibitor, on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity, a model of Parkinson's disease, in C57BL/6J mice."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56d85e7751531f7e33000001",
                            "question": "Which SLC family is FLVCR1 a member of?"
                        }
                    ],
                    "context": "Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis.Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis.Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis. Disruption of FLVCR1 function blocks development of erythroid progenitors, likely due to heme toxicity. Heme is critical for a variety of cellular processes, but excess intracellular heme may result in oxidative stress and membrane injury. Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis.Heme is critical for a variety of cellular processes, but excess intracellular heme may result in oxidative stress and membrane injury. Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56e47e0051531f7e3300001c",
                            "question": "Where are the orexigenic peptides synthesized?"
                        }
                    ],
                    "context": "Orexin A and B, orexigenic peptides produced primarily by the lateral hypothalamus tTelmisartin reduced hypothalamic mRNA levels of the orexigenic peptides melanin-concentrating hormone and prepro-orexinexpression of the orexigenic peptides, enkephalin (ENK) and galanin (GAL), in developing embryonic hypothalamic neuronshypothalamic orexigenic peptides, Such mechanisms may involve orexigenic peptides known to stimulate alcohol intake through their actions in the hypothalamic paraventricular nucleus (PVN)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5721f4b30fd6f91b68000011",
                            "question": "Which inherited disorder is known to be caused by mutations in the NEMO gene?"
                        }
                    ],
                    "context": "Incontinentia pigmenti (IP) is a rare neurocutaneous disorder with a frequency of 1 in 50,000 newborn, and is associated with mutations in IKBKG gene (NEMO) in Xq28, inherited as an X-linked dominant traitMutations in the NEMO gene give rise to a heterogeneous group of disorders, including the X-linked dominant disorder incontinentia pigmentiDe novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infantIncontinentia pigmenti (IP) is a rare, inherited, multisystem genodermatosis. It is transmitted as an X-linked dominant trait. The disorder is a consequence of mutations in the NEMO gene (Xq28) that completely abolish expression of the NF-kappaB essential modulatorIncontinentia pigmenti (IP) is a rare inherited multisystem disorder characterized by a distinctive swirling pattern of the skin; defects of teeth, hair, and nails; and ophthalmic, central nervous system, and musculoskeletal abnormalities. It progresses through several well-defined stages. IP is transmitted as a dominant X-linked trait with variable expressivity, but many--if not most--cases are sporadic. IP has been shown to result from mutations in the NEMO gene that completely abolish expression of NF-kappaB essential modulator"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "553c9f96f32186855800000c",
                            "question": "How are ultraconserved elements called when they form clusters?"
                        }
                    ],
                    "context": "We were wondering whether this approach could provide insights about utlraconserved non-coding elements (UCNEs). These elements are organized as large clusters, so-called gene regulatory blocks (GRBs) around key developmental genes. Their molecular functions and the reasons for their high degree of conservation remain enigmaticThis 'winner-takes-all' pattern suggests that UCNEs of a GRB function in a highly cooperative manner. We propose that the multitude of interactions between UCNEs is the reason for their extreme sequence conservationUCNEbase--a database of ultraconserved non-coding elements and genomic regulatory blocksThe majority of UCNEs are supposed to be transcriptional regulators of key developmental genes. As most of them occur as clusters near potential target genes, the database is organized along two hierarchical levels: individual UCNEs and ultra-conserved genomic regulatory blocks (UGRBs)These elements are organized as large clusters, so-called gene regulatory blocks (GRBs) around key developmental genes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cf36263975bb303a000007",
                            "question": "Which disease has been associated to a disruptive ALX1 protein?"
                        }
                    ],
                    "context": "Disruption of ALX1 causes extreme microphthalmia and severe facial clefting: expanding the spectrum of autosomal-recessive ALX-related frontonasal dysplasia.In the second family we identified a homozygous donor-splice-site mutation (c.531+1G>A) in the ALX1 gene, providing evidence that complete loss of function of ALX1 protein causes severe disruption of early craniofacial development. expression of Alx1, an effector of scapula blade patterning, is absent in all compound mutants.Mutations in each of the transcriptional co-activator genes - CBP, p300, Cited2, Cart1 and Carm1 - result in neural tube defects in mice.Scapular truncation in triple mutants of Tbx15, Alx4 and Cart1 indicates essential functions for Alx4 and Cart1 in the anterior part of the scapula"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "517170c48ed59a060a00000d",
                            "question": "How many selenoproteins are encoded in the human genome?"
                        }
                    ],
                    "context": "The human selenoproteome consists of 25 selenoproteins."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "534eb34b288f4dae47000002",
                            "question": "In which process Src, Cortactin and MT1-MMP are playing an essential role?"
                        }
                    ],
                    "context": "Further investigation into the underlying molecular mechanisms revealed that the levels of key modulators of invadopodium maturation, including c-Src kinase, cortactin, and membrane type 1-matrix metalloproteinase (MT1-MMP) decreased when cells were treated with 6-shogaol or pterostilbene. These data suggest that the repression of these factors might affect the maturation of invadopodia, inhibiting the metastasis of MDA-MB-231 cells. In conclusion, the present study demonstrates for the first time that 6-shogaol and pterostilbene can inhibit invadopodium formation and MMP activity in highly invasive breast cancer cells.EcTI was shown to decrease the expression and disrupt the cellular organization of molecules involved in the formation and maturation of invadopodia, such as integrin \u03b21, cortactin, neuronal Wiskott-Aldrich syndrome protein, membrane type 1 metalloprotease, and metalloproteinase-2. Moreover, gastric cancer cells treated with EcTI presented a significant decrease in intracellular phosphorylated Src and focal adhesion kinase, integrin-dependent cell signaling components.We show that Abl kinases are activated downstream of the chemokine receptor, CXCR4, and are required for cancer cell invasion and matrix degradation induced by SDF1\u03b1, serum growth factors, and activated Src kinase.Moreover, Abl kinases are readily detected at invadopodia assembly sites and their inhibition prevents the assembly of actin and cortactin into organized invadopodia structures."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5710e131a5ed216440000001",
                            "question": "In which yeast chromosome does the rDNA cluster reside?"
                        }
                    ],
                    "context": "Chromosome XII context is important for rDNA function in yeastThe rDNA cluster in Saccharomyces cerevisiae is located 450 kb from the left end and 610 kb from the right end of chromosome XII and consists of approximately 150 tandemly repeated copies of a 9.1 kb rDNA unitTo explore the biological significance of this specific chromosomal context, chromosome XII was split at both sides of the rDNA cluster and strains harboring deleted variants of chromosome XII consisting of 450 kb, 1500 kb (rDNA cluster only) and 610 kb were created. In the strain harboring the 1500 kb variant of chromosome XII consisting solely of rDNA, the size of the rDNA cluster was found to decrease as a result of a decrease in rDNA copy numberThese observations suggest that the context of chromosome XII plays an important role in maintaining a constant rDNA copy number and in physiological processes related to rDNA function in S.cerevisiae.Notably, strains harboring the 450 kb chromosome XII variant and/or the 1500 kb variant consisting solely of rDNA had shorter life spans than wild type and also accumulated extrachromosomal rDNA circles"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56e2acfe51531f7e33000014",
                            "question": "During which stage of the cell cycle is cohesin deposited on the yeast genome?"
                        }
                    ],
                    "context": "In the budding yeast, cohesin is loaded onto the chromosome during the late G1 phase, establishes sister chromatid cohesion concomitant with DNA replication, and dissociates by the telophase. Sister chromatid cohesion is mediated by cohesin, but the process of cohesion establishment during S-phase is still enigmatic.Instead, we find that cohesin stability increases at the time of S-phase in a reaction that can be uncoupled from DNA replication.By using \"single-copy\" derivatives of the 2-microm plasmid, we demonstrate that recruitment of cohesin at STB during S phase indeed translates into cohesion between plasmid molecules.In cells recovering from nocodazole-induced spindle depolymerization and G(2)/M arrest, cohesin-STB association can be established coincident with spindle restoration."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "517818508ed59a060a000035",
                            "question": "Which is the neurodevelopmental disorder associated to mutations in the X- linked gene mecp2?"
                        }
                    ],
                    "context": "Rett syndrome is caused by mutations in the gene coding for methyl CpG-binding protein 2 (MeCP2).Rett syndrome is one of the most common causes of complex disability in girls. It is characterized by early neurological regression that severely affects motor, cognitive and communication skills, by autonomic dysfunction and often a seizure disorder. It is a monogenic X-linked dominant neurodevelopmental disorder related to mutation in MECP2, which encodes the methyl-CpG-binding protein MeCP2.Recently, this syndrome has been associated with mutations of the MECP2 gene, a transcriptional repressor of still unknown target genes. Here we report a detailed mutational analysis of 62 patients from UK and Italian archives, representing the first comparative study among different populations and one of the largest number of cases so far analyzed.Out of the 365 cases, 315 had MECP2 gene mutations and 3 had de novo CDKL5 gene mutations. No patients had FOXG1 mutation.Mutations were detected in \u2248 70% of classic and \u2248 21% of variant RTT, respectively. Amongst MR cases, 2.1% carried MECP2 mutations."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56a8ee75a17756b72f000007",
                            "question": "What is the link between Dax1 and Esrrb?"
                        }
                    ],
                    "context": "Dax1 associates with Esrrb and regulates its function in embryonic stem cellsNuclear hormone receptor Dax1 is one of the crucial factors in the network. Here, we identified an orphan nuclear receptor, Esrrb (estrogen-related receptor beta), as a Dax1-interacting protein. Interaction of Dax1 and Esrrb was mediated through LXXLL motifs of Dax1 and the activation- and ligand-binding domains of Esrrb. Furthermore, Esrrb enhanced the promoter activity of the Dax1 gene via direct binding to Esrrb-binding site 1 (ERRE1, where \"ERRE\" represents \"Esrrb-responsive element\") of the promoter We also found that the transcriptional activity of Esrrb was repressed by Dax1. Furthermore, we revealed that Oct3/4, Dax1, and Esrrb have a competitive inhibition capacity for each complex. These data, together with previous findings, suggest that Dax1 functions as a negative regulator of Esrrb and Oct3/4, and these molecules form a regulatory loop for controlling the pluripotency and self-renewal capacity of ES cellsExpression of Dax1 was suppressed followed by Oct3/4 repression; however, overexpression of Esrrb maintained expression of Dax1 even in the absence of Oct3/4, indicating that Dax1 is a direct downstream target of Esrrb and that Esrrb can regulate Dax1 expression in an Oct3/4-independent manner.Interaction of Dax1 and Esrrb was mediated through LXXLL motifs of Dax1 and the activation- and ligand-binding domains of Esrrb."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "534abe8aaeec6fbd07000013",
                            "question": "Which heat shock protein is found to be upregulated during Hsp90 inhibition?"
                        }
                    ],
                    "context": "HSP90 inhibition was associated with decreased neuroendocrine ErbB and IGF-I receptor expression, decreased Erk and Akt phospho-rylation and the induction of HSP70 expression.Inhibition of Hsp90 upregulated the expression of Hsp70 and Hsp70-bound Nox2, 5 and promoted degradation.Conversely, inhibition of HSP90 significantly increased the expression of both VEGF and HGF mRNA, and induced HSP70 protein in PHH cultures in vitro."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571f33bd0fd6f91b68000003",
                            "question": "Which gene is responsible for the development of Sotos syndrome?"
                        }
                    ],
                    "context": "Sotos syndrome is a well-known overgrowth syndrome characterized by excessive growth during childhood, macrocephaly, distinctive facial appearance and learning disability. This disorder is caused by mutations or deletions in NSD1 geneSotos syndrome (SoS) is a multiple anomaly, congenital disorder characterized by overgrowth, macrocephaly, distinctive facial features and variable degree of intellectual disability. Haploinsufficiency of the NSD1 gene at 5q35.3, arising from 5q35 microdeletions, point mutations, and partial gene deletions, accounts for a majority of patients with SoSMutations and deletions of the NSD1 gene, located on chromosome 5q35, are responsible for over 90% of cases of Sotos syndrome.The NSD1 gene was recently found to be responsible for Sotos syndrome, and more than 150 patients with NSD1 alterations have been identified.Recently, deletions encompassing the nuclear receptor binding SET-Domain 1 (NSD1) gene have been described as the major cause of Japanese patients with the Sotos syndrome, whereas point mutations have been identified in the majority of European Sotos syndrome patients."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53617eeb7d100faa0900000a",
                            "question": "What is the name for anorexia in gymnasts?"
                        }
                    ],
                    "context": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.We studied 13 female juvenile elite gymnasts with anorexia athletica (AA"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "534e364e288f4dae47000001",
                            "question": "Approximately how many recombination hotspots have been found in the yeast genome?"
                        }
                    ],
                    "context": "In the fission yeast genome DSBs are located within 194 prominent peaks separated on average by 65-kbp intervals of DNA that are largely free of DSBsMost meiotic recombination is positioned at hotspots, but knowledge of the mechanisms is nebulousmeiotic recombination is initiated by double-strand DNA breaks (DSBs) which occur at relatively high frequencies in some genomic regions (hotspots) and relatively low frequencies in others (coldspots)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "533ea8fcc45e133714000010",
                            "question": "What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?"
                        }
                    ],
                    "context": "stem-loop structure called the selenocysteine incorporating sequence (SECIS)3'-UTR mRNA stem-loop termed SElenoCysteine Insertion Sequence (SECIS)Sec is inserted by a specific translational machinery that recognizes a stem-loop structure, the SECIS elementSelenocysteine Insertion Sequence (SECIS) element in the 3'UTR of the transcript.The proximal stem-loop promotes Sec insertion "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54edf81f94afd61504000014",
                            "question": "Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?"
                        }
                    ],
                    "context": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complexWe identified an interaction between the FA protein, FANCA and brm-related gene 1 (BRG1) product. BRG1 is a subunit of the SWI/SNF complex, which remodels chromatin structure through a DNA-dependent ATPase activityFANCA was demonstrated to associate with the endogenous SWI/SNF complexFANCA may recruit the SWI/SNF complex to target genes, thereby enabling coupled nuclear functions such as transcription and DNA repairFanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55200c606b348bb82c000013",
                            "question": "Which clotting factor is inhibited by betrixaban?"
                        }
                    ],
                    "context": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.Betrixaban , an orally administered direct factor Xa inhibitor, is entering a Phase III trial and undergoing investigation for similar indications as apixaban, dabigatran and rivaroxaban. Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested. These include AZD0837, betrixaban, letaxaban, darexaban, and LY517717.Most are small synthetic molecules that target thrombin (e.g. dabigatran etexilate) or factor Xa (e.g. rivaroxaban, apixaban, edoxaban, betrixaban, YM150). They must be modified and standardized for the measurement of direct FXa inhibitors (rivaroxaban, apixaban, edoxaban, betrixaban and others). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56a8b8b5a17756b72f000005",
                            "question": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?"
                        }
                    ],
                    "context": "TAF10 Interacts with the GATA1 Transcription Factor and Controls Mouse Erythropoiesis.we show that TAF10 interacts directly with GATA1 and that TAF10 is enriched on the GATA1 locus in human fetal erythroid cellsTAF10 Interacts with the GATA1 Transcription Factor and Controls Mouse Erythropoiesis"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5324bdba9b2d7acc7e00001a",
                            "question": "How is bladder wall thickness measured?"
                        }
                    ],
                    "context": "Modifications of the bladder wall (organ damage) in patients with bladder outlet obstruction: ultrasound parameters.Early identification of bladder changes by noninvasive transabdominal ultrasoundMeasurement of the bladder wall thickness (BWT) or detrusor wall thickness (DWT) by US is reliable,Also conventional US detects established signs of bladder damage: diverticulosis, trabecolations in the bladder wall (pseudo-diverticula),non-invasive US of the bladder wall"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f35ad864850a5854000004",
                            "question": "LY450139 is investigational name of which drug?"
                        }
                    ],
                    "context": "The outcomes of the clinical trials of the \u03b3-secretase inhibitor Semagacestat (LY-450139) and the \u03b3-secretase modulator (GSM) Tarenflurbil were disappointing, but may not represent the end of the \u03b3-secretase era. A selective BACE inhibitor and the \u03b3-secretase inhibitor LY450139 (semagacestat) were used to inhibit respective secretase.ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).Semagacestat (LY450139) is a novel \u03b3-secretase inhibitor currently in late-stage development by Eli Lilly and Company as a potential treatment for Alzheimer's disease (AD).  The \u03b3-secretase inhibitor LY450139 (semagacestat) lowers plasma A\u03b2(1-40) and A\u03b2(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5727ab040fd6f91b68000019",
                            "question": "Which gene has been found to be mutant in Lesch-Nyhan Disease patients?"
                        }
                    ],
                    "context": "We describe a family of seven boys affected by Lesch-Nyhan disease with various phenotypes. Further investigations revealed a mutation c.203T>C in the gene encoding HGprt of all members, with substitution of leucine to proline at residue 68 (p.Leu68Pro)Lesch-Nyhan disease (LND) is caused by deficiency of hypoxanthine guanine phosphoribosyltransferase (HPRT)Lesch-Nyhan Disease (LND) is the result of mutations in the X-linked gene encoding the purine metabolic enzyme, hypoxanthine guanine phosphoribosyl transferase (HPRT)Lesch-Nyhan disease and its attenuated variants are caused by mutations in the HPRT1 gene, which encodes the purine recycling enzyme hypoxanthine-guanine phosphoribosyltransferaseThe study of Lesch-Nyhan-diseased (LND) human brain is crucial for understanding how mutant hypoxanthine-phosphoribosyltransferase (HPRT) might lead to neuronal dysfunction. Since LND is a rare, inherited disorder caused by a deficiency of the enzyme HPRT, human neural stem cells (hNSCs) that carry this mutation are a precious source for delineating the consequences of HPRT deficiency and for developing new treatments"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "516e7fda298dcd4e51000081",
                            "question": "Which is the methyl donor of histone methyltransferases?"
                        }
                    ],
                    "context": "While SAMe is a methyl donor, MTA is an inhibitor of methylation. SAMe can convert to MTA spontaneously, so the effect of exogenous SAMe may be mediated by MTA.Based on known SET domain structures, the mutations likely affect either the lysine-substrate binding pocket, the binding site for the adenosylmethionine methyl donor, or a critical tyrosine predicted to interact with the substrate lysine epsilon-amino groupAlso, S-adenosylhomocysteine or methyl donor deficiency inhibits RIZ1 and other H3 lysine 9 methylation activities.Angiosperms synthesize S-methylmethionine (SMM) from methionine (Met) and S-adenosylmethionine (AdoMet) in a unique reaction catalyzed by Met S-methyltransferase (MMT). SMM serves as methyl donor for Met synthesis from homocysteine, catalyzed by homocysteine S-methyltransferase (HMT).Plants synthesize S-methylmethionine (SMM) from S-adenosylmethionine (AdoMet), and methionine (Met) by a unique reaction and, like other organisms, use SMM as a methyl donor for Met synthesis from homocysteine (Hcy)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5171438a8ed59a060a000007",
                            "question": "What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?"
                        }
                    ],
                    "context": "Our results further substantiate that gene scanning of all relevant RET exons is a powerful tool in the management of MEN2 patients,We identified RET mutations in seven of 13 MTCs: five RET-positive cases revealed a mutation in exon 16 (M918T) and two a mutation in exon 10 (C618S and C620S). In four of the RET-positive cases, the mutation was inherited, out of which three were reportedly associated with a multiple endocrine neoplasia type 2 (MEN2) syndrome, i.e. MEN2A (C618S), MEN2A/familial MTC (FMTC) (C620S), and MEN2B (M918T).RET gene mutation carries a risk of MEN2 and MTC in all ethnic groups in South AfricaMutational screening of the RET gene identified a common mutation (C618R) in all 8 (7 FMTC and 1 MEN2A)Gene mutation in the RET-620 position carries significant risk and may be part of a targeted investigation of high-risk areas in HSCR"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56ffd08bcf1c325851000009",
                            "question": "From which sequence does the Alu repeat originate from?"
                        }
                    ],
                    "context": "The origin of Alu-derived minisatellites appears to have been mediated by short flanking repeats, as first proposed by Haber and LouisFinally, we propose that the origin of Alu subfamilies in human populations may be related to evolution of chromosome Y.Our analysis indicates that about 60 Myr ago, before the prosimian divergence, free left and right monomers formed an Alu heterodimer connected by a 19-nucleotide-long A-rich linker.the presence of Alu-like structural motifs supports the hypothesis of the monophyletic origin of Alu and B1 repeats, i.e., from a common 7SL RNA-derived retroposing monomeric elementAlu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5313058de3eabad02100000e",
                            "question": "Abnormality in which vertebral region is important in the Bertolotti's syndrome?"
                        }
                    ],
                    "context": "Bertolotti's syndrome (BS), a form of lumbago in lumbosacral transitional vertebrae, is an important cause of low back pain in young patients.  Common causes of back pain were the ipsilateral L5-S1 facet joint, neoarticulation, the SI joint, and disc degeneration. Patients with Bertolotti's syndrome have characteristic lumbosacral anomalies and often have severe sciatica. We suggest that the intractable sciatica in this syndrome could arise from impingement of the nerve root extraforaminally by compression caused by the enlarged transverse process.Radiofrequency sensory ablation as a treatment for symptomatic unilateral lumbosacral junction pseudarticulation (Bertolotti's syndrome): a case report."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5348307daeec6fbd07000011",
                            "question": "What does iBAQ stand for in proteomic analysis?"
                        }
                    ],
                    "context": "intensity-based absolute quantification (iBAQ)Intensity-Based Absolute Quantification Index,"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54da32bc0f63c58e6e000001",
                            "question": "Which is the main target of the anti-arrhythmic activity of flecainide?"
                        }
                    ],
                    "context": "flecainide (sodium channel blocker) Flecainide is a sodium channel blocker with minimal effects expected on ventricular repolarization. Flecainide, a class I antiarrhythmic drug, inhibits Na(+) and RyR2 channels and prevents CPVT. flecainide, a Class I antiarrhythmic drug, improves left ventricular pressure gradient (LVPG) or symptoms in patients with obstructive hypertrophic cardiomyopathy (HCM).Flecainide is a class 1c antiarrhythmic that acts by blocking sodium channels to reduce intracardiac conduction and is used mainly in the treatment of supraventricular arrhythmias. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d8ea2c4b1fd0d33c000002",
                            "question": "Which is the most prevalent form of arrhythmia worldwide?"
                        }
                    ],
                    "context": "Atrial fibrillation remains the most prevalent cardiac arrhythmia, and its incidence is increasing as the population ages. Atrial fibrillation is the most prevalent sustained arrhythmia. Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia and has a significant impact on morbidity and mortality.Atrial fibrillation is the most common heart rhythm disorder in the world, with major public health impact especially due to increased risk of stroke and hospitalizations.Atrial fibrillation is the most common arrhythmia affecting patients today."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51542e44d24251bc05000081",
                            "question": "Mutations in which gene determine response to both erlotinib and gefitinib?"
                        }
                    ],
                    "context": "Mutations in the epidermal growth factor receptor gene (EGFR) are frequently observed in non-small-cell lung cancer (NSCLC),EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib, have transformed therapy for patients with EGFR-mutant NSCLC and have proved superior to chemotherapy as first-line treatment for this patient group.Adenocarcinomas, the most common histologic subtype of non-small cell lung cancer (NSCLC), are frequently associated with activating mutations in the epidermal growth factor receptor (EGFR) gene. Although these patients often respond clinically to the EGFR tyrosine kinase inhibitors erlotinib and gefitinib,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib and erlotinib are promising therapies for patients with advanced non-small-cell lung cancer (NSCLC). Patients with somatic activating mutations in the EGFR gene have dramatic response initially, but would eventually develop resistance to these TKIs.NSCLCs with EGFR mutations (exon 19 deletions or the exon 21 L858R) attain responses to EGFR tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib, with improved response rate (RR), progression-free survival (PFS) and in some reports overall survival (OS) when compared with EGFR wildtype (WT) cases."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5148e1d6d24251bc0500003a",
                            "question": "Mutation of which gene and which chromosome cause Neurofibromatosis type I?"
                        }
                    ],
                    "context": "The von Recklinghausen neurofibromatosis (NF1) gene has been localized to the pericentromeric region of chromosome 17.Nine markers from the pericentromeric region of chromosome 17 were typed in 16 British and five South African families with neurofibromatosis type 1 (NF1).Inspection of recombinant events in families informative for several markers suggests that the NF1 gene is located between the markers EW301 (cen-p11.2) and EW206 (cen-q12) and possibly distal to pHHH202 (q11.2-q12).The gene for von Recklinghausen neurofibromatosis type 1 (NF1) has recently been mapped to the pericentromeric region of human chromosome 17.In addition to reporting, in accompanying papers, their individual analyses of mapping the neurofibromatosis type 1 (NF1) gene on chromosome 17, members of the International Consortium for NF1 Linkage contributed their data for our joint analysis to determine the exact sequence of flanking markers and to obtain precise estimates and confidence limits of the recombination fractions for the closest markers, in anticipation of clinical use."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d662113706e8952800000d",
                            "question": "What is the content of the METLIN database?"
                        }
                    ],
                    "context": " The tandem mass spectrometry data acquisition enabled automatic search and matching against the METLIN tandem mass spectrometry database,the METLIN metabolomics databaseNumbers of unique metabolites that are specific to a particular sample preparation approach were also identified by online available database, Metlin. Metlin metabolomics databaseMETLIN metabolite database"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550739cf3b8a5dc045000002",
                            "question": "Which is the RNA sequence of the canonical polyadenylation signal?"
                        }
                    ],
                    "context": ". Two putative polyadenylation signal sequences (AATAAA) polyadenylation signal sequence AATAAAThe most canonical AAUAAA hexamer polyadenylation signal site (AATAAA)the canonical AATAAA motif "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f961b3cf1c325851000003",
                            "question": "What is the color of the protein Ranasmurfin?"
                        }
                    ],
                    "context": "Ranasmurfin, a blue protein from a different species of frog, displays a novel structure with a unique chromophoric crosslink.Crystallization of Ranasmurfin, a blue-coloured protein from Polypedates leucomystax.Ranasmurfin, a previously uncharacterized approximately 13 kDa blue protein found in the nests of the frog Polypedates leucomystax, has been purified and crystallized. The crystals are an intense blue colour "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53372ba3d6d3ac6a34000058",
                            "question": "Which histone modification is primarily linked to elongating transcription?"
                        }
                    ],
                    "context": "Similarly, H3K36 trimethylation, a mark associated with transcription elongation, was specifically increased at the HD locus in the striatum and not in the cerebellum.y expressing Myc protein fused with the estrogen receptor (Myc-ER) in fibroblasts, we observed that Myc, binding to the regulatory elements of Suz12, Ezh2, and Eed, induces the acetylation of histones H3 and H4 and the recruitment of elongating RNA polymerase II at their promotersA basal level of JIL-1 binding can be defined that correlates best with the methylation of histone H3 at lysine 36, a mark that is placed co-transcriptionallyRNA polymerase II signals for deacetylation through the methylation of histone H3 lysine 36 (H3K36), which provides the recruitment signal for the Rpd3S histone deacetylase complex (HDAC)Recent studies reviewed here demonstrate that histone deacetylation on the body of a transcribed gene is regulated via Set2-mediated methylation of histone H3-K36"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f02aef6e39474100004b",
                            "question": "Which interleukin is blocked by Siltuximab?"
                        }
                    ],
                    "context": "This review also summarizes the biologics targeting either IL-6 or the IL-6 receptor, including tocilizumab, sarilumab, sirukumab, olokizumab, clazakizumab, and siltuximab. Siltuximab, a chimeric monoclonal antibody with high affinity and specificity for interleukin-6, has been shown to enhance anti-multiple myeloma activity of bortezomib and corticosteroid in vitro.A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.We compared the safety and efficacy of siltuximab (S), an anti-interleukin-6 chimeric monoclonal antibody, plus bortezomib (B) with placebo (plc) + B in patients with relapsed/refractory multiple myeloma in a randomized phase 2 study. Currently, there are more effective therapeutic alternatives in multicentric Castleman disease: treatment with monotherapy of rituximab or in combination therapy with immunomodulatory drugs (thalidomide or lenalidomide, treatment with anti-IL-6 (siltuximab) or against its receptor (tocilizumab). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "551fd9c06b348bb82c000012",
                            "question": "ROSIER scale is used for which disorder?"
                        }
                    ],
                    "context": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.MATERIALS AND METHODS: Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.CONCLUSIONS: The ROSIER is a sensitive and specific stroke recognition tool for health providers' use among Chinese patients in the prehospital setting.Can the FAST and ROSIER adult stroke recognition tools be applied to confirmed childhood arterial ischemic stroke? Two adult stroke recognition tools; ROSIER (Recognition of Stroke in the Emergency Room) and FAST (Face Arm Speech Test) scales were applied retrospectively to all patients to determine test sensitivity. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d7a1047035c08008000002",
                            "question": "Which is the subcellular localization of the protein angiogenin?"
                        }
                    ],
                    "context": "Under growth conditions, ANG is located in nucleolus where it promotes ribosomal RNA (rRNA) transcription thereby stimulating cell growth. In adverse conditions, ANG is relocated to cytoplasm to promote damage repairs and cell survival. Under growth conditions, ANG undergoes nuclear translocation and accumulates in the nucleolus where it stimulates rRNA transcriptionUnder growth conditions, ANG is located in the nucleus Under stress conditions, ANG is localized to the cytoplasm and is concentrated in stress granulesSilencing ANG or inhibiting its nuclear translocation resulted in decreased nuclear LANA-1 and ANG levels,"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55054f8af73303d458000002",
                            "question": "Which bone protein is used in archaelogy for dating and species identification?"
                        }
                    ],
                    "context": "Collagen was extracted from modern and archaeological cod bones using a weak HCl solution and analysed for its sulphur isotopic composition by isotope ratio mass spectrometry (IRMS)With the high sensitivity of current generation mass spectrometers, ZooMS provides a non-destructive and highly cost-effective method to characterise collagen peptides.Archaeological bones are usually dated by radiocarbon measurement of extracted collagen. we describe three complementary preparative HPLC procedures suitable for separating and isolating single amino acids from bone collagen or hair keratin with minimal isotopic contamination. Bulk bone collagen isotopic analysis of 11 skeletons of Iron Age and Roman date gave a typical C(3) terrestrial signal ("
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f7c15a09dd18d46b000012",
                            "question": "Which gene has been implicated in Majeed Syndrome?"
                        }
                    ],
                    "context": "Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome).The gene was mapped to a 5.5 cM interval (1.8 Mb) on chromosome 18p. Examination of genes in this interval led to the identification of homozygous mutations in LPIN2 in affected individuals from the two families. We conclude that homozygous mutations in LPIN2 result in Majeed syndrome.  genetic alteration of LPIN2 in humans is known to cause Majeed syndromeMajeed syndrome is an autosomal recessive disorder characterised by the triad of chronic recurrent multifocal osteomyelitis, congenital dyserythropoietic anaemia and a neutrophilic dermatosis that is caused by mutations in LPIN2"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5523e7837b523f2123000006",
                            "question": "What is Trypan blue used for?"
                        }
                    ],
                    "context": " cell death by trypan blue exclusion assayExamination of cell viability in UCP2-transfected cells with Trypan Blue and Annexin-V staining revealed that UCP2 transfection led to significantly increased cell death.assessed for their viability by vital staining (Trypan blue)the trypan blue exclusion test of cell viability Cell viability was determined by MTT, neutral red uptake and trypan blue exclusion assays."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f045ef6e394741000058",
                            "question": "Selexipag is used for which disease?"
                        }
                    ],
                    "context": "OBJECTIVE: Selexipag is a novel, oral, selective prostacyclin (PGI2) receptor agonist in clinical development for the treatment of pulmonary arterial hypertension.Selexipag for the treatment of pulmonary arterial hypertension.This review was based on a PubMed search and focuses on the potential role of selexipag in the treatment of pulmonary arterial hypertension (PAH).Selexipag showed effects on pharmacodynamic end points obtained with right heart catheterization in a Phase II trial in patients with PAH, and is being evaluated in the ongoing Phase III trial (GRIPHON trial, Clinicaltrials.gov NCT01106014).Pending the GRIPHON trial results, selexipag could provide a convenient first-line prostacyclin treatment option for patients with PAH."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5708992ccf1c32585100000d",
                            "question": "What is the RESID database?"
                        }
                    ],
                    "context": "The RESID Database of Protein Modifications as a resource and annotation tool.The RESID Database of Protein Modifications is a comprehensive collection of annotations and structures for protein modifications and cross-links including pre-, co-, and post-translational modificationsThe RESID Database is a comprehensive collection of annotations and structures for protein pre-, co- and post-translational modifications including amino-terminal, carboxyl-terminal and peptide chain cross-link modifications.The RESID Database is a comprehensive collection of annotations and structures for protein post-translational modifications including N-terminal, C-terminal and peptide chain cross-link modifications. The RESID Database contains supplemental information on post-translational modifications for the standardized annotations appearing in the PIR-International Protein Sequence Database. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550ea8f1b305b40c5c000005",
                            "question": "Pridopidine has been tested for treatment of which disorder?"
                        }
                    ],
                    "context": "These effects of pridopidine may serve to strengthen the cortico-striatal communication and to improve motor control in Huntington's disease for which pridopidine is currently in development.A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease.We examined the effects of 3 dosages of pridopidine, a dopamine-stabilizing compound, on motor function and other features of Huntington's disease, with additional evaluation of its safety and tolerability. Although the primary analysis did not demonstrate a statistically significant treatment effect, the overall results suggest that pridopidine may improve motor function in Huntington's disease. One-year safety and tolerability profile of pridopidine in patients with Huntington disease."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5319a708b166e2b806000024",
                            "question": "Which is the target of bortezomib used in cancer therapy?"
                        }
                    ],
                    "context": "The ubiquitin-proteasome system (UPS) degrades 80 - 90% of intracellular proteins. Cancer cells take advantage of the UPS for their increased growth and decreased apoptotic cell death. Thus, the components that make up the UPS represent a diverse group of potential anti-cancer targets. The success of the first-in-class proteasome inhibitor bortezomib not only proved that the proteasome is a feasible and valuable anti-cancer target, but also inspired researchers to extensively explore other potential targets of this pathway.The ubiquitin-proteasome pathway has been identified as a potential molecular target for cancer therapy. In this study, we investigated the effect of the proteasome inhibitor bortezomib on anaplastic thyroid carcinoma (ATC) characterized by complete refractoriness to multimodal therapeutic approaches.The ubiquitin-proteasome pathway regulates many basic cellular processes and has been proven to be a promising target for cancer therapy. Bortezomib is the first U.S. Food and Drug Administration (FDA) approved proteasome inhibitor used in the treatment of newly diagnosed multiple myeloma, relapsed/refractory multiple myeloma, and mantle cell lymphoma.This review summarizes the current status of bortezomib as well as several other proteasome inhibitors that are currently under clinical and preclinical investigation.Ubiquitin-tagged substrates are degraded by the 26S proteasome, which is a multisubunit complex comprising a proteolytic 20S core particle capped by 19S regulatory particles. The approval of bortezomib for the treatment of multiple myeloma validated the 20S core particle as an anticancer drug target."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cf3f4f3975bb303a000008",
                            "question": "Which is the chromosomal location of the gene MAOA?"
                        }
                    ],
                    "context": "Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism. Using rodent-human somatic cell hybrids containing all or part of the human X chromosome, we have mapped these fragments to the region Xp21-p11."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c079b1ef6e394741000022",
                            "question": "Idarucizumab is an antidote of which drug?"
                        }
                    ],
                    "context": "With Idarucizumab and Andexanet Alfa, specific antidotes have been developed against both, direct thrombin inhibitors as well as direct Factor Xa inhibitors. Three novel molecules (idarucizumab, andexanet, and PER977) may provide the most effective and safest way of reversal. Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran.We examined the efficacy of idarucizumab, an antibody fragment binding to dabigatran, in a mouse model of OAC-ICH. Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed by idarucizumab. Thus, idarucizumab prevents excess intracerebral hematoma formation in mice anticoagulated with dabigatran and reduces mortality."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5709f027cf1c32585100001f",
                            "question": "What is the Pfam database?"
                        }
                    ],
                    "context": "The Pfam database is an important tool in genome annotation, since it provides a collection of curated protein families.Protein domains are the common currency of protein structure and function. Over 10,000 such protein families have now been collected in the Pfam database. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5178d6be8ed59a060a000038",
                            "question": "What is a popular mesaure of gene expression in RNA-seq experiments?"
                        }
                    ],
                    "context": "Measures of RNA abundance are important for many areas of biology and often obtained from high-throughput RNA sequencing methods such as Illumina sequence data. These measures need to be normalized to remove technical biases inherent in the sequencing approach, most notably the length of the RNA species and the sequencing depth of a sample. These biases are corrected in the widely used reads per kilobase per million reads (RPKM) measure."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "531dd4af267d7dd05300000d",
                            "question": "Inhibition of which enzyme is mechanism of action of alisertib?"
                        }
                    ],
                    "context": "Inhibition of AURKA using an investigational small-molecule specific inhibitor, alisertib, decreased the HDM2 protein level and induced P53 transcriptional activity. Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase.Alisertib (MLN8237) is an investigational inhibitor of Aurora A kinase (AAK).The spindle organization defects induced by alisertib have been used to develop a pharmacodynamic (PD) assay for Aurora A inhibition based on the percentage of mitotic cells with proper chromosomal alignment at the metaphase plate (% aligned spindles, abbreviated as AS). Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52ece29f98d023950500002c",
                            "question": "Which thyroid hormone transporter is implicated in thyroid hormone resistance syndrome?"
                        }
                    ],
                    "context": "Hemizygous MCT8 mutations in males cause severe psychomotor retardation, known as the Allan-Herndon-Dudley syndrome (AHDS), and abnormal serum TH levels. AHDS thus represents a type of TH resistance caused by a defect in cellular TH transport.Novel mutation in MCT8 gene in a Brazilian boy with thyroid hormone resistance and severe neurologic abnormalities.When thyroid hormone production was reduced by PTU, high doses of LT(4) (3.7 microg/kg.d) were needed to normalize serum TSH, confirming that mutation of MCT8 is a cause of resistance to thyroid hormoneOne, producing severe psychomotor defects in > 100 males from 26 families, is caused by mutations in the cell-membrane transporter of TH, MCT8"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5148691bd24251bc0500002d",
                            "question": "Which protein is affected by dusp8 activation?"
                        }
                    ],
                    "context": "Thus, rosiglitazone's neuroprotective effect after ischemia is mediated by blocking JNK phosphorylation induced by ischemia via DUSP8 upregulation.Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase.These results suggest that JNK activation by H(2)O(2) plus PDTC resulted from the down-regulation of JNK phosphatases.M3/6 is a dual-specificity phosphatase selective for JNKPhosphorylation of the M3/6 dual-specificity phosphatase enhances the activation of JNK by arsenite."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c3320a50c68dd416000008",
                            "question": "What is the incidence of cystic fibrosis in the caucasian population?"
                        }
                    ],
                    "context": "Estimates of the newborn frequency of cystic fibrosis in different Caucasian groups range from 4 times more to 40 times less common than the generally accepted figure of 1:2000.Current meconium screening trials which may be effective in populations with the incidence equal to or greater than 1:2000, may be useful for populations with an incidence as low as 1:7000 only after maximum improvement of the methodsStudies on migrant Indian population in United States and United Kingdom estimate frequency of CF as 1:10,000 to 1:40,000The frequency of common mutation F508del in Indian children is between 19% and 34%. Other mutations are heterogeneousThe delta F508 mutation was found in 9 cases (60%), of which 5 were homozygous for the disorder."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5318929fb166e2b80600001b",
                            "question": "What is the Her2 status in Li-Fraumeni syndrome?"
                        }
                    ],
                    "context": "Prevalence of germline TP53 mutations in HER2+ breast cancer patientsRecent data show that breast cancer in germline TP53 mutation carriers is commonly HER2+ (63-83 %).As seen in this case, most breast cancers in patients with LFS exhibit a triple-positive phenotype (estrogen receptor-positive/progesterone receptor-positive/HER2-positive). Breast cancers in TP53 mutation carriers recently have more often been reported to be hormone receptor and HER-2 positive by immunohistochemistry and FISH in small series.The 43 tumors from 39 women comprise 32 invasive ductal carcinomas and 11 ductal carcinomas in situ (DCIS)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51475d5cd24251bc0500001b",
                            "question": "Where is X-ray free electron laser used?"
                        }
                    ],
                    "context": "In conjunction with the XFEL temporal profile and high-flux, it is a powerful tool for studying the dynamics of time-dependent systems. Photo-induced processes and fast catalytic reaction kinetics, ranging from femtoseconds to milliseconds, will be resolvable in a wide array of systems circumventing radiation damage.We discuss the pertinent physics of the intense X-ray-matter interactions, and illustrate the importance of electron-ion collisions. Detailed simulations of the interaction process conducted with a radiative-collisional code show good qualitative agreement with the experimental results. We obtain insights into the evolution of the charge state distribution of the system, the electron density and temperature, and the timescales of collisional processes. Our results should inform future high-intensity X-ray experiments involving dense samples, such as X-ray diffractive imaging of biological systems, material science investigations, and the study of matter in extreme conditions.employment of \"exotic\" systems, such as the Free Electron LASER (FEL), that are expected to focus on the fundamental processes of life, following chemical reactions and biological processes as they happen, on unprecedented time and size scales.New data analysis approaches are outlined for the correlated fluctuations in fast WAXS, for protein nanocrystals just a few molecules on a side, and for the continuous x-ray scattering from a single virusResearch opportunities and techniques are reviewed for the application of hard x-ray pulsed free-electron lasers (XFEL) to structural biology. These include the imaging of protein nanocrystals, single particles such as viruses, pump--probe experiments for time-resolved nanocrystallography, and snapshot wide-angle x-ray scattering (WAXS) from molecules in solution. The use of femtosecond exposure times, rather than freezing of samples, as a means of minimizing radiation damage is shown to open up new opportunities for the molecular imaging of biochemical reactions at room temperature in solution"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54e0c3e71388e8454a000013",
                            "question": "Which enzyme is inhibited by Orteronel?"
                        }
                    ],
                    "context": "PURPOSE: Orteronel (TAK-700) is a non-steroidal, selective, reversible inhibitor of 17,20-lyase.The drug orteronel selectively blocked the lyase reaction of P450 17A1 but only in the case of Prog. Preclinical assessment of Orteronel(\u00ae), a CYP17A1 enzyme inhibitor in rats.Orteronel (TAK-700) is a novel and selective inhibitor of CYP17A1, which is expressed in testicular, adrenal and prostate tumor tissues.Orteronel is a nonsteroidal, selective inhibitor of 17,20-lyase that was recently in phase 3 clinical development as a treatment for castration-resistant prostate cancer. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54db5e24bcba1b1817000002",
                            "question": "What is the disorder in which mutations in U4atac snRNA are detected?"
                        }
                    ],
                    "context": "Biallelic mutations of the human RNU4ATAC gene, which codes for the minor spliceosomal U4atac snRNA, cause the developmental disorder, MOPD I/TALSTo date, nine separate mutations in RNU4ATAC have been identified in MOPD I patients.In this report, we establish a mechanistic basis for MOPD I disease and show that the inefficient splicing of genes containing U12-dependent introns in patient cells is due to defects in minor tri-snRNP formation, and the MOPD I-associated RNU4ATAC mutations can affect multiple facets of minor snRNA function.A homozygous mutation in RNU4ATAC as a cause of microcephalic osteodysplastic primordial dwarfism type I (MOPD I) with associated pigmentary disorder.We describe two brothers, born to healthy, consanguineous parents, with intrauterine and postnatal growth retardation, microcephaly with abnormal gyral pattern and partial agenesis of corpus callosum, and skeletal anomalies reminiscent of those described in MOPD type I. This was confirmed by the identification of the homozygous g.55G > A mutation of RNU4ATAC encoding U4atac snRNA."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "515d692c298dcd4e5100000a",
                            "question": "Which is the binding site motif of Sp1?"
                        }
                    ],
                    "context": "a GC-rich element (Sp1-binding site)Further analysis revealed that the DNA sequence, TTCAAGTCCCGCCCTCCGCT from -65 to -46Sp1 motif in the UCRupstream control region (UCR) containing a GC-rich motif (5'-GGGCGGG-3') and to a unique enhancer core (5'-TGCGGTC-3')A GC-rich region containing Sp1 and Sp1-like binding sites"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55149f156a8cde6b72000013",
                            "question": "Which gene fusion is the result of the \"philadelphia translocation\" or the \"philadelphia chromosome\" mutation?"
                        }
                    ],
                    "context": "Philadelphia (Ph) chromosome positive acute lymphoblastic leukemia (ALL) is a common cytogenetic abnormality associated with poor outcome in adults. This preliminary study, in the absence of substantial evidence, reported the prevalence of the BCR-ABL gene fusion in ALL patients by RT-PCR in Pakistan.The Philadelphia chromosome and its corresponding fusion gene, BCR-ABL, is one of the best-known genetic abnormalities in hematological malignancies. Major BCR-ABL translocation is much more common in chronic myelogenous leukemia (CML) and minor BCR-ABL in acute lymphoblastic leukemia. The BCR/ABL gene fusion, the hallmark of chronic myelogenous leukemia (CML) is generated in 2-10% of patients by a variant Ph translocation involving 9q34, 22q11.2, and one or more additional genomic regions. The t(9;22)(q34;q11) translocation leading to the Philadelphia (Ph) chromosome resulting in BCR-ABL gene fusion is associated with a poor prognosis in acute lymphoblastic leukemia (ALL).Chronic myeloid leukemia (CML) is genetically characterized by the presence of the reciprocal translocation t(9;22)(q34;q11), resulting in a BCR/ABL gene fusion on the derivative chromosome 22 called the Philadelphia (Ph) chromosome. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571e40a8bb137a4b0c000009",
                            "question": "Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?"
                        }
                    ],
                    "context": "Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "530cf4fe960c95ad0c00000b",
                            "question": "Which type of lung cancer is afatinib used for?"
                        }
                    ],
                    "context": "Afatinib is a novel irreversible inhibitor of the ErbB family members EGFR, tyrosine kinase-type cell surface receptors HER2 and HER4. It shows preclinical efficacy in NSCLC with common EGFR-activating mutations and the T790M mutation typically associated with EGFR TKI resistanceAt present, only first-generation EGFR-tyrosine kinase inhibitors (TKIs) (erlotinib and gefitinib) are available for clinical use. Second-generation irreversible EGFR-TKIs, such as afatinib, are still in clinical trials. In current clinical practice, EGFR-TKI is the first-line treatment of choice for metastatic NSCLC patients with tumor EGFR mutation or as salvage therapy in NSCLC patients who received systemic chemotherapy previouslyAfatinib is a small molecule covalently binding and inhibiting the EGFR, HER2 and HER4 receptor tyrosine kinases. In preclinical studies, afatinib not only inhibited the growth of models with common activating EGFR mutations, but was also active in lung cancer models harboring wild-type EGFR or the EGFR L858R/T790M double mutant. Clinical efficacy of afatinib has been extensively studied in the LUX-Lung study program. These trials showed promising efficacy in patients with EGFR-mutant NSCLC or enriched for clinical benefit from EGFR tyrosine kinase inhibitors gefitinib or erlotinibBIBW2992 is an irreversible EGFR TKI that also inhibits HER2 and vascular epidermal growth factor receptorsIn vitro work shows that this compound inhibits wild-type EGFR, EGFR exon 19 deletion, EGFR L858R, and EGFR T790M, the mutation associated with acquired resistance"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f009ef6e39474100003c",
                            "question": "Which disease is treated with Eliglustat?"
                        }
                    ],
                    "context": "Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial.We investigated whether patients stable on such treatment would remain so after switching to oral eliglustat, a selective inhibitor of glucosylceramide synthase.Patients were randomly allocated 2:1 at 39 clinics (stratified by ERT dose; block sizes of four; computer-generated centrally) to receive either oral eliglustat or imiglucerase infusions for 12 months. The non-inferiority margin was 25% for eliglustat relative to imiglucerase, assessed in all patients who completed 12 months of treatment.NTERPRETATION: Oral eliglustat maintained haematological and organ volume stability in adults with Gaucher's disease type 1 already controlled by intravenous ERT and could be a useful therapeutic option."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56afe6d40a360a5e45000017",
                            "question": "Which tool is used for promoterome mining using CAGE data?"
                        }
                    ],
                    "context": "CAGEr: precise TSS data retrieval and high-resolution promoterome mining for integrative analyses. Despite their high resolution and functional significance, published CAGE data are still underused in promoter analysis due to the absence of tools that enable its efficient manipulation and integration with other genome data types. Here we present CAGEr, an R implementation of novel methods for the analysis of differential TSS usage and promoter dynamics, integrated with CAGE data processing and promoterome mining into a first comprehensive CAGE toolbox on a common analysis platform. Crucially, we provide collections of TSSs derived from most published CAGE datasets, as well as direct access to FANTOM5 resource of TSSs for numerous human and mouse cell/tissue types from within R, greatly increasing the accessibility of precise context-specific TSS data for integrative analyses. The CAGEr package is freely available from Bioconductor at http://www.bioconductor.org/packages/release/bioc/html/CAGEr.html.Here we present CAGEr, an R implementation of novel methods for the analysis of differential TSS usage and promoter dynamics, integrated with CAGE data processing and promoterome mining into a first comprehensive CAGE toolbox on a common analysis platformCAGEr: precise TSS data retrieval and high-resolution promoterome mining for integrative analysesDespite their high resolution and functional significance, published CAGE data are still underused in promoter analysis due to the absence of tools that enable its efficient manipulation and integration with other genome data types. Here we present CAGEr, an R implementation of novel methods for the analysis of differential TSS usage and promoter dynamics, integrated with CAGE data processing and promoterome mining into a first comprehensive CAGE toolbox on a common analysis platform."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52e62bae98d0239505000015",
                            "question": "What is the life expectancy of professional athletes in respect to the general population?"
                        }
                    ],
                    "context": "In conclusion, while regular physical activity increases life expectancy, it remains unclear if high-intensity sports activities further increase life expectancy.Competitive exercise does not induce cardiac damage in individuals with healthy hearts, but does induce physiological functional and structural cardiac adaptations which have positive effects on life expectancy.It appears that elite endurance (aerobic) athletes and mixed-sports (aerobic and anaerobic) athletes survive longer than the general population, as indicated by lower mortality and higher longevity. Lower cardiovascular disease mortality is likely the primary reason for their better survival rates. On the other hand, there are inconsistent results among studies of power (anaerobic) athletes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cdf4675795f9a73e00003f",
                            "question": "Which kinase is regulating stress granule biogenesis?"
                        }
                    ],
                    "context": "5'-AMP-activated protein kinase alpha regulates stress granule biogenesisMultiple lines of evidence link AMPK activity to SG biogenesis. First, pharmacological kinase inhibition interfered with SG formation. Second, AMPK-\u03b1 knockdown combined with in-depth quantitative SG analysis revealed isoform-specific changes of SG characteristics. Third, overexpression of mutant \u03b1-subunits further substantiated that AMPK regulates SG parameters. Finally, we identified the SG-nucleating protein G3BP1 as an AMPK-\u03b12 binding partner. This interaction is stimulated by stress and notably occurs in SGsour data define the master metabolic regulator AMPK as a novel SG constituent that also controls their biogenesis5'-AMP-activated protein kinase alpha regulates stress granule biogenesis.Collectively, our data define the master metabolic regulator AMPK as a novel SG constituent that also controls their biogenesis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f00cef6e39474100003e",
                            "question": "Aleglitazar is agonist of which receptor?"
                        }
                    ],
                    "context": "Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes.Aleglitazar is a dual peroxisome proliferator-activated receptor \u03b1/\u03b3 agonist with favorable insulin-sensitizing and glucose-lowering actions, favorable effects on blood lipids, and an acceptable safety profile in short-time studies. Coupled with the previous failure of several other peroxisome proliferator-activated receptor \u03b1/\u03b3 activators, this class now holds little promise for CV therapeutics.Aleglitazar is a dual agonist of peroxisome proliferator-activated receptors with insulin-sensitizing and glucose-lowering actions and favorable effects on lipid profiles.Aleglitazar acts through balanced activation of peroxisome proliferator-activated receptors \u03b1 and \u03b3; warfarin is a commonly prescribed anticoagulant. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "532f49f8d6d3ac6a34000035",
                            "question": "What is the triple screening test performed during pregnancy measuring?"
                        }
                    ],
                    "context": "AFP--1.18 MoM and estriol--1.29 MoM and significantly higher mean median value for the free beta-hCGalpha-fetoprotein (AFP), 1.02 for human chorionic gonadotropin (hCG) and 1.01 for unconjugated estriol (uE3alpha fetoprotein (AFP), beta human chorionic gonadotropin (beta-hCG), and unconjugated estriol (uE3) alpha-fetoprotein (AFP), intact HCG and unconjugated estriol (uE3)lpha-fetoprotein (AFP), total beta human chorionic gonadotrophin (hCG) and estriol (uE(3)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56caea805795f9a73e00002c",
                            "question": "Which protein interacts with the Ragulator-RAG GTPases to control mTOR activity?"
                        }
                    ],
                    "context": "Together, the findings of our study reveal SLC38A9 as a Rag-Ragulator complex member transducing amino acid availability to mTORC1 activity.Extensive functional proteomic analysis established SLC38A9 as an integral part of the Ragulator-RAG GTPases machinery. Gain of SLC38A9 function rendered cells resistant to amino acid withdrawal, whereas loss of SLC38A9 expression impaired amino-acid-induced mTORC1 activation. Thus SLC38A9 is a physical and functional component of the amino acid sensing machinery that controls the activation of mTOR.Here, we identify the human 11-pass transmembrane protein SLC38A9 as a novel component of the Rag-Ragulator complexSLC38A9 localizes with Rag-Ragulator complex components on lysosomes and associates with Rag GTPases in an amino acid-sensitive and nucleotide binding state-dependent mannerTogether, the findings of our study reveal SLC38A9 as a Rag-Ragulator complex member transducing amino acid availability to mTORC1 activity"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f021ef6e394741000048",
                            "question": "Galassi classification is used for which disorder?"
                        }
                    ],
                    "context": " All these patients were divided into three subgroups according to Galassi classification. We are led to conclude that Fenestration is suitable for cysts of types I and II (Galassi classification), cysto-peritoneal shunting is better for cysts of type III.According to Galassi classification they were subdivided into 3 groups.According to Galassi classification they were subdivided in three groups.On follow-up CT scan and MRI, cysts of types I and II (Galassi classification) exhibited a steady tendency to reduction or obliteration."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf1d9e03868f1b06000010",
                            "question": "To the ligand of which receptors does Denosumab (Prolia) bind?"
                        }
                    ],
                    "context": "Whether the factor has the same role in humans is of clinical interest because an inhibitor for RANKL, denosumab, is already used for the treatment of bone disease and might benefit breast cancer patients.Treatment of AML cells with the clinically available RANKL Ab Denosumab resulted in enhanced NK cell anti-leukemia reactivity. The emerging clinical implication, supported by recent epidemiological studies, is that \u03b2AR-blockers and drugs interfering with RANKL signaling, such as Denosumab, could increase patient survival if used as adjuvant therapy to inhibit both the early colonization of bone by metastatic breast cancer cells and the initiation of the \"vicious cycle\" of bone destruction induced by these cells.Both the effects of RANKL on osteoclastogenesis and cytokine production by malignant cells could be blocked by disruption of RANK-RANKL interaction with denosumab.In the future, the armamentarium against osteoporotic fractures will likely be enriched by (1.) new bone anabolic substances such as antibodies directed against the endogenous inhibitors of bone formation sclerostin and dickkopf-1, PTH and PTHrp analogues, and possibly calcilytics; (2.) new inhibitors of bone resorption such as cathepsin K inhibitors which may suppress osteoclast function without impairing osteoclast viability and thus maintain bone formation by preserving the osteoclast-osteoblast crosstalk, and denosumab, an already widely available antibody against RANKL which inhibits osteoclast formation, function, and survival; and (3.) new therapeutic strategies based on an extended understanding of the pathophysiology of osteoporosis which may include sequential therapies with two or more bone active substances aimed at optimising the management of bone capital acquired during adolescence and maintained during adulthood in terms of both quantity and quality. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5549de44f35db7552600000c",
                            "question": "By which mechanism MutT proteins act against DNA lesions in bacteria?"
                        }
                    ],
                    "context": "in addition to the well-characterized hydrolysis of 8-oxo-dGTP at the \u03b1-\u03b2 position, MutT cleaves at the \u03b2-\u03b3 phosphate bond at a rate of 3% of that recorded for hydrolysis at the \u03b1-\u03b2 positionMutT also catalyzes the hydrolysis of 5-methyl-dCTPThe common substrate structure for the functionally diverse Nudix protein superfamily is nucleotide-diphosphate-X, where X is a large variety of leaving groups. The substrate specificity is known for less than 1% of the 29,400 known members. Most activities result in the release of an inorganic phosphate ion or of a product bearing a terminal phosphate moiety.the pathogen is exposed to reactive oxygen species, known to damage dGTP and GTP to 8-oxo-dGTP and 8-oxo-GTP, respectively. Incorporation of the damaged nucleotides in nucleic acids is detrimental to organisms. MutT proteins, belonging to a class of Nudix hydrolases, hydrolyze 8-oxo-G nucleoside triphosphates/diphosphates to the corresponding nucleoside monophosphates and sanitize the nucleotide pool.Here, we characterized MtuMutT1 and Rv1700 proteins of M. tuberculosis. Unlike other MutT proteins, MtuMutT1 converts 8-oxo-dGTP to 8-oxo-dGDP, and 8-oxo-GTP to 8-oxo-GDP. Rv1700 then converts them to the corresponding nucleoside monophosphates. This observation suggests the presence of a two-stage mechanism of 8-oxo-dGTP/8-oxo-GTP detoxification in mycobacteria."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56fcf1b8cf1c325851000005",
                            "question": "Which type of genes are modulated by SATB1?"
                        }
                    ],
                    "context": "Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationSATB1, a genome organizer that regulates chromatin structure and gene expression, was crucial for the phenotype and function of T(reg) cellsFoxp3, acting as a transcriptional repressor, directly suppressed the SATB1 locus and indirectly suppressed it through the induction of microRNAs that bound the SATB1 3' untranslated region.Release of SATB1 from the control of Foxp3 in T(reg) cells caused loss of suppressive function, establishment of transcriptional T(eff) cell programs and induction of T(eff) cell cytokines.Consistent with previous reports in a non-superantigen in vivo anergy model, mRNA for CD18 and the transcription factor Satb1 (special AT-rich-binding protein 1) was increased in SEB-energized T cells. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cafa845795f9a73e00002e",
                            "question": "Which protein pathway is regulating SGK1-mediated phosphorylation of FOXO3a to control cell proliferation?"
                        }
                    ],
                    "context": "The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinasethe FoxO3a transcription factor is coordinately regulated by mTORC1 and mTORC2, and plays a crucial role in controlling cell proliferationmTORC1, in coordination with mTORC2, controls cell proliferation by regulating FoxO3a gene expression and SGK1-mediated phosphorylation of FoxO3a at Ser314These results suggest that mTORC1, in coordination with mTORC2, controls cell proliferation by regulating FoxO3a gene expression and SGK1-mediated phosphorylation of FoxO3a at Ser314SGK1 overexpression suppressed CDKI expression in p18-deficient cells, whereas SGK1 knockdown induced CDKI expression in wild-type cells, resulting in the suppression of cell proliferation. These results suggest that mTORC1, in coordination with mTORC2, controls cell proliferation by regulating FoxO3a gene expression and SGK1-mediated phosphorylation of FoxO3a at Ser314."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "531af8cbb166e2b80600003a",
                            "question": "How many genes outside of the MHC locus have been genetically associated to Rheumatoid Arthritis through GWAS?"
                        }
                    ],
                    "context": "Genome-Wide Association Studies (GWAS) have allowed the characterization of more than 40 new susceptibility genes and the confirmation of a marked differential genetic background between patients expressing anti-cyclic citrullinated peptide antibodies (ACPA, approximately 80% of all RA patients) and ACPA negative RA patientsFirstly, we review here the major advances in identifying RA genetic susceptibility markers both within and outside of the MHC. The most relevant non-HLA gene single nucleotide polymorphisms (SNPs) associated with RA include PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4. Large genome-wide association studies (GWAS) have identified more than 30 loci involved in RA pathogenesis.The meta-analysis results showed that: (1) 30, 28 and 26 SNPs were significantly associated with RA (P<0.01) for the allele, dominant, and recessive models, respectively.This paper compares corresponding non-MHC genomic regions identified in rodent and human genome-wide association studies (GWAS). To date, over 30 non-MHC RA-associated loci have been identified in humans, and over 100 arthritis-associated loci have been identified in rodent models of RA"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5544de7a5beec11c10000005",
                            "question": "In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?"
                        }
                    ],
                    "context": "factors involved in RNA polymerase (RNAP) processivity or transcriptional derepression contribute to the generation of stress-induced mutations. In Bacillus subtilis, transcription-associated mutagenesis has been shown to be independent of recombination-dependent repair and, in some cases, of the Y DNA polymerases. Central to stationary-phase mutagenesis in B. subtilis is the requirement for Mfd, transcription coupling repair factorAdaptive (stationary phase) mutagenesis is a phenomenon by which nondividing cells acquire beneficial mutations as a response to stress.the level of Leu(+) reversions increased significantly in parallel with the induced increase in transcription levels. This mutagenic response was not observed under conditions of exponential growth. Since transcription is a ubiquitous biological process, transcription-associated mutagenesis may influence evolutionary processes in all organisms.Transcription-associated mutation in Bacillus subtilis cells under stress.Transcription-associated mutagenesis is increased under stress and depends on the DNA sequence."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55421ee7ccca0ce74b000002",
                            "question": "Which tumor suppressor is referred to as \"the guardian of the genome\"?"
                        }
                    ],
                    "context": "The major tumour suppressor protein, p53, is one of the most well-studied proteins in cell biology. Often referred to as the Guardian of the Genome, the list of known functions of p53 include regulatory roles in cell cycle arrest, apoptosis, angiogenesis, DNA repair and cell senescence.p53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapyThe tumor suppressor protein p53 has been described \"as the guardian of the genome\" for its crucial role in regulating the transcription of numerous genes responsible for cells cycle arrest, senescence, or apoptosis in response to various stress signals. the critical tumor suppressor p53, known as the guardian of the genomep53 is well known as the \"guardian of the genome\" for differentiated and neoplastic cells. p53 induces cell-cycle arrest and cell death after DNA damage and thus contributes to the maintenance of genomic stability."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "514a0a57d24251bc05000051",
                            "question": "Which drug should be used as an antidote in benzodiazepine overdose?"
                        }
                    ],
                    "context": "Benzodiazepine (BZD) overdose (OD) continues to cause significant morbidity and mortality in the UK. Flumazenil is an effective antidote but there is a risk of seizures, particularly in those who have co-ingested tricyclic antidepressants.Flumazenil was administered to 80 patients in 4504 BZD-related enquiries, 68 of whom did not have ventilatory failure or had recognised contraindications to flumazenil.Flumazenil is used infrequently in the management of BZD OD in the UK.Flumazenil is a benzodiazepine antagonist. It is widely used as an antidote in comatose patients suspected of having ingested a benzodiazepine overdose.Flumazenil is very useful in reversing benzodiazepine-induced sedation as well as to diagnose or treat benzodiazepine overdose."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53262cdcd6d3ac6a34000003",
                            "question": "What is the definitive treatment for low pressure headache?"
                        }
                    ],
                    "context": "This was initially treated with analgesia, caffeine, and fluids for the presumed cerebrospinal fluid (CSF) leakshe was treated for CSF leak using an epidural blood patch.Epidural blood patching may be necessary to seal the leak - CT fluoroscopy may be helpful in delivering the patch directly to the site of the leak invasive measures with epidural blood patch providing the cornerstone of the invasive measuresHowever the present results, allows us to conclude that EBP in treatment-refractory low CSF pressure headache can be considered as a treatment option."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53036faab24d855b11000001",
                            "question": "What is the incidence of sudden cardiac death among young athletes?"
                        }
                    ],
                    "context": "Sudden cardiac death is the leading cause of mortality among young athletes with an incidence of 1-2 per 100,000 athletes per annum.The incidence of SCD is expected at one case for each 200,000 young athletes per year.The incidence of sudden cardiac death (SCD) among young athletes is estimated to be 1-3 per 100,000 person years, and may be underestimated. Sudden cardiac death in a young athlete is a tragic and marking event, even though the media attention it gets is more important than its incidence (1-2/100000 per year). The sudden death of athletes under 35 years engaged in competitive sports is a well-known occurrence; the incidence is higher in athletes (approximately 2/100,000 per year) than in non-athletes (2.5 : 1), and the cause is cardiovascular in over 90%."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52fb7c512059c6d71c000069",
                            "question": "How much should be the duration of the QT interval in patients with short QT syndrome?"
                        }
                    ],
                    "context": "The short QT syndrome constitutes a new clinical entity that is associated with a high incidence of sudden cardiac death, syncope, and/or atrial fibrillation even in young patients and newborns. Patients with this congenital electrical abnormality are characterized by rate-corrected QT intervals<320 ms. QT interval is shortened when QTc is less than 350 ms (1st degree of shortening). In children with QTc below 330 ms (2nd degree of shortening) short QT syndrome should be excluded.The short-QT syndrome is a new clinical entity characterized by corrected QT intervals <300 ms and a high incidence of ventricular tachycardia (VT) and fibrillation (VF). Short QT syndrome is a newly described cardiologic entity which associates a short OT interval (QT and QTc < or = 300 ms) on the surface ECG to a high risk of syncope or sudden death due to malignant ventricular arrhythmia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c58f1b5795f9a73e000001",
                            "question": "Which species of bacteria did the mitochondria originate from?"
                        }
                    ],
                    "context": "Recently, \u03b1-proteobacteria have been shown to possess virus-like gene transfer agents that facilitate high frequency gene transfer in natural environments between distantly related lineages. This system could have driven the genomic integration of the mitochondrial progenitor and its proto-eukaryote host and contributed to the evolutionary mosaic of genes seen in modern-day prokaryotic and eukaryotic genomes.Although the Alphaproteobacteria are thought to be the closest relatives of the mitochondrial progenitor, there is dispute as to what its particular sister group is.More detailed phylogenetic analyses with additional Alphaproteobacteria and including genes from the mitochondria of Reclinomonas americana found matches of mitochondrial genes to those of members of the Rickettsiaceae, Anaplasmataceae, and Rhodospirillaceae families.Biologists agree that the ancestor of mitochondria was an alpha-proteobacterium.Mitochondria originated by permanent enslavement of purple non-sulphur bacteria."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f7fe3709dd18d46b000015",
                            "question": "Which disease is linked to mutations within BRAG1?"
                        }
                    ],
                    "context": "Mutations in BRAG1 have been identified in families with X-linked intellectual disability (XLID)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54db62a3034aea571d000001",
                            "question": "Which is the main calcium pump of the sarcoplasmic reticulum?"
                        }
                    ],
                    "context": "sarcoplasmic reticulum (SR) calcium pump (SERCA)the sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA)SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.Sarcoplasmic reticulum calcium ATPase (SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key factor in the alteration of calcium cycling."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5344155faeec6fbd07000005",
                            "question": "What is the inheritance pattern of Hunter disease or mucopolysaccharidosis II?"
                        }
                    ],
                    "context": "ysosomal diseases (LD) are inherited as autosomal recessive traits, but two important conditions have X-linked inheritance: Fabry disease and Mucopolysaccharidosis II (MPS II).unter disease, Mucopolysaccharidosis type II, is an X-linked recessive lysosomal storage disorderunter syndrome is an X-linked recessive disorderX chromosome heterozygosity and confirmed the paternal origin of one of the X chromosomes Hunter's disease in a female with an X-chromosome deletion"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52c7275103868f1b0600001c",
                            "question": "What is the inheritance pattern of Apert syndrome?"
                        }
                    ],
                    "context": "The Apert syndrome is a rare disorder of autosomal dominant inheritance caused by mutations in the FGFR2 gene at locus 10q26; patients with this syndrome present severe syndactyly, exophthalmia, ocular hypertelorism and hypoplastic midface with Class III malocclusion, besides systemic alterations.The Apert syndrome is characterized by craniosynostosis and syndactyly of hands and feet. Although most cases are sporadic, an autosomal dominant mode of inheritance is well documented.Apert syndrome, or acrocephalosyndactyly, is characterized by craniosynostosis and early epiphyseal closure resulting in various deformities of the skull, hands, and feet. Typically a sporadic condition, autosomal dominant inheritance with complete penetrance has been known to occur. We report two observations of antenatal diagnosis of Apert syndrome. This uncommon genetic disorder suggest an autosomal dominant inheritance, but almost all cases described are sporadic; the responsible gene is yet not located.The familial cases, the equal number of affected males and females, and the increased paternal age in sporadic cases strongly suggest autosomal dominant inheritance. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5139b31dbee46bd34c000004",
                            "question": "Which is the most widely used model for the study of multiple sclerosis (MS)?"
                        }
                    ],
                    "context": "experimental autoimmune encephalomyelitis (EAE) animal model of multiple sclerosisMany aspects of MS can be mimicked in the animal model of myelin oligodendrocyte glycoprotein experimental autoimmune encephalomyelitis (MOG-EAE)the chronic experimental autoimmune encephalomyelitis (EAE) mouse model of MSThe aim of our study was to characterize the sensory abnormalities and in particular the clinical signs linked to persistent pain in two models of Experimental Autoimmune Encephalomyelitis (EAE) in the ratExperimental autoimmune encephalomyelitis (EAE) is an animal model for studying multiple sclerosis (MS)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f21b722059c6d71c00000b",
                            "question": "What is the usual HER-2 status in breast cancer associated with Li-Fraumeni syndrome?"
                        }
                    ],
                    "context": "Breast cancer is the most frequent tumor in Li-Fraumeni syndrome (LFS), a rare inherited cancer syndrome associated with germline mutations in the TP53 gene. Recent data show that breast cancer in germline TP53 mutation carriers is commonly HER2+ (63-83 %).Breast cancers in TP53 mutation carriers recently have more often been reported to be hormone receptor and HER-2 positive by immunohistochemistry and FISH in small series.Most DCIS and invasive ductal carcinomas in LFS are hormone receptor positive and/or HER-2 positive.Early onset HER2-positive breast cancer is associated with germline TP53 mutations.Germline TP53 mutations predispose to early onset breast cancer in women and are associated with Li-Fraumeni syndrome."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55192892622b194345000012",
                            "question": "Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?"
                        }
                    ],
                    "context": "IFNAR1 ubiquitination is facilitated by the \u03b2Trcp E3 ubiquitin ligase that is recruited to IFNAR1 upon its degron phosphorylation, which is induced by the ligand.Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation.The SCF(betaTrcp) (Skp1-Cullin1-F-box complex) E3 ubiquitin ligase that mediates IFNAR1 ubiquitination and degradation in cells can conjugate both types of chains in vitro. Levels of IFNAR1 (regulated via degradation mediated by the betaTrcp E3 ubiquitin ligase) and IFNalpha signaling were reduced in 1205Lu melanoma cell line that harbors activated BRAF and exhibits high levels of betaTrcp ubiquitin ligase.IFNalpha promotes the phosphorylation of IFNAR1 on Ser535, followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 (beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cdf4875795f9a73e000040",
                            "question": "Which domain of TIA-1 is necessary for stress granule assembly?"
                        }
                    ],
                    "context": "Tia1/Pub1 is a stress granule component carrying a Q/N-rich prion domainCodependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survivalWe report an unanticipated link between stress granules and the serine/threonine kinase RSK2. In stressed breast cells, endogenous RSK2 colocalizes in granules with TIA-1 and poly(A)-binding protein 1, and the sequestration of RSK2 and TIA-1 exhibits codependency. The RSK2 N-terminal kinase domain controls the direct interaction with the prion-related domain of TIA-1Stress granule assembly is mediated by prion-like aggregation of TIA-1TIA-1 is an RNA binding protein that promotes the assembly of stress granules (SGs), discrete cytoplasmic inclusions into which stalled translation initiation complexes are dynamically recruited in cells subjected to environmental stress. The RNA recognition motifs of TIA-1 are linked to a glutamine-rich prion-related domain (PRD). Truncation mutants lacking the PRD domain do not induce spontaneous SGs and are not recruited to arsenite-induced SGs, whereas the PRD forms aggregates that are recruited to SGs in low-level-expressing cells but prevent SG assembly in high-level-expressing cells"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "532dcfc9d6d3ac6a34000021",
                            "question": "What is the characteristic domain of histone methyltransferases?"
                        }
                    ],
                    "context": "C-terminal SET domain that catalyzes methylation of histone H3not all members of the H3K4 methyltransferase family contain n-SET domainsprotein methyltransferases (both protein arginine and lysine methyltransferases) and the relatedness of their catalytic domains. We identified 51 protein lysine methyltransferase proteins based on similarity to the canonical Drosophila Su(var)3-9, enhancer of zeste (E(z)), and trithorax (trx) domain a SET domain histone methyltransferase A common feature of the mammalian MLL/SET1 complexes is the presence of three core components (RbBP5, Ash2L and WDR5) and a catalytic subunit containing a SET domain"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5543829fed966d112c000009",
                            "question": "Which is the major phytoalexin in alfalfa (Medicago sativa L.)?"
                        }
                    ],
                    "context": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.The isoflavonoid conjugates medicarpin-3-O-glucoside-6-O-malonate (MGM), afrormosin-7-O-glucoside (AG), and afrormosin-7-O-glucoside-6-O-malonate (AGM) were isolated and characterized from cell suspension cultures of alfalfa (Medicago sativa L.), where they were the major constitutive secondary metabolites.Alfalfa (Medicago sativa L.) cell suspension cultures accumulated high concentrations of the pterocarpan phytoalexin medicarpin, reaching a maximum within 24 hours after exposure to an elicitor preparation from cell walls of the phytopathogenic fungus Colletotrichum lindemuthianum."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f564f909dd18d46b000009",
                            "question": "Which syndrome is associated with mutations in the LYST gene?"
                        }
                    ],
                    "context": "Mutations in LYST, a gene encoding a putative lysosomal trafficking protein, cause Ch\u00e9diak-Higashi syndrome (CHS), an autosomal recessive disorder typically characterized by infantile-onset hemophagocytic syndrome and immunodeficiency, and oculocutaneous albinism. A small number of reports of rare, attenuated forms of CHS exist, with affected individuals exhibiting progressive neurodegenerative disease beginning in early adulthood with cognitive decline, parkinsonism, features of spinocerebellar degeneration, and peripheral neuropathy, as well as subtle pigmentary abnormalities and subclinical or absent immune dysfunction.Mutations in the CHS1 (LYST) gene result in CHS.Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disease characterized by variable degrees of oculocutaneous albinism, recurrent infections, and a mild bleeding tendency, with late neurologic dysfunction.Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disease resulting from mutations in the LYST/CHS1 gene, which encodes for a 429\u00a0kDa protein, CHS1/LYST, that regulates vesicle trafficking and determines the size of lysosomes and other organelles.Mutations in the CHS1 (LYST) gene result in CHS."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550618f58e1671127b000007",
                            "question": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?"
                        }
                    ],
                    "context": "The type 1 protein phosphatase (PP1) is a critical negative regulator of Ca(2+) cycling and contractility in the cardiomyocyte. In particular, it mediates restoration of cardiac function to basal levels, after beta-adrenergic stimulation, by dephosphorylating key phospho-proteins. PP1 is a holoenzyme comprised of its catalytic and auxiliary subunits. These regulatory proteins dictate PP1's subcellular localization, substrate specificity and activity. Amongst them, inhibitor-1 is of particular importance since it has been implicated as an integrator of multiple neurohormonal pathways, which finely regulate PP1 activity, at the level of the sarcoplasmic reticulum (SR). In fact, perturbations in the regulation of PP1 by inhibitor-1 have been implicated in the pathogenesis of heart failure, suggesting that inhibitor-1-based therapeutic interventions may ameliorate cardiac dysfunction and remodeling in the failing heart. Aberrant beta-adrenergic signaling and depressed calcium homeostasis, associated with an imbalance of protein kinase A and phosphatase-1 activities, are hallmarks of heart failure. Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI-1)Using this technology, we showed that inhibition of the protein phosphatase 1, by its constitutively active inhibitor-1, significantly increases cardiac contractility and calcium handling. Thus, long-term cardiac specific overexpression of the protein phosphatase 1 inhibitor-1 and the associated increases in cardiac contractility appear to herald changes in a rather small number of proteins, which may reflect important compensatory adaptations in a hyperdynamic heart [corrected]Inhibitor-1 becomes a potent inhibitor of protein phosphatase 1 when phosphorylated by cAMP-dependent protein kinase at Thr(35). Moreover, Ser(67) of inhibitor-1 serves as a substrate for cyclin-dependent kinase 5 in the brain."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cdf5195795f9a73e000045",
                            "question": "Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?"
                        }
                    ],
                    "context": "we examined whether another Hsp90 inhibitor radicicol (RA) affected P-bodies and stress granules. Treatment with RA reduced the level of the Hsp90 client protein Argonaute 2 and the number of P-bodies. Although stress granules still assembled in RA-treated cells upon heat shock, they were smaller and more dispersed in the cytoplasm than those in untreated cellsHsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodiesProcessing bodies (PBs) and stress granules (SGs) are the two main types of ribonucleoprotein complexes with which Argonautes are associated. Targeting of Argonautes to these structures seems to be regulated by different factors. In the present study, we show that heat-shock protein (Hsp) 90 activity is required for efficient targeting of hAgo2 to PBs and SGsHsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies.Treatment with RA reduced the level of the Hsp90 client protein Argonaute 2 and the number of P-bodies."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51487dead24251bc05000030",
                            "question": "Which pharmacogenetic test is available for abacavir?"
                        }
                    ],
                    "context": "Pharmacogenomic tests offer a promising strategy to improve the safety and efficacy of drug treatment. Compelling examples, such as HLA-B*5701 testing to identify patients at risk for abacavir-associated hypersensitivity, are already changing clinical careInternational HIV treatment guidelines recommend HLA-B*57:01 typing before abacavir administration, in order to reduce the incidence of abacavir hypersensitivity reactions, the major cause of early therapy discontinuation. A fast, sensitive and specific test for HLA-B*57:01 detection has been developed in the present study.The rollout of HLA-B\u22175701 into routine clinical practice as a genetic screening test to prevent abacavir hypersensitivity provides a translational roadmap for other drugs.he aim of the session, using real-world examples (KRAS/panitumumab and HLA-B*5701/abacavir), was to identify good scientific principles that would guide the design of studies to identify subgroups of responders during development programs (including marketed drugs), which could subsequently be used to guide treatment decisions.HLA-B*5701 screening to prevent abacavir hypersensitivity syndrome is an example of a test now in widespread routine clinical use in the developed world."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53147b52e3eabad021000015",
                            "question": "What is a benefit of being g6PD-deficient?"
                        }
                    ],
                    "context": "A central position of the PPP for malaria parasites is supported by the fact that human G6PD deficiency protects to a certain degree from malaria infections. The beneficial effect of thalassemia minor, sickle-cell trait, and glucose-6-phosphate dehydrogenase deficiency on survival of malaria infection may well be due to the shared feature of enhanced oxidative stress. This may inhibit parasite growth, enhance uptake of infected RBCs by spleen macrophages, and/or cause less cytoadherence of the infected cells to capillary endothelium. In conclusion, genetic variants that confer resistance to malaria are associated with RBC traits in African-Americans. G6PD deficiency has been positively selected by malaria, and recent knowledge seems to show that it also confers an advantage against the development of cancer, reduces the risk of coronary diseases and has a beneficial effect in terms of longevity.G6PD enzyme activity was directly related to susceptibility to malaria in the Brazilian Amazon, where P. vivax predominates. Severe G6PDd was associated with considerable higher risk of malaria-related transfusions."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf1f2d03868f1b06000015",
                            "question": "Which drug is benserazide usually co-administered with?"
                        }
                    ],
                    "context": "The present study utilizes in vivo amperometry to investigate the impact from unilateral 6-hydroxydopamine lesions and l-DOPA (4 mg/kg, including benserazide 15 mg/kg) -induced dyskinetic behavior on striatal basal extracellular glutamate concentration and potassium-evoked glutamate release in urethane-anesthetized rats. Co-administration of L-Dopa with peripheral DDC inhibitors (carbidopa or benserazide) is the most effective symptomatic treatment for PD.In experiment 1, l-DOPA-primed rats were pre-treated with Vehicle (0.9% NaCl), various doses of the partial 5-HT(1A) agonist, buspirone (0.25, 1.0 or 2.5 mg/kg, ip) or buspirone (2.5 mg/kg, ip)+the 5-HT(1A) antagonist, WAY100635 (0.5 mg/kg, ip) 5 min prior to l-DOPA (12 mg/kg+15 mg/kg benserazide, ip). RL-DOPA induced hyperalgesia occurred after conversion to dopamine because co-administration of benserazide, a DOPA decarboxylase inhibitor, completely abolished the L-DOPA-induced hyperalgesia. First, animals were treated with levodopa (50 mg/kg with benserazide 12.5 mg/kg, twice daily), intraperitoneally (i.p.) for 22 days. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52bf19f703868f1b06000002",
                            "question": "What is the inheritance pattern of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) caused by RYR2 mutations?"
                        }
                    ],
                    "context": "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare arrythmogenic disease characterized by exercise--or stress--induced ventricular tachyarrythmias, syncope, or sudden death, usually in the pediatric age group. Familial occurrence has been noted in about 30% of cases. Inheritance may be autosomal dominant or recessive, usually with high penetrance. The causative genes have been mapped to chromosome 1. Mutations of the cardiac ryanodine receptor gene (RyR2) have been identified in autosomal dominant pedigrees, while calsequestrin gene (CASQ2) mutations are seen in recessive cases.Previously, autosomal dominant catecholaminergic polymorphic ventricular tachycardia (CPVT [1]) was mapped to chromosome 1q42-43 with identification of pathogenic mutations in RYR2. Several mutations in the genes encoding RyR1 and RyR2 have been identified in autosomal dominant diseases of skeletal and cardiac muscle, such as malignant hyperthermia (MH), central core disease (CCD), catecholaminergic polymorphic ventricular tachycardia (CPVT), and arrhythmogenic right ventricular dysplasia type 2 (ARVD2). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5519a7d5622b194345000015",
                            "question": "Which is the most abundant membrane protein on Earth?"
                        }
                    ],
                    "context": "LHCII, the largest plant photosynthetic pigment-protein complex of photosystem II, is a most abundant membrane protein in living organisms and comprises approximately half of the pool of chlorophyll molecules in the biosphere. LHCII is the most abundant membrane protein on earth.LHCII, the most abundant membrane protein on earth, is the major light-harvesting complex of plants. ILight-harvesting pigment-protein complex of Photosystem II (LHCII) is the largest photosynthetic antenna complex of plants and the most abundant membrane protein in the biosphere.still very little is known about protein degradation and its regulation. The degradation of the most abundant membrane protein on Earth, the light-harvesting complex of Photosystem II (LHC II), is highly regulated under different environmental conditions, e."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f21e8f2059c6d71c00000c",
                            "question": "What is the most probable defect underlying triple negative breast cancer?"
                        }
                    ],
                    "context": "We have previously reported an array comparative genomic hybridization profile that identifies triple-negative breast cancers (TNBC), with BRCA1 dysfunctionBRCA1-like status was assessed in 101 patients with early-stage TNBC receiving adjuvant cyclophosphamide-based chemotherapy.Sixty-six tumors (65%) had a BRCA1-like profile."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5147c8a6d24251bc05000027",
                            "question": "Which enzyme is deficient in Krabbe disease?"
                        }
                    ],
                    "context": "Krabbe disease is a lethal, demyelinating condition caused by genetic deficiency of galactocerebrosidase (GALC) and resultant accumulation of its cytotoxic substrate, psychosine (galactosylsphingosine), primarily in oligodendrocytes (OLs).In this study, we report that accumulation of endogenous psychosine under GALC deficient Krabbe conditions impedes OL differentiation process both by decreasing the expression of myelin lipids and protein and by inducing the cell death of maturating OLs.In almost all individuals with Krabbe disease, galactocerebrosidase (GALC) enzyme activity is deficient (0%-5% of normal activity) in leukocytes isolated from whole heparinized blood or in cultured skin fibroblasts.This chapter describes in detail a practical procedure for the preparation of radiolabeled galactocerebroside and its use in the assay of galactocerebrosidase (GalCase), the enzyme deficient in globoid cell leukodystrophy (Krabbe disease).Globoid cell leukodystrophy (Krabbe disease) is an inherited neurological disorder caused by the pathogenomic accumulation of psychosine (galactosylsphingosine), a substrate for the deficient enzyme galactocerebroside beta-galactosidase."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51631154298dcd4e5100004e",
                            "question": "What disease is Velcade (bortezomib) mainly used for?"
                        }
                    ],
                    "context": "patients with multiple myeloma (MM)bortezomib, and lenalidomide have shown improved outcomes in these patients.Bortezomib, a proteasome inhibitor drug very effective against multiple myeloma, may induce the so-called bortezomib-induced peripheral neuropathy (BIPN), hardly manageable with common analgesic drugs.bortezomib have emerged as effective treatment in patients with multiple myeloma (MM).the use of thalidomide to treat multiple myeloma, and describe problems arising in the Thaled\u00ae outpatient department. METHODS: Multiple myeloma patients treated with thalidomide at Hitachi General Hospital."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52fb78572059c6d71c000067",
                            "question": "What is the prevalence of short QT syndrome?"
                        }
                    ],
                    "context": "We chose patients with a short Bazett QTc interval from a database consisting of 114,334 patients to determine the clinical characteristics and prognostic value of a short QT interval. RESULTS: A total of 427 patients (mean age 43.4 \u00b1 22.4 years) had a short QT interval with about a 1.2 times higher male predominance (234 men). Among 5,511 males, 69 subjects (1.25%) exhibited QTc < 354 msec(1/2) (2 standard deviations [SDs] below the mean in males), and among 5,473 females, 89 subjects (1.63%) exhibited QTc < 364 msec(1/2) (2 SDs below the mean in females). Only 3 subjects (0.03% in all subjects and 0.05% in males) exhibited QTc < 300 msec(1/2), however, none had clinical symptoms of short QT syndrome. Of the 19,153 subjects, two met the criteria of short QT interval and allowed for prevalence and incidence estimates for short QT interval as 0.01% and 0.39/100,000 person-years, respectively. The prevalence of QT interval <320 ms based on QTc, QTfc, and QTnc was 0.10%, 0.08%, and 0.06%, and the prevalence of QT interval <340 ms was 0.4%, 0.3%, and 0.3%, respectively. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54cf45e7f693c3b16b00000a",
                            "question": "Which is the main calcium binding protein of the sarcoplasmic reticulum?"
                        }
                    ],
                    "context": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to the lumen of terminal cisternae (TC) of the sarcoplasmic reticulum (SR).human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR),Calsequestrin is the major calcium-binding protein of cardiac and skeletal muscles whose function is to sequester Ca(2+ )in the lumen of the sarcoplasmic reticulum (SR).Calsequestrin is a calcium-binding protein known to sequester calcium accumulated in the sarcoplasmic reticulum (SR) of muscle cells during relaxation. Calsequestrin (CASQ) is the major component of the sarcoplasmic reticulum (SR) lumen in skeletal and cardiac muscles. This calcium-binding protein localizes to the junctional SR (jSR) cisternae, where it is responsible for the storage of large amounts of Ca(2+)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54ede95c94afd6150400000a",
                            "question": "What is the mode of inheritance in Fanconi anemia?"
                        }
                    ],
                    "context": "Fanconi anemia (FA) is a rare inherited syndrome with diverse clinical symptoms including developmental defects, short stature, bone marrow failure, and a high risk of malignancies. Fifteen genetic subtypes have been distinguished so far. The mode of inheritance for all subtypes is autosomal recessive, except for FA-B, which is X-linkedFanconi anemia (FA) is a recessively inherited syndrome with predisposition to bone marrow failure and malignanciesOriginal Fanconi anemia data, for which no information about the ascertainment was available, were then analyzed, with results that confirmed a monogenic autosomal recessive mode of inheritanceThe formal genetics of Fanconi's anemia were investigated on the basis of 21 families from different European countries, and of 69 families from the literature. CONCLUSIONS: 1. The result of segregation analysis is compatible with the hypothesis of a simple autosomal recessive mode of inheritance Original Fanconi anemia data, for which no information about the ascertainment was available, were then analyzed, with results that confirmed a monogenic autosomal recessive mode of inheritance."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c04412ef6e39474100001b",
                            "question": "Which molecule is targeted by Daratumumab?"
                        }
                    ],
                    "context": "Daratumumab, an investigated anti-cancer drug targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma. Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38 epitope with broad-spectrum killing activity.This review focuses on the CD38 antigen and its targeting with daratumumab and provides an update on the results of recent clinical studies involving daratumumab.BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells. CONCLUSION: DARA causes panreactivity in vitro by binding to CD38 on reagent RBCs. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f899952059c6d71c00004b",
                            "question": "Which mutation is associated with PLMS (periodic limb movements in sleep)?"
                        }
                    ],
                    "context": "We describe a 2-year-old girl affected by SBH with epilepsy and periodic limb movements (PLMs), in whom a novel \"de novo\" missense substitution, Met1Val (M1V), was identified in the DCX gene."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53161545b166e2b806000002",
                            "question": "Which DNA repair system is involved in HNPCC?"
                        }
                    ],
                    "context": "The HNPCC syndrome (hereditary non polyposis colon cancer) or Lynch syndrome stands for an autosomic dominant condition leading to the most prevalent hereditary colo-rectal cancers (CCR). MMR (mismatch repair)'s genes are involved in carcinogenesis as they play a role in ADNA mismatch repair.Mutations in the genes of the mismatch DNA repair system and of the TGF-beta-II-receptor, the main defects of the HNPCC (hereditary nonpolyposis colorectal cancer), are exclusively identified in sequences of microsatellites. In HNPCC families, germline mutations in any of four genes encoding proteins of a specialized DNA repair system, the mismatch repair, predispose to cancer development. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56ae6e650a360a5e4500000e",
                            "question": "Mention the only available genomics and developmental transcriptomics resource for the urochordate Oikopleura dioica"
                        }
                    ],
                    "context": "OikoBase: a genomics and developmental transcriptomics resource for the urochordate Oikopleura dioica.We report the development of OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome browser resource for Oikopleura dioica, a metazoan belonging to the urochordates, the closest extant group to vertebrates. OikoBase facilitates retrieval and mining of a variety of useful genomics information. First, it includes a genome browser which interrogates 1260 genomic sequence scaffolds and features gene, transcript and CDS annotation tracks. Second, we annotated gene models with gene ontology (GO) terms and InterPro domains which are directly accessible in the browser with links to their entries in the GO (http://www.geneontology.org/) and InterPro (http://www.ebi.ac.uk/interpro/) databases, and we provide transcript and peptide links for sequence downloads. Third, we introduce the transcriptomics of a comprehensive set of developmental stages of O. dioica at high resolution and provide downloadable gene expression data for all developmental stages. Fourth, we incorporate a BLAST tool to identify homologs of genes and proteins. Finally, we include a tutorial that describes how to use OikoBase as well as a link to detailed methods, explaining the data generation and analysis pipeline. OikoBase will provide a valuable resource for research in chordate development, genome evolution and plasticity and the molecular ecology of this important marine planktonic organism.We report the development of OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome browser resource for Oikopleura dioica, a metazoan belonging to the urochordates, the closest extant group to vertebrates.OikoBase: a genomics and developmental transcriptomics resource for the urochordate Oikopleura dioicaWe report the development of OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome browser resource for Oikopleura dioica, a metazoan belonging to the urochordates, the closest extant group to vertebrates"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5314bd7ddae131f847000006",
                            "question": "Which hormone receptor function is altered in patients with Donohue syndrome?"
                        }
                    ],
                    "context": "This disease is caused by a defective insulin receptor and features abnormal glucose metabolism and retarded intrauterine and postnatal growth.Biallelic insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin resistance (SIR) known as Donohue syndrome (DS) and Rabson-Mendenhall syndrome (RMS). Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation.Donohue syndrome (leprechaunism; OMIM *246200) is a rare, recessively inherited disorder of extreme insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects in insulin binding or receptor autophosphorylation and tyrosine kinase activity.Leprechaunism (Donohue syndrome): a case bearing novel compound heterozygous mutations in the insulin receptor gene."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55180ef46487737b43000006",
                            "question": "What is the typical rash associated with gluten ?"
                        }
                    ],
                    "context": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis associated with a gluten-dependent enteropathy. Dermatitis herpetiformis is an autoimmune blistering disease that appears as a cutaneous manifestation of gluten intolerance. Treatment of dermatitis herpetiformis is based on a life-long, strict gluten-free diet, which improves all clinical aspects of gluten sensitivity, and dapsone, a drug that is only effective for the skin manifestations.Dermatitis herpetiformis and coeliac disease are gluten-sensitive diseases that share immunopathological mechanisms.We report the unusual case of an 8-month-old child presenting to his general practitioner with pruritic skin lesions, subsequently proven to be dermatitis herpetiformis (DH) as the first sign of gluten-sensitive disease."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51716e808ed59a060a00000b",
                            "question": "Which is the vector of Louping ill virus?"
                        }
                    ],
                    "context": "Deer are the key hosts of the vector (Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality.n Europe the primary arthropod vectors of zoonotic diseases are ticks, which transmit Borrelia burgdorferi sensu lato (the agent of Lyme disease), tick-borne encephalitis virus and louping ill virus between humans, livestock and wildlife. Ixodes ricinus ticks and reported tick-borne disease cases are currently increasing in the UKMany vector-borne pathogens whose primary vectors are generalists, such as Ixodid ticks, can infect a wide range of host species and are often zoonotic.Tick-borne encephalitis virus (TBEV) and Louping ill virus (LIV) are viruses in the Mammalian tick-borne virus group/genus Flavivirus, causing central nervous system disease.The complex pathogen-host-vector system of the tick-borne louping-ill virus causes economic losses to sheep and red grouse in upland United Kingdom."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "554101d0234c5a7c75000002",
                            "question": "Which receptor(s) recognize lysosomal hydrolases in trans-Golgi network (TGN)?"
                        }
                    ],
                    "context": "The majority of the enzymes leave the TGN after modification with mannose-6-phosphate (M6P) residues, which are specifically recognized by M6P receptors (MPRs), ensuring their transport to the endosomal/lysosomal system.M6P receptors play a major role in the intracellular transport of newly synthesized lysosomal enzymes in mammalian cellsMannose 6-phosphate receptors (MPRs) are known to be shuttled between the trans-Golgi network (TGN) and endosomes, thereby several lysosomal hydrolases are delivered through the endocytic pathway into lysosomes.Most soluble lysosomal hydrolases are sorted in the trans-Golgi network (TGN) and delivered to the lysosomes by the mannose 6-phosphate receptor (M6PR).certain soluble lysosomal hydrolases, is sorted and trafficked to the lysosomes by sortilin."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53592c1e9a4572de6f000002",
                            "question": "Which value of nuchal translucency thickness is set as the threshold for high-risk for Down Syndrome?"
                        }
                    ],
                    "context": "Combined prenatal screening was always positive for Down syndrome when NT thickness exceeded 4.0 mmIn women aged 35 to 37 years, combined prenatal screening was always positive when NT exceeded 2.8 mm, 3.0 mm, and 3.4 mm at 11, 12, and 13 weeks of gestation, respectivelyNT is physiological for a measurement < 3 mm but the incidence of chromosomal abnormalities (essentially trisomies 21, 18 and 13) increases when NT > or = 3 mm"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "533c390bc45e13371400000b",
                            "question": "What is an acceptable sequence coverage(depth) required for human whole-exome sequencing?"
                        }
                    ],
                    "context": "A total of 5.97 Gb clean data were generated for the two samples, achieving a mean depth of coverage of 31.96 and 32.88 for the AAA and normal samples, respectively.The 1.7 Mb targeted regions were sequenced with a coverage ranged from 32\u00d7 to 45\u00d7 for the 28 genes.We performed whole-exome sequencing on 87 HCCs and matched normal adjacent tissues to an average coverage of 59\u00d7We performed WES (mean coverage approximately 40\u00d7) on 10 trios comprised of unaffected parents and a child with sporadic epilepsy characterized by difficult-to-control seizures and some combination of developmental delay, epileptic encephalopathy, autistic features, cognitive impairment, or motor deficits. Sequence processing and variant calling were performed using standard bioinformatics tools.Whole-exome sequencing achieved a high degree of coverage such that approximately 97% of targeted bases were represented by more than 10 base reads;"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "531a3a58b166e2b806000037",
                            "question": "To what extent does HPV vaccination reduce the risk for cervical cancer?"
                        }
                    ],
                    "context": "The success of HPV vaccination as a major public health prevention opportunity, however, will entirely depend on efficient infrastructures to deliver the vaccines and on the acceptance by individuals, parents and health care providers.The most effective strategy therein was vaccination of 12-year-olds, plus a temporary 12-24-year-old catch-up program covering both sexes; whereby HPV 6/11/16/18-related cervical cancer, high-grade cervical precancer, and genital wart incidence was reduced by 84-98% during year 50 following vaccine introductionthe introduction of cervical screening programs, the incidence and mortality of cervical cancer has been drastically reducedOn the assumption that the vaccine provided lifelong immunity, the cost-effectiveness ratio of vaccination of 12-year-old girls was $43,600 per quality-adjusted life-year (QALY) gained, as compared with the current screening practiceVaccine efficacy in prevention of CIN 2 or higher lesions in HPV 16 or HPV 18 negative women, who received all vaccination doses, ranges between 98% and 100%"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5156be17d24251bc05000086",
                            "question": "What disease is mirtazapine predominantly used for?"
                        }
                    ],
                    "context": "mirtazapine will make it the first-choice drug in depressive patients with gastric ulcers.If antidepressants are used to treat insomnia, sedating ones should be preferred over activating agents such as serotonin reuptake inhibitors. In general, drugs lacking strong cholinergic activity should be preferred. Drugs blocking serotonin 5-HT2A or 5-HT2C receptors should be preferred over those whose sedative property is caused by histamine receptor blockade only. The dose should be as low as possible (e.g. as an initial dose: doxepin 25 mg, mirtazapine 15 mg, trazodone 50 mg, trimipramine 25 mg). Regarding the lack of substantial data allowing for evidence-based recommendations, we are facing a clear need for well designed, long-term, comparative studies to further define the role of antidepressants versus other agents in the management of insomnia.second-generation antidepressants (selective serotonin reuptake inhibitors, nefazodone, venlafaxine, and mirtazapine) in participants younger than 19 years with MDD, OCD, or non-OCD anxiety disorders.patients 65 years or older with major depression. METHODS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122)A case report involving linezolid with citalopram and mirtazepine in the precipitation of serotonin syndrome in a critically ill bone marrow transplant patient is described in this article."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5540b9800083d1bf0e000002",
                            "question": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?"
                        }
                    ],
                    "context": "\u03b1- and \u03b2-spectrin by LC-MS/MS identifies Cys in these antiparallel chainsantiparallel spectrin heterodimersalpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimershuman erythroid alpha-spectrin repeats 13 and 14 (HEalpha13,14) and human erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel spectrin dimers.Spectrins comprise \u03b1- and \u03b2-subunits made up predominantly of a series of homologous repeating units of about 106 amino acids; the \u03b1- and \u03b2-chains form antiparallel dimers by lateral association"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "516545a8298dcd4e51000056",
                            "question": "Which is the protein (antigen) targeted by anti-Vel antibodies in the Vel blood group?"
                        }
                    ],
                    "context": "Anti-Vel is an uncommon antibody to a high-prevalence antigen. Its clinical significance and management in the prenatal setting are not well characterized.Haemolytic disease of the newborn because of rare anti-Vel.A haemolytic anti-Vel was detected in the tube test. In contrast, the particular commercial gel test kit used did not reveal the haemolytic property or specificity of the antibody."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "514c3fd7d24251bc05000062",
                            "question": "Intact macromolecular assemblies are analysed by advanced mass spectrometry. How large complexes (in molecular weight) have been studied?"
                        }
                    ],
                    "context": "Here we show that the Orbitrap mass analyzer can be used to measure protein assemblies of molecular weights approaching one megadalton with sensitivity down to the detection of single ions.Using this relationship we show that we can determine masses of both 30S subunits and intact 2.3 MDa 70S ribosomes from Thermus thermophilus.We confirm the existence of these subpopulations using tandem mass spectrometry of intact 30S subunits. Overall, the results show that, rather than uniform particles, gas-phase ribosomes consist of a number of discrete populations. More generally, the results establish a rigorous procedure for accurate mass measurement and spectral analysis of heterogeneous macromolecular assemblies."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c1f01cef6e394741000044",
                            "question": "What is targeted by Palbociclib?"
                        }
                    ],
                    "context": "BACKGROUND: Necitumumab is a second-generation, recombinant, human immunoglobulin G1 EGFR antibody. Epidermal growth factor receptor-directed monoclonal antibodies in nonsmall cell lung cancer: an update. A Southwest Oncology Group study currently prospectively evaluates the predictive biomarkers for cetuximab. In the SQUIRE phase III trial, necitumumab added to cisplatin and gemcitabine increased the survival in patients with advanced squamous cell NSCLC. BACKGROUND: Necitumumab is a second-generation recombinant human immunoglobulin G1 EGFR monoclonal antibody that competitively inhibits ligand binding. Numerous other drugs are in earlier stages of development for HNSCC treatment, including novel anti-EGFR mAbs (MEHD7945A, necitumumab, and RO5083945), small-molecule TKIs (vandetanib, icotinib, and CUDC-101), EGFR antisense, various add-on therapies to radiation and chemotherapy (bevacizumab, interleukin-12, lenalidomide, alisertib, and VTX-2337), and drugs (temsirolimus, everolimus, OSI-906, dasatinib, and PX-866) intended to overcome resistance to anti-EGFR agents. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56b1f4300a360a5e4500001b",
                            "question": "Which peptide plays a pivotal role in human cystatin C fibrillization?"
                        }
                    ],
                    "context": "Human cystatin C (HCC) is a low molecular weight member of the cystatin family (type2). HCC consists of 120 amino acids. Normally it is an inhibitor of cysteine proteases, but in pathological conditions it forms amyloid fibrils in brain arteries of young adults. An 'aggregation-prone' pentapeptide ((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide prediction algorithm developed in our lab. This peptide was synthesized and self-assembled into amyloid-like fibrils in vitro, as electron microscopy, X-ray fiber diffraction, Attenuated Total Reflectance Fourier-Transform Spectroscopy and Congo red staining studies reveal. Thus, the (47)LQVVR(51) peptide seems to have an important role in HCC fibrillization.The pentapeptide LQVVR plays a pivotal role in human cystatin C fibrillization.the (47)LQVVR(51) peptide seems to have an important role in HCC fibrillization.Thus, the (47)LQVVR(51) peptide seems to have an important role in HCC fibrillization."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5325fdf0600967d132000001",
                            "question": "What is the gold standard treatment for Iatrogenic male incontinence?"
                        }
                    ],
                    "context": "The initial treatment for SUI that persists after 12 months consists of conservative measures such as pelvic floor muscle exercises and behavioral therapy. Properly selected and informed patients can also be treated efficiently with minimally invasive procedures such as the implantation of a male suburethral sling, although the experience with such devices is not extensive. However, the implantation of artificial urinary sphincter is the gold standard therapy.treatments such as periurethral injection of bulking agents, artificial urinary sphincter (AUS) implantation, and sub-urethral sling positioning. The artificial urethral sphincter has represented, until today, the gold standard but, in the recent years, sling systems have been investigated as minimally invasive alternative options.Today, three different sling procedures are commonly performed: bone-anchored, readjustable, and trans-obturator slings systems.The bone anchored suburethral synthetic sling is a simple and attractive procedure that can produce immediate good results with low morbidity, especially when strictly selected patients are treated. BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD. It compares favourably with AUS."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5357b36cf1005d6b58000006",
                            "question": "Which is the main CHEK2 genetic variant, thought to be involved in familial breast cancer?"
                        }
                    ],
                    "context": "the two most studied breast cancer-predisposing variants of the CHEK2 gene, 1100delC and I157TThe CHEK2-1100delC mutation is recurrent in the population and is a moderate risk factor for breast cancerThe germline CHEK2-1100delC mutation was present among 8/1,646 (0.5%) sporadic, 2/400 (0.5%) early-onset and 3/302 (1%) familial breast cancer cases, but undetectable amongst 2,105 multiethnic controls, including 633 from the US.1100delC appears to be the only recurrent CHEK2 mutation associated with a potentially significant contribution to breast cancer risk in the general populationOur findings highlight the notion that clinical testing for rare missense mutations within CHEK2 may have limited value in predicting breast cancer risk, but that testing for the 1100delC variant may be valuable in phenotypically- and geographically-selected populations."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f88d292059c6d71c000036",
                            "question": "Which hormone abnormalities are common in Williams syndrome"
                        }
                    ],
                    "context": "A girl with Williams syndrome (WS) presented with elevated thyrotropin (TSH) levels (7.0 microU/ml), normal free thyroid hormone concentrations, and absent antithyroid autoantibodies.TSH response to thyrotropin-releasing hormone (TRH) injection (200 microg/mq, i.v.) was exaggerated and prolonged, suggesting subclinical hypothyroidism. The biological activity of circulating TSH was slightly below the normal range [TSH bioactivity (B) to immunoreactivity (I) ratio (TSH B/I) = 0.4, normal: 0.6-2.2].We report a boy with confirmed Williams-Beuren syndrome, who was found to have classical growth hormone deficiency and responded well to growth hormone therapy.A 31-year-old man who had been under regular hemodialysis for 6 months was diagnosed as Williams syndrome (WS) by fluorescence in situ hybridization (FISH) chromosomal analysis. The association of WS and chronic renal failure (CRF) is only rarely encountered. Endocrinological examinations revealed hypergonadotropic hypogonadism. Prolonged and exaggerated responses of adrenocorticotropin (ACTH) to insulin-induced hypoglycemia and corticotropin releasing hormone (CRH) were also noted.Involvement of the calcitonin/CGRP gene in Williams syndrome is postulated on the basis that Williams syndrome children often have infantile hypercalcemia and deficient expression of calcitonin, a hormone that lowers serum calcium levels. To test the hypothesis that mutations in the calcitonin/CGRP gene might be responsible for the reduced calcitonin levels"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5509ba931180f13250000001",
                            "question": "What is the treatment of choice  for gastric lymphoma?"
                        }
                    ],
                    "context": "The treatment of choice should be comprehensive therapy based on surgery.The treatment of choice for localized primary GI lymphoma is controversial. Complete surgical resection may increase the chance of complete remission, but mortality and relapse rates might be higher than those observed with combination chemotherapy alone.The most common gastric lymphoma are low-grade marginal zone B-cell lymphoma (MZBCL) of MALT type.In early stages of disease, H. pylori eradication alone may lead to complete lymphoma remission in up to 75% of cases. Nonresponder or locally advanced lymphoma should be treated with radiation therapy. Advanced lymphoma may be treated with the nucleoside analogon cladribine within clinical trialsIn patients with primary gastric diffuse large cell lymphoma and aggressive histology, diffuse large cell lymphoma in early stage SCT achieved good results, but surgery was associated with some cases of lethal complications. Thus it appears that CT should be considered the treatment of choice in this patient setting."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "530f900ee3eabad021000003",
                            "question": "Which hormone concentrations are altered in patients with the Allan\u2013Herndon\u2013Dudley syndrome?"
                        }
                    ],
                    "context": "This syndrome is characterized by axial hypotonia, severe mental retardation, dysarthria, athetoid movements, spastic paraplegia, and a typical thyroid hormone profile. Our case and the review of the pertinent literature suggest that Allan-Herndon-Dudley syndrome should be suspected in males with the typical neurological and thyroid profile, even in cases with normal brain myelination.Allan-Herndon-Dudley Syndrome (AHDS), an X linked condition, is characterized by congenital hypotonia that progresses to spasticity with severe psychomotor delays, in combination with altered thyroid hormone levels, in particular, high serum T3 levels. Mutations in the MCT8 gene are associated with Allan-Herndon-Dudley Syndrome (AHDS), consisting of severe psychomotor retardation and disturbed TH parameters.Allan-Herndon-Dudley syndrome (AHDS), an X linked condition, is characterized by severe intellectual disability, dysarthria, athetoid movements, muscle hypoplasia and spastic paraplegia in combination with altered TH levels, in particular, high serum T3 levels. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54e8c7220fc566b149000002",
                            "question": "Where in the cell does the proteins S100A4 and p53 interact ?"
                        }
                    ],
                    "context": "S100A4 interacts with p53 in the nucleuswe show that endogenous S100A4 and p53 interact in complex samplesusing proximity ligation assay, we show that the interaction takes place in the cell nucleus.Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "517194ef8ed59a060a000011",
                            "question": "Which is the causative agent of malaria?"
                        }
                    ],
                    "context": "lasmodium falciparum the main causative agent of malaria is an important public health vector.Plasmodium falciparum the main causative agent of malaria is an important public health vector. <Overcoming antigenic variation is one of the major challenges in the development of an effective vaccine against Plasmodium falciparum, a causative agent of human malaria.[The vivax malaria causative agent Plasmodium ovale: the present global area, intraspecies polymorphism, importation to the Russian Federation (1992-2011)].The global area for Plasmodium ovale is small as compared with that for other species of human malaria pathogens."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53551206a0726bee57000001",
                            "question": "What is the major adverse effect of adriamycin(doxorubicin)?"
                        }
                    ],
                    "context": "It remains to be seen whether inhibition by adriamycin of these systems is related to the severe cardiotoxicity, the major adverse effect of the drug that limits its clinical usefulness.Leukocytopenia was the major adverse effect among patients undergoing systemic THP administrationThe major adverse effect was bone-marrow suppression;The major adverse effect was bone marrow suppression;Cardiotoxicity is a major adverse effect of the anthracycline antibiotics and can be acute or chronic;"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56ffdc1ccf1c32585100000b",
                            "question": "Which is the most common editing modification in eukaryotic mRNA?"
                        }
                    ],
                    "context": "One of the most common forms of pre-mRNA editing is A-to-I editing, in which adenosine is deaminated to inosine, which is read as guanosine during translation.Deamination of adenine by adenosine deaminases that act on RNA (ADARs) leads to the conversion of adenine into inosine (A-I editing) recognized by the splicing and translation systems as guanine.denosine deaminases editing adenines in transport RNAs (ADATs) convert adenine into inosine in tRNAs of all eukaryotes; as a result, the diversity of tRNA forms in the cell increases.A-to-I editing events in normal and cancerous human keratinocytesA-to-I RNA editing can alter codons, substitute amino acids and affect protein sequence, structure, and function."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56cae3eb5795f9a73e000021",
                            "question": "What is the most likely age of diagnosis of Crohn's disease (CD)?"
                        }
                    ],
                    "context": "Eighteen, 17, and 12 patients were diagnosed at ages<40, 40-59, and \u226560 years, respectivelyCrohn's disease (CD) diagnosed in pediatric patients has been reported to have a more aggressive phenotype and course, with a greater prevalence of upper gastrointestinal involvement, than in adults.There was a significant association between body mass index and bone mineral density (P = 0.004) and a significant difference in the T scores of patients according to age at diagnosis (Montreal Classification: P = 0.0006) with patients diagnosed<17 years (n = 13) having lower T scores than those diagnosed at older age groups (n = 70).Increasing age of diagnosis was negatively associated with complicated disease and positively associated with colonic disease. As age of diagnosis increased, disease duration (P<0.001), family history of Inflammatory bowel disease (IBD) (P = 0.015) and perianal disease decreased (P<0.0015). Crohn's disease incidence rates in the 10-19-year age category increased by 71%, from 6.5 (1988-1990) to 11.1 (2006-2007)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5509bd6a1180f13250000002",
                            "question": "What disease is small bowel lymphoma commonly associated with"
                        }
                    ],
                    "context": "Marginal zone B-cell lymphoma of MALT in small intestine associated with amyloidosis: a rare association.This is the first case of marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) in the small intestine associated with amyloidosis in KoreaMR enterography of small-bowel lymphoma: potential for suggestion of histologic subtype and the presence of underlying celiac disease.We describe the characteristics of small-bowel lymphoma on MR enterography, identifying a number of key features that may help the interpreting radiologist in suggesting the underlying histologic subtype and whether the presence of underlying celiac disease is likely.Celiac disease is an autoimmune disorder triggered by ingestion of gluten-containing foods. Epidemiologic studies dating from the 1950s established its association with gastrointestinal malignancies, particularly small bowel lymphoma."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54e0d7471388e8454a000015",
                            "question": "Which molecule is targeted by a monoclonal antibody Secukinumab?"
                        }
                    ],
                    "context": "We identified 3 distinct clonotypes that efficiently neutralized IL17A in a cell-based in vitro assay. Their potencies were comparable to those of known neutralizing antibodies, including 2, AIN457 (secukinumab) and ixekizumab that are currently in clinical development for the treatment of various inflammatory disorders. Secukinumab, a fully human anti-IL-17A monoclonal antibody, neutralizes IL-17A, a key cytokine in the pathogenesis of psoriasis.BACKGROUND: Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.BACKGROUND: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection. We evaluated secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f9c40ddd3fc62544000001",
                            "question": "Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?"
                        }
                    ],
                    "context": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.Calcineurin signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed of catalytic and regulatory subunits. The serine/threonine-specific phosphatase functions within a signal transduction pathway that regulates gene expression and biological responses in many developmentally important cell types. Calcineurin signaling was first defined in T lymphocytes as a regulator of nuclear factor of activated T cells (NFAT) transcription factor nuclear translocation and activation.NFAT (nuclear factor of activated T cell) proteins are expressed in most immune system cells and regulate the transcription of cytokine genes critical for the immune response. The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization. Calcium activated gene transcription through Nuclear Factor of Activated T-cells, (NFAT) proteins, is emerging as a ubiquitous mechanism for the control of important physiological processes. Of the five mammalian NFAT isoforms, transcriptional activities of NFATs 1-4 are stimulated by a calcium driven association between the ubiquitous phosphatase calcineurin and the calcium-sensing protein calmodulin.Transcription factors of the NFAT (nuclear factor of activated T cells) family are expressed in most immune system cells and in a range of other cell types. Signaling through NFAT is implicated in the regulation of transcription for the immune response and other processes, including differentiation and apoptosis. NFAT normally resides in the cytoplasm, and a key aspect of the NFAT activation pathway is the regulation of its nuclear import by the Ca(2+)/calmodulin-dependent phosphatase calcineurin. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "532ff917d6d3ac6a34000038",
                            "question": "What histone trimethylation has been associated to RNA splicing?"
                        }
                    ],
                    "context": "histone H3 lysine 36 tri-methylation (H3K36Me3), exhibits different patterns around the cleavage sites of genes using multiple polyadenylation sites from those of genes using a single polyadenylation site.ChIP-sequencing data mapped onto skipped exon events reveal a correlation between histone H3K36 trimethylation peaks and skipped exons, suggesting epigenetic marks being part of alternative splicing regulation.Vezf1 interacts with Mrg15/Mrgbp, a protein that recognizes H3K36 trimethylation, consistent with the role of histone modifications at alternatively spliced sitesH2BK123ub1 is also a feature of introns in the yeast genome, and the disruption of this modification alters the intragenic distribution of H3 trimethylation on lysine 36 (H3K36me3), which functionally correlates with alternative RNA splicing in humansWe investigated whether a causal relationship exists between splicing and chromatin modification by asking whether splice-site mutations affect the methylation of histone H3K36"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52f89a002059c6d71c00004c",
                            "question": "Which deficiency is the cause of restless leg syndrome"
                        }
                    ],
                    "context": "Homozygosity for the T-allele of BTBD9 rs9296249 was associated with lower serum ferritinThis polymorphism has previously been associated with RLS, but not low iron stores in blood donors.Iron deficiency is a common cause of anemia in patients with end stage renal disease (ESRD). Intravenous iron administration, especially in those requiring treatment with erythropoiesis stimulating agents (ESA) is an essential component of the management of anemia in ESRD patients. Iron improves hemoglobin, reduces ESA dose requirement and also has nonerythropoietic effects including improvement in physical performance, cognition and amelioration of restless leg syndrome.The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome.RLS subjects had significantly lower DAT binding in the striatum compared to controls on both the Day and the Night scans."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5156be04d24251bc05000085",
                            "question": "What gene test is recommended for clopidogrel?"
                        }
                    ],
                    "context": "polymorphisms in the CYP2C19 gene affect clopidogrel pharmacokinetics.This study sought to evaluate the influence of single nucleotide polymorphisms (SNPs) on the pharmacodynamic effect of high- or standard-dose clopidogrel after percutaneous coronary intervention (PCI).CYP2C19, but not PON1 or ABCB1, is a significant determinant of the pharmacodynamic effects of clopidogrel, both early and late after PCI. In patients with high OTR identified by platelet function testing, the CYP2C19 genotype provides limited incremental information regarding the risk of persistently high reactivity with clopidogrel 150-mg maintenance dosing. (Genotype Information and Functional Testing Study [GIFT]; NCT00992420).Variants in the CYP2C19 gene influence the pharmacologic and clinical response to the standard 75-mg daily maintenance dose of the antiplatelet drug clopidogrel. OBJECTIVE: To test whether higher doses (up to 300 mg daily) improve the response to clopidogrel in the setting of loss-of-function CYP2C19 genotypes.polymorphisms in the CYP2C19 gene affect clopidogrel pharmacokinetics. These polymorphisms may be useful to identify clopidogrel nonresponders who may benefit from taking an alternative antiplatelet agent such as prasugrel and ticagrelor. Although both drugs have pharmacogenomic tests available for clinical use,"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5324ce779b2d7acc7e00001e",
                            "question": "Which drug is considered as the first line treatment of fibromyalgia?"
                        }
                    ],
                    "context": "Multimodal approaches seem to be the treatment of choice in fibromyalgiaA multidisciplinary program was developed and implemented for patients with fibromyalgia in the primary care setting. The program included education (seven sessions) and physical therapy (25 sessions).Amitriptyline for neuropathic pain and fibromyalgia in adults.Amitriptyline is a tricyclic antidepressant that is widely used to treat chronic neuropathic pain (pain due to nerve damage) and fibromyalgia, and is recommended in many guidelines. Amitriptyline should continue to be used as part of the treatment of neuropathic pain or fibromyalgia, but only a minority of patients will achieve satisfactory pain relief."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56b773a96e3f8eaf4c000003",
                            "question": "With which complexes is the protein SUS1 associated?"
                        }
                    ],
                    "context": "The yeast DUBm comprises a catalytic subunit, Ubp8, and three additional subunits, Sgf11, Sus1 and Sgf73, all of which are required for DUBm activity.the deubiquitination module (DUBm) of SAGA, which is composed of Ubp8, Sus1, Sgf11, and Sgf73.The conserved Sac3:Thp1:Sem1:Sus1:Cdc31 (TREX2) complex binds to nuclear pore complexes (NPCs)Sus1 (hENY2) participates in this coordination as part of two protein complexes: SAGA, a transcriptional co-activator; TREX-2, which functions in mRNA biogenesis and export.The deubiquitinating module (DUBm) of the SAGA coactivator contains the Ubp8 isopeptidase, Sgf11, Sus1, and Sgf73, which form a highly interconnected complex. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c3184050c68dd416000003",
                            "question": "What is the indication for isradipine?"
                        }
                    ],
                    "context": "These are the preliminary data of an open multicenter trial of antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n = 11) or isradipine (7.5 +/- 0.63 mg twice daily) in combination with bopindolol (1.16 +/- 0.12 mg once daily; n = 30) administered for 3 years to patients with essential hypertension (WHO classification I or II).  It is concluded that isradipine is safe and effective when administered long-term in the treatment of hypertensive patients with either hyperlipidemia or NIDDM.Regression of left ventricular hypertrophy with isradipine antihypertensive therapy.Isradipine monotherapy was an effective antihypertensive drug in blacks with essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass.These are the preliminary data of an open multicenter trial of antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n = 11) or isradipine (7.5 +/- 0.63 mg twice daily) in combination with bopindolol (1.16 +/- 0.12 mg once daily; n = 30) administered for 3 years to patients with essential hypertension (WHO classification I or II)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "55421398ccca0ce74b000001",
                            "question": "What type of DNA repair pathways is initiated by AlkA glycosylase?"
                        }
                    ],
                    "context": "The Escherichia coli 3-methyladenine DNA glycosylase II protein (AlkA) recognizes a broad range of oxidized and alkylated base lesions and catalyzes the hydrolysis of the N-glycosidic bond to initiate the base excision repair pathway.Schizosaccharomyces pombe has two paralogues of 3-methyladenine DNA glycosylase, Mag1p and Mag2p, which share homology with Escherichia coli AlkA. To clarify the function of these redundant enzymes in base excision repair (BER) of alkylation damageEscherichia coli alkA tagA double mutants, which are deficient in the repair of alkylated bases.AlkA, a monofunctional DNA glycosylase that acts on alkylated bases, is structurally homologous to endo III. We have now identified a shared active site motif amongst these three proteins. Using this motif as a protein database searching tool, we find that it is present in a number of other base-excision DNA repair proteins that process diverse lesions.Alkylation damage is removed by the action of DNA glycosylases, which initiate the base excision repair pathway"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54d7b457e19bba8909000004",
                            "question": "What is the \"Proteomic ruler\"?"
                        }
                    ],
                    "context": "A \"proteomic ruler\" for protein copy number and concentration estimation without spike-in standards.We show that the MS signal of histones can be used as a \"proteomic ruler\" because it is proportional to the amount of DNA in the sample, which in turn depends on the number of cells. As a result, our proteomic ruler approach adds an absolute scale to the MS readout and allows estimation of the copy numbers of individual proteins per cell."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "530cf4c54a5037880c000008",
                            "question": "What is the name of Bruton's tyrosine kinase inhibitor that can be used for treatment of chronic lymphocytic leukemia?"
                        }
                    ],
                    "context": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL. Early clinical results in CLL with other reversible and irreversible BTK inhibitors have been less promising, however, raising the question of whether BTK kinase activity is an important target of ibrutinib and also in CLL. Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib. Ibrutinib, an inhibitor of Bruton's tyrosine kinase is showing impressive responses in heavily pre-treated high-risk CLL, whether alone or in combination with MoAbs or chemotherapy.Ibrutinib acts by inhibiting the Bruton's tyrosine kinase (BTK) while idelalisib represents a first-in-class specific inhibitor of the phosphoinositol-3 kinase (PI3K) delta isoform. Furthermore, we demonstrate that the Bruton's tyrosine kinase inhibitor ibrutinib or the PI3K inhibitor idelalisib block B-cell receptor induced activation of LCP1. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f2210164850a5854000001",
                            "question": "How many disulfide bridges has the protein hepcidin got?"
                        }
                    ],
                    "context": " hepcidin, containing four disulfide bridgesCshepc has eight cysteines formed four conserved disulfide bridges, similarly to that of human'sThe native peptide of 25 amino acids (Hepc25) contains four disulfide bridges that maintain a \u03b2-hairpin motif.Hepcidin, a 25 amino acid peptide hormone containing a complex network of four disulfide bonds is the hormone regulator of iron homeostasisMolecular mass measurements of the native peptide and the reduced and alkylated peptide confirmed the sequence with four intramolecular disulfide bridges. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54e0ba781388e8454a000011",
                            "question": "Where is the metaxin complex localized?"
                        }
                    ],
                    "context": " The C-terminus plays an important role in targeting TSPO to mitochondria, whereas its import into the OMM is dependent upon the presence of the Schellman motif. Final integration of TSPO into the OMM occurs via its interaction with Metaxin 1. TOM20 (translocase of the outer mitochondrial membrane), METAXIN, and mtOM64 (outer mitochondrial membrane protein of 64 kD). The outer membrane protein METAXIN was characterized to play a role in the import of mitochondrial precursor proteins and likely plays a role in the assembly of beta-barrel proteins into the outer membrane.The mitochondrial inner membrane protein mitofilin exists as a complex with SAM50, metaxins 1 and 2, coiled-coil-helix coiled-coil-helix domain-containing protein 3 and 6 and DnaJC11. The functional role of this new complex is uncertain. However, a role in protein import related to maintenance of mitochondrial structure is suggested as mitofilin helps regulate mitochondrial morphology and at least four of the associated proteins (metaxins 1 and 2, SAM50 and CHCHD3) have been implicated in protein import, while DnaJC11 is a chaperone-like protein that may have a similar role."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56f6c11109dd18d46b00000e",
                            "question": "Which is the receptor for the immunosuppressive drug cyclosporin A (CsA)?"
                        }
                    ],
                    "context": "hemical modification of CsA has led to analogs with distinct biological activities associated with its protein receptor family, cyclophilins the CsA receptor, cyclophilinThese results would support cyclophilin as the major, if not only, intracellular receptor protein for CsA. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "536e46f27d100faa09000012",
                            "question": "Which is the gene most commonly mutated in Tay-Sachs disease?"
                        }
                    ],
                    "context": "mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriersmutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs diseaseaffected HEXA alleles were found in an Israeli Druze Tay-Sachs child born to first-cousin parentsabnormalities in the gene coding for the beta-hexosaminidase alpha subunit were analysed from fibroblast's RNAs of 42 Tay-Sachs patients In the severest phenotype of Tay-Sachs disease (infantile form), mRNA of beta-hexosaminidase alpha subunit is not produced or is unstable"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "531e2695267d7dd05300000f",
                            "question": "What is the localization of the protein encoded by the gene DNAJC11?"
                        }
                    ],
                    "context": " DnaJC11, respectively. The first three are outer membrane proteins, CHCHD3 has been assigned to the matrix space, and the other two proteins have not been described in mitochondria previously."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "515df199298dcd4e5100002a",
                            "question": "What is the lay name of the treatment for CCSVI (chronic cerebro-spinal venous insufficiency)  in multiple sclerosis."
                        }
                    ],
                    "context": "patients with relapsing-remitting (RR) multiple sclerosis (MS) receiving standard medical treatment who had been diagnosed with chronic cerebrospinal venous insufficiency (CCSVI) and underwent percutaneous transluminal angioplasty (PTA)Although it is debated whether chronic cerebro-spinal venous insufficiency (CCSVI) plays a role in multiple sclerosis (MS) development, many patients undergo endovascular treatment (ET) of CCSVIEndovascular treatment of CCSVI in patients with multiple sclerosisAlthough it is still debated whether chronic cerebro-spinal venous insufficiency (CCSVI) plays a role in multiple sclerosis (MS) development, many patients underwent endovascular treatment (ET) of CCSVI.Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) has been proposed to be associated with Multiple Sclerosis (MS). Zamboni et\u00a0al reported significant improvement in neurological outcomes in MS patients who underwent Percutaneous Transluminal Angioplasty (PTA)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53148a07dae131f847000002",
                            "question": "Which hormone abnormalities are characteristic to Pendred syndrome?"
                        }
                    ],
                    "context": "Loss or reduction of function mutations of SLC26A4 underlie Pendred syndrome, a disorder invariably leading to hearing loss with enlarged vestibular aqueducts and in some patients to hypothyroidism and goiter.Goiter development and hypothyroidism vary among affected individuals and seem to be partially dependent on nutritional iodide intake.Elucidation of the molecular basis of Pendred syndrome and the function of pendrin has provided unexpected novel insights into the pathophysiology of the inner ear, thyroid hormone synthesis, and chloride/bicarbonate exchange in the kidney.Thyroid goiter was found in 46.5% of cases.Biallelic mutations of SLC26A4 (encoding pendrin) cause Pendred syndrome (PS), an autosomal recessive genetic disorder with deafness and goiter."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "52eea4dcc8da89891000000c",
                            "question": "What is the mode of inheritance of  long QT  Jervell and Lange-Nielsen syndrome?"
                        }
                    ],
                    "context": "Homozygous or compound heterozygous mutations in KCNQ1 cause Jervell and Lange-Nielsen syndrome, a rare, autosomal-recessive form of long-QT syndrome characterized by deafness, marked QT prolongation, and a high risk of sudden death.KCNQ1 is associated with two different entities of LQTS, the autosomal-dominant Romano-Ward syndrome (RWS), and the autosomal-recessive Jervell and Lange-Nielsen syndrome (JLNS) characterized by bilateral deafnessJervell and Lange-Nielsen syndrome (JLNS) is characterized by sensorineural deafness, QT prolongation, abnormal T waves, ventricular tachyarrhythmias, and autosomal recessive inheritance.Jervell and Lange-Nielsen syndrome (JLNS) is an autosomal recessive syndrome characterised by profound congenital sensorineural deafness and prolongation of the QT interval on the electrocardiogram, representing abnormal ventricular repolarisation.Jervell and Lange-Nielsen syndrome (MIM 220400; JLNS), is a rare form of profound congenital deafness combined with syncopal attacks and sudden death due to prolonged QTc; it is an autosomal recessive trait. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "533c38b3c45e133714000009",
                            "question": "What is an approximate number of CTCF binding sites in the human genome?"
                        }
                    ],
                    "context": "To study CTCF multivalency in\u00a0vivo, we define ZF binding requirements at \u223c50,000 genomic sites in primary lymphocytes. However, only ~3,700 out of the ~5,700 CTCFL- and ~31,000 CTCF-binding sites overlap."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51542e6fd24251bc05000082",
                            "question": "Which population has a high frequency of the HLA-B*1502 allele?"
                        }
                    ],
                    "context": "A strong association between human leukocyte antigen (HLA)-B*1502 and CBZ-induced SJS/TEN has been reported in Han Chinese, Thai, Malaysian and Indian populations, but not in Caucasian or Japanese populations.found a strong association between HLA-B*1502 and CBZ-induced SJS/TEN in the Han Chinese population from central and northern China. Combined with previous studies of the southern Han Chinese subpopulation, our results suggest that HLA-B*1502 is strongly associated with CBZ-induced SJS/TEN in the whole Han Chinese population.A strong association between HLA-B*1502 and carbamazepine-induced SJS/TEN has been identified in Chinese and Thai.In the present study, we conducted a pilot study to detect a possible association of oxcarbazepine (OXC)-induced MPE with HLA-B*1502 allele in Chinese Han population.observed an increased frequency of HLA-B*1502 allele in patients (44.44%) compared with tolerant controls (11.11%), although it failed to reach statistical significance (P=0.294). CONCLUSIONS: Our findings indicate that HLA-B*1502 allele may contribute to the genetic susceptibility to OXC-induced MPE in Chinese Han population."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53442023aeec6fbd07000007",
                            "question": "Which is the substrate of the haspin kinase during mitosis?"
                        }
                    ],
                    "context": "aspin phosphorylates histone H3 at Thr3 (H3T3ph) during mitosisprotein kinase Haspin-mediated spreading of H3T3ph Haspin localizes predominantly to chromosomes and phosphorylates histone H3 at threonine-3 during mitosishaspin/Gsg2 plays an important role in mitosis, where it specifically phosphorylates Thr-3 in histone H3 (H3T3aspin/Gsg2 is a kinase that phosphorylates histone H3 at Thr-3 (H3T3ph) during mitosis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "533abc76d6d3ac6a34000064",
                            "question": "Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?"
                        }
                    ],
                    "context": "the knockdown of BMI-1 expression could lead to significant up-regulation of p16INK4aIn EC9706 cells transfected by Bmi-1 siRNA, the expression levels of p16 One important pathway regulated by Bmi-1 is that involving two cyclin-dependent kinase inhibitors, p16(Ink4a) and p19(Arf)We also observe that ROS-induced up-regulation of p16(Ink4a) occurs correlatively with ERK1/2-dependent down-regulation and subsequent dissociation from chromatin of Bmi-1Bmi-1 is important for postnatal, but not embryonic, neural stem cell (NSC) self-renewal and have identified the cell-cycle inhibitors p16/p19 as molecular targets"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "571f5c150fd6f91b68000009",
                            "question": "Which protein is found to be mutated in Friedreich's ataxia?"
                        }
                    ],
                    "context": "It is generally accepted that Friedreich's ataxia (FRDA) is caused by a deficiency in frataxin expression, a mitochondrial protein involved in iron homeostasis, which mainly affects the brain, dorsal root ganglia of the spinal cord, heart and in certain cases the pancreasFriedreich's ataxia is a severe neurodegenerative disease caused by the decreased expression of frataxin, a mitochondrial protein that stimulates iron-sulfur (Fe-S) cluster biogenesisIn eukaryotes, frataxin deficiency (FXN) causes severe phenotypes including loss of iron-sulfur (Fe-S) cluster protein activity, accumulation of mitochondrial iron and leads to the neurodegenerative disease Friedreich's ataxiaComplete absence of frataxin, the mitochondrial protein defective in patients with Friedreich's ataxia, is lethal in C. elegans, while its partial deficiency extends animal lifespan in a p53 dependent manner.Friedreich ataxia (FRDA) is a neurodegenerative disease characterized by a decreased expression of the mitochondrial protein frataxin."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "51387022bee46bd34c000002",
                            "question": "Which is the process that Conserved noncoding elements mostly regulate?"
                        }
                    ],
                    "context": "Much evidence suggests that CNEs are selectively constrained and not mutational cold-spots, and there is evidence that some CNEs play a role in the regulation of development.This result suggests that there is widespread adaptation in mammalian conserved noncoding DNA elements, some of which have been implicated in the regulation of crucially important processes, including development.Some characteristics of CNEs include their high frequency in mammalian genomes, their potential regulatory role in gene expression, and their enrichment in gene deserts nearby master developmental genesAnimal genomes possess highly conserved cis-regulatory sequences that are often found near genes that regulate transcription and development.HCNEs of both human and zebrafish function as specific developmental enhancers in zebrafish."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "533be71dfd9a95ea0d000009",
                            "question": "Which is the histone residue methylated by MLL1?"
                        }
                    ],
                    "context": "lack of interaction with the histone methyltransferase, MLL1, resulting in decreased histone H3K4me3 and gene transcriptionhistone H3K4me3 methylase MLL1 complexMEN1 encodes menin, a subunit of MLL1/MLL2-containing histone methyltransferase complexes that trimethylate histone H3 at lysine 4 (H3K4me3MLL1, MLL5, Set1 and ASH1 to be highly up-regulated during transdifferentiation of HSCs. All of these histone methyltransferases regulate methylation of lysine 4 of histone H3, which is a signature of actively transcribed genesMLL1 (Mixed Lineage Leukemia 1), a histone methyltransferase that methylates H3K4 residues"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c8274f5795f9a73e00000d",
                            "question": "Which type of cells is affected in Amyotrophic Lateral Sclerosis?"
                        }
                    ],
                    "context": "Activation of microglia, CNS resident immune cells, is a pathological hallmark of amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder affecting motor neurons.We report that both small ubiquitin-like modifier (SUMO) 1 and SUMO2/3 modify ALS-linked SOD1 mutant proteins at lysine 75 in a motoneuronal cell line, the cell type affected in ALS.Amyotrophic lateral sclerosis (ALS) is the most common adult-onset neurodegenerative disease characterized by ascending muscle weakness, atrophy and paralysis. Early muscle abnormalities that precede motor neuron loss in ALS may destabilize neuromuscular junctions, and we have previously demonstrated alterations in myogenic regulatory factor (MRF) expression in vivo and in the activation of myofiber-associated skeletal muscle satellite cells (SMSCs) in the mouse model of ALS (SOD1-G93A).Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by selective loss of motor neurons.In the ALS motor neurons, TAR DNA-binding protein of 43 kDa (TDP-43) is dislocated from the nucleus to cytoplasm and forms inclusions, suggesting that loss of a nuclear function of TDP-43 may underlie the pathogenesis of ALS."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5545e65bd355485447000001",
                            "question": "Patients of which disease could be treated by utilizing knowledge obtained from experiments suppressing TDP-43 toxicity in yeast?"
                        }
                    ],
                    "context": "Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease primarily affecting motor neurons. Mutations in the gene encoding TDP-43 cause some forms of the disease, and cytoplasmic TDP-43 aggregates accumulate in degenerating neurons of most individuals with ALS. Thus, strategies aimed at targeting the toxicity of cytoplasmic TDP-43 aggregates may be effectiveThe strongest suppressor of TDP-43 toxicity was deletion of DBR1, which encodes an RNA lariat debranching enzyme. We show that, in the absence of Dbr1 enzymatic activity, intronic lariats accumulate in the cytoplasm and likely act as decoys to sequester TDP-43, preventing it from interfering with essential cellular RNAs and RNA-binding proteins. Knockdown of Dbr1 in a human neuronal cell line or in primary rat neurons is also sufficient to rescue TDP-43 toxicity. Our findings provide insight into TDP-43-mediated cytotoxicity and suggest that decreasing Dbr1 activity could be a potential therapeutic approach for ALS"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "531464a6e3eabad021000014",
                            "question": "Mutation of which gene is associated with McLeod syndrome?"
                        }
                    ],
                    "context": "The diagnosis of MLS was confirmed by genetic testing showing a hemizygous mutation of XK gene. We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.We hypothesized that because the XK gene is X-linked, it would be easy to identify spontaneously arising red cells with a phenotype resembling the McLeod syndrome, which results from inherited XK mutations. Identification and characterization of a novel XK splice site mutation in a patient with McLeod syndrome.McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53124bdae3eabad02100000b",
                            "question": "Which is the molecular target of the immunosuppressant drug Rapamycin?"
                        }
                    ],
                    "context": "molecular target of rapamycin (mTORmolecular target of rapamycin (mTOR)molecular target of rapamycin (mTOR) molecular target of rapamycin (mTOR)molecular target of rapamycin (mTOR)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54fc91e96ad7dcbc12000001",
                            "question": "PBT2 has been tested for which disorder?"
                        }
                    ],
                    "context": "PBT2 improved cognition in a phase II clinical trial with AD patients, and further clinical testing is currently underway.In the second trial a successor compound, PBT2, was compared with placebo in 78 participants with mild Alzheimer's dementia; all were included in the intention-to-treat analysis. The second trial of PBT2 was more rigorously conducted and showed that after 12 weeks this compound appeared to be safe and well tolerated in people with mild Alzheimer's dementia. The purpose of this mini-review is to highlight the emerging notion that metal chaperones, such as PBT2 (Prana Biotechnology), modulate a variety of critical pathways affecting key aspects of the AD cascade to provide a more \"holistic\" approach to the treatment of this disease.The Alzheimer's therapeutic PBT2 promotes amyloid-\u03b2 degradation and GSK3 phosphorylation via a metal chaperone activity."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "53318685d6d3ac6a3400003d",
                            "question": "What is the mode of inheritance of Acromicric dysplasia?"
                        }
                    ],
                    "context": "AD has an autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).Finally, WMS is transmitted either by an autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance. The condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant mode of inheritance."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "511a3573df1ebcce7d000018",
                            "question": "How many tissue kallikrein genes are present in the human genome?"
                        }
                    ],
                    "context": "Tissue kallikreins are a group of closely related serine proteinases that are represented by multigene families in mice and rats.Our map specifies the distance between genes to one base pair accuracy, the relative location, and the direction of transcription of all 15 genes.The human tissue Kallikrein family consists of 15 genes with the majority shown to be differentially expressed in cancers and/or indicators of cancer prognosis.The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific expression profiles and putative proteolytic functions.The 15 human and 24 mouse kallikreins have been implicated in pathophysiology of brain, kidney, and respiratory and reproductive systems and often are used as cancer biomarkers."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56be143eef6e394741000009",
                            "question": "Name triad of Wernicke encephalopathy."
                        }
                    ],
                    "context": "In the classical form it is characterized by a typical triad (confusion, oculomotor disturbance and ataxia), however, in the majority of the cases only confusion is present. Wernicke's encephalopathy is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia. The classic triad consists of encephalopathy, oculomotor dysfunction and gait ataxia but is not seen in a majority of patients.After frequent vomiting, he presented with mental status changes, ocular abnormalities, and truncal ataxia (the classic triad).Wernicke's encephalopathy is a triad of ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c865d25795f9a73e000016",
                            "question": "Which compound is a specific inhibitor for Nox1 and Nox4?"
                        }
                    ],
                    "context": "The efficacy of the Nox1/Nox4 inhibitor GKT137831 on the manifestations of DN was studied in OVE26 mice, a model of type 1 diabetes. At both doses, GKT137831 inhibited NADPH oxidase activity, superoxide generation, and hydrogen peroxide production in the renal cortex from diabetic mice without affecting Nox1 or Nox4 protein expressionGKT136901, a specific inhibitor of Nox1- and Nox4-containing NADPH oxidase activity, attenuated ROS generation and atherosclerosis and decreased CD44 and HA expression in atherosclerotic lesions. Basal NAD(P)H oxidase activity was blocked by GKT136901 (Nox1/4 inhibitor) and by Nox1 siRNA in WKY cells and by siNOX1 and siNOX2 in SHR.GKT136901, a specific inhibitor of Nox1- and Nox4-containing NADPH oxidase activity, attenuated ROS generation and atherosclerosis and decreased CD44 and HA expression in atherosclerotic lesions"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "550e828c71445a662f000002",
                            "question": "Which molecule is targeted by the drug Gevokizumab?"
                        }
                    ],
                    "context": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1\u03b2 antibody with differential receptor-modulating properties.Gevokizumab is a potent anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2 signaling through an allosteric mechanism. These data indicate, therefore, that gevokizumab is a unique inhibitor of IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.Most recently, rising evidence reports on the use of adalimumab, etanercept, and golimumab, while use of anti-interleukin (IL)-1 agents (anakinra, canakinumab, gevokizumab), IL-6 blockers (tocilizumab), and rituximab (depleting anti-CD20 antibody) is also increasing.One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1\u03b2."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5133b9455274a5fb0700000c",
                            "question": "What is the most prominent sequence consensus for the polyadenylation site?"
                        }
                    ],
                    "context": "the cannonical polyadenylation signal sequence AATAAATwo AATAAA motifs are coded in the last exon of this geneThe results demonstrate that the intact AAUAAA is not required for RNA polyadenylation but is required for the cleavage step preceding polyadenylation to occur efficientlythe early poly(A) consensus signal was mutated from AAUAAA to UGUAAAFunctional polyadenylation [poly(A)] sites consist of two sequence elements, the AAUAAA and G/U box signals, that closely flank the site of mRNA 3'-end formation"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "54f608f85f206a0c06000007",
                            "question": "What is the Drosophila melanogaster Groucho protein?"
                        }
                    ],
                    "context": "Although a repressor could function by recruiting just a single co-repressor, many can recruit more than one, with Drosophila Brinker (Brk) recruiting the co-repressors CtBP and Groucho (Gro), Groucho (Gro) is a Drosophila corepressor required by numerous DNA-binding repressors, many of which are distributed in gradients and provide positional information during development. Drosophila Groucho (Gro) is the founding member of a family of metazoan corepressors. Tcf3 requires corepressor molecules such as Groucho (Gro)/TLE and HDAC1 for activity. We identified the transcriptional co-repressor xTLE1/Groucho as an EphrinB1 interacting protein. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56c048acef6e39474100001c",
                            "question": "Which enzyme is inhibited by Imetelstat?"
                        }
                    ],
                    "context": "The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells.The purpose of this study was to investigate the effects of a telomerase antagonistic oligonucleotide, imetelstat (GRN163L), on CSC and non-CSC populations of HER2(+) breast cancer cell lines.Imetelstat inhibited telomerase activity in both subpopulations. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells.GRN163L (Imetelstat) is a lipid-conjugated N3'\u2192P5' thio-phosphoramidate oligonucleotide that blocks the template region of telomerase. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "512d0e635274a5fb07000005",
                            "question": "Which is the most widely used anti-TNF drug?"
                        }
                    ],
                    "context": "higher rates are observed with anti-TNF Abs (e.g., infliximab) as compared with TNF receptor fusion protein (etanercept).Two of them received etanercept and the remainder adalimumab.45 cases were collected of non-TB OIs in 43 patients receiving infliximab (n=29), adalimumab (n=10) or etanercept (n=4)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "56ffd805cf1c32585100000a",
                            "question": "Which is the main difference between Alu and B1 repeats?"
                        }
                    ],
                    "context": "The mouse B1 sequence is congruent to 130 nucleotides long and shows homology with the monomeric units of the dimeric 300-nucleotide primate sequence. Here we show that some members of the mouse B1 Alu sequence family encode a small cytoplasmic RNAAlus and B1s are short interspersed repeat elements (SINEs) derived from the 7SL RNA gene. Alus and B1s exist in the cytoplasm as non-coding RNA indicating that they are actively transcribed, but their function, if any, is unknown.B1 (Alu-equivalent) is a murine short interspersed element whose amplification probably involved an RNA intermediateThe data demonstrate that a limited set of B1 sequences are expressed as processed RNA polymerase III-transcripts of a high degree of structural conservation. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "533ba85ffd9a95ea0d000008",
                            "question": "What is the frequency of mutations induced spontaneously through Ethylnitrosourea (ENU) mutagenesis?"
                        }
                    ],
                    "context": "The mutation frequency increased linearly with MNU or ENU concentration (0.01--2.0 mM); mean values were 2800 and 840 mutants per 10(6) clonable cells per mM, respectivelyThe mutation frequency induced by a 400 mg/kg dosage of ethylnitrosourea is 12 times the maximal mutation frequency achievable with a single exposure to x-rays and 36 times that reported for procarbazine, the most effective chemical mutagen previously known for mouse stem-cell spermatogoniaSpecific locus tests designed to detect recessive mutations showed that ENU is the most efficient mutagen in mouse with an approximate mutation rate of 1 in 1,000 gametes.Theoretical considerations and empirical analysis suggest that the per-base mutation frequency for a fractionated-dose treatment protocol is on the order of 1 sequence change per 10(5) bpUnlike spontaneous chromosome damage, spontaneous mutant frequencies did not differ significantly among homozygous, heterozygous, and wild-type mice (3.2 x 10(-5), 3.1 x 10(-5), and 3.1 x 10(-5), respectively; P > 0.05)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a2e5f760087bc10a000007",
                            "question": "Which is the primary protein component of Lewy bodies?"
                        }
                    ],
                    "context": "Aggregation of \u03b1-synuclein (\u03b1Syn), the primary protein component in Lewy body inclusions of patients with Parkinson's disease, arises when the normally soluble intrinsically disordered protein converts to amyloid fibrils. The primary structural component of Lewy bodies are fibrils composed primarily of alpha-synuclein, a highly conserved 140 amino acid protein that is predominantly expressed in neurons and which may play a role in synaptic plasticity and neurotransmission.Fibrillar \u03b1-synuclein (AS) is the major component of Lewy bodies, the pathological hallmark of Parkinson's disease. Alpha-synuclein (alphaS) is the primary component of Lewy bodies, the pathological hallmark of Parkinson's Disease. For alpha-synuclein, the major protein component of Lewy bodies associated with Parkinson's disease, we have used a combination of ssNMR and biochemical data to identify the key region for self-aggregation of the protein as residues 77-82 (VAQKTV). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5891f9e549702f2e01000002",
                            "question": "Willis-Ekbom disease is also known as?"
                        }
                    ],
                    "context": "Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study.Clinical features variability between familial and sporadic restless legs syndrome/Willis-Ekbom disease (RLS/WED) has been previously reported. With this retrospective cohort study, we aimed to determine the clinical and polysomnographic characteristics of 400 RLS/WED patients. \"Emplotted Narratives\" and Structured \"Behavioral Observations\" Supporting the Diagnosis of Willis-Ekbom Disease/Restless Legs Syndrome in Children with Neurodevelopmental Conditions.BACKGROUND: Willis-Ekbom disease/restless legs syndrome (WED/RLS) seems to be a frequent cause of intractable chronic insomnia (ICI) but is under-recognized in children/adolescents with neurodevelopmental conditions (NDCs), as many patients do not have the ability to express the underlying \"urge-to-move\". Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a common movement disorder characterised by an uncontrollable urge to move because of uncomfortable, sometimes painful sensations in the legs with a diurnal variation and a release with movement. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a9c532396a458e50000002",
                            "question": "How many cysteines have alpha-defensins?"
                        }
                    ],
                    "context": "Alpha defensins contain six cysteines, which form three well defined disulfide bridges under oxidizing conditions. All three kinds of defensins have six conserved cysteines There are six cysteines in the sequence of mature CFBD peptide, They typically contain six conserved cysteines whose three intramolecular disulfides stabilize a largely \u03b2-sheet structure."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a874c338c171fb5b000003",
                            "question": "What is the result of Mff overexpression in mitochondria?"
                        }
                    ],
                    "context": "The Drp1 receptor Mff is a major regulator of mitochondrial fission, and its overexpression results in increased fission. Overexpression of MFF also increases the interaction between DLP1 and Pex11p\u03b2, which knockdown of MFF, but not Fis1, abolishes.whereas Mff overexpression stimulated mitochondrial recruitment of Drp1 accompanied by mitochondrial fission"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5880be1dc872c95565000007",
                            "question": "Which enzyme is inhibited by niraparib?"
                        }
                    ],
                    "context": "While olaparib is the first PARP inhibitor to receive approval for ovarian cancer treatment, others including rucaparib and niraparib are clearly effective in this disease and, within the next year or two, the results of ongoing randomised trials will clarify their respective roles. Similar trials with other PARP inhibitors (rucaparib, niraparib and veliparib) are in progress and include non-BRCA-mutated ovarian cancer.We report here that while the activities of the four human sirtuin isoforms SIRT1, SIRT2, SIRT3 and SIRT6 are blocked by sirtuin inhibitor Ex527 in vitro, they are unaffected by the seven clinical and commonly used PARP inhibitors niraparib, olaparib, rucaparib, talazoparib, veliparib, PJ34, and XAV939. Results from a phase III trial indicate that maintenance therapy with the PARP inhibitor niraparib is more effective than placebo in slowing the progression of recurrent platinum-sensitive ovarian cancer.In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587f760792a5b8ad44000005",
                            "question": "Which peak calling algorithm employs mixture model clustering under the hood?"
                        }
                    ],
                    "context": "We developed JAMM (Joint Analysis of NGS replicates via Mixture Model clustering): a peak finder that can integrate information from biological replicates, determine enrichment site widths accurately and resolve neighboring narrow peaks. JAMM is a universal peak finder that is applicable to different types of datasets. We show that JAMM is among the best performing peak finders in terms of site detection accuracy and in terms of accurate determination of enrichment sites widths. In addition, JAMM's replicate integration improves peak spatial resolution, sorting and peak finding accuracy."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "589a246078275d0c4a00002a",
                            "question": "Which drug was tested in the TEMSO Trial for multiple sclerosis?"
                        }
                    ],
                    "context": "Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.OBJECTIVE: To report safety and efficacy outcomes from up to 9 years of treatment with teriflunomide in an extension (NCT00803049) of the pivotal phase 3 Teriflunomide Multiple Sclerosis Oral (TEMSO) trial (NCT00134563).CONCLUSIONS: In the TEMSO extension, safety observations were consistent with the core trial, with no new or unexpected AEs in patients receiving teriflunomide for up to 9 years.Teriflunomide, approved on the basis of the two placebo-controlled trials TEMSO and TOWER, demonstrated a reduction in the ARR from 0.54 to 0.37 and from 0.50 to 0.32 respectively. Using data from pivotal studies of DMF (DEFINE, NCT00420212; CONFIRM, NCT00451451), fingolimod (FREEDOMS, NCT00289978; FREEDOMS II, NCT00355134), and teriflunomide (TEMSO, NCT00134563; TOWER, NCT00751881), we calculated NNTs to prevent any relapse, more severe relapses (such as those leading to hospitalization or requiring intravenous corticosteroids), and disability worsening."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a2df9c60087bc10a000006",
                            "question": "What is the incidence of beta-thalassemia in Greek population?"
                        }
                    ],
                    "context": "Hemoglobinopathies are very common in Greece, the incidence of beta-thalassemia trait being 8% and that of sickle cell trait ranging from 1 to 32% in various districts.No statistically significant differences were found in the frequency of beta-thalassaemia trait between control subjects (8.49%) and the whole Greek population. beta-Thalassemia was found with an average incidence of 5.476% and alpha-Thalassemia with an incidence of 0.201%.Following this program, 64,814 recruits, representing 0.651% of the total Greek population and 9.917% of the 20-year-old Greek male population, were tested. beta-Thalassemia was found with an average incidence of 5.476% and alpha-Thalassemia with an incidence of 0.201%Following this program, 64,814 recruits, representing 0.651% of the total Greek population and 9.917% of the 20-year-old Greek male population, were tested. beta-Thalassemia was found with an average incidence of 5.476% and alpha-Thalassemia with an incidence of 0.201%."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5880aef4c872c95565000001",
                            "question": "What is the target of daratumumab?"
                        }
                    ],
                    "context": "Dominantly daratumumab (anti-CD38) and elotuzumab (anti-CS1) showed extraordinary effectiveness in phase I/II trials.In the last few weeks, the FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and SLAMF7, respectively.Of these agents, CD38-targeting antibodies have marked single agent activity in extensively pretreated MM, and preliminary results from studies with relapsed/refractory patients have shown enhanced therapeutic efficacy when daratumumab and isatuximab are combined with other agentsFurthermore, daratumumab, and probably also other CD38-targeting antibodies, interfere with blood compatibility testing and thereby complicate the safe release of blood products. Neutralization of the therapeutic CD38 antibody or CD38 denaturation on reagent red blood cells mitigates daratumumab interference with transfusion laboratory serologic tests. Daratumumab is a fully human anti-CD38 IgG1-\u03ba monoclonal antibody (mAb) currently being evaluated in several Phase 2 and 3 clinical studies for the treatment of multiple myeloma (MM). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a872bd38c171fb5b000002",
                            "question": "Which gene-defect causes the Vel-blood type?"
                        }
                    ],
                    "context": "A cohort of 70 Vel- individuals was found to be uniformly homozygous for a 17 nucleotide deletion in the coding sequence of SMIM1.The SMIM1 protein carries the Vel blood group antigen, and homozygosity for a 17 bp deletion in the coding region of the SMIM1 gene represents the molecular basis of the Vel- blood group phenotype."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5884c72fe56acf517600000f",
                            "question": "What molecule is targeted by Avelumab?"
                        }
                    ],
                    "context": "Several drugs targeting PD-1 (pembrolizumab and nivolumab) or PD-L1 (atezolizumab, durvalumab, and avelumab) have been approved or are in the late stages of development.We then focus on the recent breakthrough work concerning the structural basis of the PD-1/PD-Ls interaction and how therapeutic antibodies, pembrolizumab targeting PD-1 and avelumab targeting PD-L1, compete with the binding of PD-1/PD-L1 to interrupt the PD-1/PD-L1 interaction. Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).In addition, we assessed the safety and biological activity of a human anti-PD-L1 antibody (Avelumab) in chronically SIV-infected rhesus macaques.We assessed treatment with avelumab, an anti-PD-L1 monoclonal antibody, in patients with stage IV Merkel cell carcinoma that had progressed after cytotoxic chemotherapy."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5880a8ec0a76a87357000001",
                            "question": "Which R package is used for the detection of chromosomal abnormalities from microarray data?"
                        }
                    ],
                    "context": "CAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray dataCAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray data.It is implemented as an R package that analyzes Affymetrix *.CEL files and comes with flexible plotting functions, easing visualization of chromosomal abnormalities.CAFE is available from https://bitbucket.org/cob87icW6z/cafe/ as both source and compiled packages for Linux and Windows.SUMMARY: The current methods available to detect chromosomal abnormalities from DNA microarray expression data are cumbersome and inflexible. CAFE has been developed to alleviate these issues. It is implemented as an R package that analyzes Affymetrix *.CEL files and comes with flexible plotting functions, easing visualization of chromosomal abnormalities.AVAILABILITY AND IMPLEMENTATION: CAFE is available from https://bitbucket.org/cob87icW6z/cafe/ as both source and compiled packages for Linux and Windows.SUMMARY: The current methods available to detect chromosomal abnormalities from DNA microarray expression data are cumbersome and inflexible. CAFE has been developed to alleviate these issues."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58aa0c6f396a458e50000008",
                            "question": "Which is the \"bonding hormone\"?"
                        }
                    ],
                    "context": "The neurohypophysial hormone oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors, including social recognition, pair bonding, parental behavior, and stress-related responses.Neuropeptide hormone oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health. Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding.The oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in pair bonding behavior in mammalian lineages.oxytocin, a hormone involved in parent-offspring bonding"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5891c90949702f2e01000001",
                            "question": "Which tool employs self organizing maps for analyzing synonymous codon usage?"
                        }
                    ],
                    "context": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map.INteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes. In addition to computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.UNLABELLED: INteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.INCA: synonymous codon usage analysis and clustering by means of self-organizing mapINteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a32edd60087bc10a000012",
                            "question": "What is Contrave prescribed for?"
                        }
                    ],
                    "context": "Contrave(\u00ae) is a combination of naltrexone hydrochloride extended release and bupropion hydrochloride extended release for the treatment of obesityAssuming that the results of the Contrave phase III clinical program reaffirm the efficacy and safety of the drug combination, this agent could be approved and launched to become a market leader in the anti-obesity therapeutic arena.Current antiobesity medications and pharmacological strategies will be reviewed.Two new antiobesity drugs - naltrexone/bupropion (Contrave) and liraglutide (Saxenda) - were approved by the US Food and Drug Administration in 2014 and join four other approved obesity medications, including phentermine/topiramate XR (Qsymia) and lorcaserin (Belviq), to form the largest number of medications available for the treatment of obesity.The Contrave Obesity Research I (COR-I) study assessed the effect of such treatment on bodyweight in overweight and obese participants.Men and women aged 18-65 years who had a body-mass index (BMI) of 30-45 kg/m(2) and uncomplicated obesity or BMI 27-45 kg/m(2) with dyslipidaemia or hypertension were eligible for enrolment in this randomised, double-blind, placebo-controlled, phase 3 trial undertaken at 34 sites in the USA.Contrave, under development by Orexigen Therapeutics Inc for the potential treatment of obesity, is an oral, sustained-release combination of the dopamine and norepinephrine reuptake antagonist bupropion and the opioid antagonist naltrexone."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a2ced760087bc10a000004",
                            "question": "Which is the chromosome area that the human gene coding for the dopamine transporter (DAT1) is located to?"
                        }
                    ],
                    "context": "The gene encoding DAT1 consists of 15 exons spanning 60 kb on chromosome 5p15.32.The locus of the solute carrier 6A3 (SLC6A3; dopamine transporter 1; DAT1) localizes to 5p15.33; the gene has repeatedly been implicated in the etiology of ADHD. In 29 adults with attention deficit hyperactivity disorder (ADHD) striatal dopamine transporter (DAT) availability was assessed by [(99m)Tc]TRODAT-1 SPECT and correlated with 3' VNTR polymorphism of the DAT gene on chromosome 5p15.3. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR.The gene encoding DAT1 consists of 15 exons spanning 60 kb on chromosome 5p15.32. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a877cf38c171fb5b000004",
                            "question": "What type of mutation is causing the industrial melanism phenotype in peppered moths?"
                        }
                    ],
                    "context": "The industrial melanism mutation in British peppered moths is a transposable element.Here we show that the mutation event giving rise to industrial melanism in Britain was the insertion of a large, tandemly repeated, transposable element into the first intron of the gene cortex."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a3428d60087bc10a00001b",
                            "question": "What gene is mutated in Huntington's disease?"
                        }
                    ],
                    "context": "Huntington disease (HD; OMIM 143100), a progressive neurodegenerative disorder, is caused by an expanded trinucleotide CAG (polyQ) motif in the HTT gene.Huntington's disease (HD) is caused by a genetic mutation that results in polyglutamine expansion in the N-terminal regions of huntingtin.Mutations of the huntingtin protein (HTT) gene underlie both adult-onset and juvenile forms of Huntington's disease (HD).Huntington's disease is an inherited disorder caused by expansion of a CAG trinucleotide repeat in the IT15 gene, which leads to expansion of a polyglutamine tract within the protein called huntingtin.Huntington disease is a monogenic, autosomal dominant, progressive neurodegenerative disorder caused by a trinucleotide CAG repeat expansion in exon 1 of the huntingtin (HTT) gene; age of onset of clinical symptoms inversely correlates with expanded CAG repeat length"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587e07023ec846c24f000001",
                            "question": "Which software package is available for the analysis of conserved genomic loci?"
                        }
                    ],
                    "context": "PHYLUCE is a software package for the analysis of conserved genomic lociPrior to downstream inference, data from these types of targeted enrichment studies must undergo preprocessing to assemble contigs from sequence data; identify targeted, enriched loci from the off-target background data; align enriched contigs representing conserved loci to one another; and prepare and manipulate these alignments for subsequent phylogenomic inference. PHYLUCE is an efficient and easy-to-install software package that accomplishes these tasks across hundreds of taxa and thousands of enriched loci.PHYLUCE is a software package for the analysis of conserved genomic loci."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5895bc397d9090f35300000b",
                            "question": "Mutation of which gene is implicated in the Christianson syndrome?"
                        }
                    ],
                    "context": "X-linked Christianson syndrome: heterozygous female Slc9a6 knockout mice develop mosaic neuropathological changes and related behavioral abnormalities.CS is caused by mutations in the SLC9A6 gene, which encodes a multipass transmembrane sodium (potassium)-hydrogen exchanger 6 (NHE6) protein, functional in early recycling endosomes. A Christianson syndrome-linked deletion mutation (\u2206(287)ES(288)) in SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death.BACKGROUND: Christianson Syndrome, a recently identified X-linked neurodevelopmental disorder, is caused by mutations in the human gene SLC9A6 encoding the recycling endosomal alkali cation/proton exchanger NHE6. BACKGROUND: Mutations of SLC9A6 may cause an X-linked clinical syndrome first described by Christianson in 1999 in which affected males exhibited profound intellectual disability, autism, drug-resistant epilepsy, ophthalmoplegia, mild craniofacial dysmorphism, microcephaly, and ataxia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a95c711978bbde22000001",
                            "question": "What disease is the drug aducanumab targeting?"
                        }
                    ],
                    "context": " Most importantly, recent trials of three different A\u03b2 antibodies (solanezumab, crenezumab, and aducanumab) have suggested a slowing of cognitive decline in post hoc analyses of mild AD subjects. ecent results from trials of agents such as aducanumab are encouraging but must also be interpreted with caution. Such medicines could potentially delay the onset of dementia and would therefore markedly reduce its prevalence.Aducanumab is an anti-A\u03b2 antibody being developed for the treatment of AD, and interim analyses of a phase 1b clinical trial have suggested potential beneficial effects on the amyloid pathology and the cognitive status in patients treated with aducanumabThe antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a1c0f178275d0c4a000056",
                            "question": "When did the polio vaccine becomes available?"
                        }
                    ],
                    "context": "Inactivated poliovirus vaccine (IPV), developed in the USA by Jonas Salk in the early 1950s, was field tested in 1954,the use of an oral polio vaccine (OPV) during a vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a9bbe81978bbde22000007",
                            "question": "Where are Paneth cells located?"
                        }
                    ],
                    "context": "The intestinal stem cell niche comprises both epithelial cells, in particular the Paneth cell, Paneth cells have been reported in colorectal adenomas and adenocarcinomas; injury to Paneth cells (PCs) in the intestinal cryptsresence of Paneth cells at the bottom of the crypts of Lieberk\u00fchn.Paneth cells at the crypt base "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a9c152396a458e50000001",
                            "question": "Which cells secretes alpha defensin 5?"
                        }
                    ],
                    "context": "The major tissue in which HD5 is expressed is the crypt of the small intestine, an anaerobic niche that should allow for substantial pools of both oxidized and (partly) reduced HD5. Human \u03b1-defensin 5 (HD5) exhibits broad spectrum antimicrobial activity and plays an important role in mucosal immunity of the small intestine.Human enteric \u03b1-defensins (HD5 and HD6), major antimicrobial peptides produced by Paneth cells in the intestine, play important roles in intestinal innate immunity.Human \u03b1-defensin 5 (HD5), the most abundant enteric antimicrobial peptide,HD5, naturally present at very high concentrations in the mucosa of the small intestine, "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bc5e2202b8c60953000002",
                            "question": "Which human disease is associated with mutated UBQLN2"
                        }
                    ],
                    "context": "Finally, we found that mutations in UBQLN2, which lead to neurodegeneration in humans, are defective in chaperone binding, impair aggregate clearance, and cause cognitive deficits in mice.UBQLN2 mutations are detected in ALS cases.C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New ZealandMissense mutations in ubiquilin 2 (UBQLN2) cause ALS with frontotemporal dementia (ALS-FTD). Amyotrophic Lateral Sclerosis (ALS) is the most frequent motor neuron disease in adults. Classical ALS is characterized by the death of upper and lower motor neurons leading to progressive paralysis. Approximately 10\u00a0% of ALS patients have familial form of the disease. Numerous different gene mutations have been found in familial cases of ALS, such as mutations in superoxide dismutase 1 (SOD1), TAR DNA-binding protein 43 (TDP-43), fused in sarcoma (FUS), C9ORF72, ubiquilin-2 (UBQLN2), optineurin (OPTN) and others."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58b6bd2622d300530900000c",
                            "question": "Which ApoE isoform is associated with hyperlipoproteinemia?"
                        }
                    ],
                    "context": "ApoE2 which differs from apoE3 by the single amino acid substitution Arg158Cys located near the LDLR recognition site exhibits impaired binding to the receptor and an inability to promote clearance of TG-rich lipoprotein remnant particles; this isoform is associated with Type-III hyperlipoproteinemia. Type III hyperlipoproteinemia (HLP), a disorder associated with a high incidence of premature cardiovascular diseases, is characterized by the accumulation of remnant lipoproteins in the plasma. The primary genetic defect in patients with type III HLP is the presence of apolipoprotein E2 (apoE2), an isoform of apoE, and accumulation of remnant lipoproteins in the plasma has been thought to be attributable to the presence of apoE2, which bind poorly to low density lipoprotein receptors, resulting in defective remnant lipoprotein clearance. ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by the R158C allele. Reduced expression of the LDLR is believed to be a precipitating factor in the pathogenesis of type III hyperlipoproteinemia (HLP) in some humans homozygous for the apoE2 allele (APOE*2). Overall, the 2.3-fold normal level of LDLR message in heterozygotes completely ameliorates type III HLP caused by the homozygosity for the human APOE*2 allele, normalizing their plasma lipoprotein profile."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "589480b47d9090f353000007",
                            "question": "Which server is used for simulation of macromolecular diffusional association?"
                        }
                    ],
                    "context": "webSDA: a web server to simulate macromolecular diffusional association.Macromolecular interactions play a crucial role in biological systems. Simulation of diffusional association (SDA) is a software for carrying out Brownian dynamics simulations that can be used to study the interactions between two or more biological macromolecules. webSDA allows users to run Brownian dynamics simulations with SDA to study bimolecular association and encounter complex formation, to compute association rate constants, and to investigate macromolecular crowding using atomically detailed macromolecular structures. webSDA facilitates and automates the use of the SDA software, and offers user-friendly visualization of results.webSDA currently has three modules: 'SDA docking' to generate structures of the diffusional encounter complexes of two macromolecules, 'SDA association' to calculate bimolecular diffusional association rate constants, and 'SDA multiple molecules' to simulate the diffusive motion of hundreds of macromolecules.Simulation of diffusional association (SDA) is a software for carrying out Brownian dynamics simulations that can be used to study the interactions between two or more biological macromolecules. webSDA allows users to run Brownian dynamics simulations with SDA to study bimolecular association and encounter complex formation, to compute association rate constants, and to investigate macromolecular crowding using atomically detailed macromolecular structures. webSDA facilitates and automates the use of the SDA software, and offers user-friendly visualization of results. webSDA currently has three modules: SDA docking to generate structures of the diffusional encounter complexes of two macromolecules, SDA association to calculate bimolecular diffusional association rate constants, and SDA multiple molecules to simulate the diffusive motion of hundreds of macromolecules.webSDA: a web server to simulate macromolecular diffusional association"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58b56fe422d3005309000007",
                            "question": "Where do the Schwann cells and melanocytes originate from?"
                        }
                    ],
                    "context": "The development of the nervous system involves cells remaining within the neural tube (CNS) and a group of cells that delaminate from the dorsal neural tube and migrate extensively throughout the developing embryo called neural crest cells (NCC). These cells are a mesenchymal highly migratory group of cells that give rise to a wide variety of cell derivatives: melanocytes, sensory neurons, bone, Schwann cells, etc. Cell types with neural crest ancestry consequently comprise a number of specialized varieties, such as ectodermal neurons, melanocytes and Schwann cells, as well as mesodermal osteoblasts, adipocytes and smooth muscle cells. Melanocytes, the pigmented cells of the skin, and the glial Schwann cells lining peripheral nerves are developmentally derived from an early and transient ectodermal structure of the vertebrate embryo, the neural crest, which is also at the origin of multiple neural and non-neural cell types. Later, SoxE proteins drive the formation of multiple neural crest derivatives including chondrocytes, melanocytes, and cells of the peripheral nervous system, particularly Schwann cells/peripheral glia. Melanocytes and Schwann cells are derived from the multipotent population of neural crest cells."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a87bd338c171fb5b000005",
                            "question": "Where is the protein slitrk1 localized?"
                        }
                    ],
                    "context": "Slitrk1 is localized to excitatory synapses Slitrk1 is enriched in postsynaptic fractions and is localized to excitatory synapses. The porcine SLITRK1 gene is expressed exclusively in brain tissues.Six family members exist (Slitrk1-6) and all are highly expressed in the central nervous system (CNS)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a9a8631978bbde22000003",
                            "question": "Which is the enzymatic activity of OTULIN?"
                        }
                    ],
                    "context": "deubiquitinase OTULINOTULIN (FAM105B), encoding a deubiquitinase  Otulin/Gumby/FAM105b are by far the most active DUBs acting on these precursors.Removal of ubiquitin chains is mediated by deubiquitinases (DUBs). Two of them, OTULIN and CYLD,  are disassembled by the linear ubiquitin-specific deubiquitinase OTULIN"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "588f2de394c1512c50000001",
                            "question": "Which R package is used for visualization of linear and circular karyotypes?"
                        }
                    ],
                    "context": "chromDraw: an R package for visualization of linear and circular karyotypes.The chromDraw graphical tool was developed as a user-friendly graphical tool for visualizing both linear and circular karyotypes based on the same input data matrix. The output graphics, saved in two different formats (EPS and SVG), can be easily imported to and modified in presentation and image-editing computer programs. The tool is freely distributed under GNU General Public License (GPL) and can be installed from Bioconductor or from the chromDraw home page.The chromDraw graphical tool was developed as a user-friendly graphical tool for visualizing both linear and circular karyotypes based on the same input data matrix.chromDraw: an R package for visualization of linear and circular karyotypes.The chromDraw graphical tool was developed as a user-friendly graphical tool for visualizing both linear and circular karyotypes based on the same input data matrix."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bc363622d300530900001f",
                            "question": "Where is Akkermansia muciniphila found?"
                        }
                    ],
                    "context": "Akkermansia muciniphila is a Gram-negative mucin-degrading bacterium that resides in the gastrointestinal tracts of humans and animals. Individuals with obesity and type 2 diabetes differ from lean and healthy individuals in their abundance of certain gut microbial species and microbial gene richness. Abundance of Akkermansia muciniphila, a mucin-degrading bacterium, has been inversely associated with body fat mass and glucose intolerance in mice, but more evidence is needed in humans."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a5a51060087bc10a000021",
                            "question": "Which NADPH oxidase family member requires interaction with NOXO1 for function?"
                        }
                    ],
                    "context": "A unique member of this family, Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox), respectively, the latter of which is functional in vascular smooth muscle cells (VSMC). Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1.Superoxide production by Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1 (Nox activator 1) and is markedly enhanced upon cell stimulation with phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C (PKC).Phosphorylation of Thr341 allows Noxo1 to sufficiently interact with Noxa1, an interaction that participates in Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1-catalyzed superoxide production. Furthermore, Ser154 in Noxo1 is phosphorylated in both resting and PMA-stimulated cells, and the phosphorylation probably participates in a PMA-independent constitutive activity of Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1; Thus phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1 activity in different manners."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a57f9460087bc10a00001f",
                            "question": "Which mutated gene is associated with Waardenburg and Tietz syndromes?"
                        }
                    ],
                    "context": "Tietz/Waardenburg type 2A syndrome associated with posterior microphthalmos in two unrelated patients with novel MITF gene mutations.Tietz syndrome and Waardenburg syndrome type 2A are allelic conditions caused by MITF mutations. For example, mutations of the MITF gene cause Waardenburg syndrome type 2A as well as Tietz syndrome.For example, mutations of MITF, SNAI2 and SOX10 genes are observed in Waardenburg syndrome type II and mutations of EDNRB, EDN3 and SOX10 genes are responsible for Waardenburg syndrome type IV. These disorders are represented by Waardenburg syndrome, piebaldism and Tietz syndrome, and are caused by different mutations of various or the same genes. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bcabc702b8c6095300000e",
                            "question": "What gene is mutated in Sickle Cell Anemia?"
                        }
                    ],
                    "context": "Sickle cell anemia (SCA) is an inherited blood disorder. SCA patients present clinical and hematologic variability that cannot be only explained by the single mutation in the beta-globin gene.Sickle cell anemia (SCA) is an autosomal recessive disease caused by the HBB:c.20A>T mutation that leads to hemoglobin S synthesis.Sickle cell anemia is caused by a single type of mutation, a homozygous A\u2192T substitution in the \u00df globin gene.Implementation of this approach for disorders resulting from mutations affecting the beta-globin gene (e.g., beta-thalassemia and sickle cell anemia), however, has been hampered by the inability to generate recombinant viruses able to efficiently and faithfully transmit the necessary sequences for appropriate gene expression.The allele-specific PCR approach has been modified by introducing a second mismatch at the 3'-penultimate link of the primer and used to identify the sickle cell anemia mutation (A-->T transversion in the sixth codon of the human beta-globin gene causing Glu-->Val substitution in the protein), thus obviating the problem of an interpretationally ambiguous 3'-terminal mismatch including T residue."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5891b125621ea6ff7e00000e",
                            "question": "Which disease is treated with taliglucerase alfa?"
                        }
                    ],
                    "context": "Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase.Taliglucerase alfa is the first available plant cell-expressed human recombinant therapeutic protein. It is indicated for treatment of patients with type 1 Gaucher disease (GD) in adult and pediatric patients in several countries. The 36-month results of switching from imiglucerase to taliglucerase alfa treatment in adults with GD provide further data on the clinical safety and efficacy of taliglucerase alfa beyond the initial 9 months of the original study.Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-na\u00efve patients with Gaucher disease.Taliglucerase alfa is an intravenous enzyme replacement therapy approved for treatment of type 1 Gaucher disease (GD), and is the first available plant cell-expressed recombinant therapeutic protein. Herein, we report long-term safety and efficacy results of taliglucerase alfa in treatment-na\u00efve adult patients with GD."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587f795d92a5b8ad44000007",
                            "question": "What is formin associated with in the snail?"
                        }
                    ],
                    "context": "Formin Is Associated with Left-Right Asymmetry in the Pond Snail and the Frog Here, we report that a disabling mutation in one copy of a tandemly duplicated, diaphanous-related formin is perfectly associated with symmetry breaking in the pond snail. This is supported by the observation that an anti-formin drug treatment converts dextral snail embryos to a sinistral phenocopy, and in frogs, drug inhibition or overexpression by microinjection of formin has a chirality-randomizing effect in early (pre-cilia) embryos. Contrary to expectations based on existing models [3, 4 and 5], we discovered asymmetric gene expression in 2- and 4-cell snail embryos, preceding morphological asymmetry. As the formin-actin filament has been shown to be part of an asymmetry-breaking switch in vitro [6 and 7], together these results are consistent with the view that animals with diverse body plans may derive their asymmetries from the same intracellular chiral elements [8].Here, we report that a disabling mutation in one copy of a tandemly duplicated, diaphanous-related formin is perfectly associated with symmetry breaking in the pond snail.This is supported by the observation that an anti-formin drug treatment converts dextral snail embryos to a sinistral phenocopy, and in frogs, drug inhibition or overexpression by microinjection of formin has a chirality-randomizing effect in early (pre-cilia) embryos.Here, we report that a disabling mutation in one copy of a tandemly duplicated, diaphanous-related formin is perfectly associated with symmetry breaking in the pond snail."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587e1bfdfc7e8dd84f000002",
                            "question": "Which is the genome browser database for DNA shape annotations?"
                        }
                    ],
                    "context": "GBshape: a genome browser database for DNA shape annotationsOur Genome Browser for DNA shape annotations (GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/) provides minor groove width, propeller twist, roll, helix twist and hydroxyl radical cleavage predictions for the entire genomes of 94 organisms. Additional genomes can easily be added using the GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution. As biological applications, we illustrate the periodicity of DNA shape features that are present in nucleosome-occupied sequences from human, fly and worm, and we demonstrate structural similarities between transcription start sites in the genomes of four Drosophila speciesGBshape: a genome browser database for DNA shape annotations.GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution.Our Genome Browser for DNA shape annotations (GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/) provides minor groove width, propeller twist, roll, helix twist and hydroxyl radical cleavage predictions for the entire genomes of 94 organisms."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a9d8a1396a458e50000005",
                            "question": "Where is the respirasome located?"
                        }
                    ],
                    "context": "he 4.0\u00a0\u00c5 cryo-EM structure of one of the most intricate enzyme systems, the respirasome, in the mitochondrial inner membraneRespirasomes are macromolecular assemblies of the respiratory chain complexes I, III and IV in the inner mitochondrial membrane."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5890e163621ea6ff7e000004",
                            "question": "What is the target of tanezumab?"
                        }
                    ],
                    "context": "Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model.OBJECTIVE: To investigate whether the effects of nerve growth factor (NGF) inhibition with tanezumab on rats with medial meniscal tear (MMT) effectively model rapidly progressive osteoarthritis (RPOA) observed in clinical trials. Current research focuses on the development of new OA drugs (such as sprifermin/recombinant human fibroblast growth factor-18, tanezumab/monoclonal antibody against \u03b2-nerve growth factor), which aims for more effectiveness and less incidence of adverse effects than the traditional ones.Areas covered: This manuscript is a review that examines both the pharmacological properties and clinical studies of tanezumab, the most widely studied antibody to NGF, for management of osteoarthritis (OA) and low back pain. OBJECTIVE: Evaluate efficacy and safety of tanezumab, a humanized monoclonal antibody against nerve growth factor, in neuropathic pain."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5880b812c872c95565000006",
                            "question": "Which infection can be prevented with Dapivirine?"
                        }
                    ],
                    "context": "OBJECTIVES: The objectives of this study were to comprehensively assess mRNA expression of 84 drug transporters in human colorectal biopsies and six representative cell lines, and to investigate the alteration of drug transporter gene expression after exposure to three candidate microbicidal antiretroviral (ARV) drugs (tenofovir, darunavir and dapivirine) in the colorectal epithelium. The outcome of the objectives informs development of optimal ARV-based microbicidal formulations for prevention of HIV-1 infection.We evaluated the adherence and acceptability of a vaginal ring containing dapivirine, maraviroc, or both drugs for 28\u00a0days during a Phase I placebo-controlled trial in 48 HIV-negative sexually abstinent U.S. women aged 18-40.Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.Methods We conducted a phase 3, randomized, double-blind, placebo-controlled trial of a monthly vaginal ring containing dapivirine, a non-nucleoside HIV-1 reverse-transcriptase inhibitor, involving women between the ages of 18 and 45 years in Malawi, South Africa, Uganda, and Zimbabwe. Results Among the 2629 women who were enrolled, 168 HIV-1 infections occurred: 71 in the dapivirine group and 97 in the placebo group (incidence, 3.3 and 4.5 per 100 person-years, respectively). The incidence of HIV-1 infection in the dapivirine group was lower by 27% (95% confidence interval [CI], 1 to 46; P=0.05) than that in the placebo group. In an analysis that excluded data from two sites that had reduced rates of retention and adherence, the incidence of HIV-1 infection in the dapivirine group was lower by 37% (95% CI, 12 to 56; P=0.007) than that in the placebo group.Conclusions A monthly vaginal ring containing dapivirine reduced the risk of HIV-1 infection among African women, with increased efficacy in subgroups with evidence of increased adherence. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58b558d522d3005309000006",
                            "question": "Where is the proteasome located?"
                        }
                    ],
                    "context": "Cellular regulation by UPS- mediated protein degradation is a highly specific and selective process that depends on time (e.g. cell cycle) and location (nucleus, mitochondria or endoplasmic reticulum). In eukaryotic cells, regulated protein degradation of intracellular proteins is mediated largely by the ubiquitin proteasome system (UPS). We followed two key parameters of this process: the distribution of proteasomes in nuclear and cytosolic compartments, and the formation of cytoplasmic aggregate-like structures called proteasome storage granules (PSGs). Subsequently, cellular distribution of the PAI-2\u00b7proteasome complexes was established by immunogold staining and electron microscopy analyses. As judged by confocal microscopy, both proteins appeared in a diffuse cytosolic pattern, but they also could be found in a dense perinuclear and nuclear location.  Frequently ubiquitinated proteins are targeted to the proteasome for degradation in the cytosol. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bbc0fc22d300530900001c",
                            "question": "What is the indication for SLCO1B1 genotyping?"
                        }
                    ],
                    "context": "including the well-known genetic variant associated with statin-associated muscle symptoms-solute carrier organic anion transporter family, member 1B1 (SLCO1B1) rs4149056-also increase the risk of statin-associated muscle symptoms in FH patientsStatin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.Similarly, HMG Co-A reductase inhibitors, commonly known as statins, also display wide interindividual variability in plasma concentration, response and toxicity due in part to polymorphisms in transporter genes, including SLCO1B1 and ABCG2.Association of SLCO1B1 gene polymorphisms with toxicity response of high dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia. development of SLCO1B1 genotyping to avoid statin induced adverse drug reactions is discussed as a model case for transporter pharmacogenetics clinical development."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "589185cc621ea6ff7e00000b",
                            "question": "Which disease is treated with Nusinersen?"
                        }
                    ],
                    "context": "Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience.Nusinersen (ISIS-SMNRx or ISIS 396443) is an antisense oligonucleotide drug administered intrathecally to treat spinal muscular atrophy. We summarize lumbar puncture experience in children with spinal muscular atrophy during a phase 1 open-label study of nusinersen and its extension.Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy.OBJECTIVE: To examine safety, tolerability, pharmacokinetics, and preliminary clinical efficacy of intrathecal nusinersen (previously ISIS-SMNRx), an antisense oligonucleotide designed to alter splicing of SMN2 mRNA, in patients with childhood spinal muscular atrophy (SMA).METHODS: Nusinersen was delivered by intrathecal injection to medically stable patients with type 2 and type 3 SMA aged 2-14 years in an open-label phase 1 study and its long-term extension. CONCLUSIONS: Results from this study support continued development of nusinersen for treatment of SMA.CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that in children with SMA, intrathecal nusinersen is not associated with safety or tolerability concerns."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58b6978822d300530900000a",
                            "question": "Which disease the London mutation involved in?"
                        }
                    ],
                    "context": "In the present study, we used a new training paradigm in the intelliCage automatic behavioral assessment system to investigate cognitive functions of the transgenic mice harboring London mutation of the human amyloid precursor protein (APP.V717I). The novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease mouse model.One major hallmark of Alzheimer's disease (AD) is the massive loss of synapses that occurs at an early clinical stage of the disease. In this study, we characterize alterations in spine density and the expression of synapse-associated immediate early gene Arc (activity-regulated cytoskeleton-associated protein) in the hippocampal CA1 regions of two different amyloid precursor protein (APP) transgenic mouse lines before plaque development and their connection to performance in hippocampus-dependent memory tests. The density of mushroom-type spines was reduced by 34% in the basal dendrites proximal to the soma of CA1 pyramidal neurons in 5.5-month-old Tg2576 mice, carrying the Swedish mutation, compared with wild-type littermates. A similar reduction of 42% was confirmed in the same region of 8-month-old APP/Lo mice, carrying the London mutation.The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease.We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val717Ile), known as London mutation."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bc347422d300530900001e",
                            "question": "How many microorganisms are present in human normal gut?"
                        }
                    ],
                    "context": ". A major breakthrough in understanding the etiology of neurological disorders is the recent insight on the role of the gut microbiota (GM). Human GM also referred to as the \"forgotten organ\" is home to 10(13-14) microorganismsThe gut microbiome comprises the collective genome of the trillions of microorganisms residing in our gastrointestinal ecosystem.The gut microbiome (i.e. the 100 trillion symbiotic microorganisms which inhabit the mammalian gastrointestinal tract) influences numerous aspects of host metabolism, development and immunity.The microorganisms inhabiting the human gut are abundant (10(14) cells) and diverse (approximately 500 species per individual)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "588f9f83ed9bbee70d000004",
                            "question": "Viliuisk encephalomyelitis is diagnosed in which geographical area?"
                        }
                    ],
                    "context": "BACKGROUND: Viliuisk encephalomyelitis (VE) is an endemic neurological disease in Northeast Siberia and generally considered to be a chronic encephalomyelitis of unknown origin actually spreading in the Sakha (Yakutian) Republic.Communicating hydrocephalus following eosinophilic meningitis is pathogenic for chronic Viliuisk encephalomyelitis in Northeastern Siberia.Epidemiology of Viliuisk encephalomyelitis in Eastern Siberia.. An epidemic of this disease has been spreading throughout the Yakut Republic of the Russian Federation.METHODS: Detailed clinical, pathologic, laboratory, and epidemiologic studies have identified 414 patients with definite Viliuisk encephalomyelitis in 15 of 33 administrative regions of the Yakut Republic between 1940 and 1999."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a644e560087bc10a000027",
                            "question": "What is the drug target for Simtuzumab?"
                        }
                    ],
                    "context": " These results suggest that LOXL2 could be an appealing target for treatment of scar formation after glaucoma surgery, and point to the potential therapeutic benefits of simtuzumab, a humanized monoclonal antibody derived from GS-607601.These results suggest that LOXL2 could be an appealing target for treatment of scar formation after glaucoma surgery, and point to the potential therapeutic benefits of simtuzumab, a humanized monoclonal antibody derived from GS-607601These results suggest that LOXL2 could be an appealing target for treatment of scar formation after glaucoma surgery, and point to the potential therapeutic benefits of simtuzumab, a humanized monoclonal antibody derived from GS-607601.Other potential agents will be silent information regulator protein Sirtuin and antifibrotic monoclonal antibody Simtuzumab against lysyl oxidase like molecule 2.These results suggest that LOXL2 could be an appealing target for treatment of scar formation after glaucoma surgery, and point to the potential therapeutic benefits of simtuzumab, a humanized monoclonal antibody derived from GS-607601."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58c99fcc02b8c60953000029",
                            "question": "What does the human ABCC gene  product do?"
                        }
                    ],
                    "context": "structure, function, and expression of the important drug resistance-conferring members belonging to three subfamilies of the human ABC family; these are ABCB1 (MDR1/P-glycoprotein of subfamily ABCB), subfamily ABCC (MRPs), and ABCG2 (BCRP of subfamily ABCG), which are expressed in various organs. Transport proteins, including members of the multidrug resistance protein (MRP)/ABCC subfamily, have been recognized to contribute to the latter function. MRP5 (ABCC5) was identified as transmembrane transport protein for cyclic nucleotides, especially 3',5'-cyclic GMP (cGMP), indicating an additional role in signal transduction and a potential role in placenta development.According to the new nomenclature of human ABC transporter genes, the 'ABCC' gene sub-family comprises three classes involving multidrug resistance-associated proteins (MRPs), sulfonylurea receptors (SURs), and a cystic fibrosis transmembrane conductance regulator (CFTR).With the addition of these two genes, the complete human ABCC subfamily has 12 identified members (ABCC1-12), nine from the multidrug resistance-like subgroup, two from the sulfonylurea receptor subgroup, and the CFTR gene.Identification and bioinformatic characterization of a multidrug resistance associated protein (ABCC) gene in Plasmodium berghei."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58ce363b02b8c60953000046",
                            "question": "Which is the relation between coffee consumption and stroke risk?"
                        }
                    ],
                    "context": "The majority of prospective studies have reported a weak inverse association between moderate consumption of coffee and risk of stroke. However, there are yet no clear biological mechanisms whereby coffee might provide cardiovascular health benefits. Awaiting the results from further long-term RCTs and prospective studies, moderate consumption of filtered coffee, tea, and dark chocolate seems prudent."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "588f8e9794c1512c50000005",
                            "question": "Which R package is used for the analysis of genome-wide DNA methylation profiles?"
                        }
                    ],
                    "context": "methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Here, we describe an R package, methylKit, that rapidly analyzes genome-wide cytosine epigenetic profiles from high-throughput methylation and hydroxymethylation sequencing experiments. methylKit includes functions for clustering, sample quality visualization, differential methylation analysis and annotation features, thus automating and simplifying many of the steps for discerning statistically significant bases or regions of DNA methylation.Here, we describe an R package, methylKit, that rapidly analyzes genome-wide cytosine epigenetic profiles from high-throughput methylation and hydroxymethylation sequencing experiments.methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profilesHere, we describe an R package, methylKit, that rapidly analyzes genome-wide cytosine epigenetic profiles from high-throughput methylation and hydroxymethylation sequencing experiments. methylKit includes functions for clustering, sample quality visualization, differential methylation analysis and annotation features, thus automating and simplifying many of the steps for discerning statistically significant bases or regions of DNA methylation"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58cc5bae02b8c60953000037",
                            "question": "What is the incidence of new cases of X-linked adrenoleukodystrophy (ALD) in Australian and New Zealand in the late 1990's?"
                        }
                    ],
                    "context": "cases of ALD diagnosed in Australia and New Zealand between 1981 and 1996 and their families. We estimate that the combined incidence of ALD and its variants in Australasia is at least 1.6 per 100,000. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58d0dc878acda34529000004",
                            "question": "Which is the largest metabolic gene cluster in yeast?"
                        }
                    ],
                    "context": "The DAL cluster is the largest metabolic gene cluster in yeast and consists of six adjacent genes encoding proteins that enable Saccharomyces cerevisiae to use allantoin as a nitrogen source.The DAL cluster is the largest metabolic gene cluster in yeast and consists of six adjacent genes encoding proteins that enable Saccharomyces cerevisiae to use allantoin as a nitrogen source.Birth of a metabolic gene cluster in yeast by adaptive gene relocation.The DAL cluster is the largest metabolic gene cluster in yeast and consists of six adjacent genes encoding proteins that enable Saccharomyces cerevisiae to use allantoin as a nitrogen sourceBirth of a metabolic gene cluster in yeast by adaptive gene relocation"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58b6cd3222d300530900000d",
                            "question": "Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?"
                        }
                    ],
                    "context": "Among three isoforms, the apoE4 isoform is associated with increased frequency of atherosclerosis and Alzheimer's disease (AD). Homozygosity for ApoE epsilon4 is associated with atherosclerosis and Alzheimer's disease whereas ApoE epsilon2 and epsilon3 tend to be protective.Importantly, lipoproteins containing the apoE3 isoform had higher TGF-beta levels and bioactivity than those containing apoE4, a major genetic risk factor for atherosclerosis and Alzheimer's disease. ApoE4 is positively associated with atherosclerosis and late-onset and sporadic Alzheimer's disease (AD). Isoform (allele)-specific effects include the association of apoE2 with the genetic disorder type III hyperlipoproteinemia and with both increased and decreased risk for atherosclerosis and the association of apoE4 with increased risk for both atherosclerosis and Alzheimer's disease, impaired cognitive function, and reduced neurite outgrowth; isoform-specific differences in cellular signaling events may also exist. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58caf0be02b8c6095300002f",
                            "question": "What organism causes woolsorter's disease"
                        }
                    ],
                    "context": "Today, woolsorters' disease and other industrial manifestations of anthrax are extremely rare, Working independently of their more famous counterparts (Robert Koch and Louis Pasteur), Anglo-American anthrax investigators used visual representations of anthrax bacilli to persuade their peers that a specific, identifiable cause produced all forms of anthrax-malignant pustule (cutaneous anthrax), intestinal anthrax, and woolsorter's disease (pneumonic anthrax). Today, woolsorters' disease and other industrial manifestations of anthrax are extremely rare, but the increasing threat of bioterrorism means that the international dread and historical lessons of this significant condition should never be forgotten. Today, woolsorters' disease and other industrial manifestations of anthrax are extremely rare, but the increasing threat of bioterrorism means that the international dread and historical lessons of this significant condition should never be forgotten."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587e1a01fc7e8dd84f000001",
                            "question": "Which annotated database of A-to-I RNA editing is available?"
                        }
                    ],
                    "context": "RADAR: a rigorously annotated database of A-to-I RNA editingWe present RADAR--a rigorously annotated database of A-to-I RNA editingThe identification of A-to-I RNA editing sites has been dramatically accelerated in the past few years by high-throughput RNA sequencing studies. RADAR includes a comprehensive collection of A-to-I RNA editing sites identified in humans (Homo sapiens), mice (Mus musculus) and flies (Drosophila melanogaster), together with extensive manually curated annotations for each editing site. RADAR also includes an expandable listing of tissue-specific editing levels for each editing site, which will facilitate the assignment of biological functions to specific editing sitesWe present RADAR--a rigorously annotated database of A-to-I RNA editing (available at http://RNAedit.com).RADAR: a rigorously annotated database of A-to-I RNA editing."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bca2f302b8c6095300000c",
                            "question": "What chromosome is affected in Turner's syndrome?"
                        }
                    ],
                    "context": "Turner's syndrome (TS) is a chromosomal defect with partial or total absence of the X chromosome. Turner syndrome is a genetic disorder caused by the complete or partial absence of an X chromosome in affected womenTurner syndrome (TS) is a chromosomal disorder caused by complete or partial X chromosome monosomy that manifests various clinical features depending on the karyotype and on the genetic background of affected girlsCONTEXT: Turner syndrome (TS) is the most common genetic problem affecting women and occurs when an X chromosome is completely deleted, portions of an X chromosome are deleted, or chromosomal mosaicism occurs. Turner's syndrome (TS) is a chromosomal disorder that results from the loss of the entire or a part of the X-chromosome and occurs in 1/2,500 female births."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bd6c5802b8c60953000012",
                            "question": "Which disease is associated with mutations in SLC40A1 gene?"
                        }
                    ],
                    "context": "Ferroportin disease is a rare type of autosomal dominantly inherited hemochromatosis caused with mutations in the ferroportin gene (SLC40A1). The patients characteristically have hyperferritinemia but normal transferin saturations. Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4.Here we report the case of a 69-year-old Chinese Han woman who presented with liver cirrhosis, diabetes mellitus, skin hyperpigmentation, hyperferritinaemia and high transferrin saturation. Subsequent genetic analyses identified a novel heterozygous mutation (p.Cys326Phe) in the SLC40A1 gene. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.Ferroportin disease is an inherited disorder of iron metabolism and is caused by mutations in the ferroportin gene (SLC40A1). We present a patient with hyperferritinemia, iron overload in the liver with reticuloendothelial distribution and also in the spleen, and under treatment with erythropheresis. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587e3129c32c812009000002",
                            "question": "Which R / bioconductor package is used for performing SNP enrichment analysis?"
                        }
                    ],
                    "context": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervalsHere, we present traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with flexible options, including testing method, type of background and inclusion of SNPs in LDwe present traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with flexible options, including testing method, type of background and inclusion of SNPs in LDHere, we present traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with flexible options, including testing method, type of background and inclusion of SNPs in LD.traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58d4d7578acda34529000007",
                            "question": "How are looped genes identified in yest?"
                        }
                    ],
                    "context": "Gene-loop formation is dependent on regulatory proteins localized at the 5' and 3' ends of genes, such as TFIIB.Instead, activators physically interacted with the general transcription factor TFIIB when the genes were activated and in a looped configuration."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58cbf1f402b8c60953000036",
                            "question": "What is the function of the DGAT1 gene product?"
                        }
                    ],
                    "context": "Diacylglycerol acyltransferase 1 (DGAT1) catalyzes the final step in the acyl-CoA-dependent triacylglycerol biosynthesisThis genomic area includes the DGAT1 gene, which encodes acyl-CoA:diacylglycerol acyltransferase 1, the key enzyme of triglyceride biosynthesis.Diacylglycerol acyltransferase (DGAT1) is considered the key enzyme in controlling the rate of synthesis of triglycerides.Acyl-CoA:diacylglycerol acyltransferase-1 (DGAT1) catalyzes the final step of triglyceride synthesis in mammalian cells.Diacylglycerol O-acyltransferase 1 (DGAT1) is a microsomal enzyme that catalyzes the final step of triglyceride synthesis. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bac71222d3005309000013",
                            "question": "Which histone mutation is associated with gliomas?"
                        }
                    ],
                    "context": "Over 70% of diffuse intrinsic pediatric gliomas, an aggressive brainstem tumor, harbor heterozygous mutations that create a K27M amino acid substitution (methionine replaces lysine 27) in the tail of histone H3.3We show that H3.3K27M expression synergizes with p53 loss and PDGFRA activation in neural progenitor cells derived from human embryonic stem cells, resulting in neoplastic transformation.Some of these molecular changes with clinicopathological utility have been used for the first time in the most recent edition of the World Health Organization (WHO) classification of CNS tumours to define entities like ependymoma, RELA fusion-positive or diffuse midline glioma, H3 K27M-mutant.The recent discovery of somatic oncogenic mutations affecting chromatin regulation in pediatric high-grade glioma has markedly improved our understanding of disease pathogenesis, and these findings have stimulated the development of novel therapeutic approaches targeting epigenetic regulators for disease treatment.Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58cdb41302b8c60953000042",
                            "question": "What tissue is most affected in Ehlers-Danlos syndromes?"
                        }
                    ],
                    "context": "The Ehlers-Danlos syndromes (EDS) are a group of connective tissue disorders characterized by triad of joint hypermobility, skin extensibility, and tissue fragility. Ehlers-Danlos syndromes (EDSs) constitute a rare group of inherited connective tissue diseases, characterized by multisystemic manifestations and general tissue fragility.Ehlers-Danlos syndromes (EDS) are a heterogeneous group of hereditary connective tissue disorders characterized by joint hypermobility, widespread musculoskeletal pain and tissue fragility.The Ehlers-Danlos syndromes (EDS) comprise a heterogenous group of heritable disorders of connective tissue, characterized by joint hypermobility, skin hyperextensibility and tissue fragility.Ehlers-Danlos syndrome denotes a group of inherited connective tissue diseases comprising nine types."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587f7a69d8d850a152000001",
                            "question": "Which library is used for fixed-length approximate string matching?"
                        }
                    ],
                    "context": "libFLASM: a software library for fixed-length approximate string matching.We present and make available libFLASM, a free open-source C++ software library for solving fixed-length approximate string matching under both the edit and the Hamming distance models. Moreover we describe how fixed-length approximate string matching is applied to solve real problems by incorporating libFLASM into established applications for multiple circular sequence alignment as well as single and structured motif extraction. Specifically, we describe how it can be used to improve the accuracy of multiple circular sequence alignment in terms of the inferred likelihood-based phylogenies; and we also describe how it is used to efficiently find motifs in molecular sequences representing regulatory or functional regions. The comparison of the performance of the library to other algorithms show how it is competitive, especially with increasing distance thresholds.Fixed-length approximate string matching is a generalisation of the classic approximate string matching problem. We present libFLASM, a free open-source C++ software library for solving fixed-length approximate string matching. The extensive experimental results presented here suggest that other applications could benefit from using libFLASM, and thus further maintenance and development of libFLASM is desirablelibFLASM: a software library for fixed-length approximate string matching.We present libFLASM, a free open-source C++ software library for solving fixed-length approximate string matching."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "589d965a78275d0c4a000049",
                            "question": "Which polymerase transcribes pri-miRNAs?"
                        }
                    ],
                    "context": "Previous studies in vivo reported that processing of primary microRNA (pri-miRNA) is coupled to transcription by RNA polymerase II (RNAP II) and can occur co-transcriptionally. we have established a robust in vivo system in which pri-miRNA is transcribed by RNAP II and processed to pre-miRNA in HeLa cell nuclear extracts.In addition, obvious enrichments of three histone modifications (H2BK5me1, H3K36me3 and H4K20me1) as well as RNA Polymerase II (RNAPII) were observed on pre-miRNA genomic sequences corresponding to the active-promoter miRNAs and expressed miRNAsBecause the transcripts of most miRNA genes are the products of type-II RNA polymerase, pri-miRNA has a poly(A) tail and appears in expressed sequence tags (EST)Recent evidence indicates that miRNA genes are transcribed by RNA polymerase II (Pol II)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58cbb98c02b8c60953000034",
                            "question": "Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?"
                        }
                    ],
                    "context": "An overview of oculocutaneous albinism: TYR gene mutations in five Colombian individualsTo date, 230 mutations in the TYR gene have been reported as responsible for oculocutaneus albinism type 1 worldwide. TYR gene encodes the enzyme tyrosinase involved in the metabolic pathway of melanin synthesis.Mutations were identified in the TYR gene as responsible for oculocutaneous albinism type 1 in five Colombian individuals, and a new ophthalmic system was tested that corrected visual defects and symptoms in a patient with oculocutaneous albinism.Mutations in the gene for tyrosinase, the key enzyme in melanin synthesis, are responsible for oculocutaneous albinism type 1, and more than 100 mutations of this gene have been identified.The Q402 allele has been associated with autosomal recessive ocular albinism when it is in trans with a tyrosinase gene mutation associated with oculocutaneous albinism type 1."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58a6db8660087bc10a00002c",
                            "question": "Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?"
                        }
                    ],
                    "context": "The chromatin remodeler SWR1 mediates site-specific incorporation of H2A.Z by a multi-step histone replacement reaction, evicting histone H2A-H2B from the canonical nucleosome and depositing the H2A.Z-H2B dimerhe multisubunit nucleosome-remodeling enzyme complex SWR1, conserved from yeast to mammals, catalyzes the ATP-dependent replacement of histone H2A in canonical nucleosomes with H2A.Z.Our results show that the Swr1-Z domain can deliver the H2A.Z-H2B dimer to the DNA-(H3-H4)2 tetrasome to form the nucleosome by a histone chaperone mechanism.H2A.Z is deposited into chromatin by the SWR1 complex and is subject to acetylation of its four N-terminal tail lysine residues by the NuA4 and SAGA histone acetyltransferase complexes.H2A.Z deposition is controlled by SWR-C chromatin remodeling enzymes that catalyze the nucleosomal exchange of canonical H2A with H2A.Z. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5895f7e978275d0c4a000001",
                            "question": "What fruit causes Jamaican vomiting sickness?"
                        }
                    ],
                    "context": "The aril of the unripe fruit has high concentrations of HGA, the cause of Jamaican vomiting sickness, which is very often fatal.In 1976, over 100 years after Jamaican vomiting sickness (JVS) was first reported, the cause of JVS was linked to the ingestion of the toxin hypoglycin A produced by ackee fruit. Ackee apple fruit is a native fruit to Jamaica and some parts of west Africa. Its toxicity known as \"Jamaican vomiting sickness\" dates back to the nineteenth century.Jamaican Vomiting Sickness is caused by ingestion of the unripe arils of the Ackee fruit, its seeds and husks.An acute illness (Jamaican vomiting sickness) which affected two adults after eating unripe ackee fruit was investigated."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "588f9950ed9bbee70d000002",
                            "question": "Which gene is mutated in the Karak syndrome?"
                        }
                    ],
                    "context": "Mutations in PLA2G6 have been associated with disorders such as infantile neuroaxonal dystrophy, neurodegeneration with brain iron accumulation type II and Karak syndromeMutations in PLA2G6 gene have variable phenotypic outcome including infantile neuroaxonal dystrophy, atypical neuroaxonal dystrophy, idiopathic neurodegeneration with brain iron accumulation and Karak syndrome. BACKGROUND: PLA2G6 is the causative gene for infantile neuroaxonal dystrophy, neurodegeneration associated with brain iron accumulation, and Karak syndrome. PLA2G6 is the causative gene for infantile neuroaxonal dystrophy, neurodegeneration associated with brain iron accumulation, and Karak syndrome.Mutations in PLA2G6 gene have variable phenotypic outcome including infantile neuroaxonal dystrophy, atypical neuroaxonal dystrophy, idiopathic neurodegeneration with brain iron accumulation and Karak syndrome."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58ce9bf1d46b5c2951000002",
                            "question": "Which disease is associated with mutated Sox2?"
                        }
                    ],
                    "context": "Anophthalmia and microphthalmia (A/M) are developmental ocular malformations defined as the complete absence or reduction in size of the eye. A/M is a highly heterogeneous disorder with SOX2 and FOXE3 playing major roles in dominant and recessive pedigrees, respectively;anophthalmia/microphthalmia (AM) or anterior segment dysgenesis (ASD) have an estimated combined prevalence of 3.7 in 10,000 births. Mutations in SOX2 are the most frequent contributors to severe ODA, yet account for a minority of the genetic drivers.Three causative SOX2 mutations were found in subjects with syndromic A.SOX2 anophthalmia syndrome is an uncommon autosomal dominant syndrome caused by mutations in the SOX2 gene and clinically characterized by severe eye malformations (anophthalmia/microphthalmia) and extraocular anomalies mainly involving brain, esophagus, and genitalia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bfd8e902b8c60953000018",
                            "question": "Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?"
                        }
                    ],
                    "context": "Necrobiosis lipoidica diabeticorum (NLD) is a chronic condition, which is characterized by single or multiple lesions on the legs, and occurs in 0.3% of patients with diabetes.Necrobiosis lipoidica (NL) is a rare chronic granulomatous dermatitis that usually appears in the lower extremities. It affects about 0.3-1.2% of diabetic patients, the majority of whom have type 1 diabetes.A 32-year-old woman with type 2 diabetes mellitus suffering from morbid obesity with BMI 45,14\u2009kg/m(2) was operated on. Not only the type 2DM but also one of its complication known as necrobiosis lipoidica diabeticorum remitted postoperatively.Necrobiosis lipoidica is a granulomatous skin disease of unknown etiology, associated mainly with diabetes mellitus.Necrobiosis lipoidica diabeticorum is a rare disease of unclear etiology, that occurs in about 1% of diabetic patients."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58adc1ff9ef3c34033000006",
                            "question": "Which protein mediates gene loop formation in the yeast S. cerevisiae?"
                        }
                    ],
                    "context": "A transcription-independent role for TFIIB in gene looping.Moreover, looping is dependent upon the general transcription factor TFIIB: the E62K (glutamic acid 62 -->lysine) form of TFIIB adversely affects looping at every gene tested, including BLM10, SAC3, GAL10, SEN1, and HEM3TFIIB crosslinks to both the promoter and terminator regions of the PMA1 and BLM10 genes, and its association with the terminator, but not the promoter, is adversely affected by E62K and by depletion of the Ssu72 component of the CPF 3' end processing complex, and is independent of TBPWe present a high-resolution genome-wide map of TFIIB locations that implicates 3' NFRs in gene looping.Instead, activators physically interacted with the general transcription factor TFIIB when the genes were activated and in a looped configuration. TFIIB cross-linked to both the promoter and the terminator regions during the transcriptionally activated state of a gene. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58bfd0db02b8c60953000017",
                            "question": "Which virus type causes Molluscum contagiosum?"
                        }
                    ],
                    "context": "Molluscum contagiosum virus (MCV), a poxvirus pathogenic for humans, replicates well in human skin in vivo, but not in vitro in standard monolayer cell cultures.Molluscum contagiosum virus (MCV) is a poxvirus that causes tumor-like skin lesions. Molluscum contagiosum poxvirus (MCV) type 1 and type 2 encode two chemokine-like proteins MC148R1 and MC148R2. IMolluscum contagiosum virus (MCV) is a common, human poxvirus that causes small papular skin lesions that persist for long periods without signs of inflammation. All poxviruses studied encode a type 1B topoisomerase that introduces transient nicks into DNA and thereby relaxes DNA supercoils. Here we present a study of the protein domains of the topoisomerase of the poxvirus molluscum contagiosum (MCV), which allows us to specify DNA contacts made by different domains. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58cf5c5a8acda34529000003",
                            "question": "Where is base J found in the genome of Leishmania tarentolae?"
                        }
                    ],
                    "context": "Base J (\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and stops.Base J is found predominantly in repetitive DNA and correlates with epigenetic silencing of telomeric variant surface glycoprotein genes in Trypanosoma brucei.J is enriched at sites involved in RNA polymerase (RNAP) II initiation and termination.Base J (\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and stopsTelomeric localization of the modified DNA base J in the genome of the protozoan parasite Leishmania"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587e0116ae05ffb474000002",
                            "question": "Which tool is available for predicting regulatory interactions from ChIP-seq data?"
                        }
                    ],
                    "context": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq dataWe present CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's bound sites and the expression of each gene across a panel of tissues.Using both chromatin conformation capture and differential expression data, we show that CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly advantageous for predicting the long-range regulatory interactions typical of tissue-specific gene expression CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper can predict which transcription start site of a gene is regulated by a particular binding site of the TFCisMapper: predicting regulatory interactions from transcription factor ChIP-seq data."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58dfe6b56fddd3e83e000004",
                            "question": "What is the enzymatic activity of PARL?"
                        }
                    ],
                    "context": "Here we demonstrate that the mitochondrial protease presenilin-associated rhomboid-like (PARL) can affect the proteolytic processing of PINK1 and that normal PINK1 localization and stability requires PARL's catalytic activity. The mitochondrial rhomboid protease Parl governs apoptosis, morphology, metabolism and might be implicated in Parkinson's disease, but the structural basis of its activity and complex regulation remain unknown.. In this study, we evaluated the mRNA levels of presenilins-associated rhomboid-like protein (PARL) and mitochondrial content and enzyme activity from skeletal muscle isolated from insulin-resistant rats.Rhomboids are a recently discovered family of widely distributed intramembrane serine proteases. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58e75d483e8b6dc87c000005",
                            "question": "Which gene controls the expression of GATA-1 isoforms?"
                        }
                    ],
                    "context": "Mutations in exon 2 interfere with the synthesis of the full-length isoform of GATA-1 and lead to the production of a shortened isoform, GATA-1s.In this study, we report a transcriptional network in which PU.1 positively regulates GATA-1 expression in mast cell development. This isoform contains an alternatively spliced first exon (IB) that is distinct from the first exon (IE) incorporated in the major erythroid mRNA transcript.Reintroduction of PU.1 restores variant IB isoform and upregulates total GATA-1 protein expression, which is concurrent with mast cell differentiation.Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5880b073c872c95565000003",
                            "question": "Andexanet Alfa is an antidote of which clotting factor inhibitors?"
                        }
                    ],
                    "context": "Andexanet alfa is a class-specific antidote targeted to reverse the oral direct factor Xa inhibitors as well as the indirect inhibitor, enoxaparin.Idarucizumab and andexanet alfa are NOAC-specific reversal agents designed to reverse dabigatran and factor Xa inhibitors accordingly.Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation.Andexanet alfa is a specific reversal agent for Factor Xa inhibitors.In ex vivo, animal, and volunteer human studies, andexanet alfa (AnXa) was able to dose-dependently reverse Factor Xa inhibition and restore thrombin generation for the duration of drug administration. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58da111c8acda34529000010",
                            "question": "Which is the main cause of the Patau syndrome?"
                        }
                    ],
                    "context": "Trisomy 13, or Patau syndrome is a rare chromosomal disorder characterized by a triad of cleft lip and palate, postaxial polydactyly and microcephaly.Mosaic trisomy 13 is very rare, it occurs in only 5% of all patients with trisomy 13 phenotype.Among full autosomal trisomies, only trisomies of chromosome 21 (Down syndrome), 18 (Edwards syndrome) and 13 (Patau syndrome) are compatible with postnatal survival. We describe the management of the eyelid anomaly associated with Patau syndrome. Trisomy 13 is the genotype of the syndrome's phenotype. This article identifies the causes and manifestations of most of these trisomies: trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome), and trisomy 21 (Down syndrome). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58af1cb3717cd3f655000003",
                            "question": "Which is the main abnormality that arises with Sox9 locus duplication?"
                        }
                    ],
                    "context": "Autosomal XX sex reversal caused by duplication of SOX9Mutations of SOX9 leading to haploinsufficiency can cause campomelic dysplasia and XY sex reversalWe report here evidence supporting that SOX9 duplication can cause XX sex reversalFluorescent in situ hybridization (FISH) with a BAC clone containing the SOX9 gene demonstrated that the SOX9 gene is duplicated on the rearranged chromosome 17SOX9 duplication linked to intersex in deer"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58dd0dde8acda34529000027",
                            "question": "What tissue is commonly affected in Marfan's syndrome"
                        }
                    ],
                    "context": "Marfan syndrome (MS) is a connective tissue disorder that affects thousands of adolescents Fibrillin-1 mutations have also been found in several other related connective tissue disorders, such as severe neonatal Marfan syndrome, dominant ectopia lentis, familial ascending aortic aneurysm, isolated skeletal features of Marfan syndrome, and Shprintzen-Goldberg syndrome.Marfans syndrome is an Autosomal dominant disorder of the connective tissues resulting in abnormalities of the musculoskeletal system, cardiovascular system and eyes.Marfan syndrome (MFS) is a systemic disorder of the connective tissue with pleiotropic manifestations due to heterozygous FBN1 mutations and consequent upregulation of TGF\u03b2 signaling in affected tissuesMarfan syndrome (MFS) is an autosomal dominant disorder of connective tissue, caused by mutations of the microfibrillar protein fibrillin-1, that predisposes affected individuals to aortic aneurysm and rupture and is associated with increased TGF\u03b2 signaling"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58853922e56acf5176000016",
                            "question": "To which disease does the loss of CD28 expression by liver-infiltrating T cells contribute?"
                        }
                    ],
                    "context": "Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis.Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitisLoss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5880e417713cbdfd3d000001",
                            "question": "Which disease is treated with ZMapp?"
                        }
                    ],
                    "context": "This includes agents belonging to various therapeutic classes, namely direct antiviral agents (favipiravir and BCX4430), a combination of antibodies (ZMapp), type I interferons, RNA interference-based drugs (TKM-Ebola and AVI-7537), and anticoagulant drugs (rNAPc2). During the latest outbreak of Ebola virus disease in West Africa, monoclonal antibody therapy (e.g., ZMapp) was utilized to treat patients. Recent successes with monoclonal antibody cocktails ZMapp(TM) and MIL77 against Ebola virus (EBOV) infections have reignited interest in antibody-based therapeutics. The human-mouse chimeric monoclonal antibody (mAb) cocktail ZMapp, previously shown to be efficacious in EBOV (variant Kikwit) lethally infected nonhuman primates (NHPs) when administration was initiated up to 5 days, was used in some patients during the outbreak. We show that a two-antibody cocktail, MIL77E, is fully protective in NHPs when administered at 50 mg/kg 3 days after challenge with a lethal dose of EBOV variant Makona, the virus responsible for the ongoing 2014-2015 outbreak, whereas a similar formulation of ZMapp protected two of three NHPs. The growing promise of plant-made biologics is highlighted by the success story of ZMapp\u2122 as a potentially life-saving drug during the Ebola outbreak of 2014-2016. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5889eb503b87a8a73800000b",
                            "question": "Which syndrome is caused by deletion of Pds5b in mice?"
                        }
                    ],
                    "context": "Mice lacking sister chromatid cohesion protein PDS5B exhibit developmental abnormalities reminiscent of Cornelia de Lange syndrome.Pds5B mutant mice have developmental abnormalities resembling CdLSMice lacking sister chromatid cohesion protein PDS5B exhibit developmental abnormalities reminiscent of Cornelia de Lange syndromePds5B mutant mice have developmental abnormalities resembling CdLS; however the role of Pds5A in mammals and the association of PDS5 proteins with CdLS are unknown.Pds5B mutant mice have developmental abnormalities resembling CdLS; however the role of Pds5A in mammals and the association of PDS5 proteins with CdLS are unknown."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58d900428acda3452900000c",
                            "question": "What is the inheritance of Barth syndrome?"
                        }
                    ],
                    "context": "Barth syndrome (BTHS) is an X-linked recessive disease primarily affecting males.The results of our study should not only be applicable to BTHS families, but also to families with other X-linked diseases.Barth syndrome, an X-linked disorder that is characterized by cardiomyopathy, neutropenia, skeletal myopathy, and growth delay, is caused by mutations in the taffazin gene at Xq28 that result in cardiolipin deficiency and abnormal mitochondria. Barth syndrome should be considered when boys present with cardiomyopathy, especially when associated with increased left ventricular trabeculations, neutropenia, skeletal muscle weakness, or family history indicating an X-linked pattern of inheritance.Mutations in the G4.5 gene result in a wide spectrum of severe infantile X-linked cardiomyopathic phenotypes including Barth syndrome with dilated cardiomyopathy and INVM."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58de18e48acda3452900002a",
                            "question": "Which miRNA is targeted by SRY/Sox9?"
                        }
                    ],
                    "context": "Does the linear Sry transcript function as a ceRNA for miR-138?Recently, the sex determining region Y ( Sry) and the cerebellar degeneration-related protein 1 ( CDR1as) RNA transcripts have been described to function as a new class of post-transcriptional regulatory RNAs that behave as circular endogenous RNA sponges for the micro RNAs (miRNAs) miR-138 and miR-7, respectively.  it is reasonable to think that the linear Sry sense transcript could additionally act as a miRNA sponge, or as an endogenous competing RNA for miR-138.Results indicated that miR-138 directly targeted SRY-related high mobility group box 4 (SOX4) and hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1), and overexpression of SOX4 and HIF-1\u03b1 effectively reversed the miR-138-mediated suppression of cell invasion.We further show that the testis-specific circRNA, sex-determining region Y (Sry), serves as a miR-138 sponge, suggesting that miRNA sponge effects achieved by circRNA formation are a general phenomenon. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58c9a8fe02b8c6095300002a",
                            "question": "What alternate indication has Vanoxerine been repositioned for?"
                        }
                    ],
                    "context": "Vanoxerine's effects were strongly frequency-dependent and we repositioned it for treatment of atrial fibrillation and flutter.Vanoxerine: cellular mechanism of a new antiarrhythmic.Therefore, we proposed that vanoxerine might be antiarrhythmic.Vanoxerine is a promising, new, investigational antiarrhythmic drug.Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58d8e6818acda3452900000a",
                            "question": "Which gene mutations cause the Marfan syndrome?"
                        }
                    ],
                    "context": "The diagnostic criteria of Marfan syndrome (MFS) highlight the importance of a FBN1 mutation test in diagnosing MFS. A marked decrease in heart rate variability in Marfan syndrome patients with confirmed FBN1 mutations.The studies on heart rate variability (HRV), a key predictor of all-cause mortality, in Marfan syndrome (MS), up to now have not been reported, especially in patients with FBN1 mutations.Among 18 MS patients with the phenotype of MS meeting inclusion criteria 15 have had a FBN1 gene mutation. Heart rates in MS patients with the FBN1 mutation were increased in both the supine position and orthostatic test (p<0.001)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58df47f08acda3452900002f",
                            "question": "What is the indication of ARCALYST?"
                        }
                    ],
                    "context": "Rilonacept (Arcalyst(TM); Regeneron) is the first us Food and Drug Administration-approved treatment for familial cold autoinflammatory syndrome and Muckle-Wells syndrome and the first in a new line of drugs designed for longer-acting IL-1 blockade. In February 2008, Regeneron received Orphan Drug approval from the Food and Drug Administration for rilonacept in the treatment of two cryopyrin-associated periodic syndromes (CAPS) disorders, namely, familial cold-induced autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS), for children and adults 12 years and older. In February, 2008, 'Orphan Drug' approval from the Food and Drug Administration (FDA) for rilonacept (IL-1 Trap/Arcalyst(), Regeneron Pharmaceuticals, Inc) was given for the treatment of two CAPS disorders, FCAS and MWS in adults and children 12 years and older, making rilonacept the first therapy approved for the treatment of CAPS."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58e23ec66fddd3e83e000010",
                            "question": "What is the genus for the common European honey bee?"
                        }
                    ],
                    "context": "European honey bee (Apis mellifera) European honey bees (Apis mellifera) European honey bees (Apis mellifera European honey bees, Apis mellifera"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58d906b28acda3452900000d",
                            "question": "Where is the TAZ (G4.5) is located in humans?"
                        }
                    ],
                    "context": "Tafazzin (EC 2.3.1.23) is a Phospholipid Transacylase involved in Cardiolipin remodeling on mitochondrial membrane and coded by TAZ gene (Cytogenetic Location: Xq28) in human.Barth syndrome is an X-linked cardiomyopathy with neutropenia and 3-methylglutaconic aciduria. Recently, mutations in the G4.5 gene, located in Xq28, have been described in four probands with Barth syndrome. The disorder is caused by mutations in the tafazzin (TAZ/G4.5) gene located on Xq28.Disabling mutations or deletions of the tafazzin (TAZ) gene, located at Xq28, cause the disorder by reducing remodeling of cardiolipin, a principal phospholipid of the inner mitochondrial membraneThe tafazzin gene (TAZ) is located at Xq28 and encodes a protein involved in the transacylation of cardiolipin, an essential mitochondrial phospholipid"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5881f9b65bf093691f000001",
                            "question": "What do nerve-associated peripheral glial progenitors give rise to?"
                        }
                    ],
                    "context": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.We show that the parasympathetic system in mice--including trunk ganglia and the cranial ciliary, pterygopalatine, lingual, submandibular, and otic ganglia--arise from glial cells in nerves, not neural crest cells. The parasympathetic fate is induced in nerve-associated Schwann cell precursors at distal peripheral sites.Neurodevelopment. Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.Parasympathetic neurons originate from nerve-associated peripheral glial progenitorsNeurodevelopment. Parasympathetic neurons originate from nerve-associated peripheral glial progenitors."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58e793f53e8b6dc87c000008",
                            "question": "How many topological associated domains are contained in the human Hox cluster?"
                        }
                    ],
                    "context": "Initially, Hox clusters are organized as single chromatin compartments containing all genes and bivalent chromatin marks.Transcriptional activation is associated with a dynamic bi-modal 3D organization, whereby the genes switch autonomously from an inactive to an active compartment."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58dfd70c6fddd3e83e000002",
                            "question": "What is the results of inactivated ANGPLT3?"
                        }
                    ],
                    "context": "Although it appears by now that the main lipid pathways have been uncovered, and that only modulators or adaptor proteins such as those encoded by LDLRAP1, APOA5, ANGPLT3/4, and PCSK9 are currently being discoveredAngptl3 knockout mice have marked hypolipidemia, and heterozygous carriers of ANGPLT3, loss-of-function mutations were found among individuals in the lowest quartile of plasma triglycerides in population studies.  4 related individuals with primary hypolipidemia were found to be compound heterozygotes for ANGPTL3 loss-of-function mutations.Complete ANGPTL3 deficiency caused by loss-of-function mutations of ANGPTL3 is associated with a recessive hypolipidemia"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58e79e703e8b6dc87c00000a",
                            "question": "What percentage of rheumatoid arthritis patients are responsive to anti-TNF therapy?"
                        }
                    ],
                    "context": "Despite this, a substantial proportion of patients (approximately 30-40%) fail to respond to these potentially toxic and expensive therapies. Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patients with rheumatoid arthritis (RA), showing beneficial effects in approximately 50-60% of the patients."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5880c42fc872c95565000008",
                            "question": "Which disease is treated with semaglutide?"
                        }
                    ],
                    "context": "INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly being used for the treatment of type 2 diabetes mellitus, but consideration of benefits and potential adverse events is required. This review examines the state of glycemic control, weight loss, blood pressure, and tolerability, as well as the current debate about the safety of GLP-1 RAs, including risk of pancreatitis, pancreatic cancer, and thyroid cancer.METHODS: A MEDLINE search (2010-2015) identified publications that discussed longer-acting GLP-1 RAs. Search terms included GLP-1 receptor agonists, liraglutide, exenatide, lixisenatide, semaglutide, dulaglutide, albiglutide, efficacy, safety, pancreatitis, pancreatic cancer, and thyroid cancer. Seven trials have been published that have established CV safety for three DPP-4 inhibitors (alogliptin, saxagliptin, and sitagliptin), three GLP-1 receptor agonists (liraglutide, lixisenatide, and semaglutide), and one sodium-glucose cotransporter-2 inhibitor (empagliflozin). Three of those studies also established superiority with liraglutide, empagliflozin, and semaglutide at reducing the composite primary endpoint of major CV events (CV death, nonfatal myocardial infarction, and nonfatal stroke). RECENT FINDINGS: In response to guidance issued by the Food and Drug Administration, thousands of patients have been enrolled in large randomized trials evaluating the cardiovascular effects of the three newest diabetes drug classes: glucagon-like peptide-1 (GLP-1) receptor agonists, sodium glucose cotransporter 2 (SGLT-2) inhibitors, and dipeptidyl peptidase-4 (DPP-4) inhibitors. Two studies of GLP-1 receptor agonists-one of liraglutide and one of semaglutide-have shown cardiovascular benefit relative to placebo, and one study of the SGLT-2 inhibitor empagliflozin has shown benefit.New antidiabetic drugs are being developed today that expand the range of pharmacological intervention, in particular for patients with type 2 diabetes (imeglimin, semaglutide, dulaglutide, FGF 21 analogue).The effect of semaglutide, a once-weekly human glucagon-like peptide-1 (GLP-1) analog in development for type 2 diabetes (T2D), on the bioavailability of a combined oral contraceptive was investigated. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58dbb8968acda3452900001b",
                            "question": "What condition is usually represented by the acronym SUDEP?"
                        }
                    ],
                    "context": "Sudden Unexpected Death in Epilepsy (SUDEP) sudden unexpected death in epilepsy (SUDEP),Sudden unexpected death in epilepsy (SUDEP) is the most important direct seizure-related cause of death, and most cases usually occur in patients with intractable, longstanding epilepsy.Sudden unexpected death in epilepsy (SUDEP): what do patients think?OBJECTIVES: Sudden unexpected death in epilepsy (SUDEP) is a major cause of mortality in epilepsy."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5886519c3b87a8a738000007",
                            "question": "Which disease can be categorized using the Koos grading system?"
                        }
                    ],
                    "context": "The patients had Koos Grade I or II tumors and American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Class D hearing status preoperatively. METHODS: This is a retrospective review of 22 patients with VS Koos grade III and IV who were treated with STR followed by SRS.  VS was characterized by its size (Koos classification) and the presence or not of a cystic component.MAIN OUTCOME MEASURES: All data recorded were reviewed to access age, sex, tumor type, and tumor size according to the Koos classification and presenting symptoms. Facial nerve preservation surgery for koos grade 3 and 4 vestibular schwannomas."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58c6635f02b8c60953000023",
                            "question": "What is the inheritance of the glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
                        }
                    ],
                    "context": "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest red cell enzymopathy in humans and has an X-linked inheritance. The high manifestation of G6PD deficiency in women may be due to the preferential expression of the G6PD-deficient gene and X-inactivation of the normal gene, and/or to the presence of an 'enhancer' gene that makes the expression of the G6PD deficiency more likely. Study of the deficiency pattern amongst family members of the enzyme deficient subjects confirmed the X-linked inheritance of G-6-PD deficiency. The investigation of the patient's whole family showed the typical recessive X-linked inheritance of this enzyme-defect. After having described in detail the pathophysiology, symptomatology, X-chromosomal inheritance and some laboratory methods in detecting G-6-PD-deficiency by demonstrating a case of favism (Schulz et al. 1977), the authors now discuss the particularities of the enzyme deficiency in the newborn. T"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58861d413b87a8a738000002",
                            "question": "Symptoms of which disorder are evaluated with the Davidson Trauma Scale?"
                        }
                    ],
                    "context": "Besides, to study its scores' evidence of convergent, discriminant, and predictive validity in relation to other resilience questionnaires (Connor Davidson Resilience Scale 10-item version, Situated Subjective Resilience Questionnaire for Adults and Resiliency Questionnaire for Adults) and to variables such as emotions (Modified Differential Emotions Scale), coping (Person-situation Coping Questionnaire for Adults), anxiety and depression (Hospital Anxiety and Depression Scale), posttraumatic growth (Posttraumatic Growth Inventory), perceived stress (Perceived Stress Scale) and posttraumatic stress (Davidson Trauma Scale), correlation and regression analyses were conducted.Using the normalized population mean of 50 on the SF-36 MH domain score as a cut-off, positive predictive values were 16 and 55% for substantial depression; 20 and 68% for substantial anxiety (Depression Anxiety Stress Scales and HADS, respectively); and 40, 44, and 67% for substantial PTSD symptoms (IES-R, IES, and Davidson Trauma Scale, respectively).METHOD: A randomly selected representative sample of inmates in the Puerto Rico correctional system (N = 1,179) was assessed with the Spanish-language Wender Utah Rating Scale (WURS); the Composite International Diagnostic Interview (CIDI) modules for lifetime/current major depression disorder (MDD), generalized anxiety disorder (GAD), and SUD; the Davidson Trauma Scale (DTS; posttraumatic stress disorder [PTSD]); and self-reports of in-site high-risk behaviors.After correcting for multiple comparisons, no significant effects were observed on any of the outcomes among the NHW sample; however, within the NHB sample, significant gene \u00d7 environment (G \u00d7 E) interactions were observed for lifetime PTSD (P = .0029) and PTSD symptom severity (P = .0009). In each case, the APOE \u03b54 allele had no effect on the outcomes when combat exposure was low; however, when combat exposure was high, an additive effect was observed such that \u03b54 homozygotes exposed to high levels of combat reported the highest rates of PTSD (92%) and the worst symptom severity scores on the Davidson Trauma Scale (M = 79.5)Early prognostic screening for posttraumatic stress disorder with the Davidson Trauma Scale and the SPAN."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5880dba9c872c95565000009",
                            "question": "Which enzyme is inhibited by ribociclib?"
                        }
                    ],
                    "context": "Three CDK 4/6 inhibitors have been investigated for the treatment of HR(+) breast cancer, including palbociclib (PD 0332991), ribociclib (LEE011), and abemaciclib (LY2835219). The CDK 4/6 inhibitors are a novel class of therapeutics that target the CDK 4/6 kinases that promote transition through the cell cycle. Currently, palbociclib (PD0332991, Pfizer), abemaciclib (LY2835219, Lilly) and ribociclib (LEE011, Novartis) are being investigated in clinical trials. SUMMARY: Palbociclib, abemaciclib and ribociclib have demonstrated very promising clinical activity in breast cancer, liposarcoma, mantel cell lymphoma and melanoma. Moreover, CDK4/6 inhibitors have shown promising preclinical activity in glioblastoma, renal and ovarian cancer models that may provide directions for their future clinical development.Currently, three selective CDK4/6 inhibitors have been approved or are in late-stage development: palbociclib (PD-0332991), ribociclib (LEE011), and abemaciclib (LY2835219).The combination of antiestrogen therapy and ribociclib, an investigational CDK4/6 inhibitor, led to improved outcomes in women with metastatic HR-positive, HER2-negative breast cancer, according to findings presented at a meeting of the European Society for Medical Oncology. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58f4b2f070f9fc6f0f000012",
                            "question": "What is the indication for Mirabegron?"
                        }
                    ],
                    "context": "Mirabegron, the first \u03b23-adrenoceptor agonist in clinical practice, is approved for treatment of overactive bladder (OAB) syndrome symptoms.The clinical indication for mirabegron is overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency and other storage symptoms in both men and women.Mirabegron has been approved in Japan for the indication of urgency, urinary frequency and urge urinary incontinence associated with OAB, and was recently submitted for approval to U.S. and European authorities for the same indication.Mirabegron was well tolerated.The early onset of action and good overall efficacy and tolerability balance that mirabegron offers may lead to high rates of persistence with mirabegron in the long-term treatment of OABMirabegron, the selective \u03b23-adrenoceptor agonist, heralds the latest development for the treatment of overactive bladder (OAB).To present the evidence available on the efficacy and tolerability of mirabegron and to discuss this treatments potential in our setting.We reviewed 11 studies conducted with mirabegron in patients with OAB (2 phase II, 9 phase III), all studies were compared to placebo with 6 studies also including tolterodine as an additional arm"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58efa36d70f9fc6f0f000004",
                            "question": "What is the cause of Tardive dyskinesia?"
                        }
                    ],
                    "context": ": Free radicals may be involved in the pathogenesis of tardive dyskinesia (TD). Tardive dyskinesia (TD) is a serious, often disabling, movement disorder that is caused by medications that block dopamine receptors (i.e., neuroleptics, anti-emetics). Antipsychotics may cause tardive dyskinesia in humans and orofacial dyskinesia in rodents.Tardive dyskinesia (TD) is a movement disorder characterized by abnormal involuntary facial movements induced by chronic therapy with classical antipsychotic medications.The objective of this report is to draw attention to tardive dyskinesia (TD) caused by aripiprazole, a third generation antipsychotic. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58e9f0ba3e8b6dc87c00000e",
                            "question": "Which bacterium has the smallest genome in base pairs yet found?"
                        }
                    ],
                    "context": "Our results reveal that Nasuia-ALF has the smallest bacterial genome yet sequenced (112 kb), and that the Sulcia-ALF genome (190 kb) is smaller than that of Sulcia in other insect lineages.We sequenced genomes of the obligate symbionts, Sulcia muelleri and Nasuia deltocephalinicola, of the phloem-feeding pest insect, Macrosteles quadrilineatus (Auchenorrhyncha: Cicadellidae)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58b6d6f322d300530900000f",
                            "question": "What is the inheritance of hypophosphatemic rickets?"
                        }
                    ],
                    "context": "Among 35 candidate genes in this region, the dentin matrix protein 1 gene (DMP1) was sequenced to reveal a nonsense mutation 250C/T on exon 6. Previous research has shown that mutations in the DMP1 gene are responsible for autosomal recessive hypophosphatemic rickets in humans.A novel nonsense mutation in the DMP1 gene in a Japanese family with autosomal recessive hypophosphatemic rickets.Autosomal recessive hypophosphatemic rickets (ARHR) is an extremely rare disorder of autosomal recessive inheritance, characterized by hypophosphatemia resulting from renal phosphate wasting. Prenatal diagnosis for a novel splice mutation of PHEX gene in a large Han Chinese family affected with X-linked hypophosphatemic rickets."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58f4b1a170f9fc6f0f000010",
                            "question": "Which mushroom is poisonous, Amanita phalloides or Agaricus Bisporus"
                        }
                    ],
                    "context": "Seventeen edible mushrooms commercially available in Korea were analysed for their umami taste compounds (5'-nucleotides: AMP, GMP, IMP, UMP, XMP; free amino acids: aspartic, glutamic acid) and subjected to human sensory evaluation and electronic tongue measurements. Amanita virgineoides featured the highest total 5'-nucleotide content (36.9 \u00b1 1.50 mg/g), while monosodium glutamate-like components (42.4 \u00b1 6.90 mg/g) were highest in Agaricusliver transplantation improves patients' short-term post liver transplantation survival in Amanita phalloides poisoning"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58e7902b3e8b6dc87c000007",
                            "question": "Which is the most common gene signature in Rheumatoid Arthritis patients?"
                        }
                    ],
                    "context": "A five gene type I IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and disease-affected tissues of each disease and to correlate activation of this pathway in the WB with clinical measurements.RBaseline disease activity measurements correlated with a type I IFN gene signature in the WB of subjects with SLE, PM and SSc, as did various serum autoantibody levels in subjects with SLE and DM. This signature was also well correlated between disease-affected tissue and WB in subjects with SLE, DM, PM and SSc.We identified an arsenic exposure related 51-gene signature at PND1 and PND70 with several hubs of interaction (Hspa8, IgM and Hnf4a).A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative diseaseA 12-gene transcriptional 'signature' identified RA patients in the training cohort and predicted the subsequent development of RA among UA patients in the validation cohort (sensitivity 68%, specificity 70%). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "589317e849702f2e01000005",
                            "question": "Which server is used for generating modes of pseudo components of DNA, RNA and protein sequences?"
                        }
                    ],
                    "context": "Pse-in-One: a web server for generating various modes of pseudo components of DNA, RNA, and protein sequences.In this article, with a much larger number of built-in properties, we are to propose a much more flexible web server called Pse-in-One (http://bioinformatics.hitsz.edu.cn/Pse-in-One/), which can, through its 28 different modes, generate nearly all the possible feature vectors for DNA, RNA and protein sequences. Particularly, it can also generate those feature vectors with the properties defined by users themselves. These feature vectors can be easily combined with machine-learning algorithms to develop computational predictors and analysis methods for various tasks in bioinformatics and system biology. It is anticipated that the Pse-in-One web server will become a very useful tool in computational proteomics, genomics, as well as biological sequence analysis.In this article, with a much larger number of built-in properties, we are to propose a much more flexible web server called Pse-in-One (http://bioinformatics.hitsz.edu.cn/Pse-in-One/), which can, through its 28 different modes, generate nearly all the possible feature vectors for DNA, RNA and protein sequences.Pse-in-One: a web server for generating various modes of pseudo components of DNA, RNA, and protein sequencesIn this article, with a much larger number of built-in properties, we are to propose a much more flexible web server called Pse-in-One (http://bioinformatics.hitsz.edu.cn/Pse-in-One/), which can, through its 28 different modes, generate nearly all the possible feature vectors for DNA, RNA and protein sequences"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58e74bff3e8b6dc87c000004",
                            "question": "Which class of genes are mutated in Diamond Blackfan Anemia patients?"
                        }
                    ],
                    "context": "Mutations in the gene encoding ribosomal protein (RP) S19 have recently been found in 25% of patients with either the dominant or the sporadic form.We also report the prevalence of RPS 19 mutations in the Italian DBA population, as shown by an analysis of 56 patients.Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder.Three genes encoding ribosomal proteins have been associated to DBA: after RPS19, mutations in genes RPS24 and RPS17 were recently identified in a fraction of the patients.A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58eb9542eda5a57672000007",
                            "question": "Which protein is the main marker of Cajal bodies?"
                        }
                    ],
                    "context": "Coilin is widely known as the protein marker of the Cajal body, a subnuclear domain important to the biogenesis of small nuclear ribonucleoproteins and telomerase, complexes that are crucial to pre-messenger RNA splicing and telomere maintenance, respectivelyExtensive studies have characterized the interaction between coilin and the various other protein components of CBs and related subnuclear domains; however, only a few have examined interactions between coilin and nucleic acid.coilin is tightly associated with nucleic acid, displays RNase activity in vitro, and is redistributed to the ribosomal RNA (rRNA)-rich nucleoli in cells treated with the DNA-damaging agents cisplatin and etoposideHere, we report a specific in vivo association between coilin and rRNA, U small nuclear RNA (snRNA), and human telomerase RNA, which is altered upon treatment with DNA-damaging agents. Using chromatin immunoprecipitation, we provide evidence of coilin interaction with specific regions of U snRNA gene loci.Additionally, we provide evidence of coilin involvement in the processing of human telomerase RNA both in vitro and in vivo."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58cbd0d502b8c60953000035",
                            "question": "Which mutated gene causes the Ch\u00e9diak\u2013Higashi Syndrome?"
                        }
                    ],
                    "context": "We detected a homozygous missense mutation (c.4189T>G, p.F1397V) in the lysosomal trafficking regulator (LYST) gene, which is described as the causative gene for Ch\u00e9diak-Higashi syndrome (CHS). A frameshift mutation in the LYST gene is responsible for the Aleutian color and the associated Ch\u00e9diak-Higashi syndrome in American mink.As with forms of CHS in other species, we report that the mink CHS is linked to the lysosomal trafficking regulator ( LYST ) gene. LYST analysis was performed for 10 patients; seven different mutations were detected in seven patients, whereas no mutation was identified in three patients. Ch\u00e9diak-Higashi syndrome (CHS) is a rare autosomal recessive disorder characterized by immunodeficiency, neurological dysfunction, and oculocutaneous albinism. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58f3ca5c70f9fc6f0f00000d",
                            "question": "The pathogen Fusarium graminearum affects what type of plant species?"
                        }
                    ],
                    "context": "Fusarium graminearum is a broad host pathogen threatening cereal crops in temperate regions around the world. Fusarium head blight (FHB) of small cereals is a disease of global importance with regard to economic losses and mycotoxin contamination harmful to human and animal health. In Germany, FHB is predominantly associated with wheat and F. graminearum is recognised as the major causal agent of the disease, but little is known about FHB of barleyFusarium graminearum is a filamentous fungal pathogen that causes wheat Fusarium head blightDisruption of the GABA shunt affects mitochondrial respiration and virulence in the cereal pathogen Fusarium graminearum.Fusarium graminearum is an important plant pathogen that causes head blight of major cereal crops"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587e3e302420191125000002",
                            "question": "Which R / bioconductor package is used for enrichment analysis of genomic regions?"
                        }
                    ],
                    "context": "LOLA: enrichment analysis for genomic region sets and regulatory elements in R and Bioconductor.Locus Overlap Analysis (LOLA) provides easy and automatable enrichment analysis for genomic region sets, thus facilitating the interpretation of functional genomics and epigenomics data.Locus Overlap Analysis (LOLA) provides easy and automatable enrichment analysis for genomic region sets, thus facilitating the interpretation of functional genomics and epigenomics data.R package available in Bioconductor and on the following website: http://lola.computational-epigenetics.org.nsheffield@cemm.oeaw.ac.at or cbock@cemm.oeaw.ac.at.<CopyrightInformation>\u00a9 The Author 2015LOLA: enrichment analysis for genomic region sets and regulatory elements in R and BioconductorLocus Overlap Analysis (LOLA) provides easy and automatable enrichment analysis for genomic region sets, thus facilitating the interpretation of functional genomics and epigenomics data.R package available in Bioconductor and on the following website: http://lola.computational-epigenetics.org.nsheffield@cemm.oeaw.ac.at or cbock@cemm.oeaw.ac.at.<CopyrightInformation>\u00a9 The Author 2015."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58e9e7aa3e8b6dc87c00000d",
                            "question": "Which is the major RNA editing enzyme in Drosophila melanogaster?"
                        }
                    ],
                    "context": "Adenosine deaminases that act on RNA [adenosine deaminase, RNA specific (ADAR)] catalyze the site-specific conversion of adenosine to inosine in primary mRNA transcripts.TIRs were deduced to form dsRNAs as a putative target of ADAR. The ADAR RNA editing enzyme controls neuronal excitability in Drosophila melanogaster.Genetic Determinants of RNA Editing Levels of ADAR Targets in Drosophila melanogaster.RNA editing usually affects only a fraction of expressed transcripts and there is a vast amount of variation in editing levels of ADAR (adenosine deaminase, RNA-specific) targets."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58da1aa08acda34529000012",
                            "question": "Which protein is associated with hyperemesis gravidarum during pregrancy?"
                        }
                    ],
                    "context": "Maternal smoking, BMI, parity, ethnicity, fetal gender, placental weight and hyperemesis gravidarum symptoms were associated with total hCG. First trimester maternal serum PAPP-A and free \u03b2-HCG levels in hyperemesis gravidarum.HG is associated with elevated levels of PAPP-A and free \u03b2-hCG, and such changes are independent of serum indicators of thyroid and liver function.hCG promotes progesterone production by corpus luteal cells; promotes angiogenesis in uterine vasculature; promoted the fusion of cytotrophoblast cell and differentiation to make syncytiotrophoblast cells; causes the blockage of any immune or macrophage action by mother on foreign invading placental cells; causes uterine growth parallel to fetal growth; suppresses any myometrial contractions during the course of pregnancy; causes growth and differentiation of the umbilical cord; signals the endometrium about forthcoming implantation; acts on receptor in mother's brain causing hyperemesis gravidarum, and seemingly promotes growth of fetal organs during pregnancy. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58e3d9ab3e8b6dc87c000002",
                            "question": "Angelman syndrome is associated with deletion of a part of Chromosome 15 but if the deletion occurs in the paternally inherited chromosome 15, what is the disease?"
                        }
                    ],
                    "context": " Prader-Willi syndrome (PWS) results from a deletion of the paternal genes in the region of chromosome 15q11-q13.In AS, the deletion occurs in the maternally inherited chromosome 15, while in PWS the deletion is found in the paternally inherited chromosome 15.In AS, the deletion occurs in the maternally inherited chromosome 15, while in PWS the deletion is found in the paternally inherited chromosome 15In AS, the deletion occurs in the maternally inherited chromosome 15, while in PWS the deletion is found in the paternally inherited chromosome 15.However, deletions in AS occur on the maternally inherited chromosome 15, and deletions in PWS occur on the paternally derived chromosome 15."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58ea7248eda5a57672000002",
                            "question": "What is the phenotype of people carrying mutations in the gene PRDM12?"
                        }
                    ],
                    "context": "The evolutionarily conserved transcription factor PRDM12 controls sensory neuron development and pain perception.Here we show that PRDM12 is a key regulator of sensory neuronal specification in Xenopus. Modeling of human PRDM12 mutations that cause hereditary sensory and autonomic neuropathy (HSAN) revealed remarkable conservation of the mutated residues in evolution.Transcriptional regulator PRDM12 is essential for human pain perception. New therapeutic options have recently been derived from studies of individuals with congenital insensitivity to pain (CIP). Here we identified 10 different homozygous mutations in PRDM12 (encoding PRDI-BF1 and RIZ homology domain-containing protein 12) in subjects with CIP from 11 families. Prdm proteins are a family of epigenetic regulators that control neural specification and neurogenesis.  However, the study of genetic disorders rendering individuals completely unable to feel pain offers hope. All causes of congenital painlessness affect nociceptors, evolutionarily conserved specialist neurons able to sense all type of tissue damage. The discovery of new genes essential for sensing pain (SCN11A, PRDM12, and CLTCL1) has provided unexpected insights into the biological mechanisms that drive distinct stages of nociception."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58eb4ce7eda5a57672000004",
                            "question": "Which cellular function is associated with transcription factors forkhead 1 and 2 (Fkh1 and Fkh2)?"
                        }
                    ],
                    "context": "Forkhead transcription factors establish origin timing and long-range clustering in S. cerevisiae.Here we show that the yeast Forkhead transcription factors, Fkh1 and Fkh2, are global determinants of replication origin timing.Instead, we show that Fkh1 and Fkh2 are required for the clustering of early origins and their association with the key initiation factor Cdc45 in G1 phase, suggesting that Fkh1 and Fkh2 selectively recruit origins to emergent replication factories. Fkh1 and Fkh2 bind Fkh-activated origins, and interact physically with ORC, providing a plausible mechanism to cluster origins.Forkhead box O (FOXO) transcription factors have a conserved function in regulating metazoan lifespan. A key function in this process involves the regulation of the cell cycle and stress responses including free radical scavenging.We report that the deletion of both FKH genes impedes normal lifespan and stress resistance, particularly in stationary phase cells, which are non-responsive to caloric restriction. Conversely, increased expression of the FKHs leads to extended lifespan and improved stress response."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58f3c4b970f9fc6f0f00000a",
                            "question": "What type of genome, (RNA or DNA, double stranded single stranded) is found in the the virus that causes blue tongue disease?"
                        }
                    ],
                    "context": "Bluetongue virus (BTV) genome contains ten double-stranded RNA segments"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58efa1b870f9fc6f0f000003",
                            "question": "What is a \"chemobrain\"?"
                        }
                    ],
                    "context": "Frequency of chemotherapy-related cognitive impairment or \"chemobrain\" is mentioned to be significant in literature, although very little is known about the chemotherapy-caused chemobrain and its connection with metal homeostasis alteration.Cognitive decline or dementia is a debilitating problem of neurological disorders such as Alzheimer's and Parkinson's disease, including special conditions like chemobrain. Most cancer patients treated with systemic adjuvant chemotherapy endure long-lasting side effects including decrease in concentration, forgetfulness and slower thinking, which are globally termed \"chemobrain.\" The frequent use of chemotherapy to combat a range of malignancies can elicit severe cognitive dysfunction often referred to as \"chemobrain,\" a condition that can persist long after the cessation of treatment in as many as 75% of survivors.The term \"chemobrain\" is sometimes used to denote deficits in neuropsychological functioning that may occur as a result of cancer treatment. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5890fde5621ea6ff7e000009",
                            "question": "Borden classification is used for which disease?"
                        }
                    ],
                    "context": "The locations of DAVFs were the transverse-sigmoid sinus in 11, tentorium in 10, cranial vault in 9, and superior sagittal sinus, jugular bulb, foramen magnum, and middle cranial fossa in 1 each. Borden classification was type I in 7, type II in 3, and type III in 24.Transarterial glue embolization is highly effective for Borden type III DAVF with direct cortical venous drainage, but has limitations for Borden type I and II DAVFs in which the affected sinus is part of the normal venous circulation.The results of subtype (Borden and Cognard classification), venous reflux and fistula sites were also accurately exhibited in 4D-CTA.The commonly used Borden and Cognard classification systems for the prediction of clinical behavior of cranial dural arteriovenous shunts focus on the venous drainage, particularly the presence of leptomeningeal venous drainage, and on the direction of flow, particularly the presence of retrograde flow. The CS DAVFs and the NCS DAVFs were categorized using the Barrow and Borden classification systems, respectively. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58c27b7102b8c60953000021",
                            "question": "Which effects create neighborhoods of transcriptional regulation in eukaryotes?"
                        }
                    ],
                    "context": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across EukaryotesHere, we present cross-organismic evidence suggesting that most EP pairs are compatible, largely determined by physical proximity rather than specific interactions.we find that the transcription of gene neighbors is correlated over distances that scale with genome size.  We propose that enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene regulation.This is especially true in mammalian systems, where regulation often occurs through long-range enhancers in gene-rich neighborhoods, rather than proximal promoters, preventing straightforward assignment of a binding site to a target gene.We present EMBER (Expectation Maximization of Binding and Expression pRofiles), a method that integrates high-throughput binding data (e.g. ChIP-chip or ChIP-seq) with gene expression data (e.g. DNA microarray) via an unsupervised machine learning algorithm for inferring the gene targets of sets of TF binding sites"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58f0b0c070f9fc6f0f000006",
                            "question": "What is the indication for valbenazine?"
                        }
                    ],
                    "context": "VMAT2 inhibitors (e.g. deutetrabenazine and valbenazine) have been studied in the treatment of HD-related chorea, tardive dyskinesia and tics associated with Tourette syndrome.Valbenazine granted breakthrough drug status for treating tardive dyskinesia.The FDA lowered approval hurdles for valbenazine due to a successful Phase II trial, which showed a distinctive improvement in tardive dyskinesia symptoms during valbenazine administration. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58f4b9d470f9fc6f0f000016",
                            "question": "What organism causes tularemia?"
                        }
                    ],
                    "context": "Francisella tularensis, the agent of tularemia, is a Gram-negative coccobacillus primarily pathogen for animals and occasionally for humans. F. tularensis is the causative agent of zoonotic tularemiaTularemia is a zoonosis caused by Francisella tularensis that can be transmitted by several ways to human being and cause different clinical manifestationsTularemia is a bacterial zoonotic disease that is caused by Francisella tularensis and among the infectious reasons that cause fever of unknown origin (FUO) in childrenThe bacterium Francisella tularensis causes the vector-borne zoonotic disease tularemia, and may infect a wide range of hosts including invertebrates, mammals and birds"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5895f18ce370baff39000001",
                            "question": "Which method is used for prediction of novel microRNA genes in cancer-associated genomic regions?"
                        }
                    ],
                    "context": " In this work we present a new computational tool (SSCprofiler) utilizing a probabilistic method based on Profile Hidden Markov Models to predict novel miRNA precursors. Via the simultaneous integration of biological features such as sequence, structure and conservation, SSCprofiler achieves a performance accuracy of 88.95% sensitivity and 84.16% specificity on a large set of human miRNA genes. The trained classifier is used to identify novel miRNA gene candidates located within cancer-associated genomic regions and rank the resulting predictions using expression information from a full genome tiling array. Finally, four of the top scoring predictions are verified experimentally using northern blot analysis. Our work combines both analytical and experimental techniques to show that SSCprofiler is a highly accurate tool which can be used to identify novel miRNA gene candidates in the human genome. SSCprofiler is freely available as a web service at http://www.imbb.forth.gr/SSCprofiler.html.In this work we present a new computational tool (SSCprofiler) utilizing a probabilistic method based on Profile Hidden Markov Models to predict novel miRNA precursors.Our work combines both analytical and experimental techniques to show that SSCprofiler is a highly accurate tool which can be used to identify novel miRNA gene candidates in the human genome."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58f6295a70f9fc6f0f000019",
                            "question": "How many times is CLAST faster than BLAST?"
                        }
                    ],
                    "context": "CLAST was capable of identifying sequence similarities ~80.8 times faster than BLAST and 9.6 times faster than BLATFirst, CLAST was capable of identifying sequence similarities ~80.8 times faster than BLAST and 9.6 times faster than BLAT.First, CLAST was capable of identifying sequence similarities ~80.8 times faster than BLAST and 9.6 times faster than BLATFirst, CLAST was capable of identifying sequence similarities ~80.8 times faster than BLAST and 9.6 times faster than BLAT.First, CLAST was capable of identifying sequence similarities ~80.8 times faster than BLAST and 9.6 times faster than BLAT."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58ee0dd5eda5a57672000013",
                            "question": "From which cell type is leptin secreted?"
                        }
                    ],
                    "context": " Although leptin is produced mainly by white adipose tissue, several laboratories have shown low levels of leptin production by a growing number of tissues including the anterior pituitary gland.Lipolysis (stimulated by beta-adrenergic agents) and leptin secretion by adipocytes are down-regulated by neurons in coculture, effects apparently mediated by neuropeptide Y (NPY)Leptin is mainly produced and secreted by adipocytes, but other tissues and gastric glands have also recently been shown to produce it in a dual (endocrine and exocrine) mode.Leptin was also detected in some microglobules in whole saliva obtained from four healthy volunteers. Co-localization for leptin, leptin receptor and glucocorticoid receptor in the same cell type suggested a functional relationship between glucocorticoid hormone and leptin secretion also at the level of the salivary glands.Leptin, a circulating hormone secreted mainly from adipose tissues, possesses protective effects on many cell types."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "589635dd78275d0c4a000009",
                            "question": "Which tool is used for the identification of recurrent variants in noncoding regions?"
                        }
                    ],
                    "context": "LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.In cancer research, background models for mutation rates have been extensively calibrated in coding regions, leading to the identification of many driver genes, recurrently mutated more than expected. Noncoding regions are also associated with disease; however, background models for them have not been investigated in as much detail. This is partially due to limited noncoding functional annotation. Also, great mutation heterogeneity and potential correlations between neighboring sites give rise to substantial overdispersion in mutation count, resulting in problematic background rate estimation. Here, we address these issues with a new computational framework called LARVA. It integrates variants with a comprehensive set of noncoding functional elements, modeling the mutation counts of the elements with a \u03b2-binomial distribution to handle overdispersion. LARVA, moreover, uses regional genomic features such as replication timing to better estimate local mutation rates and mutational hotspots. We demonstrate LARVA's effectiveness on 760 whole-genome tumor sequences, showing that it identifies well-known noncoding drivers, such as mutations in the TERT promoter. Furthermore, LARVA highlights several novel highly mutated regulatory sites that could potentially be noncoding drivers. We make LARVA available as a software tool and release our highly mutated annotations as an online resource (larva.gersteinlab.org).LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotationsLARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5896271178275d0c4a000004",
                            "question": "Which disease is treated with lucinactant?"
                        }
                    ],
                    "context": "Lucinactant for the prevention of respiratory distress syndrome in premature infants.Lucinactant is a synthetic surfactant containing sinapultide, a bioengineered peptide mimic of surfactant-associated protein B. A meta-analysis of clinical trials demonstrates that lucinactant is as effective as animal-derived surfactants in preventing RDS in premature neonates, and in vitro studies suggest it is more resistant to oxidative and protein-induced inactivation. Its synthetic origin confers lower infection and inflammation risks as well other potential benefits, which may make lucinactant an advantageous alternative to its animal-derived counterparts, which are presently the standard treatment for RDS.We evaluated whether intratracheal lucinactant, a synthetic, peptide-containing surfactant, was safe and well-tolerated in infants with acute hypoxemic respiratory failure, and assessed its effects on clinical outcomes.An improvement in oxygenation and a significantly reduced requirement for retreatment suggests that lucinactant might improve lung function in infants with acute hypoxemic respiratory failure.CONCLUSION: These data suggest that early intervention with lucinactant may more effectively mitigate pulmonary pathophysiological sequelae of RDS than the animal-derived surfactants poractant alfa or beractant."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "589630f378275d0c4a000007",
                            "question": "Which enzyme is inhibited by ixazomib?"
                        }
                    ],
                    "context": "Over the past decade, MM therapy is significantly improved by the introduction of novel therapeutics such as immunomodulatory agents (thalidomide, lenalidomide, and pomalidomide), proteasome inhibitors (bortezomib, carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase (HDAC) inhibitors (Panobinostat).Due to the largely incurable nature of multiple myeloma, the development of newer agents is ongoing and includes new oral PIs (ixazomib), immunotherapies (e.g., CD38- or SLAMF7-targeted antibodies), and small molecules. Ixazomib (MLN9708-MLN2238), the second-generation proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently being investigated in phase I studies.In the last few weeks, the FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and SLAMF7, respectively.Ixazomib, the first oral proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly in combination with immunomodulatory drugs and it may be an attractive option for maintenance therapy. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58f4b25e70f9fc6f0f000011",
                            "question": "Hy's law measures failure for what organ?"
                        }
                    ],
                    "context": " Hy's Law of drug-induced hepatocellular jaundice causing a case-fatality rate or need for transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury Network. Enzyme elevations alone may not be harmful, but if caused by a drug and followed by jaundice (called 'Hy's law') there is a high possibility of serious DILI.No additional alleles outside those associated with liver injury patterns were found to affect potential severity as measured by Hy's Law criteria.We compared its performance with that of Hy's Law, which predicts severity of DILI based on levels of alanine aminotransferase or aspartate aminotransferase and total bilirubin, and validated the model in a separate sample.We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver aminotransferase levels above the upper limit of normal, and no pre-existing liver disease.Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "587e2300fc7e8dd84f000004",
                            "question": "Which R package could be used for the identification of pediatric brain tumors?"
                        }
                    ],
                    "context": "MethPed: an R package for the identification of pediatric brain tumor subtypesWe have therefore developed the MethPed classifier, which is a multiclass random forest algorithm, based on DNA methylation profiles from many subgroups of pediatric brain tumorsThe MethPed R package efficiently classifies pediatric brain tumors using the developed MethPed classifier. MethPed is available via Bioconductor: http://bioconductor.org/packages/MethPed/DNA methylation profiling of pediatric brain tumors offers a new way of diagnosing and subgrouping these tumors which improves current clinical diagnostics based on histopathology. We have therefore developed the MethPed classifier, which is a multiclass random forest algorithm, based on DNA methylation profiles from many subgroups of pediatric brain tumorse developed an R package that implements the MethPed classifier, making it easily available and accessible. The package can be used for estimating the probability that an unknown sample belongs to each of nine pediatric brain tumor diagnoses/subgroups"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7d51dafaa1ab7d2e000017",
                            "question": "What is the administration route of IVIG in Alzheimer's disease patients?"
                        }
                    ],
                    "context": "ntravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease.Intravenous immunoglobulin (IVIG) has shown limited promise so far in human clinical studies on Alzheimer's disease (AD), yet overwhelmingly positive preclinical work in animals and human brain cultures support the notion that the therapy remains potentially efficacious."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a43a139966455904c000008",
                            "question": "What is measured through the NOMe-Seq methodology?"
                        }
                    ],
                    "context": "Using Nucleosome Occupancy Methylome- Sequencing, NOMe-Seq, a single-molecule, high-resolution nucleosome positioning assay, we demonstrate that active, but not inactive, non-CpG island promoters display a nucleosome-depleted region (NDR) immediately upstream of the transcription start site (TSS). Using Nucleosome Occupancy Methylome- Sequencing, NOMe-Seq, a single-molecule, high-resolution nucleosome positioning assay, we demonstrate that active, but not inactive, non-CpG island promoters display a nucleosome-depleted region (NDR) immediately upstream of the transcription start site (TSS)According to our genome-wide expression and DNA methylation profiles, we find that the complete re-activation of silenced genes requires the insertion of the histone variant H2A.Z, which facilitates the acquisition of regions fully depleted of nucleosome as demonstrated by NOMe-seq (Nucleosome Occupancy Methylome-sequencing) assay.We have developed a method (NOMe-seq) that uses a GpC methyltransferase (M.CviPI) and next generation sequencing to generate a high resolution footprint of nucleosome positioning genome-wide using less than 1 million cells while retaining endogenous DNA methylation information from the same DNA strand.Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6e3299b750ff4455000040",
                            "question": "What is the main focus of the CVE R/Bioconductor package?"
                        }
                    ],
                    "context": "CVE: an R package for interactive variant prioritisation in precision oncology.Leveraging Oncotator and the Drug Gene Interaction Database, CVE offers exploration of variants within single or multiple tumour exomes to identify drivers, resistance mechanisms and to assess druggability.The CVE package allows interactive variant prioritisation to expedite the analysis of cancer sequencing studies."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "58edf567eda5a57672000011",
                            "question": "How many genes constitute the DosR regulon, controlled by the dormancy survival regulator (DosR) in Mycobacterium tuberculosis?"
                        }
                    ],
                    "context": "During this phase, at least 48 genes, collectively named Dormancy survival regulator (DosR) regulon, are important for the long-term survival of bacilli under a non-respiring state, a condition that bacilli encounter inside granulomatous lesions.The dormancy survival regulator (DosR) regulon, composed of 48 co-regulated genes, is held as essential for Mtb persistence. DosR/DevR of M. tuberculosis is a two component dormancy survival response regulator which induces the expression of 48 genes. The functional importance of tandem arrangement was established by analyzing promoter variants harboring Dev boxes with altered spacing. Conserved sequence logos were generated from 47 binding sequences which included 24 newly discovered Dev boxes. The two component sensor/regulator dosRS is a major mediator in the transcriptional response of M. tuberculosis to hypoxia and controls a regulon of approximately 50 genes that are induced under this condition."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6a3335b750ff4455000025",
                            "question": "Which algorithm is available for computing minimal absent words using external memory?"
                        }
                    ],
                    "context": "emMAW: computing minimal absent words in external memory.We present emMAW, the first external-memory algorithm for computing minimal absent words. A free open-source implementation of our algorithm is made available. This allows for computation of minimal absent words on far bigger data sets than was previously possible. Our implementation requires less than 3\u2009h on a standard workstation to process the full human genome when as little as 1\u2009GB of RAM is made available. We present emMAW, the first external-memory algorithm for computing minimal absent words.We present emMAW, the first external-memory algorithm for computing minimal absent words.Results We present emMAW, the first external-memory algorithm for computing minimal absent words."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a67b2f7b750ff445500000f",
                            "question": "Which type of urinary incontinence is diagnosed with the Q tip test?"
                        }
                    ],
                    "context": "STUDY DESIGN: 141 women who agreed to undergo midurethral sling operations due to stress urinary incontinence with hypermobile urethra were enrolled in this non-randomized prospective observational study. Preoperatively, urethral mobility was measured by Q tip test.Valsalva leak point pressure-associated Q-tip angle and simple female stress urinary incontinence symptoms.PURPOSE: To clarify the association between clinically defined simple stress urinary incontinence (SUI) symptoms and urodynamic SUI, we examined the relationship between Valsalva leak point pressure (VLPP) as measured by the Q-tip test and Stamey grade in simple female SUI.METHODS: Two hundred grade I or II female SUI patients with SUI symptom were examined by reviewing medical history; physical examination; urethral mobility as assessed by Q-tip test; stress test; and cystometry, including VLPP measurement. CONCLUSIONS: In simple female SUI, VLPP is associated with the Q-tip angle and Stamey grade, which may help to reduce some of urodynamic items.Each woman at 12 and 24 months underwent postoperative evaluation by means of urodynamics, Q-tip test, CST, transperineal ultrasonography, and administration of \"King's Health Questionnaire\" (KHQ)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "593ff22b70f9fc6f0f000023",
                            "question": "How many Groucho-related genes (GRG) are contained in the mouse genome?"
                        }
                    ],
                    "context": " We describe here the genomic organization of the mouse Grg gene. It spans approximately 7 kb on chromosome 10 and consists of seven exons.The Grg gene encodes a 197 amino acid protein homologous to the amino-terminal domain of the product of the groucho gene of the Drosophila Enhancer of split complexThe mouse Grg gene encodes a 197 amino acid nuclear protein homologous to the amino-terminal domain of the product of the groucho (gro) gene of the Drosophila Enhancer of split complex. The groucho-related genes (Grg) of the mouse comprise at least four family members.The murine grg (Groucho-related gene) products are believed to interact with transcription factors and repress transcription, thereby regulating cell proliferation and differentiation."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "590af75d70f9fc6f0f00001c",
                            "question": "Which algorithm is used by the UCSC Genome Browser?"
                        }
                    ],
                    "context": "The UCSC Genome Browser organizes data and annotations (called tracks) around the reference sequences or draft assemblies of many eukaryotic genomes and presents them using a powerful web-based graphical interface.The database is optimized to support fast interactive performance with the web-based UCSC Genome Browser, a tool built on top of the database for rapid visualization and querying of the data at many levels. The annotations for a given genome are displayed in the browser as a series of tracks aligned with the genomic sequence. Sequence data and annotations may also be viewed in a text-based tabular format or downloaded as tab-delimited flat files.The University of California Santa Cruz (UCSC) Genome Browser (genome.ucsc.edu) is a popular Web-based tool for quickly displaying a requested portion of a genome at any scale, accompanied by a series of aligned annotation \"tracks\".  The database tables underlying the Genome Browser tracks can be viewed, downloaded, and manipulated using another Web-based application, the UCSC Table Browser.The University of California Santa Cruz (UCSC) Genome Browser is a popular Web-based tool for quickly displaying a requested portion of a genome at any scale, accompanied by a series of aligned annotation \"tracks."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a8941c5bc7bade53a000002",
                            "question": "Which aminoacid position in the human CREB protein is phosphorylated?"
                        }
                    ],
                    "context": " pCREB(Ser133) as a model systemCREB and its activated form pCREB-Ser(133) (pCREB) "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "590c74d170f9fc6f0f00001e",
                            "question": "Which gene is the paralog of yeast UPC2?"
                        }
                    ],
                    "context": "Here, we examine the role of the related transcription factors Ecm22 and Upc2 in Saccharomyces cerevisiae filamentation.The zinc cluster proteins Upc2 and Ecm22 promote filamentation in Saccharomyces cerevisiae by sterol biosynthesis-dependent and -independent pathways.Upc2, a zinc-cluster transcription factor, is a regulator of ergosterol biosynthesis in yeast.The zinc cluster proteins Ecm22, Upc2, Sut1 and Sut2 have initially been identified as regulators of sterol import in the budding yeast Saccharomyces cerevisiae.Yeast studies defined a 7-bp consensus sterol-response element (SRE) common to genes involved in sterol biosynthesis and two transcription factors, Upc2 and Ecm22, which direct transcription of sterol biosynthetic genes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a89800efcd1d6a10c00000c",
                            "question": "Where is the enzyme PM20D1 localized?"
                        }
                    ],
                    "context": "we identify a secreted enzyme, peptidase M20 domain containing 1 (PM20D1), that is enriched in UCP1(+) versus UCP1(-) adipocytes A secreted enzyme, PM20D1, enriched in UCP1+ adipocytes, exhibits catalytic and hydrolytic activity to reversibly form N-acyl amino acids."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a3e8683966455904c000007",
                            "question": "Which test is used to diagnose colour synesthesia?"
                        }
                    ],
                    "context": "To remedy this deficit we have devised the Synesthesia Battery. This unified collection of tests is freely accessible online (http://www.synesthete.org). It consists of a questionnaire and several online software programs, and test results are immediately available for use by synesthetes and invited researchers. A standardized test battery for the study of synesthesia.The application and results of consistency, psychophysical, and Stroop tests are presented later.This study aims to find the most reliable way of diagnosing grapheme-colour synaesthesia based on maximising sensitivity (i.e., ability of a test to identify true synaesthetes) and specificity (i.e., ability of a test to identify true non-synaesthetes).Assessment of the hemispheric lateralization of grapheme-color synesthesia with Stroop-type tests"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7617b183b0d9ea66000022",
                            "question": "What is inhibited by a drug rilotumumab?"
                        }
                    ],
                    "context": "The hepatocyte growth factor receptor (MET) was targeted in untreated patients in a phase III trial with MoAb rilotumumab, with or without CT, but the study was stopped because of mortality excess in the rilotumumab arm. AIMS: Rilotumumab is a fully human monoclonal antibody investigated for the treatment of MET-positive gastric cancer. The hepatocyte growth factor (HGF) binding antibody rilotumumab (AMG102) was modified for use as a89Zr-based immuno-PET imaging agent to noninvasively determine the local levels of HGF protein in tumors. Furthermore, negative study data have been published for rilotumumab and ficlatuzumab, both of which block hepatocyte growth factor binding to the mesenchymal-epithelial transition (MET) receptor. In this phase 1/2 trial, rilotumumab (an anti-HGF antibody) combined with erlotinib was evaluated in patients with metastatic, previously treated non-small cell lung cancer."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a4df811966455904c00000e",
                            "question": "Which RNA polymerase II subunit carries RNA cleavage activity?"
                        }
                    ],
                    "context": "In contrast, Pol II is fully protected through association with the cleavage stimulatory factor TFIIS, which enables rapid recovery from any depth by RNA cleavage.This mechanism is also used by transcription factor IIS, a factor that can bind Pol II and induce strong RNA cleavage.  This mutant enzyme can respond to SII for transcriptional read-through and carry out SII-activated nascent RNA cleavage. In vitro, in the absence of TFIIS, the purified wt polymerase and the two mutant polymerases showed similar specific activity in polymerization, readthrough at intrinsic transcriptional arrest sites and nascent RNA cleavage. In contrast to the wt polymerase, both mutant polymerases were not stimulated by the addition of a 3-fold molar excess of TFIIS in assays of promoter-independent transcription, readthrough or cleavage.In vitro characterization of mutant yeast RNA polymerase II with reduced binding for elongation factor TFIIS."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a87e95461bb38fb2400000c",
                            "question": "Which is the transcriptome of RNA polymerase III?"
                        }
                    ],
                    "context": "RNA polymerase III (Pol III) transcribes a limited set of short genes in eukaryotes producing abundant small RNAs, mostly tRNA. The originally defined yeast Pol III transcriptome appears to be expanding owing to the application of new methods. The role of RNA polymerase (Pol) III in eukaryotic transcription is commonly thought of as being restricted to a small set of highly expressed, housekeeping non-protein-coding (nc)RNA genes. Newly identified Pol III transcripts include small nucleolar RNAs, microRNAs, short interspersed nuclear element-encoded or tRNA-derived RNAs and novel classes of ncRNA that can display significant sequence complementarity to protein-coding genes and might thus regulate their expression. RNA polymerase III (Pol III) transcribes small untranslated RNAs, such as tRNAs. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "593fe5c270f9fc6f0f000021",
                            "question": "How many PML isoforms exist in the human genome?"
                        }
                    ],
                    "context": "The PML isoforms that are most sensitive to virus infection correspond closely to those which have recently been identified as being covalently conjugated to PIC1.Using a panel of different PML isoforms, we demonstrate specific co-localization between the E6 proteins and PML isoforms I-IV, but not with PML isoforms V and VI. PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. We report that individual expression of PML isoforms I and II partially reverses the increase in ICP0-null mutant HSV-1 plaque formation that occurs in PML-depleted cells.PML, the organizer of nuclear bodies (NBs), is expressed in several isoforms designated PMLI to VII which differ in their C-terminal region due to alternative splicing of a single gene."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7d6287faa1ab7d2e00001c",
                            "question": "Which receptor does GDF15 bind?"
                        }
                    ],
                    "context": "GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.Here we show that GDF15 binds specifically to GDNF family receptor \u03b1-like (GFRAL) with high affinity, and that GFRAL requires association with the coreceptor RET to elicit intracellular signaling in response to GDF15 stimulation. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "593fe7f970f9fc6f0f000022",
                            "question": "How many of the human PML isoforms are cytosolic?"
                        }
                    ],
                    "context": "Using a system in which only a single EYFP-linked PML isoform is expressed, we demonstrate that PMLI, PMLII and PMLVI accumulate in the cytoplasm following arsenic treatment, whereas PMLIII, PMLIV and PMLV do notThe PML isoforms that are most sensitive to virus infection correspond closely to those which have recently been identified as being covalently conjugated to PIC1. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7d4721faa1ab7d2e000012",
                            "question": "What does davunetide do to microtubules?"
                        }
                    ],
                    "context": "Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).We have recently described the effects of NAP in neurodegenerative disorders, and we now review the beneficial effects of NAP and other microtubule-stabilizing agents on impairments in axonal transport"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a39453d966455904c000006",
                            "question": "Which method for subsampling of NGS reads requires only gene counts?"
                        }
                    ],
                    "context": "Our methods are broadly applicable for polymorphism discovery in moderate to large genomes even at highly diverged loci, and we established by subsampling the Illumina SBS coverage depth required to inform a broad range of functional and evolutionary studies.Interestingly, after subsampling to the same coverage for GSNAP and TopHat, we find that both mappers have similar performance, implying that the advantage of TopHat is mainly an artifact of the lower coverage. By subsampling sequence reads, we found that when using four-fold biological replication, 6 million reads per condition achieved 96% power to detect a two-fold change (or more) at a 5% false discovery rate.We introduce the subSeq R package, which uses a novel efficient approach to perform this subsampling and to calculate informative metrics at each depthsubSeq: determining appropriate sequencing depth through efficient read subsampling."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a4e50b242878bf97d000001",
                            "question": "Which topoisomerase is essential in yeast?"
                        }
                    ],
                    "context": "Yeast DNA topoisomerase II is encoded by a single-copy, essential gene.Disruption of one copy of the gene in a diploid yeast creates a recessive lethal mutation, indicating that the single DNA topoisomerase II gene of yeast has an essential function.The type II topoisomerase may have an essential role in the compaction and/or segregation of chromosomes during the nuclear division but also complement the defect of the type I enzyme whose major function is the maintenance of chromatin organization throughout the cell cycle.Since DNA topoisomerase II (EC 5.99.1.3) is an essential enzyme in yeast, heterologous topoisomerase II gene expression in yeast cells can provide a system for analyzing the structure and function of topoisomerase II genes from other species.Eukaryotic DNA topoisomerase II is an abundant nuclear enzyme that is essential for cell proliferation. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a87d73861bb38fb2400000b",
                            "question": "Which main ribotype of Clostridium difficile is responsible of the recent outbreak?"
                        }
                    ],
                    "context": " From May 2013 to May 2014, an outbreak of C.\u00a0difficile ribotype 027 occurred in a Dutch tertiary care hospital, involving 72 patients. During this period, 70 endemic cases of CDI occurred as well as 78 cases of CDI related to an outbreak of C. difficile ribotype 027The outbreak of the hypervirulent strain belonging to ribotype 027 has increased the incidence and severity of CDI in some countries.An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy. The aim of this study was to determine whether early recurrence risk was higher after infection with ribotype 027 (outbreak strain) compared with infection with endemic strain types of C.\u00a0difficile."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6e2b1bb750ff445500003e",
                            "question": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?"
                        }
                    ],
                    "context": "psygenet2r: a R/Bioconductor package for the analysis of psychiatric disease genes.Psychiatric disorders have a great impact on morbidity and mortality. Genotype-phenotype resources for psychiatric diseases are key to enable the translation of research findings to a better care of patients. PsyGeNET is a knowledge resource on psychiatric diseases and their genes, developed by text mining and curated by domain experts.Results: We present psygenet2r, an R package that contains a variety of functions for leveraging PsyGeNET database and facilitating its analysis and interpretation. The package offers different types of queries to the database along with variety of analysis and visualization tools, including the study of the anatomical structures in which the genes are expressed and gaining insight of gene's molecular function. Psygenet2r is especially suited for network medicine analysis of psychiatric disorders.The package is implemented in R and is available under MIT license from Bioconductor ( http://bioconductor.org/packages/release/bioc/html/psygenet2r.html ).Psygenet2r is especially suited for network medicine analysis of psychiatric disorders.Psygenet2r is especially suited for network medicine analysis of psychiatric disorders."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7610af83b0d9ea6600001a",
                            "question": "Which Janus kinase does decernotinib target?"
                        }
                    ],
                    "context": "The aim of this study was to evaluate the potency and selectivity of the investigational JAK3 inhibitor VX-509 (decernotinib) [(R)-2-((2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2-methyl-N-(2,2,2-trifluoroethyl)butanamide]against JAK3 kinase activity and inhibition of JAK3-mediated signaling in vitro and JAK3-dependent physiologic processes in vivo.These results demonstrate that VX-509 potently inhibits JAK3 in enzyme assays (Ki = 2.5 nM + 0.7 nM) and cellular assays dependent on JAK3 activity (IC50 range, 50-170 nM), with limited or no measurable potency against other JAK isotypes or non-JAK kinases.These findings demonstrate that VX-509 is a selective and potent inhibitor of JAK3 in vitro and modulates proinflammatory response in models of immune-mediated diseases, such as collagen-induced arthritis and delayed-type hypersensitivity. VX-509 (decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a88370c61bb38fb24000014",
                            "question": "What is the function of the gene MDA5?"
                        }
                    ],
                    "context": "Sensing of viral RNA by the cytosolic receptors RIG-I and melanoma differentiation-associated gene 5 (MDA5) leads to innate antiviral response. The host innate immune response to RNA virus infection primarily involves pathogen-sensing toll-like receptors (TLRs) TLR3 and TLR7 and retinoic acid-inducible gene I-like receptor RIG-I and melanoma differentiation associated gene 5 (MDA5)RNA PRRs are comprised of TLR3, TLR7, TLR8, RIG-I, MDA5, NLRP3, NOD2, and some other minorities.Melanoma differentiation-associated gene 5 (MDA5) is a pattern recognition receptor that recognizes cytoplasmic viral double-stranded RNA (dsRNA) and initiates rapid innate antiviral responses. MDA5 forms a filament-like multimer along the dsRNA leading to oligomerization, which in turn activates the adaptor protein mitochondrial antiviral signaling protein (MAVS) to provide a signal platform for the induction of type I interferon (IFN) and proinflammatory cytokines. The conformational switch of MDA5 causes antiviral defense, but excessive activation of the MDA5-MAVS pathway may result in autoimmune diseases.Retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), including melanoma differentiation-associated gene 5 (MDA5) and RIG-I, are crucial for host recognition of non-self RNAs, especially viral RNA. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a885daa61bb38fb24000018",
                            "question": "Which is the conserved motif of DEAD box proteins?"
                        }
                    ],
                    "context": "DEAD box proteins are putative RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing. These proteins share eight conserved amino acid motifs, including Asp(D)-Glu-(E)-Ala(A)-Asp(D) which is part of a more extended motif. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7237672dc08e987e000008",
                            "question": "Which drug can be reversed with idarucizumab?"
                        }
                    ],
                    "context": "So far only one reversal agent has been approved by the Food and Drug Administration (FDA), idarucizumab for one of the DOACs i.e., dabigatran.  New oral anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists in patients without cancer or renal failure, more so after the development of reversal agents such as idarucizumab and andexanet alfa.BACKGROUND AND OBJECTIVES: Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation. Idarucizumab resulted in immediate, complete and sustained reversal of dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and renally impaired volunteers. Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a74b1730384be9551000007",
                            "question": "Which retinal dystrophy related gene is targeted by the AAV2-hRPE65v2 drug?"
                        }
                    ],
                    "context": "Voretigene neparvovec gene replacement improved functional vision in RPE65-mediated inherited retinal dystrophy previously medically untreatable.In this open-label, randomised, controlled phase 3 trial done at two sites in the USA, individuals aged 3 years or older with, in each eye, best corrected visual acuity of 20/60 or worse, or visual field less than 20 degrees in any meridian, or both, with confirmed genetic diagnosis of biallelic RPE65 mutations, sufficient viable retina, and ability to perform standardised multi-luminance mobility testing (MLMT) within the luminance range evaluated, were eligible. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a774585faa1ab7d2e000005",
                            "question": "What is masitinib an inhibitor of?"
                        }
                    ],
                    "context": "This study evaluated the therapeutic potential of masitinib, an oral tyrosine kinase inhibitor with activity against c-Kit and platelet-derived growth factor receptors (PDGFR), to reduce ischemic brain area and neurological deficit. Masitinib, a selective tyrosine kinase inhibitor, was investigated as a radiosensitizer in three primary feline injection-site sarcoma (ISS) cell lines. Dual actions of masitinib as an inhibitor of mast cell-glia axis and a Fyn kinase blocker are discussed in the context of AD pathology."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a735b383b9d13c708000002",
                            "question": "What is the name of the RNAi investigational drug being developed against hereditary amyloidosis?"
                        }
                    ],
                    "context": "Patisiran is an investigational RNA interference (RNAi) therapeutic in development for the treatment of hereditary ATTR (hATTR) amyloidosis, a progressive disease associated with significant disability, morbidity, and mortality."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7346662dc08e987e00001a",
                            "question": "What causes \"Puffy hand syndrome\"?"
                        }
                    ],
                    "context": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious. There is a syndrome, rarely observed in rheumatology, resulting in \"puffy hands\": the puffy hand syndrome.They presented with an edema of the hands, bilateral, painless, no pitting, occurring in one of our patient during heroin intoxication, and in the other 2 years after stopping injections. In our two patients, additional investigations (biological, radiological, ultrasound) were unremarkable, which helped us, in the context, to put the diagnosis of puffy hand syndrome. Puffy hand syndrome develops after long-term intravenous drug addiction.The authors report an original clinical presentation of factitious disorders of the upper extremity in an ex-drug-addict patient with puffy hand syndrome. Puffy hand syndrome is an unrecognized complication of intravenous drug abuse. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a690487b750ff445500001f",
                            "question": "Which virus can be diagnosed with the monospot test?"
                        }
                    ],
                    "context": "Epstein-Barr virus (EBV) is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection in children but frequently results in infectious mononucleosis in adolescents. Heterophile antibody tests, including the Monospot test, are red cell or latex agglutination assays, which detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV infection. Laboratory investigations revealed that monospot test was positive, EBV serology tests; Anti-EA-D Ig G: 3+, Anti-VCA gp125 Ig G: 3+, Anti-VCA p19 Ig M: 2+, Anti EBNA-1 Ig M: negative, Anti EBNA-1 Ig M: negative, Anti EBNA-1 Ig G: negative.A 75-year-old woman presented with altered mental status, septic picture, and influenza-like symptoms. Initial investigations revealed atypical lymphocytosis, thrombocytopenia, elevated liver enzymes, and a positive monospot test result. Further investigation showed the Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus (CMV) IgM and IgG were positive, suggesting that her mononucleosis-like syndrome was due to acute CMV infection.Monospot test was positive. He subsequently had both a CT pulmonary angiogram and a CT angiogram of the aorta to exclude pulmonary embolism and aortic dissection. The CT revealed splenomegaly with a large subdiaphragmatic haematoma secondary to splenic rupture. This had likely caused referred pain through diaphragmatic irritation. He was taken to theatre for urgent splenectomy. The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection.BACKGROUND: Infection with Epstein-Barr virus (EBV) is almost ubiquitous in humans and generally occurs at two ages: infantile, which is usually asymptomatic and associated with poorer socioeconomic conditions, and adolescent, which causes infectious mononucleosis (IM) in ~25% cases. The determinants of whether the infection causes IM remain uncertain. We aimed to evaluate seasonality and temporal trends in IM.METHODS: Data from all Monospot tests, used as a marker for IM, were collected from the Grampian population over 16 years.RESULTS: Positive Monospot test results peaked at 17 years in females and 19 in males. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7d535ffaa1ab7d2e000018",
                            "question": "What does the human IVIG treatment for Alzheimer's disease contain?"
                        }
                    ],
                    "context": "Human intravenous immunoglobulin (IVIG) is a mixture of polyclonal IgG antibodies isolated and pooled from thousands of healthy human donors."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a68f448b750ff4455000018",
                            "question": "Which bacteria causes erythrasma?"
                        }
                    ],
                    "context": "Erythrasma caused by Corynebacterium minutissimum can be confused with superficial mycoses.Exogenous coproporphyrin III production by Corynebacterium aurimucosum and Microbacterium oxydans in erythrasma lesions.Erythrasma is a superficial skin disease caused by Gram-positive Corynebacterium species.AIM: To study a series of demographic features of patients suffering from pitted keratolysis, and to present a review of the Corynebacterium-associated infections, including pitted keratolysis, erythrasma, and trichobacteriosis.Corynebacterium minutissimum is the bacteria that leads to cutaneous eruptions of erythrasma and is the most common cause of interdigital foot infections. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6e4d22b750ff445500004d",
                            "question": "Mutations in which gene cause Schimke immune-osseous dysplasia?"
                        }
                    ],
                    "context": "SMARCAL1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A-Like 1), also known as HARP, is an ATP-dependent annealing helicase that stabilizes replication forks during DNA damage. Mutations in this gene are the cause of Schimke immune-osseous dysplasia (SIOD), an autosomal recessive disorder characterized by T-cell immunodeficiency and growth dysfunctions.The present report describes, for the first time, a Schimke immuno-osseous dysplasia child with SMARCAL1 missense mutation (R561H) and manifestations of intussusception secondary to Epstein-Barr virus-negative non-Hodgkin lymphoma, who expired due to septicemia following chemotherapy.Mutations in SWI/SNF2 related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 (SMARCAL1) gene are responsible for the disease.Sequence analysis revealed that patient was compound heterozygous for two SMARCAL1 mutations: a novel missense change (p.Arg247Pro) and a well-known nonsense mutation (p.Mutations in SMARCAL1, which encodes a DNA annealing helicase with roles in DNA replication fork restart, DNA repair, and gene expression modulation, cause Schimke immuno-osseous dysplasia (SIOD), an autosomal recessive disease characterized by skeletal dysplasia, renal disease, T-cell immunodeficiency, and arteriosclerosis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7234352dc08e987e000007",
                            "question": "What is the most common histological diagnosis of \"butterfly glioma\"?"
                        }
                    ],
                    "context": "Corpus callosum glioblastoma multiforme (GBM): butterfly glioma.The diagnosis of butterfly glioma (glioblastoma multiforme) was made based on imaging characteristics and was further confirmed by biopsy findings. Using Cox proportional hazards regression, the independent prognostic factors were Karnofsky Performance Status score \u226470, splenium involvement, and butterfly glioblastoma.Canine Butterfly Glioblastomas: A Neuroradiological Review.All tumors demonstrated classical histopathological features of glioblastoma multiforme (GBM), including glial cell pseudopalisading, serpentine necrosis, microvascular proliferation as well as invasion of the corpus callosum by neoplastic astrocytes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6e24a5b750ff445500003c",
                            "question": "Which workflow in Bioconductor has been developed for accessing human RNA-seq samples?"
                        }
                    ],
                    "context": "recount workflow: Accessing over 70,000 human RNA-seq samples with Bioconductor.The recount2 resource is composed of over 70,000 uniformly processed human RNA-seq samples spanning TCGA and SRA, including GTEx.recount workflow accessing over 70 000 human rna seq samples with bioconductorthe recount2 resource is composed of over 70 000 uniformly processed human rna seq samples spanning tcga and sra including gtex the processed data can be accessed via the recount2 website and the bioconductor package this workflow explains in detail how to use the package and how to integrate it with other bioconductor packages for several analyses that can be carried out with the recount2 resource in particular we describe how the coverage count matrices were computed in recount2 as well as different ways of obtaining public metadata which can facilitate downstream analyses step by step directions show how to do a gene level differential expression analysis visualize base level genome coverage data and perform an analyses at multiple feature levels this workflow thus provides further information to understand the data in recount2 and a compendium of r code to use the data."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a888b56d543831129000002",
                            "question": "What induces Arabidopsis ROF1 expression?"
                        }
                    ],
                    "context": "Endogenous ROF1 was shown to accumulate in response to high salt treatment in Arabidopsis thaliana young leaves as well as in seedlings germinated on high salt media (0.15 and 0.2 M NaCl) at both an mRNA and protein level. Arabidopsis ROF1 (AtFKBP62) is a peptidyl prolyl cis/trans isomerase and a member of the FKBP (FK506 binding protein) family. ROF1 expression is induced by heat stress and developmentally regulated.Exposure of plants to low levels of MDA using a recently developed protocol powerfully upregulated many genes on a cDNA microarray with a bias towards those implicated in abiotic/environmental stress (e.g. ROF1 and XERO2).Arabidopsis immunophilins ROF1 (AtFKBP62) and ROF2 (AtFKBP65) exhibit tissue specificity, are heat-stress induced, and bind HSP90.The abundance of ROF1 mRNA increased several-fold under stress conditions such as wounding or exposure to elevated NaCl levels."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a895f51fcd1d6a10c000004",
                            "question": "What is the preferred orientation of CTCF binding sites for chromatin looping?"
                        }
                    ],
                    "context": "Recent reports have suggested that CTCF binding is more dynamic during development than previously appreciatedConversely, CTCF binding sites in NPCs are largely preexisting in pluripotent stem cells. Only a small number of CTCF sites arise de novo in NPCs. Moreover, siRNA knockdown ofYy1specifically disrupts interactions between key NPC enhancers and their target genes. YY1-mediated interactions between NPC regulatory elements are often nested within constitutive loops anchored by CTCFAs recently reported, our data also suggest that chromatin loops preferentially form between CTCF binding sites oriented in a convergent mannerIn all instances, CTCF and cohesin recruitment were lost, and chromatin loops with distal, convergent CTCF sites were disrupted or destabilized."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7d4e9afaa1ab7d2e000013",
                            "question": "How many amino acids does davunetide consist of?"
                        }
                    ],
                    "context": "We have assessed the effects of NAP (davunetide), an eight-amino acid peptide that decreases tau hyperphosphorylation, in mice overexpressing wild-type human \u03b1-synuclein (Thy1-aSyn mice), a model that recapitulates aspects of PD. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6a02a3b750ff4455000021",
                            "question": "What protein is the most common cause of hereditary  renal amyloidosis?"
                        }
                    ],
                    "context": "ibrinogen A alpha chain amyloidosis is an autosomal dominant disease associated with mutations in the fibrinogen A alpha chain (FGA) gene, and it is the most common cause of hereditary renal amyloidosis in the UKHereditary renal amyloidosis is an autosomal dominant condition with considerable overlap with other amyloidosis typeWe suspected amyloidosis with fibrinogen A alpha chain deposits, which is the most frequent cause of hereditary amyloidosis in Europe, with a glomerular preferential affectation.Three members of a family who died with renal amyloidosis were found to share a single nucleotide substitution in the fibrinogen alpha-chain gene. A French kindred with autosomal dominant hereditary renal amyloidosis was found to have a novel mutation in the fibrinogen Aalpha-chain gene."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a742d620384be9551000002",
                            "question": "Which disease risk can be estimated with the Stop-Bang questionnaire?"
                        }
                    ],
                    "context": "STUDY OBJECTIVE: The aim of this study is to evaluate whether adding the item of \"apple body type\" to the STOP-BANG questionnaire enhances diagnostic performance of the questionnaire for detecting obstructive sleep apnea (OSA).CONCLUSION: In the sleep center setting, adding the body type item to the STOP-BANG questionnaire improves not only clinical prediction for PSG confirmed OSA but also predicts moderate to severe of OSA. High and low probability of OSA were defined as a STOP-Bang score of \u22655 (h-OSA) and of<5 (l-OSA), respectively.The STOP-BANG questionnaire improves the detection of epilepsy patients at risk for obstructive sleep apnea.We performed a quality improvement project, evaluating for improvements in the screening of OSA in epilepsy patients using the STOP-BANG questionnaire. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a74a8a70384be9551000005",
                            "question": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?"
                        }
                    ],
                    "context": "The combination of siG12D-LODER\u2122 and chemotherapy is well tolerated, safe and demonstrated a potential efficacy in patients with LAPC.An open-label Phase 1/2a study in the first-line setting of patients with non-operable LAPC was initiated. In this study patients were assigned to receive a single dose of siG12D-LODERs, in three escalating dose cohorts (0.025mg, 0.75mg and 3.0mg). The miniature biodegradable implant siG12D-LODER\u2122 was inserted into a tumor and released a siRNA drug against KRAS(G12D) along four months. This novel siRNA based drug was studied, in combination with chemotherapy, as targeted therapy for Locally Advanced Pancreatic Cancer (LAPC).RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients.The miniature biodegradable implant siG12D-LODER\u2122 was inserted into a tumor and released a siRNA drug against KRAS(G12D) along four months. This novel siRNA based drug was studied, in combination with chemotherapy, as targeted therapy for Locally Advanced Pancreatic Cancer (LAPC)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a67b48cb750ff4455000010",
                            "question": "SGOT is an abbreviation for an enzyme other wise known as alanine amino transferase, yes or no?"
                        }
                    ],
                    "context": "patients with aspartate amino transferase (SGOT), alanine amino transferase (SGPT),Alanine amino transferase (SGPT), aspartate aminotransferase (AST-SGOT), alanine amino-transferase (ALT-SGPT)Mean values of glutamate dehydrogenase (GDH), serum aspartate and alanine transferase (SGOT and SGPT), ornithine carbamoyltransferase (OCT), and gamma-glutamyltranspeptidase (gamma-GTP) tended to rise with increasing liver cell necrosis, though values of SGOT, SGPT, OCT, and gamma-GTP showed considerable overlap between the 32 patients with histologically proved hepatitis and the 68 without.Serum aspartate aminotransferase (SGOT), alanine aminotransferase (SGPT), creatinine phosphokinase (CPK), and butyric acid dehydrogenase (BDH) were determined in 94 patients before, 1(1/2) hours, and 24 hours after cardioversion."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6e3155b750ff445500003f",
                            "question": "Which R/Bioconductor package has been developed for cancer subtype identification?"
                        }
                    ],
                    "context": "CancerSubtypes: an R/Bioconductor package for molecular cancer subtype identification, validation and visualization.Identifying molecular cancer subtypes from multi-omics data is an important step in the personalized medicine. We introduce CancerSubtypes, an R package for identifying cancer subtypes using multi-omics data, including gene expression, miRNA expression and DNA methylation data. CancerSubtypes integrates four main computational methods which are highly cited for cancer subtype identification and provides a standardized framework for data pre-processing, feature selection, and result follow-up analyses, including results computing, biology validation and visualization. The input and output of each step in the framework are packaged in the same data format, making it convenience to compare different methods. The package is useful for inferring cancer subtypes from an input genomic dataset, comparing the predictions from different well-known methods and testing new subtype discovery methods, as shown with different application scenarios in the Supplementary Material.CancerSubtypes integrates four main computational methods which are highly cited for cancer subtype identification and provides a standardized framework for data pre-processing, feature selection, and result follow-up analyses, including results computing, biology validation and visualization.We introduce CancerSubtypes, an R package for identifying cancer subtypes using multi-omics data, including gene expression, miRNA expression and DNA methylation data.We introduce CancerSubtypes, an R package for identifying cancer subtypes using multi-omics data, including gene expression, miRNA expression and DNA methylation data."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6e42f1b750ff4455000046",
                            "question": "What gene is mutated in Familial Mediterranean Fever?"
                        }
                    ],
                    "context": "Familial Mediterranean fever (FMF) is caused by mutations in the MEFV gene and the spectrum of mutations among Greek-Cypriots with FMF-related symptoms was examinedFamilial Mediterranean fever (FMF) is the most common monogenic periodic fever syndrome and characterized by recurrent episodes of fever, serositis, arthritis, dermal manifestations, and long-term renal complications. The MEFV gene was described in 1997 as the gene responsible for FMF and is inherited in autosomal recessive manner.Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease that is inherited in an autosomal recessive manner and is caused by mutations in theMEFVgene MEditerranean FeVer (MEFV) gene encodes for the pyrin protein and a mutated pyrin is associated with a prolonged or augmented inflammation.The causative mutations for familial Mediterranean fever (FMF) are located in the MEFV gene, which encodes pyrin."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6e354fb750ff4455000042",
                            "question": "Which R/bioconductor package has been developed to aid in epigenomic analysis?"
                        }
                    ],
                    "context": "DeepBlueR: large-scale epigenomic analysis in R.deepbluer large scale epigenomic analysis in r"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6f960fb750ff445500005c",
                            "question": "Centor criteria are used for which disease?"
                        }
                    ],
                    "context": "Methods: MEDLINE was searched for prospective studies that reported throat culture for both GAS and non-GAS as a reference standard, and reported at least one sign, symptom, or the Centor score.METHODS: Trained pharmacy staff assessed patients presenting with a sore throat using the Centor scoring system and patients meeting three or all four of the criteria were offered a throat swab test for Streptococcus pyogenes, Lancefield group A streptococci. CONCLUSION: Clinician judgement and Centor score are inadequate tools for clinical decision-making for children presenting with sore throat. A Study to Determine if Addition of Palatal Petechiae to Centor Criteria Adds More Significance to Clinical Diagnosis of Acute Strep Pharyngitis in Children.Objective. A study to determine if addition of palatal petechiae to Centor criteria adds more value for clinical diagnosis of acute strep pharyngitis in children. Hypothesis. In children, Centor Criteria does not cover all the symptoms and signs of acute strep pharyngitis. We hypothesize that addition of palatal petechiae to Centor Criteria will increase the possibility of clinical diagnosis of group A streptococcal pharyngitis in children. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a551a8fb750ff4455000002",
                            "question": "What is a potential side effect for Tymlos?"
                        }
                    ],
                    "context": "Thus, near life-long treatment with abaloparatide in rats resulted in dose and time dependent formation of osteosarcomas, with a comparable response to hPTH(1-34) at similar exposure."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a87f44061bb38fb2400000f",
                            "question": "Which disorder has been approved for treatment with Alk inhibitors?"
                        }
                    ],
                    "context": "Alectinib and crizotinib have been approved for the therapy of NSCLC caused by anaplastic lymphoma kinase gene (ALK) rearrangementAlectinib, an anaplastic lymphoma kinase (ALK) inhibitor, is approved for treatment of patients with ALK+ non-small cell lung cancer who have progressed, on or are intolerant to, crizotinib Ceritinib is a highly selective ALK inhibitor and shows promising efficacy in non-small cell lung cancers (NSCLC) harboring the ALK gene rearrangement. Anaplastic lymphoma kinase (ALK) rearrangement is detected in 3-7% of patients with non-small-cell lung cancer. Crizotinib is an ALK inhibitor, which was approved in 2011 for the treatment of ALK-positive lung cancer. Dramatic and often prolonged responses are seen in patients withALKalterations when treated with ALK inhibitors. Three of these-crizotinib, ceritinib, and alectinib-are now FDA approved for the treatment of metastatic NSCLC positive forALKfusions"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6a3464b750ff4455000026",
                            "question": "Which algorithm has been developed in order to improve multiple circular sequence alignment using refined sequences?"
                        }
                    ],
                    "context": "MARS: improving multiple circular sequence alignment using refined sequences.We present MARS, a new heuristic method for improving Multiple circular sequence Alignment using Refined Sequences. MARS was implemented in the C++ programming language as a program to compute the rotations (cyclic shifts) required to best align a set of input sequences. Experimental results, using real and synthetic data, show that MARS improves the alignments, with respect to standard genetic measures and the inferred maximum-likelihood-based phylogenies, and outperforms state-of-the-art methods both in terms of accuracy and efficiency. Our results show, among others, that the average pairwise distance in the multiple sequence alignment of a dataset of widely-studied mitochondrial DNA sequences is reduced by around 5% when MARS is applied before a multiple sequence alignment is performed.We present MARS, a new heuristic method for improving Multiple circular sequence Alignment using Refined Sequences.Experimental results, using real and synthetic data, show that MARS improves the alignments, with respect to standard genetic measures and the inferred maximum-likelihood-based phylogenies, and outperforms state-of-the-art methods both in terms of accuracy and efficiency.RESULTS We present MARS, a new heuristic method for improving Multiple circular sequence Alignment using Refined Sequences."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6d08d5b750ff445500002c",
                            "question": "Which stapled peptide has been designed to target Ctf4?"
                        }
                    ],
                    "context": "The Ctf4/AND-1 protein hub, which links DNA replication, repair, and chromosome segregation, represents a novel target for the synthetic lethality approach. Herein, we report the design, optimization, and validation of double-click stapled peptides encoding the Ctf4-interacting peptide (CIP) of the replicative helicase subunit Sld5. By screening stapling positions in the Sld5 CIP, we identified an unorthodox i,i+6 stapled peptide with improved, submicromolar binding to Ctf4. The mode of interaction with Ctf4 was confirmed by a crystal structure of the stapled Sld5 peptide bound to Ctf4. The stapled Sld5 peptide was able to displace the Ctf4 partner DNA polymerase\u2005\u03b1 from the replisome in yeast extracts. Our study provides proof-of-principle evidence for the development of small-molecule inhibitors of the human CTF4 orthologue AND-1.Herein, we report the design, optimization, and validation of double-click stapled peptides encoding the Ctf4-interacting peptide (CIP) of the replicative helicase subunit Sld5.The stapled Sld5 peptide was able to displace the Ctf4 partner DNA polymerase\u2005\u03b1 from the replisome in yeast extracts.By screening stapling positions in the Sld5 CIP, we identified an unorthodox i,i+6 stapled peptide with improved, submicromolar binding to Ctf4.The stapled Sld5 peptide was able to displace the Ctf4 partner DNA polymerase\u2005\u03b1 from the replisome in yeast extracts."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a70d42899e2c3af26000002",
                            "question": "Mutation of which gene causes arterial tortuosity syndrome?"
                        }
                    ],
                    "context": "Mutations in SLC2A10, a gene that encodes the facilitative glucose transporter GLUT10, cause ATS.RECENT FINDINGS: Although arterial tortuosity has been primarily described in Loeys-Dietz syndrome due to TGFBR1 and TGFBR2 mutations and in arterial tortuosity syndrome due to SLC210A mutations, recent studies that use quantitative measures of tortuosity suggest that tortuosity is present in many other genetic conditions associated with aortic dilation and dissection.Arterial tortuosity syndrome (ATS) is an autosomal recessive connective tissue disorder caused by loss-of-function mutations in SLC2A10, which encodes facilitative glucose transporter 10 (GLUT10).Arterial Tortuosity Syndrome: homozygosity for two novel and one recurrent SLC2A10 missense mutations in three families with severe cardiopulmonary complications in infancy and a literature review.ATS is caused by mutations in the SLC2A10 gene, which encodes the facilitative glucose transporter 10 (GLUT10). Approximately 100 ATS patients have been described, and 21 causal mutations have been identified in the SLC2A10 gene."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a8b1264fcd1d6a10c00001d",
                            "question": "Fusarium oxysporum f. sp lycopersici. is a plant pathogen in plants producing what common food?"
                        }
                    ],
                    "context": "The Fusarium wilt caused by Fusarium oxysporum strains is the most devastating disease of cucumber, banana, and tomato. Seventy-four Fusarium oxysporum soil isolates were assayed for known effector genes present in an F. oxysporum f. sp. lycopersici race 3 tomato wilt strain (FOL MN-25) obtained from the same fields in Manatee CountyFusarium wilt caused by Fusarium oxysporum f. sp lycopersici (Fol) is one of the main diseases affecting tomatoes. Fusarium wilt is one of the most prevalent and damaging diseases of tomato. Among various toxins secreted by the Fusarium oxysporum f. sp. lycopersici (causal agent of Fusarium wilt of tomato)In vitro antifugal activity of medicinal plant extract against Fusarium oxysporum f. sp. lycopersici race 3 the causal agent of tomato wilt."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a70e4b399e2c3af26000008",
                            "question": "Glecaprevir and Pibrentasvir are used for tratment of which disease?"
                        }
                    ],
                    "context": "Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment.This phase 2, open-label study (MAGELLAN-1) evaluated the efficacy and safety of glecaprevir (GLE) + pibrentasvir (PIB) \u00b1 ribavirin (RBV) in HCV genotype 1-infected patients with prior virologic failure to HCV DAA-containing therapy.CONCLUSION: The combination of GLE and PIB was highly efficacious and well tolerated in patients with HCV genotype 1 infection and prior failure of DAA-containing therapy; RBV coadministration did not improve efficacy.Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis.The efficacy and safety of 8- and 12-week treatments with glecaprevir (ABT-493; NS3/4A protease inhibitor) and pibrentasvir (ABT-530; NS5A inhibitor) were evaluated in non-cirrhotic patients with chronic HCV genotype 1-6 infection."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a777ab9faa1ab7d2e00000a",
                            "question": "What is the drug target(s) for Belsomra?"
                        }
                    ],
                    "context": "Suvorexant (Belsomra\u00ae) is a novel sedative hypnotic drug that is prescribed to promote sleep in patients with insomnia. It is the first of a new class of drugs classified as dual orexin receptor antagonists (DORAs).dual orexin receptor antagonist suvorexant (Belsomra\u00ae) for the treatment of insomnia as a promising sign of the potential clinical utility of orexin-based therapies for the treatment of addictionSuvorexant (Belsomra\u00ae) is a dual orexin receptor antagonist approved for the treatment of insomnia.Suvorexant is a dual orexin receptor agonist and is currently approved for the treatment of insomnia in the United States and JapanSuvorexant (Belsomra(\u00ae)), a first-in-class, orally active dual orexin-1 receptor and orexin-2 receptor antagonist, has been developed by Merck for the treatment of insomnia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a8715a961bb38fb24000006",
                            "question": "Silent Allosteric Modulation of mGluR5 is a form of treatment for what disease?"
                        }
                    ],
                    "context": "silent allosteric modulation of mGluR5 has promise as a disease-modifying AD intervention with a broad therapeutic window.In brain homogenates with A\u03b2o, the interaction of PrP(C) and mGluR5 is reversed by mGluR5-directed antagonists or antibodies directed against the PrP(C) segment of amino acids 91-153. Silent allosteric modulators of mGluR5 do not alter Glu or basal mGluR5 activity, but they disrupt the A\u03b2o-induced interaction of mGluR5 with PrP(C)The assays described here have the potential to identify and develop new compounds that inhibit the interaction of PrP(C) and mGluR5, which plays a pivotal role in the pathogenesis of Alzheimer disease by transmitting the signal from extracellular A\u03b2o into the cytosol.Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.Our data show that mGluR5's role in A\u03b2o-dependent AD phenotypes is separate from its role in glutamate signaling and silent allosteric modulation of mGluR5 has promise as a disease-modifying AD intervention with a broad therapeutic window."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a75f6e083b0d9ea66000009",
                            "question": "Which data simulator is available for CLIP-SEQ experiments?"
                        }
                    ],
                    "context": "CSEQ-SIMULATOR: A DATA SIMULATOR FOR CLIP-SEQ EXPERIMENTS.CLIP-Seq protocols such as PAR-CLIP, HITS-CLIP or iCLIP allow a genome-wide analysis of protein-RNA interactions. For the processing of the resulting short read data, various tools are utilized. Some of these tools were specifically developed for CLIP-Seq data, whereas others were designed for the analysis of RNA-Seq data. To this date, however, it has not been assessed which of the available tools are most appropriate for the analysis of CLIP-Seq data. This is because an experimental gold standard dataset on which methods can be accessed and compared, is still not available. To address this lack of a gold-standard dataset, we here present Cseq-Simulator, a simulator for PAR-CLIP, HITS-CLIP and iCLIP-data. This simulator can be applied to generate realistic datasets that can serve as surrogates for experimental gold standard dataset. In this work, we also show how Cseq-Simulator can be used to perform a comparison of steps of typical CLIP-Seq analysis pipelines, such as the read alignment or the peak calling. These comparisons show which tools are useful in different settings and also allow identifying pitfalls in the data analysis.In this work, we also show how Cseq-Simulator can be used to perform a comparison of steps of typical CLIP-Seq analysis pipelines, such as the read alignment or the peak calling.CSEQ-SIMULATOR: A DATA SIMULATOR FOR CLIP-SEQ EXPERIMENTS."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a72329e2dc08e987e000006",
                            "question": "Falciform ligament sign is characteristic to which disease?"
                        }
                    ],
                    "context": "What determines the periportal free air, and ligamentum teres and falciform ligament signs on CT: can these specific air distributions be valuable predictors of gastroduodenal perforation?PURPOSE: The purpose of this retrospective study was to determine what gives rise to the periportal free air, and ligamentum teres and falciform ligament signs on CT in patients with gastrointestinal (GI) tract perforation, and whether these specific air distributions can play a clinically meaningful role in the diagnosis of gastroduodenal perforation.The readers assessed the presence of specific air distributions on CT (periportal free air, and ligamentum teres and falciform ligament signs).RESULTS: All specific air distributions were more frequently present in patients with gastroduodenal perforation than lower GI tract perforation, but only the falciform ligament sign was statistically significant (p<0.05).Regardless of the perforation sites, the falciform ligament sign was present significantly more frequently with an increase in the amount of free air on multiple logistic regression analysis (adjusted odds ratio, 1.29; p<0.001). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a735cdc3b9d13c708000004",
                            "question": "In November 2017,  in what phase  was  the clinical trial for the drug SYL040012?"
                        }
                    ],
                    "context": "This review addresses nine small-interfering RNAs (siRNAs) and one unique microRNA (miRNA) inhibitor, which entered the phase 2-3 clinical trials. The siRNAs in focus are PF-04523655, TKM-080301, Atu027, SYL040012, SYL1001, siG12D-LODER (phase 2), QPI-1002, QPI-1007, and patisiran (phase 3). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6fa31ab750ff445500005e",
                            "question": "Which method has been developed for assignment of enhancers to target genes?"
                        }
                    ],
                    "context": "McEnhancer: predicting gene expression via semi-supervised assignment of enhancers to target genes.While genomic assays can identify putative enhancers en masse, assigning target genes is a complex challenge. We devised a machine learning approach, McEnhancer, which links target genes to putative enhancers via a semi-supervised learning algorithm that predicts gene expression patterns based on enriched sequence features. Predicted expression patterns were 73-98% accurate, predicted assignments showed strong Hi-C interaction enrichment, enhancer-associated histone modifications were evident, and known functional motifs were recovered. Our model provides a general framework to link globally identified enhancers to targets and contributes to deciphering the regulatory genome.We devised a machine learning approach, McEnhancer, which links target genes to putative enhancers via a semi-supervised learning algorithm that predicts gene expression patterns based on enriched sequence features.McEnhancer: predicting gene expression via semi-supervised assignment of enhancers to target genes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a871a6861bb38fb24000009",
                            "question": "What disease is the ALK tyrosine kinase associated with?"
                        }
                    ],
                    "context": "ALK positive anaplastic large cell lymphoma is a T-cell lymphoma usually occurring in children and young adults. I A 62-year-old Caucasian non-smoking woman was diagnosed with cT4N0M0\u00a0lung adenocarcinoma. Initial biopsy showed EGFR mutation and ALK rearrangementSignificant prognostic factors included the original 4 factors used in the DS-GPA index plus 2 new factors: EGFR and ALK alterations in patients with adenocarcinomainvestigational ALK inhibitor brigatinib is active in patients with ALK-rearranged non-small cell lung cancer.Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase, initially identified through the analysis of a specific translocation associated with a rare subtype of non-Hodgkin's lymphoma."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a67ab79b750ff445500000b",
                            "question": "CURB65 score is used for stratification of which disease?"
                        }
                    ],
                    "context": "Severity assessment tools (e.g. CURB65) that are used to guide early management decisions in CAP have not been widely validated in low-income settings and locally adapted tools are required. Scores for the pneumonia severity index (PSI); CURB65 (confusion, urea, respiration, blood pressure; age>65\u2009years); Infectious Disease Society of America (IDSA) and American Thoracic Society (ATS) guidelines for severe CAP; Acute Physiology, Chronic Health Evaluation (APACHE) II; Sequential Organ Failure Assessment (SOFA); and quick SOFA (qSOFA) were calculated.Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.AIM: (i) evaluate the performance of MR-pro-ADM in reflecting the outcome and risk for CAP patients in the emergency department, and (ii) compare the prognostic performance of MR-pro-ADM with that of clinical scores PSI and CURB65.CONCLUSIONS: The present study confirms that assessment of MR-pro-ADM levels in CAP patients in addition to CURB scores increases the prognostic accuracy of CURB alone and may help rule out discrepancies arising from flawed clinical severity classification. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6d196db750ff4455000032",
                            "question": "Which resource has been developed in order to study the transcriptional regulation of GABAergic cell fate?"
                        }
                    ],
                    "context": "Subpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate.Elucidating the transcriptional circuitry controlling forebrain development requires an understanding of\u00a0enhancer activity and regulation. We generated stable transgenic mouse lines that express CreERT2and GFP from ten different enhancer elements with activity in distinct domains within the embryonic basal ganglia. We used these unique tools to generate a comprehensive regional fate map of the mouse subpallium, including sources for specific subtypes of amygdala neurons. We then focused on deciphering transcriptional mechanisms that control enhancer activity. Using machine-learning computations, in\u00a0vivo chromosomal occupancy of 13 transcription factors that regulate subpallial patterning and differentiation and analysis of enhancer activity in Dlx1/2 and Lhx6 mutants, we elucidated novel molecular mechanisms that regulate region-specific enhancer activity in the developing brain. Thus, these subpallial enhancer transgenic lines are data and tool\u00a0resources to study transcriptional regulation of GABAergic cell fate.Thus, these subpallial enhancer transgenic lines are data and tool\u00a0resources to study transcriptional regulation of GABAergic cell fate.Thus, these subpallial enhancer transgenic lines are data and tool\u00a0resources to study transcriptional regulation of GABAergic cell fate.Subpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6d1733b750ff4455000030",
                            "question": "Which resource contains accurate enhancer predictions in the developing limb?"
                        }
                    ],
                    "context": "Here we present the Limb-Enhancer Genie (LEG), a collection of highly accurate, genome-wide predictions of enhancers in the developing limb, available through a user-friendly online interface. We predict limb enhancers using a combination of>50 published limb-specific datasets and clusters of evolutionarily conserved transcription factor binding sites, taking advantage of the patterns observed at previously in vivo validated elements.Limb-Enhancer Genie: An accessible resource of accurate enhancer predictions in the developing limb.Here we present the Limb-Enhancer Genie (LEG), a collection of highly accurate, genome-wide predictions of enhancers in the developing limb, available through a user-friendly online interface.Limb-Enhancer Genie: An accessible resource of accurate enhancer predictions in the developing limb."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7877c0faa1ab7d2e00000c",
                            "question": "What is the first line treatment for sarcoidosis?"
                        }
                    ],
                    "context": "Sarcoidosis represents a non-caseating, granulomatous disorder of unknown aetiology whose clinical manifestation is heterogeneous and frequently multisystemic. The portion of patients needing systemic treatment varies: though many patients may undergo spontaneous remission, organ-threatening courses demand systemic therapy. Corticosteroids are the first-line treatment option The prevalence of cardiac sarcoidosis has exponentially increased over the past decade, primarily due to increased awareness and diagnostic modalities for the disease entity. Despite an expanding patient cohort, the optimal management of cardiac sarcoidosis remains yet to be established with a significant lack of prospective trials to support current practice. Corticosteroids remain first-line treatment of this disorder,Prednisone is used as first-line therapy for pulmonary sarcoidosis.Corticosteroids are still the first-line treatment, but alternative therapy with anti-TNF agents, like pentoxifylline, thalidomide and anti-TNF monoclonal antibodies become more interesting, especially in refractory sarcoidosis.<br>Corticosteroids are still the first-line treatment, but alternative therapy with anti-TNF agents, like pentoxifylline, thalidomide and anti-TNF monoclonal antibodies become more interesting, especially in refractory sarcoidosis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a68f005b750ff4455000016",
                            "question": "Which personality disorder is treated using dialectical behavior therapy?"
                        }
                    ],
                    "context": "Neural correlates of distraction in borderline personality disorder before and after dialectical behavior therapy.It is unknown whether neural correlates of emotion regulation change after a psychotherapy which has the goal to improve emotion dysregulation in BPD, such as dialectical behavioral therapy (DBT). In conclusion, our findings reveal changes in neural activity associated with distraction during emotion processing after DBT in patients with BPD.ObjectiveInvestigate influence and change of self-directedness (SD) in Dialectical-Behavior Therapy (DBT) for 26 female outpatients with borderline personality disorder (BPS).ConclusionDBT strengthens the SD of patients with BPD."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a79d0b8faa1ab7d2e00000d",
                            "question": "What cellular process are okazaki fragments associated with?"
                        }
                    ],
                    "context": "This review focuses on the biogenesis and composition of the eukaryotic DNA replication fork, with an emphasis on the enzymes that synthesize DNA and repair discontinuities on the lagging strand of the replication fork. Physical and genetic methodologies aimed at understanding these processes are discussed. The preponderance of evidence supports a model in which DNA polymerase \u03b5 (Pol \u03b5) carries out the bulk of leading strand DNA synthesis at an undisturbed replication fork. DNA polymerases \u03b1 and \u03b4 carry out the initiation of Okazaki fragment synthesis and its elongation and maturation, respectively. At DNA replication forks, the overall growth of the antiparallel two daughter DNA chains appears to occur 5'-to-3' direction in the leading-strand and 3'-to-5' direction in the lagging-strand using enzyme system only able to elongate 5'-to-3' direction, and I describe in this review how we have analyzed and proved the lagging strand multistep synthesis reactions, called Discontinuous Replication Mechanism, which involve short RNA primer synthesis, primer-dependent short DNA chains (Okazaki fragments) synthesis, primer removal from the Okazaki fragments and gap filling between Okazaki fragments by RNase H and DNA polymerase I, and long lagging strand formation by joining between Okazaki fragments with DNA ligase.Therefore, efficient processing of Okazaki fragments is vital for DNA replication and cell proliferation.RNA primer removal from Okazaki fragments during lagging-strand replication and the excision of damaged DNA bases requires the action of structure-specific nucleases, such as the mammalian flap endonuclease 1 (FEN-1).Lagging strand DNA replication requires the concerted actions of DNA polymerase \u03b4, Fen1 and DNA ligase I for the removal of the RNA/DNA primers before ligation of Okazaki fragments."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6900ebb750ff445500001d",
                            "question": "Which disease is diagnosed using the Finkelstein's test?"
                        }
                    ],
                    "context": "The inclusion criteria were positive Finkelstein's test and no response to non-surgical treatment for 6 weeks. Forty-eight patients with de Quervain's disease who did not respond to conservative treatment were operated with two different incisions.De Quervain's disease has different clinical features. Different tests have been described in the past, the most popular test being the Eichhoff's test, often wrongly named as the Finkelstein's test.Furthermore, we found that Finkelstein's test can give a false positive result. Therefore, ultrasound should not only be considered to improve the treatment outcome, but can also be useful as a diagnostic tool in the management of de Quervain's disease.The Finkelstein's test was positive in all cases. A successful outcome was achieved in all cases with negative Finkelstein's test."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6e1280b750ff4455000037",
                            "question": "For which type of cancer can uc.189 be used as a potential prognostic biomarker?"
                        }
                    ],
                    "context": "Upregulation of uc.189 in patients with esophageal squamous cell carcinoma and its clinicopathologic value.This study was to identify the prognostic value of uc.189 expression in esophageal squamous cell carcinomas (ESCC). Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression level of uc.189 in matched cancerous tissues and adjacent noncancerous tissues from 152 patients with ESCC. The correlation of uc.189 with clinicopathological features and prognosis were also analyzed. The expression of uc.189 was significantly higher in human ESCC compared with the adjacent noncancerous tissues (122/152, 80.3%, p<0.01), and the high level of uc.189 expression was significantly correlated with invasion of the tumor (p=0.009), advanced clinical stage (p=0.000), lymph node metastasis (p=0.000), and poor prognosis. High expression of uc.189 might reflect poor prognosis of ESCC and indicate a potential diagnostic target in ESCC patients. Uc.189 might be considered as a novel molecule involved in ESCC progression, which provides a potential prognostic biomarker and therapeutic target.This study was to identify the prognostic value of uc.189 expression in esophageal squamous cell carcinomas (ESCC).Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression level of uc.189 in matched cancerous tissues and adjacent noncancerous tissues from 152 patients with ESCC.The expression of uc.189 was significantly higher in human ESCC compared with the adjacent noncancerous tissues (122/152, 80.3%, p<0.01), and the high level of uc.189 expression was significantly correlated with invasion of the tumor (p=0.009), advanced clinical stage (p=0.000), lymph node metastasis (p=0.000), and poor prognosis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a87145861bb38fb24000004",
                            "question": "What causes Black Lung?"
                        }
                    ],
                    "context": "A prospective case-control study was undertaken to assess respiratory disability in 133 former coal miners who were claimants for \"black lung\" benefits. Consecutive assignment was made to either case or control group based on their chest radiograph having shown coal workers' pneumoconiosis or no coal workers' pneumoconiosis.It has recently been suggested that the inhalation of coal in the absence of complicated coal workers' pneumoconiosis (CWP) or smoking can lead to disabling airways obstructionHighlights in the history of efforts to prevent occupational lung disease among coal miners in the United States are reviewed. The Federal Coal Mine Health and Safety Act of 1969 is summarized, and the sources and effects of its provisions to prevent coal workers' pneumoconiosis are examined. Descriptions follow of the identification of coal workers' pneumoconiosis as a disease, identification of respirable coal mine dust as its cause, and establishment and enforcement of an exposure limitCoal workers' pneumoconiosis is a preventable occupational disorder of the respiratory system resulting from exposure to and retention of respirable coal dust. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6e2578b750ff445500003d",
                            "question": "Which package in Bioconductor has been developed with the aim to analyze differential DNA loops from sequencing data?"
                        }
                    ],
                    "context": "diffloop: a computational framework for identifying and analyzing differential DNA loops from sequencing data.To systematically assess changes in DNA looping architecture between samples, we introduce diffloop, an R/Bioconductor package that provides a suite of functions for the quality control, statistical testing, annotation, and visualization of DNA loops. To systematically assess changes in DNA looping architecture between samples, we introduce diffloop, an R/Bioconductor package that provides a suite of functions for the quality control, statistical testing, annotation, and visualization of DNA loops.diffloop: a computational framework for identifying and analyzing differential DNA loops from sequencing data.To systematically assess changes in DNA looping architecture between samples, we introduce diffloop, an R/Bioconductor package that provides a suite of functions for the quality control, statistical testing, annotation, and visualization of DNA loops."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6f853ab750ff4455000055",
                            "question": "Which disease can be diagnosed with the \"probe to bone\" test?"
                        }
                    ],
                    "context": "Clinical inflammatory signs, probe-to-bone test, and plain X-rays are postulated as the basic tests for clinical diagnosis when DFO is suspected. In patients with a new DFU, we recommend probe to bone test and plain films to be followed by magnetic resonance imaging if a soft tissue abscess or osteomyelitis is suspected. Diagnostic Accuracy of Probe to Bone to Detect Osteomyelitis in the Diabetic Foot: A Systematic Review.The probe-to-bone (PTB) test is a commonly used clinical test for osteomyelitis (OM), but its utility has been questioned in clinical settings where the prevalence of OM is low. This article aims to systematically review the accuracy of the PTB test to diagnose diabetic foot OM.Pooled sensitivity and specificity for the PTB test was 0.87 (95% confidence interval [CI], .75-.93) and 0.83 (95% CI, .65-.93), respectively. We conclude that the PTB test can accurately rule in diabetic foot OM in the high-risk patients and rule out OM in low-risk patients."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a871b8d61bb38fb2400000a",
                            "question": "What body process does the Dentate Gyrus Mossy Cell control?"
                        }
                    ],
                    "context": "We propose that this aberrant activity-dependent intrinsic plasticity, which lastingly impairs the information processing of cortical inputs in dentate gyrus, may participate in hippocampal-related cognitive deficits, such as those reported in patients with epilepsyWithin the hippocampal formation neuronal networks undergo major reorganization, including the sprouting of mossy fibers in the dentate gyrus; they establish aberrant recurrent synapses between dentate granule cells and operate via postsynaptic kainate receptors. The results of the present study indicated the importance of hippocampal Zn/lipid metabolism\u2011associated genes in recurrent neonatal seizure\u2011induced aberrant mossy fiber sprouting, which may aid the identification of novel potential targets during epileptogenesisMossy cells in the hilus of the dentate gyrus constitute a major excitatory principal cell type in the mammalian hippocampus; however, it remains unknown how these cells behave in\u00a0vivo. Here, we have used two-photon Ca2+imaging to monitor the\u00a0activity of mossy cells in awake, behaving mice. We find that mossy cells are significantly more active than dentate granule cells in\u00a0vivo, exhibit spatial tuning during head-fixed spatial navigation, and undergo robust remapping of their spatial representations in response to contextual manipulation. Our\u00a0results provide a functional characterization of mossy cells in the behaving animal and demonstrate their active participation in spatial coding and contextual representation.Recent experimental and modeling results demonstrated that surviving mossy cells in the dentate gyrus play key roles in the generation of network hyperexcitability."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6f98e6b750ff445500005d",
                            "question": "Which ligament is most commonly injured in dashboard injury?"
                        }
                    ],
                    "context": "Posterior cruciate ligament (PCL) injuries have a reported incidence of between 3 and 37%, depending on the clinical setting. The most common mechanism of injury in motor vehicle accidents is a dashboard injury or direct force to the proximal anterior tibia.Hyperflexion was the most common mechanism of injury, followed by pretibial trauma in the hyperflexed knee or in the \"dashboard\" injury. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a897a06fcd1d6a10c00000b",
                            "question": "What is the normal body temperature in dogs?"
                        }
                    ],
                    "context": "Clinical examination revealed normal rectal temperature (38.3\u00b0C)dian body temperature measured by the experienced investigator with the RDT and the NCIT were 38.3\u00b0C (range 35.5\u00b0C-41.1\u00b0C; 95% CI: 38.2-38.4\u00b0C) and 37.7\u00b0C (35.9\u00b0C-40.1\u00b0C; 95% CI: 37.7\u00b0C-37.9\u00b0C), respectively."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a6fa61ab750ff4455000060",
                            "question": "Which tool exists for microsatellite (SSR) loci detection and primer design?"
                        }
                    ],
                    "context": "FullSSR: Microsatellite Finder and Primer Designer.Microsatellites are genomic sequences comprised of tandem repeats of short nucleotide motifs widely used as molecular markers in population genetics. FullSSR is a new bioinformatic tool for microsatellite (SSR) loci detection and primer design using genomic data from NGS assay.FullSSR is a new bioinformatic tool for microsatellite (SSR) loci detection and primer design using genomic data from NGS assay.FullSSR simplifies the detection of SSRs and primer design on a big data set.FullSSR simplifies the detection of SSRs and primer design on a big data set."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a72302b2dc08e987e000005",
                            "question": "Treatment of which disease was studied in the Gore REDUCE Clinical Study?"
                        }
                    ],
                    "context": "CONCLUSIONS: Among patients with a PFO who had had a cryptogenic stroke, the risk of subsequent ischemic stroke was lower among those assigned to PFO closure combined with antiplatelet therapy than among those assigned to antiplatelet therapy alone; however, PFO closure was associated with higher rates of device complications and atrial fibrillation. (Funded by W.L. Gore and Associates; Gore REDUCE ClinicalTrials.gov number, NCT00738894 .).Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.Aims The Gore REDUCE Clinical Study (REDUCE) aims to establish superiority of patent foramen ovale closure in conjunction with antiplatelet therapy over antiplatelet therapy alone in reducing the risk of recurrent clinical ischemic stroke or new silent brain infarct in patients who have had a cryptogenic stroke. Aims The Gore REDUCE Clinical Study (REDUCE) aims to establish superiority of patent foramen ovale closure in conjunction with antiplatelet therapy over antiplatelet therapy alone in reducing the risk of recurrent clinical ischemic stroke or new silent brain infarct in patients who have had a cryptogenic stroke."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a9d29571d1251d03b000018",
                            "question": "What effect does azeliragon have on RAGE?"
                        }
                    ],
                    "context": "Expert opinion: Drugs in Phase III clinical development for AD include one inhibitor of the \u03b2-secretase cleaving enzyme (BACE) (verubecestat), three anti-A\u03b2 monoclonal antibodies (solanezumab, gantenerumab, and aducanumab), an inhibitor of receptor for advanced glycation end products (RAGE) (azeliragon) and the combination of cromolyn sodium and ibuprofen (ALZT-OP1). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a9e2386de7cb99d40000004",
                            "question": "What is the drug forxiga used for?"
                        }
                    ],
                    "context": "Dapagliflozin (forxiga\u00ae) : SGLT 2 cotransporter inhibitor as glucose-lowering agent in type 2 diabetesDapagliflozin (DAPA) (Farxiga or Forxiga) is a sodium glucose cotransporter 2 (SGLT2) inhibitor approved for type 2 diabetes mellitus(T2DM) treatment.Dapagliflozin (Forxiga) belongs to a new class of oral glucose-lowering drugs that inhibit renal glucose reabsorption and promote glycosuria.Dapagliflozin (Forxiga\u00ae) is the first in a novel class of glucose-lowering agents known as sodium-glucose co-transporter-2 (SGLT2) inhibitors and is used in the treatment of patients with type 2 diabetes.antidiabetic drug Forxiga (dapagliflozin)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a761ac3aacfb9cd4c000002",
                            "question": "What is the most common feature of the Doege\u2013Potter syndrome?"
                        }
                    ],
                    "context": "We describe a patient with Doege-Potter syndrome (solitary fibrous tumor of the pleura presenting with hypoglycemia) and illustrate several important lessons learned from the case. Solitary fibrous tumour of the pleura (SFTP) is a rare primary tumour of the pleura associated with 4% of cases with a paraneoplastic hypoglycaemia, termed Doege-Potter syndrome (DPS). Metastatic extrapleural malignant solitary fibrous tumor presenting with hypoglycemia (Doege-Potter syndrome).Doege-Potter syndrome\u00a0is a paraneoplastic\u00a0syndrome\u00a0characterized by non-islet cell tumor hypoglycemia secondary to a solitary fibrous tumor. AIM: Doege-Potter syndrome is a rare condition consisting of a mesenchymal tumor, either benign or malignant, accompanied by severe hypoglycemia. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a679e8cb750ff4455000006",
                            "question": "Milwaukee protocol was tested for treatment of which disease?"
                        }
                    ],
                    "context": "Caring for a patient with rabies: implications of the Milwaukee protocol for infection control and public health measures.The Milwaukee protocol, which to date has five reported human rabies survivors associated with its use, has been suggested as a potential management pathway for human rabies. Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned.Therapies suggested in the Milwaukee protocol include therapeutic coma, ketamine infusion, amantadine, and the screening/prophylaxis/management of cerebral vasospasm. None of these therapies can be substantiated in rabies or other forms of acute viral encephalitis.The Milwaukee protocol has been attributed to survival in rabies encephalitis despite a lack of scientific evidence supporting its therapeutic measures. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5aa4f47cd6d6b54f7900000a",
                            "question": "When is 16S rRNA Gene Sequencing used?"
                        }
                    ],
                    "context": "The different pipelines that may be used in 16S rRNA gene profiling of bacterial communities are known to have a significant impact on alpha and beta diversity measures and this may prevent direct comparison of results obtained in studies using different bioinformatic approaches to analyse raw sequences.  Metataxonomics tools analyze high-throughput sequencing data, primarily from 16S rRNA gene sequencing and DNAseq, to identify microorganisms and viruses within a complex mixture.Two biological methods were used, Ribosomal Intergenic Spacer Analysis (RISA), and 16S rRNA gene sequencing with Illumina Miseq, to evaluate the discriminating power of soil bacterial communities. The aim of this study was to assess the integration of different approaches, genotypic (16S rRNA gene sequencing), proteomic (MALDI-TOF MS) and metabolomic (1H-NMR), for the taxonomic and metabolic characterization of Lactobacillus species. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a9ac7ba1d1251d03b000013",
                            "question": "What does intepirdine target?"
                        }
                    ],
                    "context": "The 5-HT-6 receptor antagonists Idalopirdine and Intepirdine have shown the most progress in current clinical trials and warrant consideration as emerging treatments for AD. This review discusses 5-HT6 antagonists currently in clinical trials as potential treatments for AD symptomatology and how 5-HT6 physiology may play a positive role in alleviating AD symptom pathophysiology. A literature search using PubMed was conducted using the terms Idalopirdine, Intepirdine, 5-HT-6 antagonist, and AD as keywords. If current Phase-3 trials are positive, 5-HT6 antagonists such as Idalopirdine and Intepirdine may be considered as supplementary treatments to ChEI's and NMDA receptor antagonists for the symptomatic treatment of AD."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a8b27e6fcd1d6a10c00001e",
                            "question": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?"
                        }
                    ],
                    "context": "RAPIDR: an analysis package for non-invasive prenatal testing of aneuploidy.Non-invasive prenatal testing (NIPT) of fetal aneuploidy using cell-free fetal DNA is becoming part of routine clinical practice. RAPIDR (Reliable Accurate Prenatal non-Invasive Diagnosis R package) is an easy-to-use open-source R package that implements several published NIPT analysis methods. The input to RAPIDR is a set of sequence alignment files in the BAM format, and the outputs are calls for aneuploidy, including trisomies 13, 18, 21 and monosomy X as well as fetal sex. RAPIDR has been extensively tested with a large sample set as part of the RAPID project in the UK. The package contains quality control steps to make it robust for use in the clinical setting.RAPIDR (Reliable Accurate Prenatal non-Invasive Diagnosis R package) is an easy-to-use open-source R package that implements several published NIPT analysis methods.RAPIDR (Reliable Accurate Prenatal non-Invasive Diagnosis R package) is an easy-to-use open-source R package that implements several published NIPT analysis methods.RAPIDR (Reliable Accurate Prenatal non-Invasive Diagnosis R package) is an easy-to-use open-source R package that implements several published NIPT analysis methods."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a67c497b750ff4455000012",
                            "question": "Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?"
                        }
                    ],
                    "context": "Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases. Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to\u00a0discover variants associated to specific Mendelian disorders.Overall, Genomiser is able to identify causal regulatory variants as the\u00a0top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases.Overall, Genomiser is able to identify causal regulatory variants as the\u00a0top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to\u00a0discover variants associated to specific Mendelian disorders."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a9acd921d1251d03b000016",
                            "question": "In what phase of clinical trials is crenezumab? (November 2017)"
                        }
                    ],
                    "context": "Ongoing Phase III clinical trials via passive immunotherapy against A\u03b2 peptides (crenezumab, gantenerumab, and aducanumab) seem to be promising. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a76160a83b0d9ea66000020",
                            "question": "Which sequence-based algorithm for branch point prediction has been proposed?"
                        }
                    ],
                    "context": "BPP: a sequence-based algorithm for branch point prediction.BPP: a sequence-based algorithm for branch point prediction."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5aa55b45d6d6b54f7900000d",
                            "question": "What organism causes scarlet fever also known as scarletina?"
                        }
                    ],
                    "context": "Scarlet fever is one of a variety of diseases caused by group A Streptococcus (GAS).In a small epidemic of scarlet fever a healthy carrier of hemolytic streptococcus was detected; the organism carried was identical in its serological reactions with strains of hemolytic streptococci isolated from active cases of scarlet fever.No morphological or cultural characteristics peculiar to the hemolytic streptococcus from scarlet fever can be demonstrated.Application of multilocus enzyme electrophoresis and comparative sequencing of the gene (speA) encoding streptococcal pyrogenic exotoxin a (scarlet fever toxin) revealed that new waves of scarlet fever are associated with an increase in frequency of S. pyogenes clones carrying variant speA alleles.Additionally, S. pyogenes induces toxin-mediated syndromes, i. e. scarlet fever, streptococcal toxic shock syndrome (STSS) and necrotizing fasciitis (NF)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a76179d83b0d9ea66000021",
                            "question": "Which algorithm has been proposed for efficient storage of WGS variant calls?"
                        }
                    ],
                    "context": "SeqArray-a storage-efficient high-performance data format for WGS variant calls.Whole-genome sequencing (WGS) data are being generated at an unprecedented rate. Analysis of WGS data requires a flexible data format to store the different types of DNA variation. Variant call format (VCF) is a general text-based format developed to store variant genotypes and their annotations. However, VCF files are large and data retrieval is relatively slow. Here we introduce a new WGS variant data format implemented in the R/Bioconductor package 'SeqArray' for storing variant calls in an array-oriented manner which provides the same capabilities as VCF, but with multiple high compression options and data access using high-performance parallel computing.Results: Benchmarks using 1000 Genomes Phase 3 data show file sizes are 14.0\u2009Gb (VCF), 12.3\u2009Gb (BCF, binary VCF), 3.5\u2009Gb (BGT) and 2.6\u2009Gb (SeqArray) respectively. Reading genotypes in the SeqArray package are two to three times faster compared with the htslib C library using BCF files. For the allele frequency calculation, the implementation in the SeqArray package is over 5 times faster than PLINK v1.9 with VCF and BCF files, and over 16 times faster than vcftools. When used in conjunction with R/Bioconductor packages, the SeqArray package provides users a flexible, feature-rich, high-performance programming environment for analysis of WGS variant data.Here we introduce a new WGS variant data format implemented in the R/Bioconductor package 'SeqArray' for storing variant calls in an array-oriented manner which provides the same capabilities as VCF, but with multiple high compression options and data access using high-performance parallel computing.<br><b>Results</b>: Benchmarks using 1000 Genomes Phase 3 data show file sizes are 14.0\u2009Gb (VCF), 12.3\u2009Gb (BCF, binary VCF), 3.5\u2009Gb (BGT) and 2.6\u2009Gb (SeqArray) respectively.When used in conjunction with R/Bioconductor packages, the SeqArray package provides users a flexible, feature-rich, high-performance programming environment for analysis of WGS variant data.<br><b>Availability and Implementation</b>: http://www.bioconductor.org/packages/SeqArray.<br><b>Contact</b>: zhengx@u.washington.edu.<br><b>Supplementary information</b>: Supplementary data are available at Bioinformatics online.<br>Here we introduce a new WGS variant data format implemented in the R/Bioconductor package 'SeqArray' for storing variant calls in an array-oriented manner which provides the same capabilities as VCF, but with multiple high compression options and data access using high-performance parallel computing."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a774fdcfaa1ab7d2e000008",
                            "question": "Which protein is regulated by Tudor interacting repair regulator (TIRR)?"
                        }
                    ],
                    "context": "The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response.In this study, we identified the Tudor-interacting repair regulator (TIRR) that specifically associates with the ionizing radiation-induced foci formation region of 53BP1. 53BP1 and TIRR form a stable complex, which is required for their expression. Moreover, the 53BP1-TIRR complex dissociates after DNA damage, and this dissociation may be ataxia telangiectasia mutated-dependent. Similar to 53BP1, loss of TIRR restores PARPi resistance in BRCA1-deficient cells. Collectively, our data identified a novel 53BP1-TIRR complex in DNA damage response. TIRR may play both positive and negative roles in 53BP1 regulation. On the one hand, it stabilizes 53BP1 and thus positively regulates 53BP1. On the other hand, its association with 53BP1 prevents 53BP1 localization to sites of DNA damage, and thus TIRR is also an inhibitor of 53BP1.TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.P53-binding protein 1 (53BP1) is a multi-functional double-strand break repair protein that is essential for class switch recombination in B lymphocytes and for sensitizing BRCA1-deficient tumours to poly-ADP-ribose polymerase-1 (PARP) inhibitors. Central to all 53BP1 activities is its recruitment to double-strand breaks via the interaction of the tandem Tudor domain with dimethylated lysine 20 of histone H4 (H4K20me2). Here we identify an uncharacterized protein, Tudor interacting repair regulator (TIRR), that directly binds the tandem Tudor domain and masks its H4K20me2 binding motif. Upon DNA damage, the protein kinase ataxia-telangiectasia mutated (ATM) phosphorylates 53BP1 and recruits RAP1-interacting factor 1 (RIF1) to dissociate the 53BP1-TIRR complex. However, overexpression of TIRR impedes 53BP1 function by blocking its localization to double-strand breaks. Depletion of TIRR destabilizes 53BP1 in the nuclear-soluble fraction and alters the double-strand break-induced protein complex centring 53BP1. These findings identify TIRR as a new factor that influences double-strand break repair using a unique mechanism of masking the histone methyl-lysine binding function of 53BP1.In this study, we identified the Tudor-interacting repair regulator (TIRR) that specifically associates with the ionizing radiation-induced foci formation region of 53BP1."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a804f71faa1ab7d2e00001d",
                            "question": "Which algorithm is used for detection of long repeat expansions?"
                        }
                    ],
                    "context": "Identifying large expansions of short tandem repeats (STRs), such as those that cause amyotrophic lateral sclerosis (ALS) and fragile X syndrome, is challenging for short-read whole-genome sequencing (WGS) data. A solution to this problem is an important step toward integrating WGS into precision medicine. We developed a software tool called ExpansionHunter that, using PCR-free WGS short-read data, can genotype repeats at the locus of interest, even if the expanded repeat is larger than the read length. We applied our algorithm to WGS data from 3001 ALS patients who have been tested for the presence of theC9orf72repeat expansion with repeat-primed PCR (RP-PCR). Compared against this truth data, ExpansionHunter correctly classified all (212/212, 95% CI [0.98, 1.00]) of the expanded samples as either expansions (208) or potential expansions (4). Additionally, 99.9% (2786/2789, 95% CI [0.997, 1.00]) of the wild-type samples were correctly classified as wild type by this method with the remaining three samples identified as possible expansions. We further applied our algorithm to a set of 152 samples in which every sample had one of eight different pathogenic repeat expansions, including those associated with fragile X syndrome, Friedreich's ataxia, and Huntington's disease, and correctly flagged all but one of the known repeat expansions. Thus, ExpansionHunter can be used to accurately detect known pathogenic repeat expansions and provides researchers with a tool that can be used to identify new pathogenic repeat expansions.Thus, ExpansionHunter can be used to accurately detect known pathogenic repeat expansions and provides researchers with a tool that can be used to identify new pathogenic repeat expansions.We developed a software tool called ExpansionHunter that, using PCR-free WGS short-read data, can genotype repeats at the locus of interest, even if the expanded repeat is larger than the read length."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a9ac4e81d1251d03b000011",
                            "question": "Which brain tumors does neuroligin-3 promote?"
                        }
                    ],
                    "context": "An important mechanism that mediates this neural regulation of brain cancer is activity-dependent cleavage and secretion of the synaptic adhesion molecule neuroligin-3 (NLGN3), which promotes glioma proliferation through the PI3K-mTOR pathway. However, the necessity of NLGN3 for glioma growth, the proteolytic mechanism of NLGN3 secretion, and the further molecular consequences of NLGN3 secretion in glioma cells remain unknown. Here we show that HGG growth depends on microenvironmental NLGN3, identify signalling cascades downstream of NLGN3 binding in glioma, and determine a therapeutically targetable mechanism of secretion. Patient-derived orthotopic xenografts of paediatric GBM, DIPG and adult GBM fail to grow in Nlgn3 knockout mice. NLGN3 stimulates several oncogenic pathways, such as early focal adhesion kinase activation upstream of PI3K-mTOR, and induces transcriptional changes that include upregulation of several synapse-related genes in glioma cells.This work defines a promising strategy for targeting NLGN3 secretion, which could prove transformative for HGG therapy.Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a8056a2faa1ab7d2e00001f",
                            "question": "Which web resource for LIR motif-containing proteins in eukaryotes has been developed?"
                        }
                    ],
                    "context": "iLIR database: A web resource for LIR motif-containing proteins in eukaryotes.In the past few years it has been revealed that Atg8-interacting proteins include not only receptors but also components of the core autophagic machinery, proteins associated with vesicles and their transport, and specific proteins that are selectively degraded by autophagy. Atg8-interacting proteins contain a short linear LC3-interacting region/LC3 recognition sequence/Atg8-interacting motif (LIR/LRS/AIM) motif which is responsible for their interaction with Atg8-family proteins. These proteins are referred to as LIR-containing proteins (LIRCPs). So far, many experimental efforts have been carried out to identify new LIRCPs, leading to the characterization of some of them in the past 10\u00a0years. Given the need for the identification of LIRCPs in various organisms, we developed the iLIR database ( https://ilir.warwick.ac.uk ) as a freely available web resource, listing all the putative canonical LIRCPs identified in silico in the proteomes of 8 model organisms using the iLIR server, combined with a Gene Ontology (GO) term analysis. Additionally, a curated text-mining analysis of the literature permitted us to identify novel putative LICRPs in mammals that have not previously been associated with autophagy.Given the need for the identification of LIRCPs in various organisms, we developed the iLIR database ( https://ilir.warwick.ac.uk ) as a freely available web resource, listing all the putative canonical LIRCPs identified in silico in the proteomes of 8 model organisms using the iLIR server, combined with a Gene Ontology (GO) term analysis.iLIR database: a web resource for LIR motif-containing proteins in eukaryotes.Given the need for the identification of LIRCPs in various organisms, we developed the iLIR database ( https://ilir.warwick.ac.uk ) as a freely available web resource, listing all the putative canonical LIRCPs identified in silico in the proteomes of 8 model organisms using the iLIR server, combined with a Gene Ontology (GO) term analysis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a9d31711d1251d03b00001c",
                            "question": "What is the approximate size of gas vesicles?"
                        }
                    ],
                    "context": "This number remained relatively constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a9700adfcd1d6a10c00002c",
                            "question": "Sclerostin regulates what process?"
                        }
                    ],
                    "context": " Sclerostin is a soluble antagonist of Wnt/\u03b2-catenin signaling secreted primarily by osteocytes. Current evidence indicates that sclerostin likely functions as a local/paracrine regulator of bone metabolism rather than as an endocrine hormone. After discovering that lack of Sost/sclerostin expression is the cause of the high bone mass human syndromes Van Buchem disease and sclerosteosis, extensive animal experimentation and clinical studies demonstrated that sclerostin plays a critical role in bone homeostasis and that its deficiency or pharmacological neutralization increases bone formationSclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.The osteocyte product sclerostin is emerging as an important paracrine regulator of bone mass.Sclerostin is a secreted inhibitor of Wnt signaling and plays an essential role in the regulation of bone mass."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a96c74cfcd1d6a10c000029",
                            "question": "What illness is transmitted by the Lone Star Tick, Amblyomma americanum?"
                        }
                    ],
                    "context": "Today,A americanumremains an important vector for tick-borne illness. In addition to others, species ofRickettsia,Ehrlichia, andBorreliaare all transmitted by the lone star tick. Southern tick-associated rash illness and anaphylaxis to red meat following tick bites have been attributed to the lone star tick.Lone Star tick (Amblyomma americanum) and the rash is called STARI (southern tick-associated rash illness).Amblyomma americanum (Lone star tick) is an important disease vector in the United States. It transmits several human pathogens, including the agents of human monocytic ehrlichiosis, tularemia, and southern tick-associated rash illness.E. chaffeensis is maintained in a complex cycle involving white-tailed deer (WTD; Odocoileus virginianus) as a primary reservoir and the lone star tick (LST; Amblyomma americanum) as a primary vector."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7639419e632bc066000005",
                            "question": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?"
                        }
                    ],
                    "context": "DeepLoc: prediction of protein subcellular localization using deep learning.DeepLoc: prediction of protein subcellular localization using deep learning."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7347a02dc08e987e00001b",
                            "question": "Gallbladder carriage is a well recognised means of spread of which bacteria?"
                        }
                    ],
                    "context": "Carriage prevalence of Salmonella enterica serotype Typhi in gallbladders of adult autopsy cases from Mozambique.CONCLUSIONS: We report a high prevalence of S. Typhi in gallbladders among adult autopsy cases from Mozambique.Salmonella Extracellular Matrix Components Influence Biofilm Formation and Gallbladder Colonization.Salmonella enterica serovar Typhi, the causative agent of typhoid fever in humans, forms biofilms encapsulated by an extracellular matrix (ECM). Biofilms facilitate colonization and persistent infection in gallbladders of humans and mouse models of chronic carriage.In vitro modeling of gallbladder-associated Salmonella spp. colonization."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a7373f63b9d13c708000008",
                            "question": "Which disease is treated with Fexinidazole?"
                        }
                    ],
                    "context": "n the search for new therapeutics, the repurposing of the broad-spectrum antiprotozoal drug fexinidazole has completed Phase III trials with the anticipation that it will be the first oral treatment for HAT. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.Therefore, we aimed to assess the safety and efficacy of an oral regimen of fexinidazole (a 2-substituted 5-nitroimidazole with proven trypanocidal activity) versus nifurtimox eflornithine combination therapy in patients with late-stage g-HAT.INTERPRETATION: Our findings show that oral fexinidazole is effective and safe for the treatment of T b gambiense infection compared with nifurtimox eflornithine combination therapy in late-stage HAT patients.AIM: Fexinidazole (FEX) is a nitroimidazole being developed as a new trypanocide treatment for human African trypanosomiasis/sleeping sickness. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a95765bfcd1d6a10c000028",
                            "question": "What part of what body organ controls the circadian clock?"
                        }
                    ],
                    "context": "the suprachiasmatic nucleus (SCN) of the hypothalamus acts as the central clock in mammals, the circadian expression of clock genes In mammals, the suprachiasmatic nucleus (SCN) of the hypothalamus is the site of the main circadian clockThe suprachiasmatic nucleus (SCN) of the hypothalamus orchestrates daily rhythms of physiology and behavior in mammals. The suprachiasmatic nucleus houses the central circadian clock and is characterized by the timely regulated expression of clock genes.Clock genes control circadian rhythms both centrally, in the suprachiasmatic nucleus of the brain and peripherally, within every organ of the body."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a992b371d1251d03b00000a",
                            "question": "What does MetaHIT stand for?"
                        }
                    ],
                    "context": "The importance of microbiome constituency is so relevant that several consortia like the Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human microbiome. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5aa3fb7ad6d6b54f79000009",
                            "question": "What drug cures hepatitis C?"
                        }
                    ],
                    "context": "Sofosbuvir-based therapy cures hepatitis C virus infectionSofosbuvir-based therapy cures hepatitis c virus infection after prior treatment failures in a patient with concurrent lymphoma.The emerging archetypal example is the outcry over the cost of sofosbuvir, a drug proved to cure hepatitis C infection"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5aa824a8fcf4565872000002",
                            "question": "What is the drug Tecfidera used against?"
                        }
                    ],
                    "context": "Dimethyl fumarate (Tecfidera\u2122) is an effective therapy for relapsing forms of multiple sclerosis (MS).dimethyl fumarate (Tecfidera(\u00ae)) for multiple sclerosis.Tecifidera is approved for the treatment of relapsing-remitting multiple sclerosisDimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ad3aa47133db5eb78000004",
                            "question": "Which organ express and secretes the hormone FGF21?"
                        }
                    ],
                    "context": "We have previously shown that Fibroblast growth factor 21 (Fgf21) is expressed in the thymus as well as in the liver. Fibroblast growth factor 21 (FGF21) is an important endocrine metabolic regulator expressed in multiple tissues including liver and adipose tissue. Although highest levels of expression are in pancreas, little is known about the function of FGF21 in this tissue."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "589a247078275d0c4a000035",
                            "question": "Dinutuximab is used for treatment of which disease?"
                        }
                    ],
                    "context": "PURPOSE: Dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma.Dinutuximab: A Review in High-Risk Neuroblastoma.Dinutuximab (ch14.18; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-2 and isotretinoin for the postconsolidation treatment of patients with high-risk neuroblastoma. Dinutuximab administered in combination with GM-CSF, IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis and limited therapeutic options.Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ac24c9495d0062724000002",
                            "question": "What is the ChIP-exo method used for?"
                        }
                    ],
                    "context": "ChIP-exo method for identifying genomic location of DNA-binding proteins with near-single-nucleotide accuracy.ChIP-exo allows identification of a nearly complete set of the binding locations of DNA-binding proteins at near-single-nucleotide resolution with almost no background.Precise Identification of DNA-Binding Proteins Genomic Location by Exonuclease Coupled Chromatin Immunoprecipitation (ChIP-exo).A significant improvement of the ChIP-seq technique results from the addition of an exonuclease treatment during the immunoprecipitation step (ChIP-exo) that lowers background noise and more importantly increases the identification of binding sites to a level near to single-base resolution by effectively footprinting DNA-bound proteins. The ChIP-exo Method: Identifying Protein-DNA Interactions with Near Base Pair Precision."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5abc9ecffcf4565872000021",
                            "question": "Where do mitochondrial DNA deletion breakpoints tend to occur?"
                        }
                    ],
                    "context": "n this work, we performed a computational analysis of the human mitochondrial genome using the \"Pattern Finder\" G-quadruplex (G4) predictor algorithm to assess whether G4-forming sequences reside in close proximity (within 20 base pairs) to known mitochondrial DNA deletion breakpoints.Circular dichroism and UV spectral analysis demonstrated that mitochondrial G-rich sequences near deletion breakpoints prevalent in human disease form G-quadruplex DNA structures.Direct repeat sequences are not required at the breakpoints of age-associated mitochondrial DNA deletions in rhesus monkeys.Most of the analyzed deletion breakpoints showed nucleotide repeats flanking the deletions. Currently, the multiple types of GQ sequences and their association with human mtDNA stability are unknown.<br><b>RESULTS</b>: Here, we show an association between human mtDNA deletion breakpoint locations (sites where DNA ends rejoin after deletion of a section) and sequences with G-quadruplex forming potential (QFP), and establish the ability of selected sequences to form GQ in vitro."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ac138aa95d0062724000001",
                            "question": "Which is the enzymatic activity of nardilysin?"
                        }
                    ],
                    "context": "Nardilysin (N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding of the precursor forms of various growth factors and cytokines by enhancing the protease activities of a disintegrin and metalloproteinase (ADAM) proteins. nardilysin (N-arginine dibasic convertase;"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ab147edfcf4565872000013",
                            "question": "The Mantoux test detects what latent infection/disease?"
                        }
                    ],
                    "context": "screened for TB infection with a Mantoux tuberculin skin test The present study reports the results of a three-year TB surveillance among HCW in a large teaching hospital in Rome, using TST (by standard Mantoux technique)Laboratory diagnostic testing of cellular immunity against pathogenic mycobacteria employs the tuberculin skin test (TST, Mantoux tuberculin test) tuberculin skin test (TST) performed according to the Mantoux method. Diaskintest\u00ae test and Mantoux test with 2TE PPD-L were concurrently carried out in 300 children and adolescents with tuberculosis and followed up in risk groups at a tuberculosis dispensary to determine the sensitivity of the new skin test in active tuberculosis infection."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a9d99ac4e03427e73000002",
                            "question": "What is measured with the Proseek panels?"
                        }
                    ],
                    "context": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit PROSEEK Multiplex CVD and PROSEEK Multiplex INF A multiplex proximity extension assay allowed us to measure 157 cardiovascular disease (CVD) and inflammatory disease-related biomarkers in patients from the international, multicenter, and randomized trial;Plasma concentrations of MMP12 were measured at baseline in 3394 subjects with high-risk for cardiovascular disease (CVD) using the Olink ProSeek CVD I array. The samples were analyzed with a multiplex proximity extension assay in which 92 inflammation-related proteins were measured simultaneously (Proseek Multiplex Inflammation I; Olink Bioscience, Uppsala, Sweden)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ab1483bfcf4565872000014",
                            "question": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?"
                        }
                    ],
                    "context": "domestic dogs and cats can be interpreted in terms of their descent from members of the order Carnivora.The dentition, sense of taste and meal patterning of domestic dogs and cats can be interpreted in terms of their descent from members of the order Carnivora."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a896c26fcd1d6a10c000007",
                            "question": "In which syndrome is the RPS19 gene most frequently mutated?"
                        }
                    ],
                    "context": "The RPS19 mutation group was associated with higher requirement for chronic treatment for anemia than other DBA groups.Twenty-one cases of DBA admitted in our hospital from Dec 2008 to Aug 2012 were screened by PCR for mutations in the nine known genes associated with DBA: RPS19, RPS24, RPS17, RPL5, RPL11, RPS7, RPL35a, RPS10 and RPS26The results found that 8 patients (38.1%) with DBA had mutations in the genes coding for ribosomal protein, in which RPS19 mutation was identified in 3 patients, RPS24, RPS7, RPL5, RPL11 and RPL35A mutations were identified respectively in 1 of the patient.The hypospadias can be observed in some patients with RPS19 mutation and some dactyl anomalies are associated with RPL11 and RPL5 mutations.A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ac37afc0340b9f058000002",
                            "question": "What type of sequences do enhancers evolve from?"
                        }
                    ],
                    "context": "The sequences of some gene regulatory elements diverge considerably, even between closely related species. The trend is one of high divergence of cis-regulatory elements between species, possibly compensated by extensive creation and loss of regulatory elements and rewiring of their target genes. These studies have identified enhancers that were pivotal for morphological divergence and highlighted how novel genetic networks shaping form emerged from pre-existing ones.Most of the recently evolved enhancers arise from ancestral DNA exaptation, rather than lineage-specific expansions of repeat elements.santomea enhancer activity evolved from a weak ancestral activity."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5abcf010fcf4565872000023",
                            "question": "What nerve is involved in carpal tunnel syndrome?"
                        }
                    ],
                    "context": "In this study, it was aimed to determine whether median nerve epineurectomy is beneficial in the surgical management of carpal tunnel syndromeWe believe that median nerve epineurectomy is unnecessary in the surgical management of primary CTS since it has no influence on the midtermCarpal tunnel syndrome (CTS) is a focal compressive neuropathy of the median nerve at the level of the wrist. CTS, which may occur in as many as 25% of patients who undergo carpal tunnel release, most commonly results from an incomplete transverse carpal ligament release or an incorrect initial diagnosis. Patients with recurrent symptoms often have perineural fibrosis that tethers the median nerve. Ultrasound is an established method of viewing the median nerve in the carpal tunnel syndrome (CTS)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ace17c30340b9f058000009",
                            "question": "Which olfactory gene senses androsterone?"
                        }
                    ],
                    "context": "any mammals can decipher these scent codes to discern the gender, age, endocrine status, social status, and genotype of conspecifics using dedicated sensory receptors in their olfactory system.A previously reported association between the olfactory receptor OR7D4 and the androstenone was not detected until we specifically typed this gene (P = 1.1 \u00d7 10(-4)). These findings suggest that 1) the perceived intensity of some but not all odorants is a heritable trait, 2) use of a current genome-wide marker panel did not detect a known olfactory genotype-phenotype association, and 3) person-to-person differences in androstenone perception are influenced by OR7D4 genotype and perhaps by variants of other genes.The flavor of ethanol was related to variation within an olfactory receptor gene (OR7D4) and a gene encoding a subunit of the epithelial sodium channel (SCNN1D).A previously reported association between the olfactory receptor OR7D4 and the androstenone was not detected until we specifically typed this gene (P = 1.1 \u00d7 10(-4))."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5abd13e1fcf4565872000029",
                            "question": "Where in the body would the navicular bone be found?"
                        }
                    ],
                    "context": "The accessory navicular (AN) is an accessory ossicle anatomically located on the medial side of the foot, proximal to the navicular and continuous with the tibialis posterior tendon.A 16-year-old boy developed left foot pain of unknown cause that was unresponsive to conservative treatment, associated with fever and difficulty walking. He was admitted to our hospital with osteomyelitis of the accessory and body of the navicular bone"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ac716810340b9f058000003",
                            "question": "Name an lncRNA associated with dilated cardiomyopathy."
                        }
                    ],
                    "context": "In the previous study, we generated a rat model of dilated cardiomyopathy (DCM) induced by adriamycin and found that the expression of lncRNA H19 was significantly upregulated in myocardial tissue.The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ace19420340b9f05800000a",
                            "question": "Which gene is responsible for red hair?"
                        }
                    ],
                    "context": "Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans.Individuals with red hair have a predominance of phaeomelain in hair and skin and/or a reduced ability to produce eumelanin, which may explain why they fail to tan and are at risk from UVR. In mammals the relative proportions of phaeomelanin and eumelanin are regulated by melanocyte stimulating hormone (MSH), which acts via its receptor (MC1R), on melanocytes, to increase the synthesis of eumelanin and the product of the agouti locus which antagonises this actionOur findings suggest that in humans, as in other mammals, the MC1R is a control point in the regulation of pigmentation phenotype and, more importantly, that variations in this protein are associated with a poor tanning response.In humans, melanocortin 1 receptor variants are associated with red hair and fair skin, and work in progress from our laboratory suggests that certain melanocortin 1 receptor variants may preferentially be associated with hair color rather than skin type. Red hair in man is due to certain loss of function mutations of one of the peptide products of the pro-opiomelanocortin (POMC) gene, the melanocortin-1 receptor (MC1R, MIM 155555)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5abd5a62fcf4565872000031",
                            "question": "Which bacteria was EcoRI, restriction endonuclease isolated from?"
                        }
                    ],
                    "context": ". Among hundreds of restriction endonucleases, the Eco R1 enzyme is the most useful and widely investigated enzyme. After sonication and ultracentrifugation, crude extracts of E. coli RY 13 An endonuclease having EcoRI specificity is produced by bacteria containing the ColE1 plasmid.Such bacterial cells fail to express restriction or modification functions in vivo, and phage or plasmid DNA obtained from ColE1-containing cells has unmodified EcoRI sites that are cleaved in vitro by purified EcoRI endonuclease or by enzyme extracted from bacteria that carry ColE1.[Characteristics of RecA-independent recombination of plasmids in E. coli cells producing restriction endonuclease EcoRI]. The purification of the EcoRI restriction enzyme from a strain of Escherichia coli that over-produces this enzyme was hampered by the insolubility of the protein, and hence the purification procedure was modified to optimize the recovery of active enzyme"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a8980d2fcd1d6a10c00000d",
                            "question": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?"
                        }
                    ],
                    "context": "Brown adipose tissue (BAT) mitochondria are distinct from their counterparts in other tissues in that ATP production is not their primary physiologic role. BAT mitochondria are equipped with a specialized protein known as uncoupling protein 1 (UCP1). UCP1 short-circuits the electron transport chain, allowing mitochondrial membrane potential to be transduced to heat, making BAT a tissue capable of altering energy expenditure and fuel metabolism in mammals without increasing physical activity.Uncoupling protein 1 (UCP1) is the hallmark protein responsible for cold- and diet-induced thermogenesis in brown adipose tissue (BAT).Thermogenesis is an important homeostatic mechanism essential for survival and normal physiological functions in mammals. Both brown adipose tissue (BAT) (i.e.uncoupling protein 1 (UCP1)-based)UCP1's central role in non-shivering thermogenesis is acknowledgedJAK2 promotes brown adipose tissue function and is required for diet- and cold-induced thermogenesis in mice."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a9e202bde7cb99d40000002",
                            "question": "Which method is Proseek based on?"
                        }
                    ],
                    "context": "We used proximity extension immunoassay (PEA, Proseek Multiplex, Olink) to assess the serum levels of ninety-two inflammation-related proteins in Czech patients with SLE (n\u00a0=\u00a075) and age-matched healthy control subjects (n\u00a0=\u00a023).Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a885add61bb38fb24000017",
                            "question": "What is the H4S47C cleavage mapping method used for?"
                        }
                    ],
                    "context": "To identify nucleosomes with alternative structures genome-wide, we used H4S47C-anchored cleavage mapping, which revealed that 5% of budding yeast (Saccharomyces cerevisiae) nucleosome positions have asymmetric histone-DNA interactions.Micrococcal nuclease (MNase) sequence-based profiles of asymmetric nucleosome positions revealed a corresponding asymmetry in MNase protection near the dyad axis, suggesting that the loss of DNA contacts around H4S47 is accompanied by protection of the DNA from MNase. To resolve this controversy, we have applied H4S47C-anchored cleavage mapping, which reveals the precise position of histone H4 in every nucleosome in the genome. To map fission yeast centromeres, we applied H4S47C-anchored cleavage mapping and native and cross-linked chromatin immunoprecipitation with paired-end sequencing.We find that cleavage patterns at centromeres are unique within the genome and are incompatible with symmetrical structures, including octameric nucleosomes and (Cse4/H4)2 tetrasomes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5aacd487fcf4565872000007",
                            "question": "Which human gene encode for DNA polymerase \u03b8?"
                        }
                    ],
                    "context": "DNA polymerase theta (pol \u03b8) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes. DNA polymerase theta (pol \u03b8) is encoded in the genomes of many eukaryotes, though not in fungi. Pol \u03b8 is encoded by the POLQ gene in mammalian cells."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ac0a82d19833b0d7b000003",
                            "question": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?"
                        }
                    ],
                    "context": "Biweekly intravenous (i.v.) administration of the PPMO restored the dystrophin expression in nearly 100% skeletal muscle fibers in all age groups. This was associated with the restoration of dystrophin-associated proteins including functional glycosylated dystroglycan and neuronal nitric synthase. However, therapeutic outcomes clearly depended on severity of the disease at the time the treatment started."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ac725250340b9f058000006",
                            "question": "Which miRNA is associated with the circular RNA ciRS-7?"
                        }
                    ],
                    "context": "In addition, according to recent studies, circular RNA-7 (ciRS-7) acts as a sponge of miR-7 and thus inhibits its activity. Numerous evidences have confirmed expression of miR-7 is dysregulated in cancer tissues, however, whether ciRS-7 invovled in oncogenesis by acting as sponge of miR-7 remains unclear. Most recently, a study reported ciRS-7 acted as an oncogene in hepatocellular carcinoma through targeting miR-7 expression. This suggest ciRS-7/ miR-7 axis affects oncogenesis, and it provides a new perspective on the mechanisms of decreased miR-7 expression in cancer tissues. This review summarizes the structure and function of circRNAs and provides evidence for the impact of ciRS-7 in promoting the development of cancer by acting as sponge of miR-7."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ad6e431133db5eb7800000e",
                            "question": "Which test is used for the definition of colour-blindness?"
                        }
                    ],
                    "context": "12 patients had color blindness based on the Ishihara testBasque students (174 males and 218 females), using the Ishihara test cards (1987).The results obtained from male individuals by 919 Ishihara-tests were only considered, categorized and graphically represented according to their age groups.A cross-sectional descriptive and analytical study was conducted among 633 TUMS Clinical Laboratory Sciences' Students and Hospitals' Clinical Laboratories' Employees to detect color-blindness problems by Ishihara Test.Results of Isihara colour blindness tests."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ac08fe7d0c506ce46000003",
                            "question": "Of what origin is the MCF-7 cell line?"
                        }
                    ],
                    "context": " an ER+ breast cancer cell line (MCF-7) Two different types of tumor cells, MCF-7 and MDA-MB-231, both from the same origin of breast carcinoma cells, MCF7, and PC3 adenocarcinoma cell lines.MCF7, Hs578t and MDA-MB-231 breast cancer cell lines"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ab2cc66fcf4565872000015",
                            "question": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?"
                        }
                    ],
                    "context": "Etravirine is an effective and well-tolerated recently approved non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV type-1-infected patients with previous antiretroviral treatment experience. Considering the importance of combining antiretrovirals for their optimal use in treating HIV, a number of drug-drug interactions with etravirine and other antiretrovirals have been evaluated. Etravirine is a weak inducer of cytochrome P450 (CYP)3Aoreover, medications prescribed to HIV-positive patients may also be CYP3A inhibitors and inducers: Tipranavir, in the absence of ritonavir, is a CYP3A inducer, and ritonavir is a CYP3A inhibitor. F"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ace238e0340b9f05800000d",
                            "question": "Which human chromosome is the product of fusion?"
                        }
                    ],
                    "context": "The evolution of African great ape subtelomeric heterochromatin and the fusion of human chromosome 2.We propose a model where an ancestral human-chimpanzee pericentric inversion and the ancestral chromosome 2 fusion both predisposed and protected the chimpanzee and human genomes, respectively, to the formation of subtelomeric heterochromatin. It is known that human chromosome 2 originated from the fusion of two ancestral primate chromosomes. Origin of human chromosome 2: an ancestral telomere-telomere fusion.We conclude that the locus cloned in cosmids c8.1 and c29B is the relic of an ancient telomere-telomere fusion and marks the point at which two ancestral ape chromosomes fused to give rise to human chromosome 2."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ac09a7b19833b0d7b000001",
                            "question": "Where is the EpCam protein mainly located?"
                        }
                    ],
                    "context": "The following cell-surface markers were immunohistochemically analyzed: E-cadherin, epithelial membrane antigen (EMA), human epidermal growth receptor type 2 (Her2/neu), carcinoembryonic antigen (CEA), \u03b1v\u03b26 integrin and epithelial cell adhesion molecule (EpCAM).Tumor cells display increased EpCAM expression that often correlates with the loss of strict basolateral localization.Papillary thyroid carcinoma shows loss of EpCAM membranous expression and increased cytoplasmic/nuclear accumulation.Epithelial cell adhesion molecule (EpCAM) (CD326) is a surface glycoprotein expressed by invasive carcinomas and some epithelia.Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein, which is frequently and highly expressed on carcinomas, tumor-initiating cells, selected tissue progenitors, and embryonic and adult stem cells"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5abbe429fcf456587200001c",
                            "question": "What is the drug target for Eliquis (Apixaban)?"
                        }
                    ],
                    "context": "The new oral anticoagulants (NOAC) include dabigatran etexilate (Pradaxa\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto\u00ae), Apixaban (Eliquis) and Edoxaban (Lixiana\u00ae), which are direct anti-Xa inhibitorsThe new direct oral anticoagulants directly targeting thrombin (factor IIa) or factor-Xa, are currently used for the treatment of deep venous thrombosis and pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa; Apixaban, Eliquis).Apixaban (Eliquis), rivaroxaban (Xarelto), and edoxaban (Savaysa) are the new Xa inhibitors that have been recently approved by the U.S. FDA and are in current clinical practice.The direct factor Xa inhibitor apixaban (Eliquis(\u00ae)) has predictable pharmacodynamics and pharmacokinetics and does not require routine anticoagulation monitoring.The new oral anticoagulants (NOAC) include dabigatran etexilate (Pradaxa\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto\u00ae), Apixaban (Eliquis) and Edoxaban (Lixiana\u00ae), which are direct anti-Xa inhibitors."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5abbfd97fcf456587200001d",
                            "question": "What is the Formalin test used for?"
                        }
                    ],
                    "context": "And persistent pain produced by peripheral tissue injury and inflammation was modeled by formalin test.The aim of the present study was to evaluate the antinoceptive interaction between the opioid analgesic, tapentadol, and the NSAID, ketorolac, in the mouse orofacial formalin test. experimental nociception using formalin testIn vivo antinociceptive activity (formalin test) The formalin test has been used in monkeys for assessing pain."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ab90a79fcf456587200001b",
                            "question": "What drug treatment can cause a spinal epidural hematoma?"
                        }
                    ],
                    "context": "Spinal epidural hematomas are rare entity in neurosurgery practice. Most of them are spontaneous due to anticoagulant therapy and called spontaneous spinal epidural hematomas (SSEHs).Spinal epidural hematoma (SEH) is a rare disease that causes cord compression and neurologic deficit. Spontaneous SEH is related to minor trauma, bleeding disorders, and anticoagulant medications.Chronic Spinal Subdural Hematoma Associated with Antiplatelet Therapy.pinal subdural hematoma associated with antiplatelet therapyThe authors report a case of acute spinal epidural hematoma occurring in a patient receiving antiplatelet drugs."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ace1a590340b9f05800000b",
                            "question": "What percentage of Homo sapiens DNA is of Neanderthal origin?"
                        }
                    ],
                    "context": "We find that the power to reject ancient admixture might be particularly low if the population size of Homo sapiens was comparable to the Neanderthal population size.Our results indicate that 3.6% of the Neanderthal genome is shared with roughly 65.4% of the average European gene pool, which clinally diminishes with distance from Europe.Here, we present evidence of Neanderthal introgression within the chromosome 3p21.31 region, occurring with a high frequency in East Asians (ranging from 49.4% to 66.5%) and at a low frequency in Europeans.This introgression was under positive natural selection, reached a frequency of>50%, and introduced a homocysteine level- and pigmentation-associated allele (rs460879-T) into East Asians. Hybridization between humans and Neanderthals has resulted in a low level of Neanderthal ancestry scattered across the genomes of many modern-day humans. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ace2d600340b9f05800000e",
                            "question": "What phenotype is associated with the V60L mutation in the human MC1R gene?"
                        }
                    ],
                    "context": "An additional three low-penetrance alleles V60L, V92M, and R163Q have odds ratios 6, 5, and 2 relative to the wild-type allele. Genetic association and cellular function of MC1R variant alleles in human pigmentation.We have investigated 174 individuals from 11 large kindreds with a preponderance of red hair and an additional 99 unrelated redheads, for MC1R variants and have confirmed that red hair is usually inherited as a recessive characteristic with the R151C, R160W, D294H, R142H, 86insA and 537insC alleles at this locus. The V60L variant, which is common in the population may act as a partially penetrant recessive allele. In vitro expression studies revealed that variant receptors with reduced cell surface expression, including V60L, D84E, R151C, I155T, R160W and R163Q, showed a corresponding impairment in cAMP coupling.Among the fifteen MC1R variants identified, the nine most common were V60L, V92M, R151C, R160W, R163Q, R142H, D294H, D84E, and I155T."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5aac543bfcf4565872000004",
                            "question": "What biologic process in the body is associated with Mast cells?"
                        }
                    ],
                    "context": "Mast cells (MCs) may play an important role in plaque destabilization and atherosclerotic coronary complications.Mast cells are significantly involved in IgE-mediated allergic reactions Mast cells (MCs) are innate immune cells that are a major source of costimulatory signals and inflammatory mediators in the intestinal mucosaMast cells and basophils are innate immune cells with overlapping functions that contribute to anti-helminth immunity. Mast cells are widely distributed throughout the body, predominantly near blood vessels and nerves, and express effector functions in allergic reactions, inflammatory diseases, and host defense."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5abcf0b0fcf4565872000024",
                            "question": "What causes leishmaniasis?"
                        }
                    ],
                    "context": "we will focus on the shape and form ofLeishmaniaspp., a group of very successful protozoan parasites that cause a range of diseases from self-healing cutaneous leishmaniasis to visceral leishmaniasisIn conclusion, our data demonstrates that in susceptible mice L. (L.) amazonensis, a causative agent of tegumentary leishmaniasis, causes pathological changes similar to those produced by Leishmania (L.) infantum in both humans and canids.American Tegumentary Leishmaniasis is caused by parasites of the genus Leishmania, and causes significant health problems throughout the Americas.Leishmaniasis is a tropical infection caused by the protozoan, belonging to the group of Leishmania which causes Old World and New World disease.Visceral leishmaniasis (VL) is caused by the protozoan parasite Leishmania donovani and transmitted by the bite of infected sandfly Phlebotomus argentipes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5a74eaa50384be955100000b",
                            "question": "What part of the body is affected by mesotheliomia?"
                        }
                    ],
                    "context": "Malignant pleural mesothelioma (MPM) is a rare and aggressive malignant diseaseMalignant pleural mesothelioma (MPM) is a hard to treat malignancy arising from the mesothelial surface of the pleura.Malignant pleural mesothelioma is a highly aggressive tumor associated with asbestos exposure."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ace12be0340b9f058000007",
                            "question": "Which gene is responsible for proper speech development?"
                        }
                    ],
                    "context": "The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation.Transcription factor forkhead box protein P2 (FOXP2) plays an essential role in the development of language and speech.Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia.Mutations in FOXP2 cause developmental verbal dyspraxia (DVD), but only a few cases have been described.Our results indicate that absence of paternal FOXP2 is the cause of DVD in patients with SRS with maternal UPD7. The data also point to a role for differential parent-of-origin expression of FOXP2 in human speech development."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5be48c39133db5eb7800001d",
                            "question": "What does the pembrolizumab companion diagnostic test assess?"
                        }
                    ],
                    "context": "The initial approval and subsequent studies of pembrolizumab required and utilized a companion diagnostic test, Dako's IHC 22C3, to assess PD-L1 status of patients."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5f56501a4c55d80b00002a",
                            "question": "What is the combined effect of Nfat and miR-25?"
                        }
                    ],
                    "context": "Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure.Here we report that increased calcineurin/Nfat signalling and decreased miR-25 expression integrate to re-express the basic helix-loop-helix (bHLH) transcription factor dHAND (also known as Hand2) in the diseased human and mouse myocardium."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c65b7657c78d6947100000c",
                            "question": "Which Lisp framework has been developed for image processing?"
                        }
                    ],
                    "context": "FunImageJ: a Lisp framework for scientific image processing.FunImageJ is a Lisp framework for scientific image processing built upon the ImageJ software ecosystem. The framework provides a natural functional-style for programming, while accounting for the performance requirements necessary in big data processing commonly encountered in biological image analysis.<b>Summary</b>: FunImageJ is a Lisp framework for scientific image processing built upon the ImageJ software ecosystem."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5acf74460340b9f058000013",
                            "question": "Which gene controls the consistency of cerumen (ear wax)?"
                        }
                    ],
                    "context": "A single nucleotide polymorphism (SNP) in ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian descentOur findings also reveal that ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and suggest that other biochemical pathways must be involvedABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of the auditory canal and the secretion of axillary odor precursors.Recent studies link a single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11) to the production of different types of axillary odorants and cerumen"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5be44ed3133db5eb78000016",
                            "question": "What is the origin of human breast milk bacteria?"
                        }
                    ],
                    "context": "In the past years, results provided by different research groups suggest that certain bacteria from the maternal gastrointestinal tract could translocate through a mechanism involving mononuclear immune cells, migrate to the mammary glands via an endogenous cellular route (the bacterial entero-mammary pathway), and subsequently colonize the gastrointestinal tract of the breast-fed neonate."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ad83cd6133db5eb78000010",
                            "question": "Which species is the carrier of the SFTS ( severe fever with thrombocytopenia syndrome) virus?"
                        }
                    ],
                    "context": "Seroprevalence in animal species were: goats (66.8%), cattle (28.2%), dogs (7.4%), pigs (4.7%), chickens (1.2%), geese (1.7%), rodents (4.4%) and hedgehogs (2.7%).The possibility that SFTSV transmission may occur by both the transstadial and transovarial routes was suggested by the fact that viral RNA was detected in H. longicornis at all developmental stages. Tick-derived sequences shared over 95.6% identity with human- and animal-derived isolates. This study provides evidence that implicates ticks as not only vectors but also, reservoirs of SFTSV.Severe fever with thrombocytopenia syndrome (SFTS) is a new emerging zoonosis.A survey of reptile-associated ticks and their infection status with severe fever with thrombocytopenia syndrome (SFTS) virus was conducted to determine the relative abundance and distribution among lizards, skinks, and snakes in the Republic of Korea (ROK).In total, 84 ixodid ticks belonging to two genera (Ixodes and Amblyomma) were collected from 28/132 (21.2%) lizards, skinks, and snakes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c58474786df2b9174000001",
                            "question": "Which algorithm has been developed for the automatic extraction of co-expressed gene clusters from gene expression data?"
                        }
                    ],
                    "context": "Clust: automatic extraction of optimal co-expressed gene clusters from gene expression data.We present clust, a method that solves these problems by extracting clusters matching the biological expectations of co-expressed genes and outperforms widely used methods. Additionally, clust can simultaneously cluster multiple datasets, enabling users to leverage the large quantity of public expression data for novel comparative analysis. Clust is available at https://github.com/BaselAbujamous/clust .We present clust, a method that solves these problems by extracting clusters matching the biological expectations of co-expressed genes and outperforms widely used methods.Additionally, clust can simultaneously cluster multiple datasets, enabling users to leverage the large quantity of public expression data for novel comparative analysis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5be47fcb133db5eb7800001a",
                            "question": "Which member of the human mycobiota is associated to atherosclerosis?"
                        }
                    ],
                    "context": "Interestingly, the relative abundance of Mucor racemosus was negatively associated both with FRS and cIMT.Variable importance in projection scores showed that M. racemosus abundance had the same impact in the model as waist-to-hip ratio, high-density lipoprotein-cholesterol, fasting triglycerides or fasting glucose, suggesting that M. racemosus relative abundance in the gut may be a relevant biomarker for cardiovascular risk."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5f094c1a4c55d80b00000c",
                            "question": "Where is the protein Bouncer located?"
                        }
                    ],
                    "context": "Membrane-bound Bouncer "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c2f669e133db5eb78000031",
                            "question": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?"
                        }
                    ],
                    "context": "By comparing three species (Saccharomyces cerevisiae, Candida glabrata, and S. castellii) that underwent WGD to a nonduplicated outgroup (Kluyveromyces lactis), and by using a synteny framework to establish orthology and paralogy relationships at each duplicated locus, we show that 56% of ohnolog pairs show significantly asymmetric protein sequence evolutionIn particular, we analyze the evolution of WGD and non-WGD paralogs from the domain viewpoint, in comparison with a more standard functional analysis of the genes. The two genomes subsequently converged onto similar current sizes (5,600 protein-coding genes each) and independently retained sets of duplicated genes that are strikingly similar. Almost half of their surviving single-copy genes are not orthologs but paralogs formed by WGD, as would be expected if most gene pairs were resolved independently.The two genomes are related by a 1:2 mapping, with each region of K. waltii corresponding to two regions of S. cerevisiae, as expected for whole-genome duplication."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c58962286df2b9174000007",
                            "question": "Which intoxication is associated with Burton's line?"
                        }
                    ],
                    "context": "The patient's serum lead concentration was substantially elevated and he perhaps demonstrated Burton's line. The second patient presented with abdominal pain and a Burton's line. The lead level was 52\u03bcg/dL and free erythrocyte protoporphyrin was 262\u03bcg/dL. Burton's line in lead poisoning.This paper sketches the early history and remembers the important contribution of Henry Burton, who described the gums to be bordered by a narrow leaden-blue line, about the one-twentieth part of an inch in width, whilst the substance of the gum apparently retained its ordinary colour and condition."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c59872b86df2b9174000017",
                            "question": "Which tool has been developed for coverage calculation for genomes?"
                        }
                    ],
                    "context": "Mosdepth: quick coverage calculation for genomes and exomes.Mosdepth is a new command-line tool for rapidly calculating genome-wide sequencing coverage. It measures depth from BAM or CRAM files at either each nucleotide position in a genome or for sets of genomic regions. Genomic regions may be specified as either a BED file to evaluate coverage across capture regions, or as a fixed-size window as required for copy-number calling. Mosdepth uses a simple algorithm that is computationally efficient and enables it to quickly produce coverage summaries. We demonstrate that mosdepth is faster than existing tools and provides flexibility in the types of coverage profiles produced.Availability and implementation: mosdepth is available from https://github.com/brentp/mosdepth under the MIT license."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5be48987133db5eb7800001c",
                            "question": "Which type of sarcoma has been associated with members of the oral microbiome?"
                        }
                    ],
                    "context": "Alterations in the oral microbiota may be associated with disorders such as gingivitis, periodontitis, childhood caries, alveolar osteitis, oral candidiasis and endodontic infections. In the immunosuppressed population, the spectrum of potential oral disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi's sarcoma, oral warts and other diseases. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c307474133db5eb78000033",
                            "question": "Which complex is bound by estrogen-related receptor \u03b2 (Esrrb)?"
                        }
                    ],
                    "context": "Knockdown of Mp1 redirected FGF4 signaling from differentiation toward pluripotency and up-regulated the pluripotency-related genes Esrrb, Rex1, Tcl1, and Sox2.Dax1 associates with Esrrb and regulates its function in embryonic stem cells.Here, we identified an orphan nuclear receptor, Esrrb (estrogen-related receptor beta), as a Dax1-interacting protein.Dax1 is a direct downstream target of Esrrb and that Esrrb can regulate Dax1 expression in an Oct3/4-independent manner.Co-motif discovery identifies an Esrrb-Sox2-DNA ternary complex as a mediator of transcriptional differences between mouse embryonic and epiblast stem cells"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c632542e842deac6700000d",
                            "question": "Which approach was used to diagnose a patient with Cutis Verticis Gyrata-Intellectual Disability (CVG-ID) syndrome?"
                        }
                    ],
                    "context": "Cutis Verticis Gyrata-Intellectual Disability (CVG-ID) syndrome is a rare neurocutaneous syndrome characterized by intellectual disability and scalp folds and furrows that are typically absent at birth and are first noticed after puberty. First reported in 1893, the syndrome was mainly identified in subjects living in psychiatric institutions, where it was found to have a prevalence of up to 11.4%. Most patients were reported in the literature during the first half of the 20th century. CVG-ID is now a less reported and possibly under-recognized syndrome. Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of this syndrome.Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of this syndrome."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c58b99586df2b9174000012",
                            "question": "Cemiplimab is used for treatment of which cancer?"
                        }
                    ],
                    "context": "PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. In the dose-escalation portion of the phase 1 study of cemiplimab, a deep and durable response was observed in a patient with metastatic cutaneous squamous-cell carcinoma.CONCLUSIONS: Among patients with advanced cutaneous squamous-cell carcinoma, cemiplimab induced a response in approximately half the patients and was associated with adverse events that usually occur with immune checkpoint inhibitors.Cemiplimab Approved for Treatment of CSCC.The FDA greenlighted the PD-1 inhibitor cemiplimab to treat patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for surgery or radiation. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5be494a0133db5eb7800001f",
                            "question": "Which cancer has the kynureninase pathway been associated to?"
                        }
                    ],
                    "context": "Involvement of the kynurenine pathway in human glioma pathophysiology.These results provide further evidence for the involvement of the KP in glioma pathophysiology and highlight a potential role of KP products as novel and highly attractive therapeutic targets to evaluate for the treatment of brain tumors, aimed at restoring anti-tumor immunity and reducing the capacity for malignant cells to produce NAD(+), which is necessary for energy production and DNA repair."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c34ac49da8336e21a000006",
                            "question": "In which way does DNA hydroxymethylation affect patients with Systemic Lupus Erythematosus?"
                        }
                    ],
                    "context": "Our results showed that BDH2 expression was decreased, intracellular iron was increased, global DNA hydroxymethylation level was elevated, while methylation level was reduced in lupus CD4+ T cells compared with healthy controlsAltered DNA methylation and hydroxymethylation as well as histone modifications mediate changes in chromatin accessibility and gene expression in immune cells from SLE patients.DNA hydroxymethylation was more recently identified as an activating epigenetic mark.On the other hand, certain miRNAs, RFX1, defective ERK pathway signaling, Gadd45\u03b1 and DNA hydroxymethylation have been proposed as potential mechanisms leading to DNA hypomethylation in lupus.Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c532ad97e3cb0e23100001a",
                            "question": "Which database associates human noncoding SNPs with their three-dimensional interacting genes?"
                        }
                    ],
                    "context": "3DSNP: a database for linking human noncoding SNPs to their three-dimensional interacting genes.3DSNP is a valuable resource for the annotation of human noncoding genome sequence and investigating the impact of noncoding variants on clinical phenotypes. The 3DSNP database is available at http://biotech.bmi.ac.cn/3dsnp/.Recent high-throughput chromosome conformation capture studies have outlined the principles of these elements interacting and regulating the expression of distal target genes through three-dimensional (3D) chromatin looping. Here we present 3DSNP, an integrated database for annotating human noncoding variants by exploring their roles in the distal interactions between genes and regulatory elements. 3DSNP integrates 3D chromatin interactions, local chromatin signatures in different cell types and linkage disequilibrium (LD) information from the 1000 Genomes Project.Here we present 3DSNP, an integrated database for annotating human noncoding variants by exploring their roles in the distal interactions between genes and regulatory elements.3DSNP is a valuable resource for the annotation of human noncoding genome sequence and investigating the impact of noncoding variants on clinical phenotypes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c011057133db5eb78000025",
                            "question": "In which phase of clinical trials was sutezolid in 2018?"
                        }
                    ],
                    "context": "After decades of quiescence in the development of antituberculosis medications, bedaquiline and delamanid have been conditionally approved for the treatment of drug-resistant tuberculosis, while several other novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase II clinical trials. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c0112dd133db5eb78000026",
                            "question": "For which disease is sutezolid developed?"
                        }
                    ],
                    "context": "Various molecules, such as derivatives of fluoroquinolones (e.g. gatifloxacin, moxifloxacin and DC-159a), rifamycins (rifapentine), oxazolidinones (linezolid, sutezolid/PNU-100480), diarylquinolines (TMC207/bedaquiline), antifungal azoles, pyrrole (LL3858), nitroimidazopyran (PA824), nitroimidazole (OPC67683, TBA-354), diamine (SQ109) and benzothiazinone (BTZ043) are being developed in an attempt to combat the disease. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c588d0986df2b9174000003",
                            "question": "What brain procedure can be done using the NeuroBlate system?"
                        }
                    ],
                    "context": " At 3 years of age, he underwent stereotactic laser ablation with an aim of disconnection of the lesion. The procedure was performed with the NeuroBlate SideFire probe. The authors perform a systematic analysis of two commercially available MRgLITT systems used in neurosurgery: the Visualase\u00ae thermal therapy and NeuroBlate\u00ae Systems.We describe the history and rationale of laser neurosurgery as well as the two available SLT systems (Visualase\u00ae and NeuroBlate\u00ae; CE marks pending). INTRODUCTION: We describe the feasibility of using minimally invasive robotic laser interstitial thermotherapy (LITT) for achieving an anterior two-thirds\u00a0as well as a complete corpus callosotomy.METHODS: Ten probe trajectories were plotted on normal magentic resonance imaging (MRI) scans using the Brainlab Stereotactic Planning Software (Brainlab, Munich, Germany). The NeuroBlate\u00ae System (Monteris Medical, MN, USA) was used to conform the thermal burn to the corpus callosum along the trajectory of the probe.Here, we briefly describe the history and rationale of laser neurosurgery as well as the technical key features of the two currently available systems for magnetic resonance-guided LiTT (Visualase\u00ae, NeuroBlate\u00ae; CE marks pending for both)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c580aff07647bbc4b00001a",
                            "question": "Which ultraconserved element is associated with Embryonic Stem Cells (ESC) self-renewal?"
                        }
                    ],
                    "context": "An Ultraconserved Element Containing lncRNA Preserves Transcriptional Dynamics and Maintains ESC Self-Renewal.Ultraconserved elements (UCEs) show the peculiar feature to retain extended perfect sequence identity among human, mouse, and rat genomes. Most of them are transcribed and represent a new family of long non-coding RNAs (lncRNAs), the transcribed UCEs (T-UCEs). Despite their involvement in human cancer, the physiological role of T-UCEs is still unknown. Here, we identify a lncRNA containing the uc.170+, named T-UCstem1, and provide in\u00a0vitro and in\u00a0vivo evidence that it plays essential roles in embryonic stem cells (ESCs) by modulating cytoplasmic miRNA levels and preserving transcriptional dynamics.Here, we identify a lncRNA containing the uc.170+, named T-UCstem1, and provide in\u00a0vitro and in\u00a0vivo evidence that it plays essential roles in embryonic stem cells (ESCs) by modulating cytoplasmic miRNA levels and preserving transcriptional dynamics."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c581e1507647bbc4b00001c",
                            "question": "Which algorithm has been developed for trio-based benchmarking of variant calls?"
                        }
                    ],
                    "context": "geck: trio-based comparative benchmarking of variant calls.Classical methods of comparing the accuracies of variant calling pipelines are based on truth sets of variants whose genotypes are previously determined with high confidence. An alternative way of performing benchmarking is based on Mendelian constraints between related individuals. Statistical analysis of Mendelian violations can provide truth set-independent benchmarking information, and enable benchmarking less-studied variants and diverse populations.Results: We introduce a statistical mixture model for comparing two variant calling pipelines from genotype data they produce after running on individual members of a trio. We determine the accuracy of our model by comparing the precision and recall of GATK Unified Genotyper and Haplotype Caller on the high-confidence SNPs of the NIST Ashkenazim trio and the two independent Platinum Genome trios. We show that our method is able to estimate differential precision and recall between the two pipelines with 10-3 uncertainty."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c55d9b707647bbc4b000009",
                            "question": "Which molecule is targeted by Caplacizumab?"
                        }
                    ],
                    "context": "Caplacizumab, a nanobody that blocks the interaction between VWF and platelets, has shown promising results in decreasing the time to recover from the acute events that will hopefully translate into long-term clinical benefit for patients.Ablynx, a Sanofi Company, has developed the anti-von Willebrand factor Nanobody\u00ae caplacizumab (Cablivi\u2122) for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP).Promising agents under evaluation include N-acetylcysteine, bortezomib, recombinant ADAMTS13 and caplacizumab, an inhibitor of the glycoprotein-Ib/IX-von Willebrand factor axis.The most promising candidates for future treatment of TTP are: rituximab for termination of the autoimmune process, caplacizumab for prevention of platelet-VWF-interaction, and recombinant ADAMTS13 for replacement of the inhibited or missing enzyme.Promising agents under evaluation include caplacizumab (an inhibitor of the glycoprotein-Ib/IX-Von-Willebrand factor axis), N-acetylcysteine, recombinant ADAMTS13, and anti-plasmocyte compounds."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ad4d758133db5eb78000007",
                            "question": "Which is the main component of the Lewy body?"
                        }
                    ],
                    "context": "neuronal inclusions composed of \u03b1-synuclein (Lewy bodies) is considered the typical pathologic correlate of PD the era of alpha-synuclein, the protein present in Lewy bodies. Lewy bodies comprise of aggregated intracellular vesicles and proteins and \u03b1-synuclein is reported to be a major protein component. he Lewy body constituents, \u03b1-synuclein and small ubiquitin-related modifier-1(SUMO-1)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c2cf051133db5eb78000030",
                            "question": "How many pseudogenes are contained in the C. elegans genome?"
                        }
                    ],
                    "context": "Evidence suggesting that a fifth of annotated Caenorhabditis elegans genes may be pseudogenesThe remaining explanation is that most of the annotated genes in the recently duplicated category are pseudogenes, a proportion corresponding to 20% of all of the annotated C. elegans genes At least 4% of the annotated C. elegans genes can be recognized as pseudogenes simply from closer inspection of the sequence dataover 18,000 transcripts in each sampleThe remaining explanation is that most of the annotated genes in the recently duplicated category are pseudogenes, a proportion corresponding to 20% of all of the annotated C. elegans genes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5f0d071a4c55d80b000010",
                            "question": "What is cluster of differentiation?"
                        }
                    ],
                    "context": "The characterisation of the MSCs was determined by their cluster of differentiation (CD) marker profile. The samples were immunohistochemically stained for cluster of differentiation (CD)4, CD8, CD16, CD25, CD56 and CD68 using immunofluorescence in order to identify different T-lymphocyte populations and macrophages. definition of recognised cellular antigens (designated by CD: Cluster of Differentiation)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c56b96e07647bbc4b000010",
                            "question": "Which tool has been developed for tagging biomedical concepts via interactive learning?"
                        }
                    ],
                    "context": "ezTag: tagging biomedical concepts via interactive learning.To support annotating a wide variety of biological concepts with or without pre-existing training data, we developed ezTag, a web-based annotation tool that allows curators to perform annotation and provide training data with humans in the loop. ezTag supports both abstracts in PubMed and full-text articles in PubMed Central. It also provides lexicon-based concept tagging as well as the state-of-the-art pre-trained taggers such as TaggerOne, GNormPlus and tmVar. ezTag is freely available at http://eztag.bioqrator.org.To support annotating a wide variety of biological concepts with or without pre-existing training data, we developed ezTag, a web-based annotation tool that allows curators to perform annotation and provide training data with humans in the loop."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5f30c91a4c55d80b000025",
                            "question": "Which cells produce Interleukin 17A?"
                        }
                    ],
                    "context": "Several studies have shown an increased expression/release of Th17 related cytokine, IL-17A in ASD. interleukin (IL)-17A, secreted from T helper type 17 (TH17) cells, IL-17A, markedly produced by TH17 cellsIL-22 and IL-17A derive from both independent and overlapping lineages, defined as T helper (Th)22 and IL-22+ Th17 cells."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ad35d01133db5eb78000003",
                            "question": "What is the genetic cause of Roberts syndrome?"
                        }
                    ],
                    "context": " Mutations in Esco2 cause Roberts syndrome, a developmental disease characterized by severe prenatal retardation as well as limb and facial abnormalities. Genetic mapping studies reveal that mutations in cohesion pathways are responsible for multispectrum developmental abnormalities termed cohesinopathies. These include Roberts syndrome (RBS),Roberts syndrome and SC phocomelia syndrome are rare autosomal recessive genetic disorders representing the extremes of the spectrum of severity of the same condition, caused by mutations in ESCO2 gene. Roberts syndrome (RBS) is a human developmental disorder caused by mutations in the cohesin acetyltransferase ESCO2.RBS arises due to autosomal recessive mutations in cohesin auxiliary factorESCO2, the gene that encodes an N-acetyltransferase which targets the SMC3 subunit of the cohesin complex. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6be8f07c78d69471000032",
                            "question": "Which database has been developed that contains experimentally-confirmed carbonylated proteins?"
                        }
                    ],
                    "context": "CarbonylDB: a curated data-resource of protein carbonylation sites.Protein carbonylation, a chemically diverse oxidative post-translational modification, is widely considered as the biomarker for oxidative stress and protein damage. Despite their importance and extensive studies, no database/resource on carbonylated proteins/sites exists. As such information is very useful to research in biology/medicine, we have manually curated a data-resource (CarbonylDB) of experimentally-confirmed carbonylated proteins/sites.Results: The CarbonylDB currently contains 1495 carbonylated proteins and 3781 sites from 21 species, with human, rat and yeast as the top three species. We have made further analyses of these carbonylated proteins/sites and presented their occurrence and occupancy patterns. Carbonylation site data on serum albumin, in particular, provides a fine model system to understand the dynamics of oxidative protein modifications/damage.As such information is very useful to research in biology/medicine, we have manually curated a data-resource (CarbonylDB) of experimentally-confirmed carbonylated proteins/sites.Results\nThe CarbonylDB currently contains 1495 carbonylated proteins and 3781 sites from 21 species, with human, rat and yeast as the top three species.Results The CarbonylDB currently contains 1495 carbonylated proteins and 3781 sites from 21 species, with human, rat and yeast as the top three species."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6ffde47c78d69471000059",
                            "question": "What is CIBERSORT used for?"
                        }
                    ],
                    "context": "We recently described CIBERSORT, a versatile computational method for quantifying cell fractions from bulk tissue gene expression profiles (GEPs). We introduce CIBERSORT, a method for characterizing cell composition of complex tissues from their gene expression profiles. By applying CIBERSORT, a computational approach for inferring leukocyte representation in bulk tumor transcriptomes, we identified complex associations between 22 distinct leukocyte subsets and cancer survival. We applied an established computational approach (CIBERSORT) to bulk gene expression profiles of almost 11,000 tumours to infer the proportions of 22 subsets of immune cells. We investigated associations between each cell type and survival and response to chemotherapy, modelling cellular proportions as quartiles. Finally, we characterised the overall abundance of tumour-infiltrating immune cells in breast cancers from TCGA and METABRIC using ESTIMATE and relative frequency of 22 immune cell subsets in breast cancers from METABRIC using CIBERSORT"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c73ad367c78d69471000099",
                            "question": "Which molecule is targeted by Olaratumab?"
                        }
                    ],
                    "context": "Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFR\u03b1 Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic Cancer.BACKGROUND AND OBJECTIVES: Olaratumab is a recombinant human monoclonal antibody that binds to platelet-derived growth factor receptor-\u03b1 (PDGFR\u03b1).Conclusions: Overall, these data indicate that olaratumab, alone and in combination with standard of care, blocks the growth of some preclinical PDGFR\u03b1-expressing pediatric bone and soft tissue tumor models. Recent randomised phase II trial data have indicated that the addition of olaratumab, a novel monoclonal antibody against platelet-derived growth factor receptor alpha (PDGFR\u03b1), to doxorubicin confers an unprecedented improvement in overall survival to patients with anthracycline-na\u00efve advanced soft tissue sarcoma.While preclinical data show that olaratumab specifically inhibits PDGFR\u03b1-mediated oncogenic signalling with attendant anti-tumour effects, a lack of correlation between pharmacodynamics markers of PDGFR\u03b1 inhibition and clinical benefit from olaratumab suggest other mechanisms beyond modulation of downstream PDGFR\u03b1 molecular pathways."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c7b1a5fd774d0424000000c",
                            "question": "A herd immunity of what percentage of the population is required to prevent sporadic outbreaks?"
                        }
                    ],
                    "context": "herd immunity exceeding 95% is required to prevent sporadic viral outbreaks in a population.However, a herd immunity exceeding 95% is required to prevent sporadic viral outbreaks in a population.However, a herd immunity exceeding 95% is required to prevent sporadic viral outbreaks in a population. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5219f67e3cb0e231000006",
                            "question": "As of September 2018, what machine learning algorithm is used to for cardiac arrhythmia detection from a  short single-lead ECG recorded by a wearable device?"
                        }
                    ],
                    "context": "SVM approach for cardiac arrhythmias detection in short single-lead ECG recorded by a wearable deviceMulti-stage SVM approach for cardiac arrhythmias detection in short single-lead ECG recorded by a wearable device.<AbstractText Label=\"OBJECTIVE\" NlmCategory=\"OBJECTIVE\">Use of wearable ECG devices for arrhythmia screening is limited due to poor signal quality, small number of leads and short records, leading to incorrect recognition of pathological events. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c630666e842deac6700000c",
                            "question": "Which microRNA is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions?"
                        }
                    ],
                    "context": "MIR137 is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions.CONCLUSIONS\nThis study suggests that MIR137 is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions.CASE PRESENTATION\nWe describe a 10-year-old boy with syndromic obesity who carries a novel 1p21.3\u00a0deletion overlapping the critical region with the MIR137 gene only.CONCLUSIONS\nThis study showed that dosage effects of MIR137 are associated with 1p21.3 microdeletions and may therefore contribute to the ID phenotype in patients with deletions harbouring this miRNA.CONCLUSIONS This study suggests that MIR137 is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c74111f7c78d694710000a1",
                            "question": "Which transcription factor binding site is contained in Alu repeats?"
                        }
                    ],
                    "context": "Remarkably, we identified a novel abundant NF-\u03baB-binding site residing in specialized Alu-repetitive elements having the potential for long range transcription regulation, thus suggesting that in addition to its known role, NF-\u03baB has a primate-specific function and a role in human evolution.A de novo motif enrichment analysis uncovers secondary TFBSs (AP1, SP1) at characteristic distances from NF-\u03baB/RelA TFBSs."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c536b857e3cb0e23100001c",
                            "question": "What disease is treated with Laparoscopic Heller Myotomy (LHM)?"
                        }
                    ],
                    "context": " To compare the outcome of per oral endoscopic myotomy (POEM) and laparoscopic Heller myotomy (LHM) for the treatment of esophageal achalasiaPeroral endoscopic myotomy leads to higher rates of abnormal esophageal acid exposure than laparoscopic Heller myotomy in achalasiaPeroral endoscopic myotomy (POEM) is an emerging endoscopic treatment for achalasia and the long-term efficacy of POEM remains to be evaluated. This study compared the outcomes of POEM with that of the standard laparoscopic Heller myotomy (LHM) for achalasia.The aim of this study was to compare robotic-assisted laparoscopic Heller myotomy (RAHM) with laparoscopic Heller myotomy (LHM) in terms of efficacy and safety."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c73ad027c78d6947100008d",
                            "question": "What is evaluated with the SAD PERSONS scale?"
                        }
                    ],
                    "context": "METHOD: We compared the predictive accuracy of the Manchester Self-Harm Rule (MSHR), ReACT Self-Harm Rule (ReACT), SAD PERSONS Scale (SPS) and Modified SAD PERSONS Scale (MSPS) in an unselected sample of patients attending hospital following self-harm.Clinicians completed a standard suicide risk instrument (modified SAD PERSONS scale), a 10-point Likert scale assessment of judgment of patient suicide risk (Clinician Prediction Scale), and a measure of their emotional responses to the patient (Therapist Response Questionnaire-Suicide Form). AimsTo evaluate the performance of risk scales (Manchester Self-Harm Rule, ReACT Self-Harm Rule, SAD PERSONS scale, Modified SAD PERSONS scale, Barratt Impulsiveness Scale); and patient and clinician estimates of risk in identifying patients who repeat self-harm within 6 months.Predicting suicide with the SAD PERSONS scale.The SAD PERSONS suicide risk assessment scale is widely implemented in clinical settings despite limited supporting evidence. This article aims to determine the ability of the SAD PERSONS scale (SPS) to predict future suicide in the emergency department."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c783d32d774d04240000004",
                            "question": "Which human disease is experimental autoimmune encephalomyelitis (EAE) model for?"
                        }
                    ],
                    "context": "experimental autoimmune encephalomyelitis (EAE), an animal model of MSxperimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosisrelapsing MS and its model, experimental autoimmune encephalomyelitis (EAE)experimental autoimmune encephalomyelitis (EAE), an animal model of MS"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c76d0417c78d694710000a8",
                            "question": "What is the cause if the rare disease cystinosis?"
                        }
                    ],
                    "context": "Cystinosis is a rare, autosomal recessive disorder leading to defective transport of cystine out of lysosomes.Cystinosis is a rare autosomal recessive disorder resulting from defective lysosomal transport of cystine due to mutations in the cystinosin lysosomal cystine transporter (CTNS) gene. Cystinosin, a lysosomal transporter is involved in the efflux of cystine from the lysosome to the cytosol. Mutations in the human cystinosin gene (CTNS) cause cystinosis, a recessive autosomal disorder. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6545bae842deac6700001d",
                            "question": "Which molecular does daratumumab target?"
                        }
                    ],
                    "context": "The addition of daratumumab (anti-CD38 antibody) augmented NK-cell cytotoxicity against target cells expressing high CD38, but not against CD38 low or negative target cells also in the presence of TME."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c7161f47c78d69471000066",
                            "question": "What is etarfolatide used for?"
                        }
                    ],
                    "context": "99mTc-etarfolatide, an imaging agent for folate receptor in healthy Japanese adults In contrast, the noninvasive single-photon emission computed tomography-based companion imaging agent, (99m)Tc-etarfolatide ((99m)Tc-EC20), is in development for use as a companion diagnostic with the FR\u03b1-targeted folate conjugate,OBJECTIVE\nTechnetium etarfolatide ((99m)Tc-EF) is a radioactive diagnostic imaging agent that was developed to assess the expression of folate receptors in tumors.OBJECTIVE\nThrough binding to folate receptor-\u03b2 (FR-\u03b2), the new (99m)Tc-EC20 (Etarfolatide) imaging technique detects activated but not resting macrophages in\u00a0vivo.In contrast, the noninvasive single-photon emission computed tomography-based companion imaging agent, (99m)Tc-etarfolatide ((99m)Tc-EC20), is in development for use as a companion diagnostic with the FR\u03b1-targeted folate conjugate, vintafolide (EC145), to identify patients whose tumors express FR\u03b1."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6aef167c78d69471000023",
                            "question": "Which tool has been developed for GPU-accelerated alignment of bisulfite-treated DNA sequences?"
                        }
                    ],
                    "context": "Arioc: GPU-accelerated alignment of short bisulfite-treated reads.The alignment of bisulfite-treated DNA sequences (BS-seq reads) to a large genome involves a significant computational burden beyond that required to align non-bisulfite-treated reads. In the analysis of BS-seq data, this can present an important performance bottleneck that can be mitigated by appropriate algorithmic and software-engineering improvements. One strategy is to modify the read-alignment algorithms by integrating the logic related to BS-seq alignment, with the goal of making the software implementation amenable to optimizations that lead to higher speed and greater sensitivity than might otherwise be attainable.Results: We evaluated this strategy using Arioc, a short-read aligner that uses GPU (general-purpose graphics processing unit) hardware to accelerate computationally-expensive programming logic. We integrated the BS-seq computational logic into both GPU and CPU code throughout the Arioc implementation. We then carried out a read-by-read comparison of Arioc's reported alignments with the alignments reported by well-known CPU-based BS-seq read aligners. With simulated reads, Arioc's accuracy is equal to or better than the other read aligners we evaluated. With human sequencing reads, Arioc's throughput is at least 10 times faster than existing BS-seq aligners across a wide range of sensitivity settings.Results\nWe evaluated this strategy using Arioc, a short-read aligner that uses GPU (general-purpose graphics processing unit) hardware to accelerate computationally-expensive programming logic.We then carried out a read-by-read comparison of Arioc's reported alignments with the alignments reported by well-known CPU-based BS-seq read aligners."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c646fd3e842deac6700001a",
                            "question": "Which disease is gemtuzumab ozogamicin used for?"
                        }
                    ],
                    "context": "Gemtuzumab ozogamicin (GO) is an anti-CD33 antibody-drug conjugate for the treatment of acute myeloid leukemia (AML). Although GO shows a narrow therapeutic window in early clinical studies, recent reports detailing a modified dosing regimen of GO can be safely combined with induction chemotherapy, and the combination provides significant survival benefits in AML patients."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c61d278e842deac67000005",
                            "question": "Which disease can be classified with the Awaji Criteria?"
                        }
                    ],
                    "context": "Adoption of the Awaji criteria significantly increased the yield of EMG-positive segments in the cervical (P\u2009<\u20090.0005) and lumbosacral (P\u2009<\u20090.0001) regions, and upgraded 19 patients into the probable category and 1 patient into the definite category.The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population.However, previous studies that have assessed the diagnostic sensitivities of the Awaji criteria (AC) and the revised El Escorial criteria (rEEC) in patients with ALS have been inconsistent, most of them were consensual regarding the advantage of Awaji over conventional criteria. Our study sought to compare the roles of AC and rEEC in the diagnosis of ALS.CONCLUSIONS: Our data demonstrated that the AC exhibited greater diagnostic sensitivity than the rEEC in a Chinese ALS population. OBJECTIVE: To assess the added prognostic value of the aggregated clinical and electrodiagnostic data, which define a given diagnostic category according to the Awaji or revised El Escorial criteria at time of diagnosis in patients with amyotrophic lateral sclerosis (ALS)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6473b2e842deac6700001b",
                            "question": "Where does gemtuzumab ozogamicin bind?"
                        }
                    ],
                    "context": "Gemtuzumab ozogamicin is a CD33-targeted antibody-drug conjugate joined to calicheamicin. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5312097e3cb0e231000011",
                            "question": "Where, in what US state, was there a measles outbreak in an Amish community"
                        }
                    ],
                    "context": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio, Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in OhioCONCLUSIONS\nThe key epidemiologic features of a measles outbreak in the Amish community in Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who sought vaccination.Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio pushing the annual cases to the highest national number reported in the last 20 years.Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio, resulting in 368 cases reported."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c65abd17c78d69471000009",
                            "question": "What is the predicted function for TMEM132 family?"
                        }
                    ],
                    "context": "TMEM132: an ancient architecture of cohesin and immunoglobulin domains define a new family of neural adhesion molecules.Here we show the full domain architecture of human TMEM132 family proteins solved using in-depth sequence and structural analysis. We reveal them to be five previously unappreciated cell adhesion molecules whose domain architecture has an early holozoan origin prior to the emergence of choanoflagellates and metazoa. The extra-cellular portions of TMEM132 proteins contain five conserved domains including three tandem immunoglobulin domains, and a cohesin domain homologue, the first such domain found in animals. These findings strongly predict a cellular adhesion function for TMEM132 family, connecting the extracellular medium with the intracellular actin cytoskeleton.These findings strongly predict a cellular adhesion function for TMEM132 family, connecting the extracellular medium with the intracellular actin cytoskeleton.These findings strongly predict a cellular adhesion function for TMEM132 family, connecting the extracellular medium with the intracellular actin cytoskeleton. These findings strongly predict a cellular adhesion function for TMEM132 family, connecting the extracellular medium with the intracellular actin cytoskeleton.<br><b>Contact</b>: luis.sanchez-pulido@igmm.ed.ac.uk.<br><b>Supplementary information</b>: Supplementary data are available at Bioinformatics online.<br>"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c0115e0133db5eb78000029",
                            "question": "What type of topoisomerase inhibitor is gepotidacin?"
                        }
                    ],
                    "context": "Gepotidacin, a novel triazaacenaphthylene antibacterial agent, is the first in a new class of type IIA topoisomerase inhibitors with activity against many biothreat and conventional pathogens, including Neisseria gonorrhoeae"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5f1f371a4c55d80b00001a",
                            "question": "What is the normal function p53?"
                        }
                    ],
                    "context": "The three p53 family members, p53, p63 and p73, are structurally similar and share many biochemical activities. Yet, along with their common fundamental role in protecting genomic fidelity, each has acquired distinct functions related to diverse cell autonomous and non-autonomous processes. The tumor suppressor p53 is a key regulator of apoptosis induced by various cellular stresses.Direct functional restoration of p53 as a transcription factor has been difficult to achieve in the clinic. The tumour suppressor gene TP53 is the most frequently mutated gene in cancer. Wild-type p53 can suppress tumour development by multiple pathways."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5249077e3cb0e23100000b",
                            "question": "What is the 3D tomography imaging technique for diagnosis of  eye disease?"
                        }
                    ],
                    "context": "To compare the effect of elevated intraocular pressure (IOP) on retinal capillary filling in elderly vs adult rats using optical coherence tomography angiography OCT data were captured using an optical microangiography (OMAG) scanning protocol and then post-processed to obtain both structural and vascular images. Optical coherence tomography is used routinely in management of diabetic eye diseaseThe study aims to evaluate the use of optical coherence tomography combined with a fundus camera compared with a fundus camera onlyTo evaluate the ability of new Swept source (SS) optical coherence tomography (OCT) technology to detect changes in retinal and choroidal thickness in patients with Parkinson's disease"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c65897a7c78d69471000006",
                            "question": "Which was the first mutant IDH2 inhibitor to be approved for patients with acute myeloid leukemia?"
                        }
                    ],
                    "context": "Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia.The various findings about enasidenib revealed that it has been designed to allosterically inhibit mutated IDH2 to treat R/R AML patientsEnasidenib or AG-221was introduced by FDA as an anticancer agent which was developed as a first in class, a selective allosteric inhibitor of the tumor target i.e. IDH2 for Relapsed or Refractory AML. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5310c37e3cb0e231000010",
                            "question": "What part of the body is affected by Meniere's disease?"
                        }
                    ],
                    "context": "Steroids have been widely used to treat inner-ear diseases such as sudden sensorineural hearing loss, tinnitus, and Meniere's disease.Meniere's disease is an inner ear disease, M\u00e9ni\u00e8re's Disease (MD) is a chronic, non-life threatening inner ear disease, The utricular duct was blocked in 16 (76%) ears affected by Meniere's disease and 11 (52%) normal ears (p = 0.112).Meniere's disease is (grossly) equally common in each sex, and right and left ears are affected with fairly equal frequency."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c65901c7c78d69471000008",
                            "question": "Which disease is PGT121 used for?"
                        }
                    ],
                    "context": "We investigated adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-1-infected bone marrow-liver-thymus (BLT) humanized mice.In HIV-1-infected BLT humanized mice, Ad5.PGT121 resulted in a greater reduction of viral loads than did AAV1.PGT121. Ad5.PGT121 also led to more-sustained virologic control than purified PGT121 IgG. Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV-1-infected humanized mice. We investigated adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV-1-specific bNAb PGT121. Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV-1-infected humanized mice."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c78080e7c78d694710000ae",
                            "question": "What is the cause of Sandhoff disease?"
                        }
                    ],
                    "context": "Sandhoff disease (SD) is a genetic disorder caused by a mutation of the \u03b2-subunit gene \u03b2-hexosaminidase B (HexB) in humans, which results in the massive accumulation of the ganglioside GM2 and related glycosphingolipids in the nervous system.Sandhoff disease, one of the GM2 gangliosidoses, is a lysosomal storage disorder characterized by the absence of \u03b2-hexosaminidase A and B activity and the concomitant lysosomal accumulation of its substrate, GM2 ganglioside. Sandhoff disease results from the defective activity of \u03b2-hexosaminidase, leading to accumulation of ganglioside GM2.Sandhoff disease (SD) results from mutations in the HEXB gene, subsequent deficiency of N-acetyl-\u03b2-hexosaminidase (Hex) and accumulation of GM2 gangliosides"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c65468ce842deac6700001e",
                            "question": "Name one CCR4 targeted drug."
                        }
                    ],
                    "context": "Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.We evaluated mogamulizumab, a humanized anti-CCR4 monoclonal antibody that targets infected cells, in patients with HAM-TSP."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c51f01e07ef653866000002",
                            "question": "Which algorithm has been developed for finding conserved non-coding elements (CNEs) in genomes?"
                        }
                    ],
                    "context": "CNEFinder: finding conserved non-coding elements in genomes.We fill this gap by presenting CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria. The results presented here show the tool's ability of identifying CNEs accurately and efficiently.CNEFinder: finding conserved non-coding elements in genomes.Free software under the terms of the GNU GPL (https://github.com/lorrainea/CNEFinder).Currently, there are no tools published in the literature for systematically identifying CNEs in genomes.<br><b>Results</b>: We fill this gap by presenting CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria.We fill this gap by presenting CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c531d8f7e3cb0e231000017",
                            "question": "What causes Bathing suit Ichthyosis(BSI)?"
                        }
                    ],
                    "context": "Bathing suit ichthyosis (BSI) is an uncommon phenotype classified as a minor variant of autosomal recessive congenital ichthyosis (ARCI).OBJECTIVES: We report a case of BSI in a 3-year-old Tunisian girl with a novel mutation of the transglutaminase 1 gene (TGM1)Bathing suit ichthyosis is caused by transglutaminase-1 deficiency: evidence for a temperature-sensitive phenotype.Bathing suit ichthyosis (BSI) is a striking and unique clinical form of autosomal recessive congenital ichthyosis characterized by pronounced scaling on the bathing suit areas but sparing of the extremities and the central face. Bathing suit ichthyosis.Bathing suit ichthyosis (BSI) is a rare variant of autosomal recessive lamellar ichthyosis due to transglutaminase-1 (TGase-1) gene mutations leading to a temperature sensitive phenotype. Bathing suit ichthyosis is caused by recessive, temperature-sensitive mutations in the transglutaminase-1 gene (TGM1).Bathing suit ichthyosis (BSI) is a rare variant of autosomal recessive lamellar ichthyosis due to transglutaminase-1 (TGase-1) gene mutations leading to a temperature sensitive phenotype."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5205137e3cb0e231000001",
                            "question": "What type of data does the UK biobank resource contain?"
                        }
                    ],
                    "context": "The UK Biobank resource with deep phenotyping and genomic data.The UK Biobank project is a prospective cohort study with deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom, aged between 40 and 69 at recruitment. The open resource is unique in its size and scope. A rich variety of phenotypic and health-related information is available on each participant, including biological measurements, lifestyle indicators, biomarkers in blood and urine, and imaging of the body and brain. Follow-up information is provided by linking health and medical records. Genome-wide genotype data have been collected on all participants, providing many opportunities for the discovery of new genetic associations and the genetic bases of complex traits.The UK Biobank resource with deep phenotyping and genomic data.The UK Biobank project is a prospective cohort study with deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom, aged between 40 and 69 at recruitment. BACKGROUND\nThe UK Biobank is a unique resource for biomedical research, with extensive phenotypic and genetic data on half a million adults from the general population.BACKGROUND The UK Biobank is a unique resource for biomedical research, with extensive phenotypic and genetic data on half a million adults from the general population."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c7039207c78d69471000065",
                            "question": "Which molecule is targeted by upadacitinib?"
                        }
                    ],
                    "context": "We summarise the development and recent application of Janus kinase (JAK) inhibitors in the treatment of IMIDs, including first-generation pan-JAK inhibitors (tofacitinib, baricitinib, ruxolitinib, peficitinib) and second-generation selective JAK inhibitors (decernotinib, filgotinib, upadacitinib).Upadacitinib is a Janus kinase 1 inhibitor currently being evaluated in phase III rheumatoid arthritis trials.BACKGROUND AND OBJECTIVES: Upadacitinib is a janus kinase (JAK) 1 inhibitor being developed for the treatment of rheumatoid arthritis (RA) and other inflammatory diseases.RESULTS: In randomised controlled trials primary efficacy endpoints were met for tofacitinib (JAK 1/3 inhibitor-phase III), upadacitinib (JAK 1 inhibitor-phase II) and AJM300 (\u03b14-integrin antagonist-phase II) in ulcerative colitis.Upadacitinib is a Janus kinase 1 inhibitor under development for the treatment of several inflammatory disorders including rheumatoid arthritis (RA). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c51f9dd07ef653866000005",
                            "question": "Which random forest method has been developed for detecting Copy Numbers Variants (CNVs)?"
                        }
                    ],
                    "context": "CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.We describe the development and implementation of a bioinformatics algorithm, copy number variation-random forest (CNV-RF), that incorporates a machine learning component to identify CNVs from targeted NGS data."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5f29a81a4c55d80b00001f",
                            "question": "What is the indication for Truvada?"
                        }
                    ],
                    "context": "pre-exposure prophylaxis (PrEP) and the recent approval by the FDA of the supplemental indication for Truvada as PrEP tenofovir disoproxil fumarate 300 mg (TDF)/emtricitabine 200 mg (FTC) (Truvada, Gilead Sciences) as antiretroviral preexposure prophylaxis (PrEP) to reduce the risk for HIV acquisition In January 2011, following publication of evidence of safety and efficacy of daily oral tenofovir disoproxil fumarate 300 mg (TDF)/emtricitabine 200 mg (FTC) (Truvada, Gilead Sciences) as antiretroviral preexposure prophylaxis (PrEP) to reduce the risk for HIV acquisition among MSM in the iPrEx trial, CDC issued interim guidance to make available information and important initial cautions on the use of PrEP in this population. In this commentary, we review literature on sexual behavior change accompanying PrEP use, discuss risk compensation concerns and the &amp;quot;Truvada whore&amp;quot; stereotype as PrEP barriers, question the appropriateness of restricting PrEP access because of risk compensation, and consider sexual pleasure as a benefit of PrEP, an acceptable motive for seeking PrEP, and a core element of health. BACKGROUND\nDaily pre-exposure prophylaxis (PrEP) with Truvada (a combination of emtricitabine (FTC) and tenofovir (TFV) disoproxil fumarate (TDF)) is a novel HIV prevention strategy recently found to prevent HIV transmission in men who have sex with men and heterosexual couples."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5b4a941a4c55d80b000002",
                            "question": "Mutations in which gene have been found in patients with the CLAPO syndrome?"
                        }
                    ],
                    "context": "CLAPO syndrome: identification of somatic activating PIK3CA mutations and delineation of the natural history and phenotype.CLAPO syndrome is a rare vascular disorder characterized by capillary malformation of the lower lip, lymphatic malformation predominant on the face and neck, asymmetry, and partial/generalized overgrowth. Here we tested the hypothesis that, although the genetic cause is not known, the tissue distribution of the clinical manifestations in CLAPO seems to follow a pattern of somatic mosaicism.METHODS: We clinically evaluated a cohort of 13 patients with CLAPO and screened 20 DNA blood/tissue samples from 9 patients using high-throughput, deep sequencing.RESULTS: We identified five activating mutations in the PIK3CA gene in affected tissues from 6 of the 9 patients studied; one of the variants (NM_006218.2:c.248T>C; p.Phe83Ser) has not been previously described in developmental disorders.CONCLUSION\nWe describe for the first time the presence of somatic activating PIK3CA mutations in patients with CLAPO.CONCLUSION We describe for the first time the presence of somatic activating PIK3CA mutations in patients with CLAPO.Here we tested the hypothesis that, although the genetic cause is not known, the tissue distribution of the clinical manifestations in CLAPO seems to follow a pattern of somatic mosaicism.<br><b>METHODS</b>: We clinically evaluated a cohort of 13 patients with CLAPO and screened 20 DNA blood/tissue samples from 9 patients using high-throughput, deep sequencing.<br><b>RESULTS</b>: We identified five activating mutations in the PIK3CA gene in affected tissues from 6 of the 9 patients studied; one of the variants (NM_006218.2:c.248T>C; p.Phe83Ser) has not been previously described in developmental disorders.<br><b>CONCLUSION</b>: We describe for the first time the presence of somatic activating PIK3CA mutations in patients with CLAPO."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6b7fb27c78d6947100002d",
                            "question": "Burosumab is used for treatment of which disease?"
                        }
                    ],
                    "context": "In particular, a humanized monoclonal antibody for FGF23 (burosumab) is a promising treatment in patients with XLH and TIO. In February 2018, the EMA granted subcutaneous burosumab conditional marketing authorization for the treatment of X-linked hypophosphataemia (XLH) with radiographic evidence of bone disease in children one year of age and older and adolescents with growing skeletons. In April 2018, the US FDA approved burosumab for the treatment of XLH in adults and children one year of age and older. CONCLUSIONS: In children with X-linked hypophosphatemia, treatment with burosumab improved renal tubular phosphate reabsorption, serum phosphorus levels, linear growth, and physical function and reduced pain and the severity of rickets.Burosumab-twza (Crysvita) for a rare inherited form of rickets; ibalizumab-uiyk (Trogarzo) for human immunodeficiency virus type 1 infection; and tildrakizumab-asmn (Ilumya) for adults with moderate-to-severe plaque psoriasis.A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c629937e842deac67000008",
                            "question": "What is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?"
                        }
                    ],
                    "context": "Loss-of-function nuclear factor \u03baB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.The genetic cause of primary immunodeficiency disease (PID) carries prognostic information.OBJECTIVE: We conducted a whole-genome sequencing study assessing a large proportion of the NIHR BioResource-Rare Diseases cohort.METHODS: In the predominantly European study population of principally sporadic unrelated PID cases (n\u00a0=\u00a0846), a novel Bayesian method identified nuclear factor \u03baB subunit 1 (NFKB1) as one of the genes most strongly associated with PID, and the association was explained by 16 novel heterozygous truncating, missense, and gene deletion variants.We show that heterozygous loss-of-function variants in NFKB1 are the most common known monogenic cause of CVID, which results in a temporally progressive defect in the formation of immunoglobulin-producing B cells.CONCLUSION\nWe show that heterozygous loss-of-function variants in NFKB1 are the most common known monogenic cause of CVID, which results in a temporally progressive defect in the formation of immunoglobulin-producing B cells.Monoallelic loss-of-function mutations in NFKB1 were recently recognized as the most common monogenic cause of common variable immunodeficiency (CVID)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c7839edd774d04240000003",
                            "question": "When is serum AFP used as marker?"
                        }
                    ],
                    "context": "AFP serum were considered independent predictors for macrovascular invasion in HCC patientsPost-hepatectomy HLs of AFP and DCP are predictors of long-term outcome in patients with HCC.Ovarian Sertoli-Leydig cell tumors (SLCTs) are uncommon neoplasms that are occasionally associated with an elevated level of serum alpha fetoprotein (AFP), a marker of germ cell neoplasms, particularly yolk sac tumor (YST). Serum \u03b1-Fetoprotein (AFP) is a widely used diagnostic biomarker, but it has limited sensitivity and is not elevated in all HCC cases so, we incorporate a second blood-based biomarker, des'\u03b3 carboxy-prothrombin (DCP), that has shown potential as a screening marker for HCC.In addition, AFP, a hepatic stem cell marker, was expressed at the highest level in the control groups."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6e05f37c78d69471000049",
                            "question": "RV3-BB vaccine is used for prevention of which viral infection?"
                        }
                    ],
                    "context": "Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.Serological responses to rotavirus NSP2 occur following wild-type infection; however, it is unknown if serological responses to NSP2 occur following administration of rotavirus vaccines. The phase IIa immunogenicity trial of RV3-BB provided an opportunity to investigate the serological responses to NSP2 following vaccination.Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.BACKGROUND: The RV3-BB human neonatal rotavirus vaccine aims to provide protection from severe rotavirus disease from birth.Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6bec987c78d69471000033",
                            "question": "What is the most common pediatric glioma?"
                        }
                    ],
                    "context": "High-grade gliomas (HGG) are the most common malignant brain tumors in the pediatric population and account for a large subset of all pediatric central nervous system neoplasms. Gliomas are the most common type of brain cancer in the pediatric patients, constituting about 50% of all childhood intracranial tumors.Gliomas are the most common malignant primary brain tumors, of which glioblastoma is the most malignant form (WHO grade IV), and notorious for treatment resistance.Pilocytic astrocytoma (PA) is the most common glioma in pediatric patients and occurs in different locations. Gliomas are the most common primary central nervous system (CNS) neoplasms in children and adolescents and are thought to arise from their glial progenitors or stem cells"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c7aae9dd774d0424000000a",
                            "question": "What is the function of the protein encoded by the gene STING?"
                        }
                    ],
                    "context": "Stimulator of interferon genes (STING) is an adaptor protein that plays an important role in the activation of type I interferons in response to cytosolic nucleic acid ligands. Recent evidence indicates involvement of the STING pathway in the induction of antitumor immune response. STING (stimulator of interferon genes) is a cytosolic sensor for cyclic dinucleotides and also an adaptor molecule for intracellular DNA receptors. The production of cytokines in response to DNA-damage events may be an important host defense response to help prevent the escape of pre-cancerous cells. The innate immune pathways involved in these events are known to be regulated by cellular molecules such as stimulator of interferon genes (STING), which controls type I interferon and pro-inflammatory cytokine production in response to the presence of microbial DNA or cytosolic DNA that has escaped from the nucleus."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6e0f537c78d6947100004a",
                            "question": "Which molecule is inhibited by larotrectinib?"
                        }
                    ],
                    "context": "We evaluated the efficacy and safety of larotrectinib, a highly selective TRK inhibitor, in adults and children who had tumors with these fusions.CONCLUSIONS: Larotrectinib had marked and durable antitumor activity in patients with TRK fusion-positive cancer, regardless of the age of the patient or of the tumor type.Larotrectinib, a highly selective small-molecule inhibitor of the TRK kinases, had shown activity in preclinical models and in adults with tumours harbouring TRK fusions.INTERPRETATION: The TRK inhibitor larotrectinib was well tolerated in paediatric patients and showed encouraging antitumour activity in all patients with TRK fusion-positive tumours.In the 2017 American Society for Clinical Oncology annual meeting, larotrectinib (LOXO-101), Loxooncology's oral, potent, and selective inhibitor of tropomyosin receptor kinases (TRK), demonstrated unprecedented efficacy on unresectable or metastatic solid tumors with neurotrophic tropomyosin receptor kinase (NTRK)-fusion proteins in adult and pediatric patients."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6e16eb7c78d6947100004e",
                            "question": "Sweat Chloride Testing is used  for which disease?"
                        }
                    ],
                    "context": "Screen-positive newborns and patients with high clinical suspicion for CF are always recommended to undergo confirmatory sweat chloride testing with interpretations based on updated reference intervals.BACKGROUND: Sweat chloride testing for diagnosis of cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.CFTR dysfunction can be demonstrated using sweat chloride testing, CFTR molecular genetic analysis, or CFTR physiologic tests.In eighty-three patients (26.4%) CFTR mutational analysis was done without corresponding sweat chloride testing.Herein we report the first characterization of the sweat metabolome from screen-positive CF infants and identify metabolites associated with disease status that complement sweat chloride testing. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c51fb7a07ef653866000006",
                            "question": "Which deep learning algorithm has been developed for variant calling?"
                        }
                    ],
                    "context": "Despite rapid advances in sequencing technologies, accurately calling genetic variants present in an individual genome from billions of short, errorful sequence reads remains challenging. Here we show that a deep convolutional neural network can call genetic variation in aligned next-generation sequencing read data by learning statistical relationships between images of read pileups around putative variant and true genotype calls. The approach, called DeepVariant, outperforms existing state-of-the-art tools. The learned model generalizes across genome builds and mammalian species, allowing nonhuman sequencing projects to benefit from the wealth of human ground-truth data. We further show that DeepVariant can learn to call variants in a variety of sequencing technologies and experimental designs, including deep whole genomes from 10X Genomics and Ion Ampliseq exomes, highlighting the benefits of using more automated and generalizable techniques for variant calling."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c51fe8907ef653866000007",
                            "question": "What is the percentage of individuals at risk of dominant medically actionable disease?"
                        }
                    ],
                    "context": "1 in 38 individuals at risk of a dominant medically actionable disease.Our study shows that 1 in 38 healthy individuals (2.7%) has a (likely) pathogenic variant in one of 59 medically actionable dominant disease genes for which the American College of Medical Genetics and Genomics (ACMG) recommends disclosure.Our study shows that 1 in 38 healthy individuals (2.7%) has a (likely) pathogenic variant in one of 59 medically actionable dominant disease genes for which the American College of Medical Genetics and Genomics (ACMG) recommends disclosure. 1 in 38 individuals at risk of a dominant medically actionable disease.Clinical genomic sequencing can identify pathogenic variants unrelated to the initial clinical question, but of medical relevance to the patients and their families. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6f14297c78d69471000052",
                            "question": "What is the triad of Melkersson-Rosenthal syndrome?"
                        }
                    ],
                    "context": "Melkersson-Rosenthal syndrome (MRS) is a rare syndrome of facial nerve palsy, facial edema, and lingua plicata that can be difficult to treat.BACKGROUND AND OBJECTIVE: Melkersson Rosenthal syndrome (MRS) is a rare disorder of unknown etiology and comprises the triad: orofacial edema, recurrent facial paralysis and lingua plicata. Melkersson Rosenthal syndromes (MRS) is a rare autosomal dominantly inherited neurocutaneous syndrome characterised by a triad of facial (seventh cranial) nerve palsy, recurrent orofacial swelling and fissuring of the tongue. Melkersson-Rosenthal Syndrome (MRS) is a rare disorder consisting of a triad of persistent or recurrent orofacial edema, relapsing facial paralysis and fissured tongue. When it presents in a triad encompassing facial nerve palsy, lip swelling, and fissured or furrowed tongue it is called Melkersson-Rosenthal syndrome while monosymptomatic or oligosymptomatic forms are referred to as granulomatous cheilitis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c71d6d27c78d6947100006a",
                            "question": "Fecal transplantation is used to treat infection with what bacteria?"
                        }
                    ],
                    "context": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile, a common hospital-acquired infectionMini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis Following Total Colectomy.We aimed to assess the asymptomatic Clostridium difficile carriage rates following fecal microbiota transplantationHigh-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria.Fecal microbiota transplantation (FMT) is becoming a more widely used technology for treatment of recurrent Clostridum difficile infection (CDI). Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c0117fd133db5eb7800002a",
                            "question": "When did delafloxacin receive its first approval in the USA for acute bacterial skin and skin structure infections?"
                        }
                    ],
                    "context": "The drug is being investigated or considered as a treatment for various bacterial infections and in June 2017 received approval in the USA for the treatment of acute bacterial skin and skin structure infections. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c71d7ca7c78d6947100006b",
                            "question": "Erenumab, used to treat migraine headaches, binds to what protein?"
                        }
                    ],
                    "context": "Monoclonal antibodies (mAbs) targeting calcitonin gene-related peptide (CGRP) signaling are being explored as prophylactic treatments for migraine. Erenumab (AMG 334) is the first potent, selective, and competitive human mAb antagonist of the CGRP receptor.Monoclonal antibodies (mAbs) targeting the calcitonin-gene-related peptide (CGRP) pathway have been developed for episodic and chronic migraine prevention, either through binding the CGRP ligand (eptinezumab, fremanezumab, galcanezumab) or the CGRP receptor (erenumab).monoclonal antibodies against calcitonin gene-related peptide (eptinezumab, galcanezumab, fremanezumab) and the calcitonin gene-related peptide receptor (erenumab). To date, these monoclonal antibodies have shown promising efficacy in clinical trials, with no major safety concerns. If ongoing long-term studies show that their efficacy can be maintained, this may herald a new era for effective antimigraine therapies.BACKGROUND\nMigraine prevention with erenumab and\u00a0migraine induction by calcitonin gene-related peptide (CGRP) both carry notable individual variance.Background We evaluated the effect of erenumab, a fully human monoclonal antibody that inhibits the canonical calcitonin gene-related peptide receptor, on migraine-related disability, impact, and health-related quality of life among patients with episodic migraine."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c53143b7e3cb0e231000013",
                            "question": "What is a prolactinoma and where in the body would they be found?"
                        }
                    ],
                    "context": "Prolactinomas are pituitary tumors with a very low prevalence in childhood and adolescence compared to adulthoodProlactinomas are the most frequent functioning pituitary adenomas,Prolactinomas are the most common secretory pituitary adenoma.Prolactinoma is the most common type of primary pituitary tumors."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c5b268986df2b9174000019",
                            "question": "Which is the database of somatic mutations in normal cells?"
                        }
                    ],
                    "context": "DSMNC: a database of somatic mutations in normal cells.Luckily, the recent development of single-cell genomics biotechnologies enables the screening and collection of the somatic mutations, especial single nucleotide variations (SNVs), occurring in normal cells. Here, we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues. In the current version, the database collected \u223c0.8 million SNVs accumulated in \u223c600 single normal cells (579 human cells and 39 mouse cells). The database interface supports the user-friendly capability of browsing and searching the SNVs and their annotation information. DSMNC, which serves as a timely and valuable collection of somatic mutations in individual normal cells, has made it possible to analyze the burdens and signatures of somatic mutations in various types of heterogeneous normal cells. Therefore, DSMNC will significantly improve our understanding of the characteristics of somatic mutations in normal cells.Here, we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues. DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin, occur in somatic cells during DNA replication per cell-division. Here, we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c72ade07c78d69471000070",
                            "question": "Which enzyme is inhibited by a drug Lorlatinib?"
                        }
                    ],
                    "context": "PURPOSE OF REVIEW: We describe recent developments in the rapidly evolving field of anaplastic lymphoma kinase-targeting agents.RECENT FINDINGS: Five targeted drugs are currently available in the clinic via regular approval or named patient programs, including crizotinib, ceritinib, alectinib, brigatinib and lorlatinib.IMPORTANCE: The identification of anaplastic lymphoma kinase (ALK) rearrangements in 2-5% of non-small cell lung cancer (NSCLC) patients led to the rapid clinical development of its oral tyrosine kinase inhibitor (TKI). Crizotinib was the first ALK inhibitor approved and utilised in the treatment of ALK+ NSCLC patients in the second line setting first and subsequently in the first line one. Since then many other ALK inhibitors have been developed (ceritinib, alectinib, brigatinib, lorlatinib,etc) and the treatment paradigm of these patients has considerably drifted. The questions regarding their treatment at progression remains unanswered at the moment.RESULTS: ALK T1151Sins mutation was detected when the patient developed resistance to ceritinib, and undetectable when she responded to lorlatinib. ALK G1202R, the most frequent plasma mutation detected after progression on a second-generation TKI, was consistently suppressed during treatment with lorlatinib.Among patients treated with the third-generation ALK TKI lorlatinib, variant 3 was associated with a significantly longer progression-free survival than variant 1 (hazard ratio, 0.31; 95% CI, 0.12 to 0.79; P = .011). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c53191a7e3cb0e231000016",
                            "question": "What periodontal disease associated bacteria is also associated with Alzheimer's disease?"
                        }
                    ],
                    "context": "Among bacteria special attention is focused on spirochetes family and on periodontal pathogens such as Porphyromonas gingivalis or Treponema denticola that could cause chronic periodontitis and possibly contribute to the clinical onset of AD. working hypothesis links extrinsic inflammation as a secondary cause of AD. This hypothesis suggests a compromised oral hygiene leads to a dysbiotic oral microbiome whereby Porphyromonas gingivalis, a keystone periodontal pathogen, with its companion species, orchestrates immune subversion in the host."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c7813f57c78d694710000b0",
                            "question": "How does the Cholera toxin enter a cell?"
                        }
                    ],
                    "context": "Cholera toxin (CT), which is secreted by V. cholerae, can enter host cells by binding to GM1, a monosialoganglioside widely distributed on the plasma membrane surface of various animal epithelial cells. The five B-subunits (CTB5) of the Vibrio cholerae (cholera) toxin can bind to the intestinal cell surface so the entire AB5 toxin can enter the cell. Simultaneous binding can occur on more than one of the monosialotetrahexosylganglioside (GM1) units present on the cell surface. we test the role of glycolipid crosslinking as a raft targeting and ordering mechanism using the well-studied raft marker cholera toxin B pentamer (CTxB) that binds up to five GM1 glycosphingolipids to enter host cells."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c571dd307647bbc4b000016",
                            "question": "What organism causes hepatic capillariasis?"
                        }
                    ],
                    "context": "hepatic capillariasis, caused by the parasite Capillaria hepatica,Capillaria hepatica which accidentally infects humans is a zoonotic parasite of mammalian liver, primarily rodents and causes hepatic capillariasisCapillaria hepatica (C. hepatica) is a parasitic nematode causing hepatic capillariasis in numerous mammalsCapillaria hepatica which accidentally infects humans is a zoonotic parasite of mammalian liver, primarily rodents and causes hepatic capillariasis.One of them is hepatic capillariasis, caused by the parasite Capillaria hepatica, primarily a disease of rodents, with hepatic manifestations in humans."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6b810e7c78d6947100002e",
                            "question": "Cerliponase alfa is apprived for treatment of which disease?"
                        }
                    ],
                    "context": "Study of Intraventricular Cerliponase Alfa for CLN2 Disease.BACKGROUND: Recombinant human tripeptidyl peptidase 1 (cerliponase alfa) is an enzyme-replacement therapy that has been developed to treat neuronal ceroid lipofuscinosis type 2 (CLN2) disease, a rare lysosomal disorder that causes progressive dementia in children.CONCLUSIONS: Intraventricular infusion of cerliponase alfa in patients with CLN2 disease resulted in less decline in motor and language function than that in historical controls. Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study.Treatment with intracerebroventricular (ICV)-delivered cerliponase alfa enzyme replacement therapy (ERT) in a Phase 1/2 study of 24 subjects with CLN2 disease resulted in a meaningful preservation of motor and language (ML) function and was well tolerated. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c73ace87c78d69471000084",
                            "question": "Which molecule is inhibited by ivosidenib?"
                        }
                    ],
                    "context": "Different combinations and new formulations of cytotoxic agents, such as clofarabine or CPX-351, are newer options for specific subsets of patients. Finally, targeted agents inhibiting multiple kinases (rigosertib), BCL2 (venetoclax) or mutant IDH1 (ivosidenib), IDH2 (enasidenib), FLT3 (sorafenib, midostaurin) or spliceosome components (H3B-8800) are other novel options.Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.Here, we report the discovery of AG-120 (ivosidenib), an inhibitor of the IDH1 mutant enzyme that exhibits profound 2-HG lowering in tumor models and the ability to effect differentiation of primary patient AML samples ex vivo.  Ivosidenib (AG-120) is an oral, targeted, small-molecule inhibitor of mutant IDH1.A phase I study suggests that ivosidenib can induce remission in patients with relapsed or refractory acute myeloid leukemia characterized by IDH1 mutations."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c61f767e842deac67000007",
                            "question": "Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?"
                        }
                    ],
                    "context": "Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.To this end, a number of approaches for estimating telomere length from whole-genome sequencing data have been proposed. Here we present Telomerecat, a novel approach to the estimation of telomere length. Previous methods have been dependent on the number of telomeres present in a cell being known, which may be problematic when analysing aneuploid cancer data and non-human samples. Telomerecat is designed to be agnostic to the number of telomeres present, making it suited for the purpose of estimating telomere length in cancer studies. Telomerecat also accounts for interstitial telomeric reads and presents a novel approach to dealing with sequencing errors. We show that Telomerecat performs well at telomere length estimation when compared to leading experimental and computational methods. Furthermore, we show that it detects expected patterns in longitudinal data, repeated measurements, and cross-species comparisons. We also apply the method to a cancer cell data, uncovering an interesting relationship with the underlying telomerase genotype.Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.Telomere length is a risk factor in disease and the dynamics of telomere length are crucial to our understanding of cell replication and vitality. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c72f6b17c78d6947100007f",
                            "question": "Which enzyme is deficient in Wolman disease?"
                        }
                    ],
                    "context": "Wolman's disease, also known as lysosomal acid lipase (LIPA) deficiency, is a rare autosomal-recessive disorder characterized by complete absence of the LIPA enzyme. The diagnosis of Wolman's disease was made postnatally by biochemical testing, which indicated absence of LIPA enzyme activity and gene sequencing, which confirmed homozygosity for the G66V mutation within the LIPA gene.These include Wolman disease (WD) and Cholesteryl Ester Storage Disease (CESD) which both result from mutations in LIPA, the gene that encodes lysosomal acid lipase (LAL).BACKGROUND: Deficiency of lysosomal acid lipase (LAL) causes Wolman disease and cholesterol ester storage disease. BACKGROUND: Lysosomal acid lipase deficiency is an autosomal recessive metabolic disease with a wide range of severity from Wolman Disease to Cholesterol Ester Storage Disease.  In humans, loss-of-function mutations of LIPA cause rare lysosomal disorders, Wolman disease, and cholesteryl ester storage disease, in which LAL enzyme replacement therapy has shown significant benefits in a phase 3 clinical trial. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c89623bf9c2ba6b28000005",
                            "question": "Which cancer is associated with increased levels of Serum alpha fetoprotein (AFP) ?"
                        }
                    ],
                    "context": "In the competing-risk regression, the sum of tumor number and size and of log10 level of AFP were significantly associated with HCC-specific death (P < .001), returning an average c-statistic of 0.780 (95% confidence interval, 0.763-0.798).Ovarian Sertoli-Leydig cell tumors (SLCTs) are uncommon neoplasms that are occasionally associated with an elevated level of serum alpha fetoprotein (AFP), a marker of germ cell neoplasms, particularly yolk sac tumor (YST). Serum \u03b1-Fetoprotein (AFP) is a widely used diagnostic biomarker, but it has limited sensitivity and is not elevated in all HCC cases so, we incorporate a second blood-based biomarker, des'\u03b3 carboxy-prothrombin (DCP), that has shown potential as a screening marker for HCC. Cirrhosis in patients with chronic hepatitis C increases the risk of hepatocellular carcinoma (HCC), and surveillance with ultrasound (US) and alpha-fetoprotein (AFP) is recommended. The combination of enhancement patterns on CEUS and serum tumor markers (AFP and CA19-9) may be a potentially specific diagnostic method to differentiate CHC from HCC and CC."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c8cdfe50101eac870000004",
                            "question": "Which protein is the Mitochondrial carrier homolog 2 (MTCH2) receptor for?"
                        }
                    ],
                    "context": "These results implicate Mtch2 as a mitochondrial target of tBIDMitochondrial Carrier Homolog 2 (MTCH2) acts as a receptor for the BH3 interacting-domain death agonist (BID) in the mitochondrial outer membrane. MTCH2, a proposed receptor for tBIDtBid recruitment to mitochondria, which is facilitated by its receptor MTCH2 at the outer mitochondrial membrane (OMM)Recent studies report mitochondrial carrier homolog 2 (MTCH2) as a novel and uncharacterized protein that acts as a receptor-like protein for the truncated BH3-interacting domain death agonist (tBID) protein in the outer membrane of mitochondria. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c84346b75a4a5d219000001",
                            "question": "What organism causes Rhombencephalitis?"
                        }
                    ],
                    "context": "Rhombencephalitis caused by Listeria monocytogenesListeria rhombencephalitis is caused by infection with Listeria monocytogenes and is associated with a high mortality rate in humans and ruminantsA pastured 2-y-old cross-breed bull developed brainstem encephalitis (rhombencephalitis); Listeria monocytogenes was isolated from the braiListeria monocytogenes is associated with rhombencephalitis.Infection with bacteria of the genus Listeria is the most common cause of rhombencephalitis."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c73acef7c78d69471000088",
                            "question": "Which receptor is targeted by Erenumab?"
                        }
                    ],
                    "context": "Monoclonal antibodies (mAbs) targeting calcitonin gene-related peptide (CGRP) signaling are being explored as prophylactic treatments for migraine. Erenumab (AMG 334) is the first potent, selective, and competitive human mAb antagonist of the CGRP receptor. Erratum: Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab [Corrigendum].PURPOSE OF REVIEW: Monoclonal antibodies (mAbs) targeting the calcitonin-gene-related peptide (CGRP) pathway have been developed for episodic and chronic migraine prevention, either through binding the CGRP ligand (eptinezumab, fremanezumab, galcanezumab) or the CGRP receptor (erenumab). Erenumab, a human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, is being evaluated for migraine prevention.Currently, there is considerable excitement regarding monoclonal antibodies against calcitonin gene-related peptide (eptinezumab, galcanezumab, fremanezumab) and the calcitonin gene-related peptide receptor (erenumab). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c85234775a4a5d219000007",
                            "question": "What antibiotic is currently used as the standard of care for Clostridium Difficile infection as of 2018"
                        }
                    ],
                    "context": " Fidaxomicin has recently been introduced as a new antibiotic that has been shown to significantly reduce the recurrence of this infection.Fidaxomicin is a new antibiotic used to treat Clostridium difficile infection (CDI). Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c8973f3d558e5f232000007",
                            "question": "Which was the first gene therapy to receive marketing authorization in the European Union?"
                        }
                    ],
                    "context": "Alipogene tiparvovec (Glybera\u00ae) is the first gene therapy to receive Marketing Authorization in the European Union; GENIALL (GENetherapy In the MAnagement of Lipoprotein Lipase Deficiency), a 15-year registry focusing on LPLD was launched in 2014 as part of its Risk Management Plan."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c8974bcd558e5f232000008",
                            "question": "Which company produces Glybera?"
                        }
                    ],
                    "context": "Interestingly, the RM development cycle seems to obey the Gartner hype cycle, now at the enlightenment phase, after past exaggerated expectations and discouragements, as suggested by increasing numbers of clinical trials and recent market approvals of RM solutions in both Europe (Glybera and Holoclar\u00ae from Chiesi Pharma and Strimvelis\u00ae from GSK) and Japan (Remestemcel-L from Mesoblast\u00ae)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c73ad077c78d69471000090",
                            "question": "Safinamide is approved for treatment of which disease?"
                        }
                    ],
                    "context": "Safinamide has been recently approved as an add-on to levodopa therapy for Parkinson disease.  These data are consistent with the anticonvulsant and antiparkinsonian actions of safinamide and provide support for the nondopaminergic mechanism of its action.Safinamide: a new hope for Parkinson's disease?The loss of dopaminergic neurons (DAn) and reduced dopamine (DA) production underlies the reasoning behind the gold standard treatment for Parkinson's disease (PD) using levodopa (L-DOPA). Recently licensed by the European Medicine Agency (EMA) and US Food and Drug Administration (FDA), safinamide [a monoamine oxidase B (MOA-B) inhibitor] is an alternative to L-DOPA; as we discuss here, it enhances dopaminergic transmission with decreased secondary effects compared with L-DOPA. Overall, safinamide can be considered to have potential antidyskinetic and neuroprotective effects and future trials and/or studies should be performed to provide further evidence for its potential as an anti-PD drug."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c920fc3ecadf2e73f000011",
                            "question": "What is the tradename of apixaban?"
                        }
                    ],
                    "context": "The direct factor Xa inhibitor apixaban (Eliquis(\u00ae)) has predictable pharmacodynamics and pharmacokinetics and does not require routine anticoagulation monitoring. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6ab4c17c78d6947100001d",
                            "question": "Under which environment does SELANSI run?"
                        }
                    ],
                    "context": "This work presents SELANSI (SEmi-LAgrangian SImulation of GRNs), a software toolbox for the simulation of stochastic multidimensional gene regulatory networks. SELANSI exploits intrinsic structural properties of gene regulatory networks to accurately approximate the corresponding Chemical Master Equation with a partial integral differential equation that is solved by a semi-lagrangian method with high efficiency. Networks under consideration might involve multiple genes with self and cross regulations, in which genes can be regulated by different transcription factors. Moreover, the validity of the method is not restricted to a particular type of kinetics. The tool offers total flexibility regarding network topology, kinetics and parameterization, as well as simulation options.Availability and implementation: SELANSI runs under the MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.Availability and implementation\nSELANSI runs under the MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.The tool offers total flexibility regarding network topology, kinetics and parameterization, as well as simulation options.<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.<br><b>Contact</b>: antonio@iim.csic.es.<br>SELANSI runs under the MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c92871decadf2e73f000016",
                            "question": "What is the name of the Cas13 based diagnostic test for the Zika and dengue viruses?"
                        }
                    ],
                    "context": "In this study, we demonstrate that the Cas13-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) platform can detect Zika virus (ZIKV) and dengue virus (DENV) in patient samples at concentrations as low as 1 copy per microliter."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c920f13ecadf2e73f000010",
                            "question": "What type of drug is apixaban?"
                        }
                    ],
                    "context": "Like other direct oral anticoagulants (DOACs), apixaban has generally predictable pharmacological properties and does not require routine anticoagulation monitoring."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c72b7277c78d69471000073",
                            "question": "What the chromsomal location of the gene that is deleted in Potocki-Shaffer syndrome?"
                        }
                    ],
                    "context": "In Potocki-Shaffer syndrome (PSS), the full phenotypic spectrum is manifested when deletions are at least 2.1\u2009Mb in size at 11p11.2Potocki-Shaffer syndrome (PSS, OMIM #601224) is a rare contiguous gene deletion syndrome caused by haploinsufficiency of genes located on the 11p11.2p12.Potocki-Shaffer syndrome (PSS) is a contiguous gene deletion syndrome that results from haploinsufficiency of at least two genes within the short arm of chromosome 11[del(11)(p11.2p12)]. Construction of a natural panel of 11p11.2 deletions and further delineation of the critical region involved in Potocki-Shaffer syndromePotocki-Shaffer syndrome is a rare contiguous gene deletion syndrome due to haploinsufficiency of the 11p11.2p12 region and is characterized by craniofacial abnormalities, developmental delay, intellectual disability, multiple exostoses, and biparietal foramina."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c7d5ae9d774d04240000010",
                            "question": "Which tissue secretes vaspin?"
                        }
                    ],
                    "context": "Vaspin expression is increased in white adipose tissueVisceral adipose tissue-derived serine protease inhibitor (Vaspin) is an adipocytokine that has been shown to exert anti-inflammatory effects and inhibits apoptosis under diabetic conditions."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c83fd8e617e120c34000004",
                            "question": "Phlorotannin is extracted from what plant?"
                        }
                    ],
                    "context": "Brown algae are rich in polyphenolic compounds, phlorotannins, which have been found to possess high in vitro antioxidant capacity, especially DPPH radical scavenging activity, due to the high number of hydroxyl groups.phlorotannins present in brown seaweedsPhlorotannins, phenolic compounds produced exclusively by seaweedsPhlorotannin is the collective term for polyphenols derived from brown algae belonging to the genera Ascopyllum, Ecklonia, Eisenia, Fucus and Sargassum etc.Here we report that eckmaxol, a phlorotannin extracted from the brown alga Ecklonia maxima, could produce neuroprotective effects in SH-SY5Y cells. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c7d5fcfd774d04240000011",
                            "question": "Where are pannexins localized?"
                        }
                    ],
                    "context": "Pannexins are a family of integral membrane proteins with distinct post-translational modifications, sub-cellular localization and tissue distribution. Pannexins (Panx1, 2, 3) are channel-forming glycoproteins expressed in mammalian tissues.Pannexins (Panx) are proteins with a similar membrane topology to connexins, the integral membrane protein of gap junctions. Panx1 channels are generally of major importance in a large number of system and cellular processes and their function has been thoroughly characterized. In contrast, little is known about channel structure and subcellular distribution.Pannexins (Panxs) are a multifaceted family of ion and metabolite channels that play key roles in a number of physiological and pathophysiological settings. These single membrane large-pore channels exhibit a variety of tissue, cell type, and subcellular distributions. Pannexins (Panx) are proteins homologous to the invertebrate gap junction proteins called innexins (Inx) and are traditionally described as transmembrane channels connecting the intracellular and extracellular compartments. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6acb107c78d6947100001f",
                            "question": "Which tool is used to visualise the junction sites of chloroplast genomes?"
                        }
                    ],
                    "context": "IRscope: an online program to visualize the junction sites of chloroplast genomes.Here, we announce a new visualization tool that is specifically designed for chloroplast genomes. It allows the users to depict the genetic architecture of up to ten chloroplast genomes in the vicinity of the sites connecting the inverted repeats to the short and long single copy regions. The software and its dependent libraries are fully coded in R and the reflected plot is scaled up to realistic size of nucleotide base pairs in the vicinity of the junction sites. We introduce a website for easier use of the program and R source code of the software to be used in case of preferences to be changed and integrated into personal pipelines. The input of the program is an annotation GenBank (.gb) file, the accession or GI number of the sequence or a DOGMA output file. The software was tested using over a 100 embryophyte chloroplast genomes and in all cases a reliable output was obtained.Availability and implementation: Source codes and the online suit available at https://irscope.shinyapps.io/irapp/ or https://github.com/Limpfrog/irscope.IRscope: an online program to visualize the junction sites of chloroplast genomes.Source codes and the online suit available at https://irscope.shinyapps.io/irapp/ or https://github.com/Limpfrog/irscope."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c8fee200101eac87000000f",
                            "question": "What is the difference between CRISPR-Cas12a and CRISPR-Cpf1?"
                        }
                    ],
                    "context": "n the present review, we attempt to highlight most recent advances in CRISPR-Cpf1 (CRISPR-Cas12a) system in particular, considering ground expeditions of the nature and the biology of this system, introducing novel Cpf1 variants that have broadened the versatility and feasibility of CRISPR-Cpf1 system, and lastly the great impact of the CRISPR-Cpf1 system on the manipulation of the genome of prokaryotic, mammalian, and plant models is summarized. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6ad2997c78d69471000020",
                            "question": "Which Python tool has been developed for network-based stratification of tumor mutations?"
                        }
                    ],
                    "context": "pyNBS: a Python implementation for network-based stratification of tumor mutations.We present pyNBS: a modularized Python 2.7 implementation of the network-based stratification (NBS) algorithm for stratifying tumor somatic mutation profiles into molecularly and clinically relevant subtypes.Summary\nWe present pyNBS: a modularized Python 2.7 implementation of the network-based stratification (NBS) algorithm for stratifying tumor somatic mutation profiles into molecularly and clinically relevant subtypes.pyNBS: a Python implementation for network-based stratification of tumor mutations.The package, along with examples and data, can be downloaded and installed from the URL https://github.com/idekerlab/pyNBS.<b>Summary</b>: We present pyNBS: a modularized Python 2.7 implementation of the network-based stratification (NBS) algorithm for stratifying tumor somatic mutation profiles into molecularly and clinically relevant subtypes."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c8fef490101eac870000010",
                            "question": "Through which protein interaction does MLP regulate F-actin dynamics?"
                        }
                    ],
                    "context": "Muscle LIM protein interacts with cofilin 2 and regulates F-actin dynamics in cardiac and skeletal muscle.This interaction has direct implications in actin cytoskeleton dynamics in regulating CFL2-dependent F-actin depolymerization, with maximal depolymerization enhancement at an MLP/CFL2 molecular ratio of 2:1. Deregulation of this interaction by intracellular pH variations, CFL2 phosphorylation, MLP or CFL2 gene mutations, or expression changes, as observed in a range of cardiac and skeletal myopathies, could impair F-actin depolymerization, leading to sarcomere dysfunction and disease."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c8d15cf0101eac870000009",
                            "question": "Where is fatty acid binding protein 2 expressed?"
                        }
                    ],
                    "context": " human intestinal fatty acid binding protein 2 gene (FABP2) The human fatty acid binding protein (FABP2) is involved in intestinal absorption and intracellular trafficking of long-chain fatty acids.The human intestinal fatty acid binding protein 2 (FABP2) mediates fat absorption by binding and intracellular trafficking of long-chain free fatty acids.intestinal epithelial cells [FABP2 (fatty acid binding protein 2),enterocyte markers like villin, zonula occluden (ZO1), fatty acid binding protein 2 (FABP2)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c72f5247c78d6947100007e",
                            "question": "Which gene mutation is associated with Woodhouse Sakati syndrome?"
                        }
                    ],
                    "context": "Phenotypic Variability of c.436delC DCAF17 Gene Mutation in Woodhouse-Sakati Syndrome. CASE REPORT We illustrate the phenotypic variability of 5 patients with WSS due to the previously reported homozygous single nucleotide deletion c.436delC in the DCAF17 gene, identified in 2008.The disease is caused by biallelic pathogenic variants in the DCAF17 gene.Sequence variants in the gene DCAF17, encoding nucleolar substrate receptor, were identified as the underlying cause of inherited WSS.Exome sequencing revealed a novel biallelic deletion in the DCAF17 gene underlying Woodhouse Sakati syndrome."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c73acec7c78d69471000086",
                            "question": "Losigamone can be used for treatment of which disease?"
                        }
                    ],
                    "context": "Losigamone add-on therapy for focal epilepsy.In recent years, many newer AEDs have been investigated as add-on therapy for focal epilepsy; losigamone is one of these drugs and is the focus of this systematic review. For the efficacy outcomes, results did show that participants taking losigamone were significantly more likely to achieve a 50% or greater reduction in seizure frequency (RR 1.76, 95% CI 1.14 to 2.72), but associated with a significant increase of treatment withdrawal when compared with those taking placebo (RR 2.16, 95% CI 1.28 to 3.67). AUTHORS' CONCLUSIONS: The results of this review showed that losigamone did reduce seizure frequency but was associated with more treatment withdrawals when used as an add-on therapy for people with focal epilepsy. Losigamone add-on therapy for partial epilepsy."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c909b6cecadf2e73f000005",
                            "question": "How many pseudokinases are there in the human kinome?"
                        }
                    ],
                    "context": "The human protein kinome comprises 535 proteins that, with the exception of approximately 50 pseudokinases, control intracellular signaling networks by catalyzing the phosphorylation of multiple protein substrates. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c6d65637c78d69471000038",
                            "question": "Which tool has been developed for visualization of non-covalent contacts?"
                        }
                    ],
                    "context": "Visualization and analysis of non-covalent contacts using the Protein Contacts Atlas.Visualizations of biomolecular structures empower us to gain insights into biological functions, generate testable hypotheses, and communicate biological concepts. Typical visualizations (such as ball and stick) primarily depict covalent bonds. In contrast, non-covalent contacts between atoms, which govern normal physiology, pathogenesis, and drug action, are seldom visualized. We present the Protein Contacts Atlas, an interactive resource of non-covalent contacts from over 100,000 PDB crystal structures. We developed multiple representations for visualization and analysis of non-covalent contacts at different scales of organization: atoms, residues, secondary structure, subunits, and entire complexes. The Protein Contacts Atlas enables researchers from different disciplines to investigate diverse questions in the framework of non-covalent contacts, including the interpretation of allostery, disease mutations and polymorphisms, by exploring individual subunits, interfaces, and protein-ligand contacts and by mapping external information.The Protein Contacts Atlas enables researchers from different disciplines to investigate diverse questions in the framework of non-covalent contacts, including the interpretation of allostery, disease mutations and polymorphisms, by exploring individual subunits, interfaces, and protein-ligand contacts and by mapping external information.We present the Protein Contacts Atlas, an interactive resource of non-covalent contacts from over 100,000 PDB crystal structures.Visualization and analysis of non-covalent contacts using the Protein Contacts Atlas.Visualizations of biomolecular structures empower us to gain insights into biological functions, generate testable hypotheses, and communicate biological concepts. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c9158a5ecadf2e73f000008",
                            "question": "Which malignancies is Keytruda approved for before 2017?"
                        }
                    ],
                    "context": "FDA previously approved Keytruda for treatment of several types of malignancies, such as metastatic melanoma, metastatic non-small-cell lung cancer, recurrent or metastatic head and neck cancer, refractory Hodgkin lymphoma, and urothelial carcinoma, all of which carry positive programmed death-1/programmed death-ligand 1 biomarkers."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c915a8becadf2e73f000009",
                            "question": "Which was the first approved tumor treatment using a common biomarker rather than specified tumor locations in the body?"
                        }
                    ],
                    "context": "On May 23, 2017, the US Food and Drug Administration (FDA) approved a treatment for cancer patients with positive microsatellite instability-high (MSI-H) markers or mismatch repair deficient (dMMR) markers. This approach is the first approved tumor treatment using a common biomarker rather than specified tumor locations in the body."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c915ca7ecadf2e73f00000b",
                            "question": "What does Prevnar 13 consist of?"
                        }
                    ],
                    "context": "The 13-valent pneumococcal conjugate vaccine (Prevenar 13(\u00ae), Prevnar 13(\u00ae)) [PCV13] consists of 13 serotype-specific polysaccharides of Streptococcus pneumoniae (pneumococcus), each covalently conjugated to a non-toxic immunogenic carrier protein."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c920df7ecadf2e73f00000f",
                            "question": "What is the route of administration of apixaban?"
                        }
                    ],
                    "context": "Apixaban (Eliquis\u00ae) is an oral, direct factor Xa inhibitor that is available for use in the treatment and secondary prevention of venous thromboembolism (VTE). Like other direct oral anticoagulants (DOACs), apixaban has generally predictable pharmacological properties and does not require routine anticoagulation monitoring. In large phase III trials, oral apixaban was noninferior to subcutaneous enoxaparin sodium overlapped with and followed by oral warfarin (enoxaparin/warfarin) in the treatment of adults with acute VTE over 6\u00a0months with regard to the incidence of recurrent VTE or VTE-related death (AMPLIFY), and was significantly more effective than placebo in the prevention of recurrent VTE or all-cause mortality over 12\u00a0months in patients who had completed 6-12\u00a0months' anticoagulation treatment for VTE (AMPLIFY-EXT). "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c632cc1e842deac6700000f",
                            "question": "What is the cause of a STAG3 truncating variant?"
                        }
                    ],
                    "context": "STAG3 truncating variant as the cause of primary ovarian insufficiency.Primary ovarian insufficiency (POI) is a distressing cause of infertility in young women. POI is heterogeneous with only a few causative genes having been discovered so far. Our objective was to determine the genetic cause of POI in a consanguineous Lebanese family with two affected sisters presenting with primary amenorrhoea and an absence of any pubertal development. Multipoint parametric linkage analysis was performed. Whole-exome sequencing was done on the proband. Linkage analysis identified a locus on chromosome 7 where exome sequencing successfully identified a homozygous two base pair duplication (c.1947_48dupCT), leading to a truncated protein p.(Y650Sfs*22) in the STAG3 gene, confirming it as the cause of POI in this family. Exome sequencing combined with linkage analyses offers a powerful tool to efficiently find novel genetic causes of rare, heterogeneous disorders, even in small single families. This is only the second report of a STAG3 variant; the first STAG3 variant was recently described in a phenotypically similar family with extreme POI. Identification of an additional family highlights the importance of STAG3 in POI pathogenesis and suggests it should be evaluated in families affected with POI.STAG3 truncating variant as the cause of primary ovarian insufficiency.Primary ovarian insufficiency (POI) is a distressing cause of infertility in young women. Two rare loss-of-function variants in the STAG3 gene leading to primary ovarian insufficiency.A homozygous NOBOX truncating variant causes defective transcriptional activation and leads to primary ovarian insufficiency."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c93ea7cecadf2e73f00001d",
                            "question": "What are there sex differences in SAMHD1 activity?"
                        }
                    ],
                    "context": "Sex influences SAMHD1 activity and susceptibility to HIV-1 in primary human macrophages.Investigations into the mechanism governing these sex-dependent differences revealed that the host restriction factor SAMHD1 exists in a hyperphosphorylated, less active state in male-derived macrophages. In addition, the major kinase responsible for SAMHD1 phosphorylation, CDK1, exhibited lower levels of expression in female-derived macrophages in all tested donor pairs. The sex-dependent differences in viral restriction imposed by SAMHD1 were abrogated upon its depletion. We conclude that SAMHD1 is an essential modulator of infectivity in a sex-dependent manner in macrophages, constituting a novel component of sex differences in innate immune control of HIV-1."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c88b8a275a4a5d21900000b",
                            "question": "What is the difference between COG133 and COG112?"
                        }
                    ],
                    "context": "Most notably, fusion of COG133 to a protein transduction domain creates COG112, a modified apoE-mimetic peptide with significantly enhanced anti-inflammatory bioactivities in vitro, and improved therapeutic effects on EAE in vivo, which renders a nearly full remission from the disability."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c890ad575a4a5d21900000d",
                            "question": "Which plant does oleuropein originate from?"
                        }
                    ],
                    "context": "Oleuropein Is Responsible for the Major Anti-Inflammatory Effects of Olive Leaf Extract.Oleuropein is the only OLE component that has shown anti-inflammatory effects at a concentration of 20\u2009\u03bcg/mL.Downregulation of TNF\u03b1 secretion in PMNCs culture in response to OLE treatment indicates that this polyphenol-rich extract has an anti-inflammatory effect, and oleuropein is the major OLE component responsible for this effect. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5ca0bf00ecadf2e73f000045",
                            "question": "Reslizumab is a humanized monoclonal antibody to treat what specific type of asthma?"
                        }
                    ],
                    "context": "Since IL-5 plays an important role in the maturation, survival and migration of eosinophils, hence the pathogenesis of eosinophilic asthma, biotherapeutics targeting IL-5/IL-5R\u03b1 have been developed and/or marketed, including Mepolizumab, Reslizumab, and Benralizumab.Reslizumab, a humanized mAb against IL-5, reduces the number of eosinophils in the blood and lungs. Based on efficacy and safety data from pivotal RCTs, reslizumab had been approved for use as an add-on maintenance treatment of severe asthma with an eosinophilic phenotype in adults who have a history of exacerbations despite receiving their current asthma medicines. Reslizumab in the treatment of severe eosinophilic asthmaReslizumab is a humanized monoclonal (immunoglobulin G4/\u03ba) antibody that binds with high affinity to circulating human IL-5 and downregulates the IL-5 signaling pathway, potentially disrupting the maturation and survival of eosinophils.Reslizumab (Cinqaero\u00ae; Cinqair\u00ae) is a humanized monoclonal antibody against interleukin-5 (IL-5), a cytokine mediator of eosinophilic airway inflammation."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c890e6d75a4a5d21900000f",
                            "question": "What is another name for the plant Sideritis scardica?"
                        }
                    ],
                    "context": "Sideritis scardica Griseb. (ironwort, mountain tea), an endemic plant of the Balkan Peninsula, has been used in traditional medicine in the treatment of gastrointestinal complaints, inflammation, and rheumatic disorders. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c9904eaecadf2e73f00002e",
                            "question": "From where is gamabufotalin (GBT) isolated?"
                        }
                    ],
                    "context": "RCFs of cinobufagin to gamabufotalin, bufotalin, bufalin and resibufogenin were determined as 1.05, 0.895, 1.09 and 0.913, respectively. The characteristic chromatogram and QAMS established in this study could effectively control the quality of toad venom and provide scientific evidence for the improvement of the quality standard of the toad venom to be described in Chinese Pharmacopoeia We identified three bufadienolides-the steroid-like compounds arenobufagin, gamabufotalin, and telocinobufagin-from the boreal toad,In the current study, gamabufotalin (GBT) was isolated from toad venomGamabufotalin, a bufadienolide compound from toad venom"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c9a6693ecadf2e73f000031",
                            "question": "What is a mitosome?"
                        }
                    ],
                    "context": "Mitosomes are the simplest and the least well-studied type of anaerobic mitochondria. The mitosomes have abandoned typical mitochondrial traits such as the mitochondrial genome and aerobic respiration and their single role known to date is the formation of iron-sulfur clustersa mitosome, a relict mitochondrion with a greatly reduced metabolic capability.he highly divergent mitochondrion-related organelle, the mitosome, in the anaerobic/microaerophilic protozoan parasite Entamoeba histolytica based on the potential mitochondrion-targeting signal."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c897082d558e5f232000004",
                            "question": "What is the price of KYMRIAH treatment in 2019?"
                        }
                    ],
                    "context": "At the time of the writing of this article, there are two CAR T cells available, Kymriah, produced by Novrtis with a price tag of US$475,000 and Yescarta produced by Gilead Pharmaceuticals with a price tag of US$373,000, neither price including the required hospital admission in order to administer the agent in addition to potential treatment of side effects. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5cb0856decadf2e73f000058",
                            "question": "Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway"
                        }
                    ],
                    "context": "The flavoenzyme dihydroorotate dehydrogenase (DHODH) catalyzes the fourth reaction of the de novo pyrimidine biosynthetic pathway, which exerts vital functions in the cells, especially within DNA and RNA biosynthesis. Human dihydroorotate dehydrogenase (HsDHODH) is a key enzyme of pyrimidine de novo biosynthesis pathwayDihydroorotate dehydrogenase (DHODH) mediates the fourth step of de novo pyrimidine biosynthesis and is a proven drug target for inducing immunosuppression in therapy of human disease as well as a rapidly emerging drug target for treatment of malaria.This review focuses on recent studies to exploit the fourth enzyme in the de novo pyrimidine biosynthetic pathway of P. falciparum, dihydroorotate dehydrogenase (PfDHODH), as a new target for drug discovery.The flavoenzyme dihydroorotate dehydrogenase catalyzes the stereoselective oxidation of (S)-dihydroorotate to orotate in the fourth of the six conserved enzymatic reactions involved in the de novo pyrimidine biosynthetic pathway."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c896f60d558e5f232000003",
                            "question": "What is the indication for KYMRIAH?"
                        }
                    ],
                    "context": "Two autologous chimeric antigen receptor (CAR) T cell therapies (Kymriah\u2122 and Yescarta\u2122) were recently approved by the FDA. Kymriah\u2122 is for the treatment of pediatric patients and young adults with refractory or relapse (R/R) B cell precursor acute lymphoblastic leukemia and Yescarta\u2122 is for the treatment of adult patients with R/R large B cell lymphoma. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c9e6407ecadf2e73f000034",
                            "question": "Where is the protein protamine 2 expressed?"
                        }
                    ],
                    "context": "This work aimed at investigating the effect of resveratrol on (1) DNA integrity and (2) fertilizing capacity of sperm by quantifying the presence of key paternal transcripts considered as markers for male fertility (protamine 1 [PRM1] and protamine 2 [PRM2]) biomarkers associated with spermatogenesis, including azoospermia-like (DAZL), phosphoglycerate kinase 2 (PGK2), and protamine 2 (PRM2).  Protamines are sperm nuclear proteins with a crucial role in chromatin condensation. Expression of germ cell-specific proteins such as POU5F1, DAZL, TNP1, TNP2, PRM1 and PRM2Human sperm express two types of protamine: protamine 1 (P1) and the family of protamine 2 (P2) proteins,"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c910ae0ecadf2e73f000007",
                            "question": "Which company developed opdivo?"
                        }
                    ],
                    "context": "As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer (Bristol-Myers Squibb) of nivolumab (Opdivo\u00ae) to submit evidence of its clinical and cost effectiveness for metastatic or unresectable urothelial cancer."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c9efde8ecadf2e73f000039",
                            "question": "What is the cause of Krabbe disease?"
                        }
                    ],
                    "context": "Krabbe disease (KD) is a rare disease caused by the deficiency of \u03b2-galactocerebrosidase. Globoid cell leukodystrophy (GLD), or Krabbe disease, is an inherited, neurologic disorder that results from deficiency of a lysosomal enzyme, galactosylceramidase.Krabbe disease is a rare neurodegenerative genetic disorder caused by deficiency of galactocerebrosidase. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c89623bf9c2ba6b28000004",
                            "question": "Name a CFL2 mutation which is associated with nemaline myopathy?"
                        }
                    ],
                    "context": "Because a mutation in CFL2 was identified in a family with nemaline myopathy, we performed sequence analysis of the gene and a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met) of CFL2 was identified in both siblings. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c9789a9ecadf2e73f000024",
                            "question": "What cellular process is the gene product of NANOG involved in?"
                        }
                    ],
                    "context": "The objective of this study was to explore the prognostic value of cancer stem cell markers, namely CD133, NANOG, and NOTCH1, in early stage oral squamous cell carcinoma (OSCC) transcription factors (TFs) such as Oct4, Sox2, and Nanogexpression of breast CSCs markers (CD44, ALDH1A1, Nanog, and Oct4),pluripotency markers OCT-4, SOX-2 and NANOG The obtained induced pluripotent stem cell (iPSC) line showed pluripotency verified by the expression of pluripotency markers, NANOG, SOX2, OCT4,"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c9791d2ecadf2e73f000026",
                            "question": "Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?"
                        }
                    ],
                    "context": "Cat fleas (Ctenocephalides felis) carrying Rickettsia felis and Bartonella species in Hong Kong. Morphological examination of 174 fleas from dogs and cats living in Hong Kong revealed only cat fleas (Ctenocephalides felis).The main arthropod reservoir and vector is the cat flea, Ctenocephalides felis, yet more than 20 other species of fleas, ticks, and mites species have been reported to harbour R. felis.The cat flea, Ctenocephalides felis, is currently the only known biological vector of R. felis; however, molecular evidence of R. felis in other species of fleas as well as in ticks and mites suggests a variety of arthropod hosts.Rickettsia felis: from a rare disease in the USA to a common cause of fever in sub-Saharan Africa.Rickettsia felis is a spotted fever group rickettsia that has been definitely described in 2002. Within the last 20 years, there have been a growing number of reports implicating R. felis as a human pathogen, parallel to the fast-growing reports of the worldwide detection of R. felis in arthropod hosts, mainly the cat flea Ctenocephalides felis felis. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c897167d558e5f232000005",
                            "question": "What does the strimvelis treatment consist of?"
                        }
                    ],
                    "context": "Strimvelis (autologous CD34+ cells transduced to express adenosine deaminase [ADA]) is the first ex vivo stem cell gene therapy approved by the European Medicines Agency (EMA), indicated as a single treatment for patients with ADA-severe combined immunodeficiency (ADA-SCID) who lack a suitable matched related bone marrow donor. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5cb0e4a6ecadf2e73f00005b",
                            "question": "What is predicted using SURFY?"
                        }
                    ],
                    "context": "o enable analysis of the human surfaceome, we developed the surfaceome predictor SURFY, based on machine learning."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c897555d558e5f232000009",
                            "question": "Which was the first adeno-associated virus vector gene therapy product approved in the United States?"
                        }
                    ],
                    "context": "Gene therapy utilizing viral vectors has experienced recent success, culminating in U.S. Food and Drug Administration approval of the first adeno-associated virus vector gene therapy product in the United States: Luxturna for inherited retinal dystrophy."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c89773ed558e5f23200000a",
                            "question": "Which gene therapy treatment is FDA approved for retinal dystrophy?"
                        }
                    ],
                    "context": "Gene therapy utilizing viral vectors has experienced recent success, culminating in U.S. Food and Drug Administration approval of the first adeno-associated virus vector gene therapy product in the United States: Luxturna for inherited retinal dystrophy. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c9fb428ecadf2e73f000041",
                            "question": "Salivary Cortisol is a biomarker for what disease/syndrome/condition?"
                        }
                    ],
                    "context": "Salivary cortisone, as a biomarker for psychosocial stress, is associated with state anxiety and heart rate.ortisol as a stress biomarkerThe salivary cortisol level reflects psychological stress, and it is a good index to assess chronic stress.SUMMARY\nSalivary cortisol and cortisone can be used to assess cortisol excess, deficiency and hydrocortisone replacement, with salivary cortisone having the advantage of detection when serum cortisol levels are low and there is no interference from oral hydrocortisone.Salivary cortisone is a superior marker of serum cortisol compared with salivary cortisol, specifically when serum cortisol is low and during hydrocortisone therapy when contamination of saliva may result in misleading salivary cortisol concentrations."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c8fe7cb0101eac87000000c",
                            "question": "What does RUNX2 stand for?"
                        }
                    ],
                    "context": "Runt related factor-2 (Runx2)"
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c9ff25eecadf2e73f000043",
                            "question": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?"
                        }
                    ],
                    "context": "The Cobb-Stainsby forefoot arthroplasty combines partial phalangectomy (Stainsby) with extensor tendon transfer to the metatarsal head (Cobb). The Cobb-Stainsby forefoot arthroplasty combines partial phalangectomy (Stainsby) with extensor tendon transfer to the metatarsal head (Cobb).The Cobb-Stainsby forefoot arthroplasty combines partial phalangectomy (Stainsby) with extensor tendon transfer to the metatarsal head (Cobb).The Cobb-Stainsby forefoot arthroplasty combines partial phalangectomy (Stainsby) with extensor tendon transfer to the metatarsal head (Cobb)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c900b9eecadf2e73f000004",
                            "question": "Which company produces patisiran?"
                        }
                    ],
                    "context": "Patisiran has been developed by Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hATTR) in adults and subsequently approved in the EU for the treatment of hATTR in adults with stage 1 or 2 polyneuropathy."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5caa0247ecadf2e73f000055",
                            "question": "What protein is recruited by Crumbs to regulate tracheal development?"
                        }
                    ],
                    "context": "We propose that early endocytosis maintains normal steady-state levels of Crumbs, which recruits apical phosphorylated (active) Moe, which in turn regulates seamless tube shapeThere, Crb, acting in parallel with the epidermal growth factor receptor (Egfr) pathway, is required for tracheal cell apical constriction and for organising an actomyosin complex, which we propose is mediated by Crb recruitment of moesin (Moe)."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5caa06d0ecadf2e73f000056",
                            "question": "Where in the body, is ghrelin secreted?"
                        }
                    ],
                    "context": "Ghrelin, an orexigenic peptide, is secreted from endocrine cells in the gastric mucosa.Ghrelin is a recently described hormone secreted by the stomach.BACKGROUND\nGhrelin is secreted mainly in the stomach and plays a role in food intake regulation.BACKGROUND\nGhrelin is a body weight-regulating peptide produced and secreted primarily by the gastric mucosa.These results suggest that (1) endogenous centrally released ghrelin participates in the regulation of food intake and body weight, (2) acyl ghrelin is secreted from the stomach, (3) intestinal hormones stimulate ghrelin release from the stomach, and (4) regulation of the diurnal rhythm of ghrelin is complex, since ghrelin secretion is augmented under conditions of both gastric emptying and filling."
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5c93e8bdecadf2e73f00001c",
                            "question": "Which syndrome is associated to SAMHD1 gene mutations?"
                        }
                    ],
                    "context": "Its emerging role as an effector of innate immunity is affirmed by mutations in the SAMHD1 gene that cause the severe autoimmune disease, Aicardi-Goutieres syndrome (AGS) and that are linked to cancer. "
                }
            ]
        },
        {
            "paragraphs": [
                {
                    "qas": [
                        {
                            "id": "5cb39707ecadf2e73f000060",
                            "question": "What is the results of mutations in the gene autoimmune regulator?"
                        }
                    ],
                    "context": "a rare inherited disorder called autoimmune polyendocriopathy candidiasis ectodermal dystrophy (APECED) caused by mutations in autoimmune regulator (AIRE) gene.The crucial role played by AIRE in central immune tolerance emerged in the studies on the pathogenesis of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy, a rare inherited polyendocrine/autoimmune disease. Autoimmune polyendocrine syndrome type 1 (APS-1; OMIM #240300), also referred to as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), is a rare monogenic autoimmune disorder caused by mutations in the autoimmune regulator (AIRE) gene. Autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a primary immunodeficiency caused by mutations in the autoimmune regulator gene (AIRE)"
                }
            ]
        }
    ]
}